data_2pq4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pq4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.222 0.534 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 HG13 ' A' ' 49' ' ' VAL . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.48 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.519 ' CD1' HD23 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 61' ' ' GLN . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 64' ' ' GLU . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.51 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.237 0.541 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.465 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 11' ' ' ALA . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.459 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.307 0.575 . . . . 72.52 110.327 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 70.04 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 62.24 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 72.11 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 70.42 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 75.44 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.22 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.34 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 75.52 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 74.35 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.44 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.43 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.3 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.41 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 75.53 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 74.2 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.32 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.3 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.45 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.45 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.23 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.52 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 74.3 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.54 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 74.3 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 75.22 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 61.53 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.04 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 71.21 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 50' ' ' VAL . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.41 110.106 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 73.35 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 74.22 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.24 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 71.41 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.43 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 73.43 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.04 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 75.33 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 75.31 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.05 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 75.24 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.13 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 72.14 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.519 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 63.24 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 65.23 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 71.24 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 73.02 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 65.24 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.24 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.526 ' CG2' ' HB2' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 72.22 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.41 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 61' ' ' GLN . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.15 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.516 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 75.34 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.34 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 64' ' ' GLU . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 74.12 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.22 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.14 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 75.21 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.563 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 73.32 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 73.45 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 74.35 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 73.4 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.23 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.527 HG21 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.41 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' HG2' ' A' ' 16' ' ' GLN . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 73.54 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 74.11 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.21 110.229 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 71.12 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.52 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 74.33 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 70.1 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 71.3 110.163 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.303 0.573 . . . . 65.34 110.143 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 75.42 110.206 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 15' ' ' ALA . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.21 110.205 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.43 110.219 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 74.4 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.45 110.109 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 74.31 110.19 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 73.31 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 72.32 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 71.31 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.22 110.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 72.12 110.22 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 72.41 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.501 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 74.22 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.32 0.581 . . . . 71.43 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 75.4 110.23 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 63.14 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.449 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 71.32 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.43 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 76' ' ' SER . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.04 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.13 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.43 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.33 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.54 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.22 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.14 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 72.12 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.41 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.44 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.53 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 75.31 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 74.14 109.848 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.33 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.15 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.15 110.281 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.35 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.21 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.05 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.34 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 74.21 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.24 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 75.23 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.44 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.34 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.23 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.43 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 70.54 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 75.4 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 72.34 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 71.2 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' B' ' 17' ' ' ALA . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.24 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.445 ' O ' ' CG1' ' A' ' 49' ' ' VAL . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.44 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.449 HG12 ' CB ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.31 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 74.12 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.33 110.222 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 71.55 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.24 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.32 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 55.41 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.43 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.42 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.51 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.55 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 74.11 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 64' ' ' GLU . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 74.31 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 75.24 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 73.43 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.42 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.41 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 75.33 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.42 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.43 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 HG23 HG11 ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.02 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 74.43 110.111 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 73.33 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.41 110.313 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 72.24 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 74.21 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 75.11 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 74.43 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.3 110.132 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.452 ' HG2' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.262 0.553 . . . . 61.11 110.082 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 73.5 110.205 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 73.43 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.44 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.459 HG21 ' O ' ' B' ' 11' ' ' ALA . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 64.21 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 74.54 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 73.03 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.51 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.42 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.24 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 72.31 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.12 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.33 110.185 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 74.01 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.302 0.572 . . . . 75.14 110.146 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG22 ' N ' ' A' ' 11' ' ' CYS . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 72.03 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 10' ' ' VAL . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 73.43 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.33 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 ' CD1' HG11 ' A' ' 51' ' ' VAL . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 74.24 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG1' ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.41 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.11 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 71.32 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.43 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 75.1 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 72.12 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 73.14 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.53 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 73.24 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.15 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.492 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 71.11 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.33 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 64.45 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 73.34 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.22 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.52 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 62.25 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.43 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 74.21 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.22 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 74.03 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.31 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.3 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 73.11 110.194 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.54 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.01 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.42 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.45 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 74.45 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 65.13 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.33 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 47' ' ' LEU . 2.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.35 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 74.4 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 48' ' ' ILE . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.51 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.33 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 70.11 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 71.53 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.2 110.26 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.521 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.33 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.21 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.2 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 73.14 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.433 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 64.21 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 73.15 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 70.45 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 61' ' ' GLN . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 74.41 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.52 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.4 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 72.32 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 71.51 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.23 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 71.02 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.54 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.43 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.01 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.02 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 70.22 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG22 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 74.3 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 74.22 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 73.31 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 73.23 110.305 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 72.21 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.31 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.32 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.2 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.32 110.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.211 0.529 . . . . 75.21 110.141 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.453 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.12 110.069 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.24 110.194 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' B' ' 11' ' ' ALA . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.52 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 74.14 110.131 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 75.01 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.21 110.158 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 73.05 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 75.44 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.02 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.04 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 64.25 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.454 HD12 ' CG1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.11 110.301 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.426 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.6 mt-30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.373 0.606 . . . . 74.42 110.109 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 74.34 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 72.21 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 79' ' ' TYR . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 72.5 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 73.3 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 65.35 110.11 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.23 110.263 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.32 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.05 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.42 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 70.45 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.42 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 73.44 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 72.23 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.05 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.503 ' CG1' ' N ' ' A' ' 26' ' ' SER . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.44 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 73.21 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 64.11 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 72.24 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.23 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 13.3 t-20 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.43 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 74.42 110.276 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.41 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 73.14 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.11 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' HG23 ' A' ' 49' ' ' VAL . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.24 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.43 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.03 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.53 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.54 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.15 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 74.11 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.448 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.04 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.42 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 73.13 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 64.53 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CD1' HD23 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.12 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 49' ' ' VAL . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.43 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.32 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.457 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.13 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 73.21 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.34 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 63.02 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.13 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.34 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.12 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 75.12 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.508 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 75.21 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 61' ' ' GLN . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 73.55 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.33 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.51 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 75.15 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 71.4 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.53 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.43 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.12 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.11 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 71.2 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.44 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 44.22 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.45 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 72.23 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.43 110.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.01 110.183 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 72.12 110.204 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.506 ' CB ' HD21 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 75.21 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 73.02 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 74.51 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.24 110.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.478 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.264 0.554 . . . . 73.53 110.132 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.13 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 73.45 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 75.23 110.192 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 71.34 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 75.12 110.061 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 73.24 110.091 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.21 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 75.53 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 73.53 110.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.21 110.227 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 74.3 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.493 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 75.44 110.322 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.237 0.542 . . . . 73.23 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.417 HG21 ' N ' ' A' ' 11' ' ' CYS . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.43 110.24 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.35 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 79' ' ' TYR . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.23 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.32 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 63.03 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 49' ' ' VAL . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.42 110.303 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 74.11 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.4 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.42 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 65.41 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.01 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 75.41 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.52 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.12 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 73.04 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.4 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.31 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.41 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 65.44 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.52 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.53 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.42 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.21 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 75.44 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.41 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.3 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 71.2 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 30' ' ' ASN . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 75.21 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 74.35 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.54 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.21 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.45 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.44 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 73.41 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.21 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.31 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 75.21 110.385 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 73.03 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.53 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.12 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.44 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 71.21 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.22 110.137 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.23 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.03 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 75.22 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 70.53 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 72.4 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 74.12 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 75.03 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 75.01 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.498 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 72.42 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.45 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 64' ' ' GLU . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.42 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 74.05 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 71.5 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 75.22 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.591 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 72.12 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.03 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.24 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.34 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 71.43 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.02 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 75.15 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.21 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 74.12 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.24 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.32 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 74.42 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 74.21 110.168 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.252 0.548 . . . . 75.31 110.151 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.461 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 74.13 110.07 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 74.5 110.136 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.461 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.04 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.05 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.51 109.934 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 20' ' ' ALA . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 74.31 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 52.14 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 64.42 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.44 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' B' ' 16' ' ' ALA . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.23 110.186 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 73.43 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 60.12 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.53 110.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.31 0.576 . . . . 70.33 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.03 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.55 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.52 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.12 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 63.21 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 75.05 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 63.21 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.42 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 74.15 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 73.55 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.43 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.34 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.45 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 73.33 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.464 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 75.14 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.44 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.41 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.04 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 75.22 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.437 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 75.23 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 63.23 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.22 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 73.3 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.04 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.41 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.33 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 30' ' ' ASN . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 75.02 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.43 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 75.44 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 75.03 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.53 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 72.44 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.22 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.51 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 74.54 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.426 ' C ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.11 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 72.24 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 HD22 ' B' ' 23' ' ' LEU . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 72.33 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.42 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.43 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 73.54 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.54 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 74.44 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 74.11 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.33 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.32 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.32 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.34 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 61.13 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 75.42 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.24 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.432 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 73.4 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 75.24 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 75.52 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.45 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.1 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 75.41 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.12 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 75.25 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.32 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 74.24 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 72.31 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.428 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 72.44 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.31 110.206 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.14 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 75.15 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 16' ' ' ALA . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.54 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.55 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 75.42 110.109 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.443 ' O ' HG12 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.227 0.537 . . . . 74.23 109.953 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.454 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.32 109.934 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.34 110.102 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 73.23 110.246 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 11' ' ' ALA . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.33 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.31 109.989 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 75.24 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.404 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 73.23 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.13 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.03 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 74.14 110.107 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 23' ' ' LEU . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 62.13 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 75.22 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 72.23 110.359 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.184 0.516 . . . . 74.15 110.308 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.43 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.53 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 75.42 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 73.13 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 73.14 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 65.55 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.44 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.43 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 75.03 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 75.25 110.964 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.2 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 75.11 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.34 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.41 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 73.24 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.507 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.01 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 75.24 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 73.23 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.51 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 72.21 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.438 ' HB2' HG21 ' A' ' 37' ' ' VAL . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.04 110.217 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.44 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 74.4 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.33 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.53 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 74.12 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 30' ' ' ASN . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 74.11 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 75.12 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 74.21 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.11 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.01 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 74.55 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 63.12 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.44 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.44 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' O ' HD21 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.24 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 75.53 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CG1' HD12 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 70.14 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 29' ' ' LEU . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 75.33 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.485 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.11 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.31 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 54.11 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 63.4 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 74.54 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.22 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.34 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.05 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.34 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.4 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 74.1 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 64.22 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 63.31 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.23 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.34 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 74.41 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.528 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 73.2 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.43 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 65' ' ' SER . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.35 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.34 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.34 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 72.11 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.441 HD23 ' CA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 75.15 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 75.13 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 63.33 110.289 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 73.44 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 72.2 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 74.45 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.53 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 71.3 110.162 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.167 0.508 . . . . 54.22 110.047 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.45 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.53 110.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.558 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 73.11 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 11' ' ' ALA . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 74.42 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.23 110.225 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.3 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.453 ' O ' ' HB1' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.31 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.51 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 65.51 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.52 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.03 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.4 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.508 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 75.32 110.32 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 74.13 110.118 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 71.43 110.231 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.505 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 71.13 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.498 ' CA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 71.14 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 76' ' ' SER . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 72.02 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 66' ' ' VAL . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.11 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 72.02 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 74.12 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 74.45 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.44 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 73.21 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.34 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 75.31 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.14 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 74.35 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 74.24 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.12 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.33 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 72.53 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.33 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.04 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.13 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.44 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 74.01 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 49' ' ' VAL . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.45 110.211 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 74.21 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 54.33 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 73.4 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.22 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.1 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.42 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 72.02 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 61.03 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 72.32 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 74.42 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.15 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 64.34 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' CA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 74.42 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.32 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 70.14 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.24 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.42 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.55 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.2 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.31 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 75.2 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 73.44 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 61' ' ' GLN . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.43 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.2 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 72.44 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 74.11 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.13 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 71.33 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 73.43 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 73.44 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 75.54 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 71.15 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.24 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.13 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.516 HG22 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 75.41 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 75.14 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 75.13 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.22 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.35 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.51 ' CB ' HD22 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.35 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.33 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.33 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.42 110.098 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.275 0.56 . . . . 72.5 110.076 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 54.44 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.23 110.183 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.13 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 11' ' ' ALA . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.12 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 74.5 110.108 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 74.11 110.172 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.15 110.172 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.33 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 61.42 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 64.23 110.13 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 74.2 110.234 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.45 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.406 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.51 110.296 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.075 0.464 . . . . 73.22 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 71.12 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 75.13 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 54.44 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.23 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 76' ' ' SER . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 64.22 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.41 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 73.43 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.3 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.14 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.01 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 75.13 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.32 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 74.03 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 71.31 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.508 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.15 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.22 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.11 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 73.43 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.14 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 73.41 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 65.24 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.53 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.13 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.41 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.04 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HA ' HG23 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.02 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.42 110.047 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.22 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.31 110.201 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 73.24 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.23 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.22 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.05 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 53.11 109.755 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.426 ' C ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.3 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.21 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.02 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 73.05 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.03 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.14 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.52 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.24 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.24 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.45 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.43 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.34 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 73.35 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD11 ' HB1' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 75.44 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 61' ' ' GLN . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 73.52 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 75.01 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 74.54 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.42 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.53 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 73.11 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 72.0 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.22 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.24 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.22 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.45 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.42 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 75.14 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 75.2 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.419 ' C ' ' HB3' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.22 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 75' ' ' VAL . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 74.34 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.22 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.43 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 73.02 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.45 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.12 110.131 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.438 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 64.22 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.15 110.08 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.1 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.464 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.13 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 11' ' ' ALA . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.32 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 73.22 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.2 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 72.2 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.12 110.188 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 75.13 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.41 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 71.42 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 63.31 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 74.44 110.245 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.241 0.543 . . . . 74.31 110.346 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 74.04 110.13 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.44 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.543 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.14 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.526 ' CD1' HG12 ' A' ' 51' ' ' VAL . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.1 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' ILE . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.22 109.88 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 72.44 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.21 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.32 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.54 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.41 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.41 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.52 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.43 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.44 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.11 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.497 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.32 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.44 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.44 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.32 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 73.05 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.31 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 65.01 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.53 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 73.55 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 65.03 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' CG2' ' A' ' 49' ' ' VAL . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 71.43 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.31 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.13 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HB2' HG11 ' A' ' 50' ' ' VAL . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.15 110.182 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.15 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 74.21 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.11 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.13 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 72.43 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 71.31 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.53 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.46 ' O ' HD21 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 75.4 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.32 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.21 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.3 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 13' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 74.13 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.12 110.189 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 74.42 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.44 110.238 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.34 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 75.53 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.44 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 72.12 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.22 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 61' ' ' GLN . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.33 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 74.25 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 63.54 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 74.52 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 74.24 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.55 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.553 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 75.13 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 74.41 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.44 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 74.1 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 60.12 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.41 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.33 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 72.11 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 64.33 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 72.23 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD1' HD22 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.43 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.33 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.32 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.42 110.147 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.325 0.583 . . . . 74.51 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 74.32 110.101 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.31 110.05 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 74.23 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.22 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 72.51 110.047 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.32 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.55 110.077 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.34 110.061 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 71.24 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 54.13 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.22 110.183 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 72.42 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.414 ' HG ' ' OE1' ' A' ' 46' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 73.41 110.215 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.251 0.548 . . . . 75.21 109.995 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 74.51 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.42 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.561 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.34 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 73.41 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' B' ' 17' ' ' ALA . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.01 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.506 ' CG2' HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 74.13 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 73.32 110.046 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.4 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.42 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.14 110.986 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.22 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.52 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.41 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 75.32 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.04 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.489 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 75.13 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 65.01 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 72.05 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 73.42 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 74.03 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 64.03 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 63.52 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.13 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 74.4 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.23 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.33 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 70.22 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 75.01 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.13 110.231 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG12 ' A' ' 48' ' ' ILE . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.12 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 74.41 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' C ' ' CD ' ' A' ' 43' ' ' PRO . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 75.55 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.21 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.5 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.15 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 73.05 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.31 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.31 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.524 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 75.54 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.512 ' CD1' HD13 ' B' ' 23' ' ' LEU . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 74.12 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 75.43 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 64.23 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 72.31 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 72.0 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.32 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.42 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 74.11 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 71.43 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 74.03 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 74.34 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.24 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.442 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.12 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.43 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 64' ' ' GLU . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.1 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 75.04 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 62.33 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 67' ' ' ARG . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 74.45 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.21 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.04 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 74.43 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 73.54 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 35.42 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.465 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 75.14 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 72.23 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 63.42 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 73.41 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 74.31 110.042 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.34 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.12 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 74.14 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 74.5 110.237 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.441 ' O ' HG12 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.182 0.515 . . . . 71.31 110.152 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.448 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 73.33 110.084 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 65.01 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.14 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.448 HG22 ' O ' ' B' ' 11' ' ' ALA . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 74.44 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 70.33 110.1 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 75.33 110.197 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 14' ' ' VAL . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.41 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 72.12 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.14 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 72.32 110.096 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.41 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.4 110.461 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.235 0.541 . . . . 74.0 110.196 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 75.31 110.233 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 64.23 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.538 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.13 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.44 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 76' ' ' SER . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 74.4 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 75.31 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 74.41 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.41 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 73.12 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.13 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.42 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.536 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.2 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.32 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.31 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 74.35 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.468 HD11 HG12 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 75.4 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 74.4 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.52 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.3 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 74.34 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.462 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.41 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 70.14 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.51 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 74.23 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.3 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 64.54 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 55.45 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.54 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.33 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.03 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 74.14 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.44 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 74.35 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.55 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.23 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 62.35 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.556 ' CG ' ' CD1' ' B' ' 23' ' ' LEU . 6.9 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 65.42 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.45 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CD1' ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 75.12 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 71.14 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.482 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 72.4 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 73.45 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.32 110.256 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.512 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.01 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.34 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 73.33 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 53.42 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.02 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.512 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.52 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 72.33 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 71.44 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 72.55 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 74.31 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 72.32 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 71.23 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.55 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 74.23 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.45 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 71.33 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.3 110.624 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 63.13 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 70.33 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.24 110.198 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 74.32 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 77' ' ' LEU . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 73.31 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 74.41 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 74.42 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 65.23 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 73.23 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.02 110.265 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 74.34 109.998 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.43 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.22 110.072 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.1 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 11' ' ' ALA . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.23 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.32 110.006 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 70.11 110.1 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.33 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 70.03 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 74.45 110.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 64.35 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 75.5 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 46' ' ' GLN . 3.9 tp . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 75.53 110.396 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.429 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.252 0.548 . . . . 75.44 110.181 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' A' ' 52' ' ' GLU . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.14 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.42 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.55 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.41 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 74.41 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' B' ' 23' ' ' LEU . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.22 109.933 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 73.43 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.492 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.54 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.43 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 74.2 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.42 110.863 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.11 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 75.15 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.11 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.51 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 74.22 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 74.53 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.31 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 74.43 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.51 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 73.41 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 t-20 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.2 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 63.31 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 73.45 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.35 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 73.1 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' CG2' ' A' ' 49' ' ' VAL . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 75.43 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.11 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.3 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 75.11 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.23 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.2 110.36 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.509 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.43 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.42 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.463 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 74.52 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 74.41 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.463 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.24 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' CB ' ' B' ' 17' ' ' ALA . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.34 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 73.11 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.509 HG13 ' CB ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 75.41 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.4 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 72.3 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 70.14 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 63.22 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.42 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.52 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.475 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.51 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.579 ' CG2' ' CB ' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.34 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 74.11 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 61' ' ' GLN . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 73.12 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.03 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.24 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.493 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 74.14 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.2 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 71.11 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.14 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.35 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.42 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.12 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.44 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 74.12 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 75.15 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.22 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 62.21 110.334 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 14' ' ' VAL . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 62.11 109.833 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 72.12 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 72.24 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.31 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' NE2' ' NE2' ' A' ' 9' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.4 110.147 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.464 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.306 0.574 . . . . 75.13 110.036 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.448 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 74.24 110.073 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.05 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 71.12 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.12 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 73.23 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 71.33 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.524 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.2 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 14' ' ' VAL . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 64.55 110.1 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 65.42 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 64.4 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.41 110.119 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 54.45 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.469 ' CD1' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 73.54 110.277 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.183 0.516 . . . . 74.15 110.267 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.34 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.32 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.523 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 73.4 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 75.11 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 71.44 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 71.41 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 73.31 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.523 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 64.11 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.42 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.31 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.32 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 74.54 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.4 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 61.12 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 75.13 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 74.42 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 64.23 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 63.42 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.04 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 75.22 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.23 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.44 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 74.32 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.21 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 73.42 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 64.1 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.44 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 73.42 110.267 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 75.51 110.128 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.51 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.42 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.44 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.11 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 74.34 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.22 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.45 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' HD22 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.13 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 73.32 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 65.24 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.51 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.11 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 51' ' ' VAL . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 70.34 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.43 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 63.32 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 72.5 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 75.04 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 73.21 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.4 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.13 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.31 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 74.23 109.87 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.3 110.516 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.34 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 74.44 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.05 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.02 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.541 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.53 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.44 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 73.13 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 65.14 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.4 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.506 HG22 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 74.43 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 72.13 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 74.45 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.22 110.33 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.24 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 73.01 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 75.12 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 73.53 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.41 110.21 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.269 0.557 . . . . 71.13 110.049 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.462 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 71.24 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.21 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 62.23 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.22 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 65.12 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 63.24 110.068 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 62.31 110.101 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.31 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 72.25 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 70.31 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' B' ' 23' ' ' LEU . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 75.41 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 71.01 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.461 HD12 ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 75.34 110.346 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.33 0.586 . . . . 74.21 109.728 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.21 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.31 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.22 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.31 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 75.34 109.953 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.21 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 64.23 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 74.43 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.53 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.33 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.53 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 73.11 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 71.14 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.42 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' HD21 ' A' ' 29' ' ' LEU . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 73.14 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.35 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.22 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.54 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.43 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 71.5 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.4 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 74.34 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.43 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 70.34 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.52 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.51 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 75.11 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 71.3 110.24 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 75.23 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.24 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 74.13 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 73.31 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 63.44 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.14 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 44.12 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' HD21 ' A' ' 47' ' ' LEU . 3.7 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 75.51 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 72.21 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.43 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.42 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 75.52 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.41 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.473 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.51 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 72.13 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 73.34 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.03 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.34 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.21 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 74.23 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 64.14 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 61' ' ' GLN . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.5 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.487 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 74.21 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.14 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 64' ' ' GLU . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 71.24 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 74.13 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 55.35 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.43 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.01 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.51 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 72' ' ' VAL . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 70.32 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 74.41 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 71.34 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.523 HG21 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.32 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 72.44 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 64.24 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 74.44 110.393 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.11 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 75.52 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 74.42 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.44 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.226 0.536 . . . . 74.55 110.138 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 40.14 110.159 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.24 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 70.41 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.51 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 73.14 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 74.44 110.066 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 70.11 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 73.52 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.33 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 51.54 110.18 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 72.0 110.237 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.34 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.507 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.51 110.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.242 0.544 . . . . 74.44 109.989 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.44 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 72.41 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.467 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.31 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 74.24 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 74.11 110.022 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.53 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 46' ' ' GLN . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.22 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.33 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 73.21 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.04 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.33 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 75.1 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 72.55 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.12 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.03 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 73.13 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 65.44 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 75.14 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.1 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.22 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.23 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 75.41 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 72.33 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 71.24 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 75.52 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.54 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.32 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 72.13 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.12 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 71.2 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 75.51 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.34 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 74.43 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.05 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.44 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 50.11 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.461 ' HB3' ' OE1' ' A' ' 16' ' ' GLN . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 74.23 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.35 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 48' ' ' ILE . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.02 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 75.22 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 74.0 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.513 ' CG1' HD13 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.03 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.33 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.21 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 64.21 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 75.25 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 74.24 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.45 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.03 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.21 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 74.24 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 75.34 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.31 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 71.21 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.549 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.43 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 60.51 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 75.32 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.43 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 73.33 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.22 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.521 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.31 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 73.52 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.32 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 70.52 110.292 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 71.24 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 61.33 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.23 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.506 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.21 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.43 109.857 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.465 ' O ' HG21 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.302 0.572 . . . . 74.34 110.091 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 74.23 110.148 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.506 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 74.05 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 10' ' ' LYS . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.14 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 72.41 110.09 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.44 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 72.02 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 61.3 110.163 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 71.35 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.32 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 72.54 110.183 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 62.31 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 75.43 110.211 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 74.43 110.138 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.438 HG21 ' N ' ' A' ' 11' ' ' CYS . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 75.43 110.224 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.53 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.12 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HA ' ' CB ' ' A' ' 77' ' ' LEU . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.32 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 76' ' ' SER . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 74.14 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 71.13 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.13 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.51 ' CA ' HD21 ' A' ' 73' ' ' LEU . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 74.34 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.54 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.35 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 61.43 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.41 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.505 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.1 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 73.34 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 74.01 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 73.25 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.15 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' HG11 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 74.41 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.54 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.42 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 74.11 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 54.0 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.54 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.44 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 72.4 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 74.32 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 41.35 110.259 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.12 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 73.31 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 71.12 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 53.4 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 73.11 109.661 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.463 ' O ' HD22 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 73.13 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.43 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' B' ' 17' ' ' ALA . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.24 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 49' ' ' VAL . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 74.33 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 75.01 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.467 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 74.14 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.31 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 74.42 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 75.11 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.2 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.31 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 74.11 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.15 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 53' ' ' ALA . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.21 110.187 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 61' ' ' GLN . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.11 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.522 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 73.44 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.43 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.32 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.03 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.12 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 71.03 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.32 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.21 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 75.33 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.33 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.51 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG22 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.13 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 75.35 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.44 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 74.53 110.251 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.04 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 75.02 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 74.41 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.23 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 73.41 110.139 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.21 0.528 . . . . 65.43 109.759 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.454 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 71.54 109.827 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.462 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 74.33 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.32 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 75.32 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 73.01 109.682 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 74.41 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 48' ' ' ILE . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.45 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.41 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.01 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.34 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.31 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.42 110.356 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.2 0.524 . . . . 62.31 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.35 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.13 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 73.13 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.506 ' CD1' HG11 ' A' ' 51' ' ' VAL . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.22 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.34 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.2 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.447 ' HG2' ' HB1' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 63.4 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.3 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 75.11 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.43 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 73.05 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 75.14 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 75.3 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 74.42 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.45 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.498 ' CG1' ' N ' ' A' ' 26' ' ' SER . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.11 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 73.13 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.11 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.54 109.855 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 74.04 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 70.32 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.31 110.185 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.12 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.13 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.34 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.15 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.41 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.23 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 74.33 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.34 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.41 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.41 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 75.0 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 74.24 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 71.32 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.1 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 64.55 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.11 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 72.23 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 74.35 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.53 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 13' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 75.12 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 74.23 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 75.4 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.14 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.21 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.31 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.34 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.55 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 74.11 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 61' ' ' GLN . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.41 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.54 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 72.5 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 75.31 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.556 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 74.23 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.01 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 74.21 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.556 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.54 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.432 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 72.43 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.22 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 74.22 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.51 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.41 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.03 110.042 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 72.41 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.21 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.33 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.32 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 71.31 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.57 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.14 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.3 110.027 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.236 0.541 . . . . 75.22 110.086 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 74.13 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 72.42 110.055 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.41 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.52 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.33 110.046 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.04 110.027 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.4 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.21 110.18 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.33 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.5 110.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.04 110.227 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 75.41 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.453 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 73.42 110.518 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.321 0.581 . . . . 71.23 110.238 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 74.23 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.42 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.34 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.13 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 72.2 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.449 HG23 HG11 ' A' ' 49' ' ' VAL . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 63.35 110.269 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.11 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 74.35 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 74.01 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.14 111.017 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.21 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 75.44 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 63.25 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.32 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.21 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.41 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 74.12 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 62.31 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 49' ' ' VAL . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 75.33 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.58 ' ND2' ' CG2' ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 75.21 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 65.24 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 75.24 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.41 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.52 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.1 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 75.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.58 ' CG2' ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.44 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.22 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.13 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.04 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.491 ' C ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.41 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 63.12 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.32 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 74.23 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.31 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 73.1 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 75.34 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 48' ' ' ILE . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.35 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 29' ' ' LEU . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.22 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.51 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.34 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.14 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 75.23 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.44 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.31 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.51 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 75.4 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.2 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.457 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 73.2 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 61' ' ' GLN . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 72.41 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.505 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.33 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' SER . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.1 110.444 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.32 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 75.22 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.32 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.11 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.12 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.41 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 74.13 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.33 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.02 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.21 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.435 HD23 ' CA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 72.34 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.54 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.04 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.04 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 73.43 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.42 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 75.04 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.54 110.054 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.247 0.546 . . . . 72.3 110.099 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.455 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 60.24 110.037 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 72.52 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.572 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 74.2 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 65.2 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.41 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.43 110.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 48' ' ' ILE . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 63.34 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ALA . . . . . 0.419 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 75.54 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 70.3 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 72.31 110.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 72.22 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 75.24 110.277 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 52.58 -166.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.2 OUTLIER -85.54 124.96 32.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.232 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.403 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 1.0 OUTLIER -175.71 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.438 ' HB3' ' HG2' ' A' ' 83' ' ' GLU . 1.5 m170 -141.17 124.93 16.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -166.76 123.97 1.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.34 166.09 26.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 19.5 m95 -104.04 -70.93 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -155.51 121.83 5.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 81' ' ' GLN . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG23 HG13 ' A' ' 49' ' ' VAL . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.48 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.519 ' CD1' HD23 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG12 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.519 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.519 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 61' ' ' GLN . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 64' ' ' GLU . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG22 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.51 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.37 129.32 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' O ' HG11 ' A' ' 10' ' ' VAL . 4.2 tp-100 -129.45 102.0 6.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 82' ' ' GLN . 4.7 pm0 -161.58 139.04 8.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -99.73 118.88 37.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.898 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 5.4 pt-20 178.72 -46.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.174 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 47.8 tt0 -166.57 171.25 11.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.136 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . -121.38 133.64 9.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 1.6 pp20? -177.61 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.346 -1.091 . . . . 0.0 110.193 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.44 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 34.9 mt-10 -141.06 -164.79 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.462 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -117.94 174.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.047 1.551 . . . . 0.0 110.464 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.295 0.569 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -99.42 70.89 1.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 2.1 tt -107.97 109.22 20.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 1.3 t -148.03 64.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.457 ' HD3' ' HB2' ' B' ' 9' ' ' MET . 0.0 OUTLIER -177.73 -32.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 6.0 ttt180 -50.78 -23.19 2.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -78.31 -39.94 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.7 OUTLIER -80.55 -39.77 27.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.436 -0.79 . . . . 0.0 109.769 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.457 ' HB2' ' HD3' ' B' ' 5' ' ' ARG . 1.4 ttp -66.81 -48.71 68.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.49 -29.34 10.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.465 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 11' ' ' ALA . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.459 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.519 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -66.17 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.2 t -82.42 162.06 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.216 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -108.26 82.15 1.5 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.0 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.031 1.542 . . . . 0.0 110.422 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.89 21.14 16.46 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.448 ' CG1' ' O ' ' B' ' 28' ' ' VAL . 64.9 t -108.48 7.91 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -1.134 . . . . 0.0 110.206 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' B' ' 31' ' ' ALA . . . -129.65 -66.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -44.08 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' B' ' 29' ' ' ALA . . . -137.35 6.57 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 18.8 m -59.85 -14.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.456 ' O ' HG13 ' B' ' 33' ' ' VAL . 2.9 p -105.99 133.82 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -108.26 -126.74 5.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 2.8 mm100 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.21 -1.17 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 72.22 109.604 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.09 13.55 9.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -1.168 . . . . 65.51 110.159 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.409 ' O ' ' HG2' ' A' ' 4' ' ' MET . 7.0 p80 -165.33 161.09 18.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 75.12 110.146 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -175.0 84.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 73.11 110.22 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -132.66 123.4 26.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 62.24 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -163.51 118.44 1.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 72.44 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -151.39 172.09 16.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 74.24 110.224 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -102.83 -69.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 75.11 110.218 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.56 122.61 6.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 72.52 110.327 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 70.04 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 62.24 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.488 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 72.11 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 49' ' ' VAL . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 70.42 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 75.44 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.22 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.481 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.34 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 75.52 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 74.35 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.44 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.43 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.3 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.41 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 75.53 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 74.2 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.499 ' CD1' HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.32 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.3 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.45 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.45 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.23 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.52 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 74.3 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.54 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 74.3 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 75.22 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 61.53 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.04 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.521 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 71.21 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' HB3' ' CE ' ' B' ' 9' ' ' MET . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.41 110.106 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 73.35 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 74.22 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.524 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.24 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 71.41 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.43 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 73.43 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.04 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' O ' HD21 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 75.33 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 75.31 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.05 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 75.24 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.13 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 72.14 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.519 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 63.24 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 65.23 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 71.24 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 73.02 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 65.24 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.24 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.526 ' CG2' ' HB2' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 72.22 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.41 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG13 ' N ' ' A' ' 61' ' ' GLN . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.15 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.516 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 75.34 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.34 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 64' ' ' GLU . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 74.12 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.529 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.22 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.14 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 75.21 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.563 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 73.32 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 73.45 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 74.35 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 73.4 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.23 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.527 HG21 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.41 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.481 ' CD1' ' HG2' ' A' ' 16' ' ' GLN . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 73.54 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 74.11 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.21 110.229 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 71.12 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.52 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 74.33 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.488 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 70.1 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 126.49 44.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 71.3 110.163 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.456 ' O ' HG11 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -129.83 107.15 9.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 63.03 110.272 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.53 138.71 9.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 75.34 110.219 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.7 145.32 27.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 75.15 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 21.2 pt-20 -172.63 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 73.15 110.182 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.462 ' HB3' ' O ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 57.95 95.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 72.45 110.227 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.18 -168.7 27.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.485 -1.446 . . . . 64.11 109.485 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 -36.78 7.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -1.085 . . . . 73.14 110.187 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -111.1 -179.77 3.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 73.13 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -157.66 100.66 1.84 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 64.01 110.188 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 124.043 1.549 . . . . 73.03 110.431 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.458 ' O ' ' HB3' ' B' ' 7' ' ' SER . 24.0 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.316 0.579 . . . . 71.52 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -96.61 90.45 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 73.2 110.351 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.491 HD21 ' CB ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -114.82 -26.96 7.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 70.25 110.439 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 2.6 m -152.26 -72.08 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 74.52 110.255 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' B' ' 4' ' ' SER . 0.1 OUTLIER 179.89 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.33 -0.856 . . . . 73.5 110.145 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.447 ' O ' ' HG2' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -66.54 -23.07 66.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 75.51 110.198 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.491 ' CB ' HD21 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -80.64 -37.69 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 71.32 109.785 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.3 t80 -77.54 -39.33 46.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 72.42 109.807 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.491 ' CE ' ' HB3' ' A' ' 38' ' ' ALA . 8.8 ttp -68.8 -51.18 43.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -0.838 . . . . 72.34 110.189 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.517 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.35 -28.64 55.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 65.34 110.143 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 75.42 110.206 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 15' ' ' ALA . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.21 110.205 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.435 ' HB3' ' O ' ' B' ' 9' ' ' MET . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.43 110.219 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 74.4 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.45 110.109 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 74.31 110.19 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 73.31 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.501 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 72.32 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 71.31 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.22 110.12 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 72.12 110.22 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 72.41 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.501 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.1 OUTLIER -67.62 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 74.22 110.267 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 68.2 m -81.49 162.16 23.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 75.24 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.51 ' CG1' ' HB ' ' B' ' 28' ' ' VAL . 78.1 t -108.1 82.22 1.46 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 64.4 110.185 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.7 Cg_endo -72.51 -89.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.91 1.479 . . . . 73.13 110.473 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.63 40.87 2.64 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 74.12 109.579 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.51 ' HB ' ' CG1' ' B' ' 25' ' ' VAL . 64.1 t -107.68 -1.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 74.21 110.236 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.82 -20.28 7.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 75.4 110.266 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.37 116.43 28.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 72.41 110.245 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -132.28 81.63 1.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 75.45 110.28 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 2.1 p 179.5 -32.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 75.22 110.195 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -43.17 106.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.273 -0.892 . . . . 74.43 110.2 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.53 41.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 62.22 109.517 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 72.32 110.152 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.53 -1.428 . . . . 55.34 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -157.48 -43.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 71.25 110.101 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.1 OUTLIER -175.98 -164.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 71.22 110.22 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.505 ' CG ' ' O ' ' A' ' 4' ' ' MET . 3.1 ptt? -177.93 98.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 63.12 110.24 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -122.35 117.94 27.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -0.959 . . . . 73.24 110.174 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.77 119.14 0.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 75.04 110.18 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -152.46 154.01 34.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 73.33 110.303 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -110.04 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 74.03 110.135 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -153.56 121.68 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 71.43 110.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.455 ' O ' ' HB3' ' A' ' 81' ' ' GLN . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 75.4 110.23 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 63.14 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.449 ' CB ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 71.32 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.43 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 76' ' ' SER . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.04 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.13 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.43 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.33 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.54 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.22 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.14 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 72.12 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' O ' HG23 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.41 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.487 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.44 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.53 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 75.31 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 74.14 109.848 179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.33 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.15 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.15 110.281 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.35 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.21 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.05 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.34 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 74.21 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.24 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 75.23 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.44 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.34 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.23 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.43 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 70.54 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 75.4 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 72.34 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 71.2 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.51 HD13 ' CB ' ' B' ' 17' ' ' ALA . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.24 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.445 ' O ' ' CG1' ' A' ' 49' ' ' VAL . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.44 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 HG12 ' CB ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.31 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 74.12 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.33 110.222 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 71.55 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.24 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.32 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 55.41 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.43 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.42 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.51 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.55 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 74.11 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 HG23 ' N ' ' A' ' 64' ' ' GLU . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 74.31 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 75.24 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 73.43 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.42 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.41 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 75.33 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.42 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.43 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 HG23 HG11 ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.02 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 74.43 110.111 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 73.33 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.41 110.313 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 72.24 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 74.21 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 75.11 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 74.43 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 136.48 33.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.3 110.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' HB3' ' O ' ' A' ' 10' ' ' VAL . 43.5 tp60 -132.44 104.23 6.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 75.31 110.211 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -161.39 138.61 8.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 70.13 110.359 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -104.15 149.05 25.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 64.45 110.117 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -175.18 -75.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 63.02 110.375 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 9.5 tt0 -177.93 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 74.42 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.86 172.2 43.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.585 -1.406 . . . . 72.4 109.585 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -148.32 -39.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.206 . . . . 72.3 110.19 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' O ' ' OG1' ' A' ' 89' ' ' THR . 21.5 mt-10 -114.68 151.19 34.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 75.33 110.188 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 88' ' ' GLU . 43.1 p 43.43 69.89 2.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 74.53 110.206 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.8 0 O-C-N 124.047 1.551 . . . . 61.33 110.518 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.402 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.333 0.587 . . . . 70.22 110.123 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HG2' ' C ' ' B' ' 1' ' ' MET . 1.1 mmpt? -136.91 160.59 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 73.44 110.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.65 58.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 75.14 110.228 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -86.89 64.91 8.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 54.43 110.221 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -39.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 63.21 110.179 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -71.17 -15.44 62.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 73.51 110.235 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.84 -35.52 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 72.53 109.738 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 2.6 t80 -80.4 -43.38 21.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.477 -0.764 . . . . 72.22 109.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 3.1 ttp -65.99 -47.53 74.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 75.31 110.111 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.452 ' HG2' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -53.01 -31.51 41.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 61.11 110.082 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 73.5 110.205 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 73.43 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.505 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.44 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.459 HG21 ' O ' ' B' ' 11' ' ' ALA . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 64.21 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 74.54 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 73.03 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.51 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.42 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.24 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 72.31 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.12 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.33 110.185 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 74.01 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.3 OUTLIER -67.08 -162.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.452 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 6.7 m -82.74 162.0 21.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 72.44 110.153 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.482 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 27.3 m -107.94 82.58 1.48 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 74.43 110.245 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.1 Cg_endo -72.05 -89.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.038 1.546 . . . . 74.32 110.473 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.66 39.75 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.579 -1.408 . . . . 75.1 109.579 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.14 -75.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -1.184 . . . . 74.11 110.185 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.475 ' O ' ' CG ' ' B' ' 30' ' ' ARG . . . -176.87 28.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.296 -0.878 . . . . 72.42 110.362 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.475 ' CG ' ' O ' ' B' ' 29' ' ' ALA . 5.5 mtm-85 -154.38 145.26 22.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 71.22 110.222 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.56 18.91 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 74.12 110.258 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.444 ' O ' HG11 ' B' ' 33' ' ' VAL . 11.7 p -122.41 -22.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.87 . . . . 74.24 110.248 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.444 HG11 ' O ' ' B' ' 32' ' ' VAL . 15.7 m -143.0 148.89 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 74.43 110.228 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.33 12.87 69.98 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.61 -1.396 . . . . 73.31 109.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 72.44 110.261 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.574 -1.41 . . . . 73.3 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' HIS . 6.1 t -76.52 110.51 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -1.119 . . . . 71.52 110.21 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 38.5 m-70 59.61 147.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.45 110.207 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 26.3 ttt -178.4 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 71.4 110.202 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' CB ' ' OE1' ' A' ' 83' ' ' GLU . 33.4 p-80 -142.22 120.23 12.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 74.44 110.194 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 16.7 m -166.74 116.3 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 72.1 110.188 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.67 168.24 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 73.51 110.305 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -111.81 -71.86 0.74 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.851 . . . . 74.42 110.155 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.5 126.39 8.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 75.14 110.146 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.459 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 72.03 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.427 ' N ' HG22 ' A' ' 10' ' ' VAL . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 73.43 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.33 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' CD1' HG11 ' A' ' 51' ' ' VAL . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 74.24 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG1' ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.41 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.11 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 71.32 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.43 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 75.1 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 72.12 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 73.14 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.526 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.53 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 73.24 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.15 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.492 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 71.11 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.33 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 64.45 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 73.34 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.22 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.52 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 62.25 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.43 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 74.21 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.22 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 74.03 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.31 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.3 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 73.11 110.194 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.54 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.01 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.42 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.45 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 74.45 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 65.13 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.33 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.461 ' O ' HD23 ' A' ' 47' ' ' LEU . 2.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.35 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 74.4 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 48' ' ' ILE . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.51 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.504 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.33 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 70.11 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 71.53 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.2 110.26 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.521 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.33 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.21 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.2 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 73.14 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.433 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 64.21 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.521 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 73.15 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.448 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 70.45 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.511 HG13 ' N ' ' A' ' 61' ' ' GLN . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 74.41 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.511 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.52 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.4 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 72.32 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.533 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 71.51 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.23 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 71.02 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.54 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.43 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.01 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.02 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 70.22 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG22 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 74.3 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 74.22 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 73.31 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 73.23 110.305 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.461 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 72.21 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.31 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.32 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.2 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 126.39 45.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.32 110.06 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -138.2 110.59 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 75.04 110.268 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.3 138.71 16.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 73.44 110.287 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' OE1' ' CB ' ' A' ' 5' ' ' HIS . 4.3 mt-10 -102.03 147.52 26.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 75.21 110.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER 174.37 -100.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 64.12 110.192 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -84.75 161.54 19.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 75.42 110.158 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.57 139.73 25.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.529 -1.428 . . . . 65.1 109.529 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -173.06 39.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -1.122 . . . . 65.33 110.259 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 7.2 pt-20 -76.38 144.62 39.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 63.31 110.146 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -164.2 161.36 16.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 73.42 110.237 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 124.12 1.589 . . . . 55.04 110.426 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 74.34 110.296 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -90.95 -21.38 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 74.35 110.296 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' B' ' 4' ' ' SER . 1.5 tp -93.86 -166.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 74.31 110.17 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' B' ' 3' ' ' LEU . 0.5 OUTLIER 171.74 50.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 73.45 110.214 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -59.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.91 . . . . 74.45 110.226 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.2 ttt-85 -46.49 -29.19 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 72.45 110.29 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.1 t -74.88 -41.89 58.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 71.42 109.831 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.63 -38.99 28.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 72.1 109.866 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -67.15 -52.93 35.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 70.33 110.171 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -52.26 -27.01 13.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 75.21 110.141 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.453 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.12 110.069 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.24 110.194 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.453 HG22 ' O ' ' B' ' 11' ' ' ALA . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.52 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 74.14 110.131 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.441 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 75.01 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.21 110.158 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 73.05 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 75.44 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.02 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.495 ' HB1' ' CG1' ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.04 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 64.25 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.454 HD12 ' CG1' ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.9 -162.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.11 110.301 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 75.3 m -82.86 162.1 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 73.34 110.157 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.52 ' CG1' ' HB ' ' B' ' 28' ' ' VAL . 12.0 t -108.3 81.91 1.45 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 74.43 110.148 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.6 Cg_endo -72.96 -56.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.043 1.549 . . . . 72.12 110.408 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.458 ' O ' ' HB1' ' B' ' 31' ' ' ALA . . . -141.04 31.24 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.422 . . . . 74.13 109.544 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.52 ' HB ' ' CG1' ' B' ' 25' ' ' VAL . 42.8 t -57.31 -29.78 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 72.34 110.304 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.19 -7.03 54.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 72.44 110.241 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mtm-85 -124.99 38.18 4.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 71.24 110.138 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' B' ' 27' ' ' GLY . . . -146.33 33.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 64.2 110.127 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.47 ' CG2' ' N ' ' B' ' 33' ' ' VAL . 5.3 m -93.68 -40.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -0.843 . . . . 75.43 110.236 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.47 ' N ' ' CG2' ' B' ' 32' ' ' VAL . 8.8 p -154.87 170.21 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 65.31 110.129 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.91 161.52 12.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.569 -1.412 . . . . 75.02 109.569 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 75.13 110.204 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.574 -1.411 . . . . 62.31 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t 47.36 48.31 16.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.317 -1.108 . . . . 74.22 110.143 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -134.43 -68.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 73.34 110.305 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 ttt -175.91 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 74.13 110.224 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -125.48 125.04 42.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.845 . . . . 75.25 110.096 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 m -165.33 104.21 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 73.12 110.358 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -152.28 169.1 23.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 73.13 110.286 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.458 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 82.8 m95 -112.77 -73.41 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 74.12 110.155 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.458 ' HG3' ' O ' ' A' ' 8' ' ' TRP . 2.6 mt-30 -153.6 124.41 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 74.42 110.109 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 74.34 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 72.21 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.462 ' OG ' ' HB3' ' A' ' 79' ' ' TYR . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 72.5 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.506 HD21 ' CB ' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 73.3 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 65.35 110.11 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.23 110.263 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.32 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.05 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.42 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 70.45 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.42 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 73.44 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.553 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 72.23 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.05 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.503 ' CG1' ' N ' ' A' ' 26' ' ' SER . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.44 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.553 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 73.21 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 64.11 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 72.24 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.23 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.526 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 13.3 t-20 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.43 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 74.42 110.276 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.41 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 73.14 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.11 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.439 ' SG ' HG23 ' A' ' 49' ' ' VAL . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.24 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.526 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.43 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.03 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.53 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.54 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.15 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 74.11 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.448 ' CB ' ' OE1' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.04 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.42 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.458 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 73.13 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 64.53 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CD1' HD23 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.12 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.447 ' O ' ' CG1' ' A' ' 49' ' ' VAL . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.43 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.32 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.457 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.13 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 73.21 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.34 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 63.02 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.13 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.34 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.12 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 75.12 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.508 HD13 ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 75.21 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.502 HG13 ' N ' ' A' ' 61' ' ' GLN . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 73.55 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.33 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.51 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 75.15 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 71.4 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.53 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.43 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.12 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.11 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 71.2 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.44 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 44.22 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 HG21 ' HB ' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.45 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.45 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 72.23 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.43 110.14 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.01 110.183 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 72.12 110.204 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.506 ' CB ' HD21 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 75.21 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 73.02 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 74.51 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -97.43 134.73 40.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.24 110.198 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 102.38 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 74.23 110.276 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.438 ' NE2' ' CE1' ' A' ' 80' ' ' HIS . 3.5 pt20 -158.54 138.65 12.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 74.55 110.21 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.2 132.33 42.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 72.12 110.321 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.61 27.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 73.13 110.161 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.51 58.06 3.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 74.02 110.268 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -46.75 157.52 0.5 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 74.24 109.551 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.51 -1.36 8.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -1.222 . . . . 72.25 110.191 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.56 132.03 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 74.2 110.164 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -89.26 143.68 31.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 75.15 110.157 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 74.1 110.528 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 72.12 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' B' ' 2' ' ' LYS . 5.7 ptpt -141.23 85.69 1.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 74.14 110.231 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.509 HD22 ' N ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -116.43 -173.89 2.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.943 . . . . 74.14 110.189 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -146.67 46.52 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 73.2 110.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.97 -64.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 73.52 110.144 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.489 ' HB3' ' CD1' ' B' ' 3' ' ' LEU . 25.7 ttt180 -60.43 -16.81 39.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 71.32 110.134 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 43.7 t -80.91 -39.01 26.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 72.33 109.731 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.56 -43.38 39.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.362 -0.836 . . . . 74.54 109.763 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.461 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 8.1 ttp -66.23 -54.62 22.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 74.12 110.106 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.478 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.2 OUTLIER -55.25 -33.08 62.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 73.53 110.132 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.13 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 73.45 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' B' ' 9' ' ' MET . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 75.23 110.192 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 71.34 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 75.12 110.061 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 73.24 110.091 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.21 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 75.53 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 73.53 110.189 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.21 110.227 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 74.3 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.493 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.65 -162.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 75.44 110.322 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 7.3 t -82.76 162.24 21.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 72.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.485 ' CG1' HG22 ' B' ' 28' ' ' VAL . 94.4 t -107.66 82.99 1.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 74.53 110.161 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.3 Cg_endo -72.1 -90.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 64.34 110.394 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.1 34.34 5.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.559 -1.416 . . . . 71.13 109.559 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' B' ' 25' ' ' VAL . 77.2 t -55.57 -17.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -1.218 . . . . 74.54 110.211 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.485 ' O ' ' NE ' ' B' ' 30' ' ' ARG . . . -157.36 -62.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 74.32 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -174.58 138.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 74.21 110.179 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -57.71 -17.93 18.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 74.1 110.294 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' B' ' 30' ' ' ARG . 16.7 m -43.59 -27.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 73.31 110.288 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.94 60.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 72.32 110.309 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.14 116.68 3.51 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.502 -1.439 . . . . 62.34 109.502 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.165 . . . . 74.24 110.166 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.608 -1.397 . . . . 64.32 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 156.8 34.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -1.162 . . . . 72.54 110.258 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' MET . 42.2 m80 -97.69 -89.95 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.107 -0.995 . . . . 73.24 110.273 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.406 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 174.68 70.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 74.42 110.164 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 14.0 p80 -138.76 117.72 12.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 74.22 110.273 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 15.2 m -166.8 118.12 0.94 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 75.53 110.269 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -143.01 167.17 22.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 64.22 110.252 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.443 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 92.8 m95 -112.79 -69.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 74.41 110.182 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 8' ' ' TRP . 3.3 mm-40 -158.66 127.02 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 73.23 110.122 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.465 HG12 ' HB3' ' A' ' 81' ' ' GLN . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.43 110.24 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.35 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.466 ' OG ' ' HB3' ' A' ' 79' ' ' TYR . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.23 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' CD1' HG13 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.32 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' HB2' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 63.03 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 49' ' ' VAL . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.42 110.303 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.45 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 74.11 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.4 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.42 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 65.41 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.527 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.01 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 75.41 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.52 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.12 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 73.04 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.4 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.31 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.41 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 65.44 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.52 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.53 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.42 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.21 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 75.44 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.41 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.3 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 71.2 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 30' ' ' ASN . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 75.21 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 74.35 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.54 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.21 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.45 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.44 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 73.41 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.21 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.31 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 75.21 110.385 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 73.03 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.526 HD12 ' CD2' ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.53 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.12 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.44 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 HG13 ' CD1' ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 71.21 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.22 110.137 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.53 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.23 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.03 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 75.22 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 70.53 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 72.4 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.53 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 74.12 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.52 ' CD1' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 75.03 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 75.01 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.498 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 72.42 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.45 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 64' ' ' GLU . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.42 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 74.05 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 71.5 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 75.22 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.591 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 72.12 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.03 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.24 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.34 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 71.43 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.02 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 75.15 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.21 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 74.12 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.41 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.24 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.32 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 74.42 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 136.56 33.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 74.21 110.168 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.465 ' HB3' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -133.61 112.26 11.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.297 -0.877 . . . . 74.51 110.179 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.17 138.59 14.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 74.13 110.29 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.99 119.04 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 63.15 110.219 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.2 pt-20 -135.71 -35.78 0.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 74.42 110.21 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.8 mp0 62.81 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.232 -0.917 . . . . 72.44 110.153 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.16 -147.51 5.75 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.565 -1.414 . . . . 75.14 109.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 51.04 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -1.095 . . . . 74.33 110.209 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -139.2 157.93 45.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 72.43 110.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.06 167.38 18.45 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 63.24 110.216 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.303 -1.825 0 O-C-N 124.058 1.557 . . . . 62.12 110.482 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 3' ' ' LEU . 5.6 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.18 0.514 . . . . 74.35 110.215 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.67 -68.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 74.22 110.151 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' B' ' 1' ' ' MET . 0.2 OUTLIER -145.16 102.19 3.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -0.972 . . . . 72.42 110.232 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.7 40.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 75.13 110.198 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.76 -60.26 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 72.4 110.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -19.25 46.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 72.11 110.304 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 53.5 m -80.43 -36.72 33.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 71.43 109.777 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.436 ' O ' ' HB3' ' B' ' 11' ' ' ALA . 2.5 t80 -80.63 -43.14 20.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.433 -0.792 . . . . 75.41 109.771 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.2 ttp -67.08 -48.65 67.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 75.53 110.28 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.515 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.15 -31.62 32.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 75.31 110.151 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.461 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 74.13 110.07 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 74.5 110.136 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.461 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.04 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.05 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' B' ' 28' ' ' VAL . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.51 109.934 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' B' ' 20' ' ' ALA . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 74.31 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 52.14 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 64.42 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.44 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' B' ' 16' ' ' ALA . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.23 110.186 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.441 ' HB2' HG13 ' A' ' 14' ' ' VAL . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 73.43 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 60.12 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.526 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.69 -162.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.53 110.327 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' B' ' 18' ' ' ALA . 58.3 p -75.46 162.03 28.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 54.24 110.307 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' B' ' 25' ' ' VAL . 13.5 p -112.6 73.62 1.49 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 74.24 110.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.487 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 46.4 Cg_endo -72.97 -90.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.966 1.509 . . . . 72.35 110.471 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.19 75.67 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.581 -1.408 . . . . 54.15 109.581 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.503 ' CG1' HG23 ' B' ' 25' ' ' VAL . 72.3 t -71.37 -16.82 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -1.193 . . . . 73.35 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.443 ' HB2' ' CG2' ' B' ' 25' ' ' VAL . . . -163.1 -58.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 70.31 110.282 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.1 OUTLIER 61.95 74.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 74.44 110.208 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -67.56 -9.35 41.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 74.15 110.192 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.529 ' O ' ' CG1' ' B' ' 33' ' ' VAL . 13.5 t 61.12 13.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 75.22 110.171 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' B' ' 32' ' ' VAL . 9.9 p 38.51 35.14 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 75.14 110.53 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 35' ' ' GLN . . . 176.87 95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 63.32 109.559 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' B' ' 34' ' ' GLY . 5.4 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 61.1 110.187 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 5' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.445 . . . . 71.12 109.489 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -153.24 -86.9 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -1.16 . . . . 65.23 110.118 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.3 OUTLIER -150.53 48.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 74.3 110.291 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.0 tmm? 179.37 71.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 71.12 110.16 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.509 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 37.6 m80 -130.32 121.48 26.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 73.1 110.258 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -160.23 113.11 2.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 65.33 110.141 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.04 172.11 15.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 72.32 110.236 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 57.6 m95 -102.61 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 74.43 110.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -153.3 121.82 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 70.33 110.053 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.03 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.55 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.52 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.12 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 63.21 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 75.05 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 63.21 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.452 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.512 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.42 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 74.15 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 73.55 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.43 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.34 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.45 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 73.33 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.464 ' O ' HD22 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 75.14 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.44 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.41 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.04 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 75.22 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.437 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 75.23 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 63.23 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.22 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 73.3 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.04 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.41 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.33 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 30' ' ' ASN . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 75.02 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.43 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 75.44 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 75.03 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.53 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 72.44 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.22 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.51 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 74.54 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.426 ' C ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.11 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 72.24 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD12 HD22 ' B' ' 23' ' ' LEU . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 72.33 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.499 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.42 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.43 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 73.54 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.54 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 74.44 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 74.11 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.33 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.32 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.32 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.34 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 61.13 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 75.42 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.24 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.432 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 73.4 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.486 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 75.24 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.524 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 75.52 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.45 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.1 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 75.41 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.12 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 75.25 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.32 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG21 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 74.24 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 72.31 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.428 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 72.44 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.31 110.206 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.14 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' CB ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 75.15 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' B' ' 16' ' ' ALA . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.54 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.55 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -101.04 126.53 47.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 75.42 110.109 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' GLN . 17.5 pt20 -135.03 111.17 9.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 63.52 110.186 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.43 138.6 8.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 73.45 110.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.82 145.06 30.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 74.34 110.296 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 16.2 pt-20 -170.73 -35.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 54.41 110.223 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -175.82 57.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 75.42 110.28 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -150.61 -137.97 2.78 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 43.21 109.5 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' GLU . 3.7 tp10 66.01 46.49 2.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -1.074 . . . . 75.3 110.246 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' GLU . 2.4 pt-20 -55.53 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.075 -1.016 . . . . 55.24 110.234 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.527 ' N ' ' HD2' ' A' ' 90' ' ' PRO . 1.3 m -42.66 -55.51 7.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 72.1 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 89' ' ' THR . 44.0 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.66 1.347 . . . . 74.5 110.372 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.405 ' O ' ' O ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 74.21 110.175 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' B' ' 1' ' ' MET . 0.2 OUTLIER 59.5 156.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 64.22 110.196 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' B' ' 3' ' ' LEU . 3.6 pp -100.97 151.96 21.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 74.11 110.199 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.38 23.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 75.51 110.247 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.438 ' CZ ' ' HB2' ' B' ' 5' ' ' ARG . 6.4 tpp85 -159.33 -56.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 72.44 110.222 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -52.31 -23.22 5.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 73.44 110.079 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.479 ' CB ' HD13 ' B' ' 3' ' ' LEU . 1.6 t -77.45 -40.46 43.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 74.33 109.671 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.2 t80 -80.55 -39.4 27.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -0.836 . . . . 75.33 109.707 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' B' ' 13' ' ' ALA . 1.8 ttp -65.29 -52.19 55.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 72.14 110.193 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.443 ' O ' HG12 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.34 -34.3 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 74.23 109.953 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.454 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.32 109.934 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.34 110.102 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' B' ' 9' ' ' MET . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 73.23 110.246 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.454 HG22 ' O ' ' B' ' 11' ' ' ALA . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.33 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.31 109.989 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 75.24 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.404 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 73.23 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.13 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.03 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 74.14 110.107 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.433 ' HB2' HD11 ' B' ' 23' ' ' LEU . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 62.13 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 75.22 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.455 HD22 HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -69.88 -162.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 72.23 110.359 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 16.5 m -82.94 162.25 21.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 71.41 110.296 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.513 ' CG1' ' HB ' ' B' ' 28' ' ' VAL . 72.8 t -107.64 82.69 1.39 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 73.14 110.137 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.1 Cg_endo -71.85 -89.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.092 1.575 . . . . 72.14 110.773 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.58 43.96 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.797 -1.321 . . . . 63.05 109.797 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.513 ' HB ' ' CG1' ' B' ' 25' ' ' VAL . 37.2 t -73.05 -25.18 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -1.171 . . . . 75.13 109.95 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' B' ' 30' ' ' ARG . . . -125.18 -7.67 7.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 70.53 110.057 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 68.15 96.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 72.32 110.162 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -45.74 -33.53 3.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 65.31 110.244 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' B' ' 30' ' ' ARG . 6.7 m -42.36 -27.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 75.04 110.245 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 31' ' ' ALA . 56.0 t -90.52 108.17 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 72.11 110.205 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.53 61.11 0.44 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.439 -1.464 . . . . 62.43 109.439 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.421 -1.047 . . . . 75.11 110.228 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.612 -1.395 . . . . 71.42 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -141.53 -154.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 74.13 110.248 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -176.08 -167.35 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 71.44 110.217 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.02 72.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 74.23 110.142 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 40.7 m170 -121.53 122.87 40.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 73.43 110.221 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.5 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -154.33 118.95 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 72.2 110.146 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.47 171.69 14.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 64.12 110.232 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -110.72 -76.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 74.23 110.13 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.57 125.29 2.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 74.15 110.308 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.43 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.53 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.518 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 75.42 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 73.13 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 73.14 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.419 HG22 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 65.55 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.44 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.43 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 75.03 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 75.25 110.964 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.2 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 75.11 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.34 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.41 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.46 ' O ' HG21 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 73.24 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.507 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.01 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 75.24 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 73.23 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.51 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 72.21 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.438 ' HB2' HG21 ' A' ' 37' ' ' VAL . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.04 110.217 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.44 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 74.4 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.33 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.53 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 74.12 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG21 ' HB2' ' A' ' 30' ' ' ASN . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 74.11 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 75.12 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 74.21 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.11 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.01 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 74.55 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.49 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 63.12 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.44 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.44 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' O ' HD21 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.24 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 75.53 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CG1' HD12 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 70.14 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.453 HG22 ' HB3' ' A' ' 29' ' ' LEU . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 75.33 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.485 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 HG12 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.11 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.516 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.31 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.522 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 54.11 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 63.4 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 74.54 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.22 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.34 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.522 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.05 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.34 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.52 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.4 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 74.1 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 64.22 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.509 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 63.31 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.528 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.23 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.34 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.52 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 74.41 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.528 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 73.2 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.43 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 65' ' ' SER . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.35 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.34 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.34 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 72.11 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.441 HD23 ' CA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 75.15 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 75.13 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 63.33 110.289 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.453 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 73.44 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 72.2 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 74.45 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.558 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.53 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 136.26 35.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 71.3 110.162 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.52 102.07 6.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 72.42 110.184 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -161.5 138.7 8.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 74.55 110.399 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 6' ' ' THR . 1.8 mp0 -80.73 120.37 24.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 75.0 110.227 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 4.0 pt-20 175.21 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.866 . . . . 74.23 110.243 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 33.3 mm-40 56.79 49.91 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 74.53 110.287 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -98.41 -133.42 7.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 65.13 109.52 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 69.36 5.82 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -1.131 . . . . 74.43 110.307 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.5 pt-20 33.62 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.629 0.728 . . . . 73.41 111.431 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER 66.16 68.05 0.66 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.316 -0.865 . . . . 72.45 110.241 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.039 1.547 . . . . 62.42 110.493 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.541 . . . . 75.43 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.41 -72.28 0.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 70.1 110.276 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -119.79 114.48 22.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 75.14 110.185 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -150.9 72.91 1.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 70.25 110.213 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.57 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 75.25 110.188 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -75.4 -20.92 58.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 75.5 109.98 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.0 t -77.16 -39.92 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 71.23 109.617 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.497 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.1 t80 -80.27 -34.79 36.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 75.13 109.562 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.444 ' HE1' HG13 ' A' ' 50' ' ' VAL . 13.1 ttp -70.16 -55.46 9.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 71.45 110.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.32 -30.17 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 54.22 110.047 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.45 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.53 110.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.558 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 73.11 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.525 ' CG2' ' HG2' ' B' ' 26' ' ' PRO . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 74.42 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.23 110.225 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.3 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.453 ' O ' ' HB1' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.31 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.51 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 65.51 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.52 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.03 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.4 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.508 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.4 OUTLIER -62.9 -162.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 75.32 110.32 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.43 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.4 OUTLIER -81.74 161.7 23.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.388 -0.82 . . . . 73.21 110.179 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.454 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 32.8 m -109.25 78.67 1.08 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 71.22 110.206 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.525 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 46.9 Cg_endo -72.96 -57.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.991 1.521 . . . . 74.14 110.52 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 30' ' ' ARG . . . -89.58 -35.96 7.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.546 -1.422 . . . . 73.3 109.546 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 54.9 t -46.32 -43.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -1.109 . . . . 72.24 110.128 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.65 -8.0 51.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 73.32 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' B' ' 34' ' ' GLY . 9.4 mtp180 55.85 78.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 72.55 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 0.62 57.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 74.13 110.187 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 61.1 t -54.58 -39.84 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 75.42 110.222 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.1 p -179.61 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 74.14 110.144 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' B' ' 30' ' ' ARG . . . 136.32 -69.57 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.411 . . . . 65.01 109.571 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.273 -1.133 . . . . 73.01 110.234 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.656 -1.378 . . . . 70.12 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 -3.78 7.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.312 -1.111 . . . . 73.31 110.228 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 4' ' ' MET . 22.2 p-80 -122.91 162.77 21.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 71.44 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.1 ttt -179.17 70.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 75.11 110.247 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.503 ' O ' ' CD2' ' A' ' 5' ' ' HIS . 9.9 p-80 -127.83 118.64 24.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 75.23 110.206 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 21.2 m -166.81 123.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 75.11 110.222 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -152.28 168.67 24.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 64.33 110.201 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -108.61 -69.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 75.34 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.91 121.67 5.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 74.13 110.118 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 81' ' ' GLN . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 71.43 110.231 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.505 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 71.13 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.498 ' CA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 71.14 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 HD22 ' CB ' ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 76' ' ' SER . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 72.02 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.446 HG22 HG13 ' A' ' 66' ' ' VAL . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.11 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.466 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 72.02 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.519 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 74.12 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 74.45 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.44 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 73.21 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.34 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.551 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 75.31 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.14 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 74.35 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.457 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 74.24 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.12 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.33 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 72.53 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 HD23 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.33 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.04 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.13 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.44 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 74.01 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 49' ' ' VAL . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.45 110.211 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 74.21 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 54.33 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 73.4 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.22 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.1 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.42 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 72.02 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 61.03 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 72.32 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 74.42 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.15 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 64.34 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' CA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 74.42 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' O ' HG11 ' A' ' 51' ' ' VAL . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.32 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 70.14 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.524 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.24 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.42 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.449 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.55 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.2 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.31 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 75.2 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 73.44 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 61' ' ' GLN . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.43 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.2 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 72.44 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.513 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 74.11 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.13 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.526 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 71.33 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 73.43 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.542 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 73.44 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 75.54 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 71.15 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.24 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.13 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.516 HG22 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 75.41 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 75.14 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 75.13 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.22 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.432 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.35 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.51 ' CB ' HD22 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.35 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.33 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.33 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.53 135.27 34.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.42 110.098 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.477 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 18.3 tp60 -129.62 101.97 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 71.24 110.301 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -161.41 138.7 8.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 71.41 110.27 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 3.5 mm-40 -90.37 118.93 30.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 63.41 110.212 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 6.2 pt-20 175.7 -162.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 72.12 110.176 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 67.2 tp60 -87.07 50.93 2.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 63.12 110.205 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' HA2' ' OE2' ' A' ' 87' ' ' GLU . . . -101.91 -143.08 13.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.467 -1.453 . . . . 71.32 109.467 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.441 ' OE2' ' HA2' ' A' ' 86' ' ' GLY . 1.4 pm0 -179.48 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -1.183 . . . . 74.31 110.221 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 2.8 pt-20 -47.24 123.54 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 71.14 110.175 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 157.57 46.22 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 74.42 110.157 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 123.871 1.458 . . . . 75.44 110.41 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.265 0.555 . . . . 60.42 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.85 102.7 2.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.917 . . . . 72.05 110.21 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -78.73 -77.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 75.11 110.313 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 3' ' ' LEU . 0.6 OUTLIER 42.19 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 64.14 110.267 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -137.49 -59.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 74.44 110.354 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.451 ' HB3' HD11 ' B' ' 3' ' ' LEU . 0.3 OUTLIER -55.39 -30.65 60.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 74.44 110.261 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.6 t -75.45 -40.41 57.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 70.41 109.765 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.56 -38.81 28.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 74.11 109.739 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' B' ' 13' ' ' ALA . 7.2 ttp -65.94 -54.27 28.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 74.23 110.231 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.02 -31.86 43.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 72.5 110.076 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 54.44 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.23 110.183 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.13 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 11' ' ' ALA . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.12 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 74.5 110.108 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 74.11 110.172 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.15 110.172 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.406 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.33 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 61.42 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 64.23 110.13 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 74.2 110.234 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.45 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.406 ' CB ' ' HA ' ' B' ' 18' ' ' ALA . 0.3 OUTLIER -63.85 -162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.51 110.296 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.444 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.3 t -82.74 162.04 21.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 73.24 110.33 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' B' ' 28' ' ' VAL . 15.4 m -109.05 80.24 1.29 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 65.12 110.212 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.2 Cg_endo -73.03 -56.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.964 1.507 . . . . 74.24 110.465 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.15 -9.28 57.16 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.465 -1.454 . . . . 61.41 109.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.459 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 98.3 t -80.92 6.35 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -1.118 . . . . 73.5 110.256 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.89 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 75.05 110.189 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mtm180 -68.73 -142.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.305 -0.872 . . . . 72.12 110.146 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 59.64 16.15 5.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 71.1 110.194 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.461 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 8.6 p -118.71 -10.7 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.892 . . . . 72.05 110.298 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 5.9 t 61.83 103.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 73.2 110.192 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 35' ' ' GLN . . . -143.08 17.99 2.33 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.542 -1.423 . . . . 75.41 109.542 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' B' ' 34' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 73.52 110.184 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.41 . . . . 72.11 109.574 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 56.29 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 71.43 110.282 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 4' ' ' MET . 8.1 t-160 57.03 28.0 14.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 74.4 110.193 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.2 ttm 175.82 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 73.5 110.201 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 17.0 p80 -131.71 118.22 19.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 72.54 110.349 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 6' ' ' THR . 6.3 t -166.72 124.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 74.35 110.281 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -152.54 157.02 40.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 73.44 110.317 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.438 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 69.2 m95 -107.17 -70.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 74.54 110.161 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -157.37 121.82 4.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 73.22 110.217 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 71.12 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 75.13 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 54.44 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.23 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 76' ' ' SER . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 64.22 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.41 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 73.43 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.3 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.14 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.01 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 75.13 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.32 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 74.03 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 71.31 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.508 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.15 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.22 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.11 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.508 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 73.43 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.14 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 73.41 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 65.24 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.53 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.13 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.41 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.04 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HA ' HG23 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.02 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.42 110.047 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.22 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.31 110.201 -179.666 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 73.24 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.23 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.22 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.05 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 53.11 109.755 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.426 ' C ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.3 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.21 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.462 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.02 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 73.05 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.03 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.14 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.52 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.523 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.24 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.24 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.45 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.43 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.34 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 73.35 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD11 ' HB1' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 75.44 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 61' ' ' GLN . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 73.52 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 75.01 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 74.54 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.505 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.42 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.53 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 73.11 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 72.0 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.22 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.24 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.22 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.45 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.42 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 75.14 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 75.2 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.419 ' C ' ' HB3' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.22 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 HG11 ' O ' ' A' ' 75' ' ' VAL . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 74.34 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.466 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.22 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.43 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 73.02 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.464 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.45 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.19 136.27 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.12 110.131 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -130.57 103.04 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 72.24 110.258 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.3 138.71 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 64.42 110.253 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -85.69 118.74 25.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 70.3 110.198 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 179.94 30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.872 . . . . 75.02 110.316 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 20.7 mm100 60.19 49.74 7.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 75.22 110.078 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -103.57 169.77 18.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.421 . . . . 74.33 109.549 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 5.2 tt0 69.48 38.75 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 74.44 110.228 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.526 ' O ' ' CG2' ' A' ' 89' ' ' THR . 22.5 mt-10 -151.17 -164.89 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 74.12 110.136 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -179.84 130.14 0.25 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.952 . . . . 72.15 110.118 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 123.841 1.443 . . . . 73.13 110.422 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.213 0.53 . . . . 74.31 110.177 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -106.53 -89.57 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 74.42 110.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' B' ' 3' ' ' LEU . 3.4 pp -96.36 136.79 36.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.845 . . . . 72.31 110.14 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.26 45.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 73.43 110.278 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -145.22 -51.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 75.2 110.217 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 8.9 ttt180 -55.87 -19.47 11.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 73.53 110.211 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -38.04 28.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 71.11 109.698 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.58 -41.06 24.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 72.32 109.852 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ttp -66.92 -48.92 67.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 73.03 110.195 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.438 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.99 -30.52 25.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 64.22 110.11 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.15 110.08 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.1 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.464 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.13 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 11' ' ' ALA . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.32 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 73.22 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.2 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 72.2 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.12 110.188 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 75.13 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.41 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 71.42 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 63.31 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' B' ' 17' ' ' ALA . 0.2 OUTLIER -63.92 -162.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 74.44 110.245 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.42 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.7 t -82.4 161.99 22.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 62.42 110.246 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.33 81.86 1.86 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 74.53 110.254 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.466 ' HD2' HG22 ' B' ' 28' ' ' VAL . 45.8 Cg_endo -72.7 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 75.14 110.477 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.23 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.57 -1.412 . . . . 74.54 109.57 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.466 HG22 ' HD2' ' B' ' 26' ' ' PRO . 53.3 t -91.41 -47.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -1.168 . . . . 70.33 110.225 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 30' ' ' ARG . . . -117.93 -74.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 74.42 110.192 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.464 ' O ' ' CB ' ' B' ' 31' ' ' ALA . 2.5 mtp-105 -60.61 -142.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 75.14 110.181 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' B' ' 30' ' ' ARG . . . 65.86 25.44 11.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 73.42 110.236 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.93 -25.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 75.55 110.185 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 t -52.06 107.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 55.21 110.29 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -146.06 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 72.41 109.589 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 5.5 mt-30 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.304 -1.115 . . . . 74.32 110.148 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.535 -1.426 . . . . 74.53 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.75 -147.14 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 65.02 110.198 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.0 OUTLIER 60.94 86.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 73.31 110.219 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.45 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.2 ttm -179.56 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 75.3 110.365 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.25 118.32 33.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 72.24 110.143 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.89 128.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 71.14 110.012 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.14 170.02 16.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 74.14 110.145 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 82.7 m95 -109.22 -71.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 75.32 110.225 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.401 ' O ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -153.95 126.98 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 74.31 110.346 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 81' ' ' GLN . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 74.04 110.13 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.44 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.543 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.14 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.526 ' CD1' HG12 ' A' ' 51' ' ' VAL . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.1 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 48' ' ' ILE . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.22 109.88 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 72.44 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.21 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.32 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.537 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.54 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.41 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.41 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.537 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.52 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.555 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.43 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.44 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.11 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.497 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.32 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.44 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.44 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.32 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 73.05 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.31 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 65.01 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.53 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 73.55 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 65.03 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.502 ' SG ' ' CG2' ' A' ' 49' ' ' VAL . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 71.43 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.31 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.13 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.453 ' HB2' HG11 ' A' ' 50' ' ' VAL . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.15 110.182 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.15 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 74.21 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.11 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.13 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 72.43 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 71.31 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.53 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.46 ' O ' HD21 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 75.4 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.32 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.21 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.3 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 HG12 ' CD1' ' A' ' 13' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 74.13 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.12 110.189 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 74.42 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 8' ' ' TRP . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.44 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.34 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 75.53 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.44 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 72.12 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 ' N ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.22 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 61' ' ' GLN . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.33 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.491 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 74.25 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 63.54 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.521 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.553 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 74.52 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 74.24 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.55 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.553 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 75.13 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 74.41 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.44 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 74.1 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 60.12 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.41 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.449 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.33 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 72.11 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 64.33 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 72.23 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.507 ' CD1' HD22 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.43 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.33 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.32 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -100.11 132.97 45.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.42 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.452 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.59 111.01 7.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 64.42 110.159 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -156.68 138.64 14.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 74.33 110.376 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -103.56 145.96 29.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 72.04 110.184 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -167.36 -169.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 71.11 110.233 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 3.2 pt20 -105.65 143.09 34.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 73.22 110.289 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 87' ' ' GLU . . . 48.53 -173.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.549 -1.42 . . . . 74.22 109.549 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' GLY . 1.9 mt-10 42.91 54.19 4.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -1.158 . . . . 73.13 110.224 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' O ' HG21 ' A' ' 89' ' ' THR . 6.2 mt-10 -69.76 143.66 52.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 71.44 110.174 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -158.15 134.86 6.56 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.143 -0.973 . . . . 73.44 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.0 1.527 . . . . 74.24 110.412 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.29 0.567 . . . . 75.22 110.253 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.406 ' CG ' ' N ' ' B' ' 3' ' ' LEU . 2.0 ptpt -145.58 -41.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 72.13 110.234 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' B' ' 3' ' ' LEU . 2.6 tt -94.34 116.25 28.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.211 -0.93 . . . . 73.52 110.118 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.09 30.49 2.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 75.51 110.117 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 -63.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 74.25 110.22 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.1 OUTLIER -48.57 -23.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 74.13 110.253 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.523 ' CB ' HD23 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -80.05 -35.74 36.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 72.5 109.731 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.7 t80 -80.61 -41.53 23.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 70.31 109.763 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.2 ttp -67.93 -47.52 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 71.52 110.031 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.526 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.94 -31.67 63.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 74.51 110.107 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 74.32 110.101 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.31 110.05 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 74.23 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.22 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 72.51 110.047 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.32 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.55 110.077 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.34 110.061 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 71.24 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 54.13 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.22 110.183 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 72.42 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.414 ' HG ' ' OE1' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -70.04 -163.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 73.41 110.215 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.425 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 0.5 OUTLIER -79.48 162.26 25.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 71.44 110.172 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 20.8 m -112.16 71.74 1.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 63.53 110.244 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.516 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 44.8 Cg_endo -72.48 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.942 1.496 . . . . 74.2 110.562 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 29' ' ' ALA . . . -43.35 -26.61 0.63 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 73.12 109.732 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.458 ' CG2' ' HB ' ' B' ' 25' ' ' VAL . 63.8 t -42.39 -26.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 75.11 110.297 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 27' ' ' GLY . . . -111.3 -39.2 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 75.22 110.232 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.23 46.02 19.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 64.4 110.249 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.47 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -84.96 -1.37 56.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 74.02 110.256 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 34' ' ' GLY . 3.5 t 64.19 11.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.915 . . . . 73.42 110.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.9 t 65.11 -66.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.603 -0.686 . . . . 63.41 110.265 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -171.73 69.16 0.12 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.493 -1.443 . . . . 63.21 109.493 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' B' ' 34' ' ' GLY . 10.7 tp60 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.24 -1.153 . . . . 64.32 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 73.04 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.04 -39.2 3.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -1.062 . . . . 74.13 110.234 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 4' ' ' MET . 60.9 m-70 -118.97 120.68 37.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 75.41 110.148 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 178.65 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 63.22 110.307 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.446 ' O ' ' OG1' ' A' ' 6' ' ' THR . 11.8 p80 -114.37 116.26 28.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 75.31 110.194 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 15.8 m -167.34 125.96 1.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 70.5 110.175 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.459 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 32.6 m120 -142.22 146.45 35.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 72.3 110.23 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -103.94 -69.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.885 . . . . 75.4 109.97 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 -152.96 121.56 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 75.21 109.995 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 81' ' ' GLN . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 74.51 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.42 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.561 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.34 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 73.41 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' B' ' 17' ' ' ALA . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.01 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.506 ' CG2' HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 74.13 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 73.32 110.046 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.4 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.42 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.14 110.986 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.22 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.52 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.41 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 75.32 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.04 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.489 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 75.13 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 65.01 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 72.05 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 73.42 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 74.03 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.459 ' HB2' HG23 ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 64.03 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 63.52 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.13 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 74.4 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.23 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.33 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 70.22 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 75.01 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.13 110.231 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' HG12 ' A' ' 48' ' ' ILE . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.12 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 74.41 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' C ' ' CD ' ' A' ' 43' ' ' PRO . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 75.55 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.21 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.5 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.15 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 73.05 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.31 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.31 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.524 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 75.54 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.512 ' CD1' HD13 ' B' ' 23' ' ' LEU . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 74.12 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 75.43 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 64.23 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 72.31 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 72.0 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.32 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.42 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 74.11 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 71.43 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 74.03 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 74.34 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.24 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.442 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.12 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.43 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 64' ' ' GLU . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.1 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.54 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 75.04 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 62.33 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 HG23 ' N ' ' A' ' 67' ' ' ARG . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 74.45 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.21 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.04 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 74.43 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 73.54 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 35.42 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.465 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 75.14 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.483 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 72.23 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 63.42 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' CG1' ' O ' ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 73.41 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 74.31 110.042 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.34 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.12 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 74.14 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -93.59 136.59 33.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 74.5 110.237 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.524 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.6 112.27 8.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.888 . . . . 73.33 110.388 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.08 138.84 17.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 73.5 110.234 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 44.6 mt-10 -96.36 136.72 36.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 63.35 110.234 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.52 -172.67 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 71.52 110.187 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.37 163.56 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 72.03 110.218 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.44 139.97 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.619 -1.392 . . . . 73.32 109.619 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.64 55.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 75.34 110.285 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 4.9 pt-20 -106.46 -164.39 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 65.25 110.23 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 110.09 30.58 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.382 -0.824 . . . . 73.33 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 123.933 1.491 . . . . 70.44 110.433 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.267 0.556 . . . . 73.15 110.222 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.45 85.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 74.33 110.218 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.67 -53.59 4.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 74.05 110.158 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -176.06 -63.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 74.5 110.312 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.481 ' C ' ' CD ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -163.49 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 73.11 110.245 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -69.16 -20.48 64.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 73.25 110.145 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -78.79 -39.99 34.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 74.42 109.806 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.51 -41.18 24.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.873 . . . . 74.03 109.853 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.48 -53.24 51.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 72.41 110.291 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.441 ' O ' HG12 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.76 -33.45 10.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.912 . . . . 71.31 110.152 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.448 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 73.33 110.084 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 65.01 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.14 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.448 HG22 ' O ' ' B' ' 11' ' ' ALA . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 74.44 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.501 ' HA ' ' CG2' ' B' ' 28' ' ' VAL . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 70.33 110.1 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.452 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 75.33 110.197 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.409 ' HB3' HG22 ' A' ' 14' ' ' VAL . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.41 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 72.12 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.14 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 72.32 110.096 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.41 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -69.96 -162.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.4 110.461 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.457 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 7.5 p -79.72 162.43 25.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 74.4 110.105 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.48 ' CG2' ' HB1' ' B' ' 29' ' ' ALA . 4.2 p -108.45 78.33 0.85 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 74.44 110.243 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.6 Cg_endo -72.66 -89.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.024 1.539 . . . . 71.2 110.534 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.47 -11.64 83.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.59 -1.404 . . . . 64.44 109.59 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.501 ' CG2' ' HA ' ' B' ' 15' ' ' ALA . 57.8 t -58.87 -17.12 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 75.13 110.131 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.48 ' HB1' ' CG2' ' B' ' 25' ' ' VAL . . . -116.07 -27.89 6.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 64.13 110.175 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -91.77 23.66 3.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -0.855 . . . . 73.13 110.353 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.33 -2.04 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 72.22 110.274 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.434 HG23 ' N ' ' B' ' 33' ' ' VAL . 33.6 m -112.16 -17.95 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.228 -0.92 . . . . 75.14 110.158 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.434 ' N ' HG23 ' B' ' 32' ' ' VAL . 57.6 t -82.26 -72.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 74.04 110.256 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.29 153.24 14.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.52 -1.432 . . . . 73.4 109.52 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.227 -1.161 . . . . 74.14 110.242 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.499 -1.44 . . . . 74.42 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -93.27 70.7 4.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -1.16 . . . . 73.23 110.159 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 146.13 42.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 75.35 110.241 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.16 70.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 71.32 110.206 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 27.9 p80 -142.55 120.22 11.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 74.32 110.22 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -163.44 112.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 75.3 110.247 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -150.93 171.57 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 73.12 110.213 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.95 -74.37 0.66 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 75.44 110.24 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.44 125.96 2.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 74.0 110.196 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 75.31 110.233 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' ' CD1' ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 64.23 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.538 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.13 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' CD1' ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.44 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 76' ' ' SER . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 74.4 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 75.31 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.528 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 74.41 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.41 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.536 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 73.12 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.13 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.42 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.2 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.559 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.32 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.31 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.455 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 74.35 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.468 HD11 HG12 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 75.4 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 74.4 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.52 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.3 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.465 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 74.34 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.462 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.41 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 70.14 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.51 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 74.23 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.3 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 64.54 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 55.45 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.54 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.33 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.03 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 74.14 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.44 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 74.35 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.55 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.23 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 62.35 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.556 ' CG ' ' CD1' ' B' ' 23' ' ' LEU . 6.9 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 65.42 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.45 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.493 ' CD1' ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 75.12 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.448 HG23 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 71.14 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.482 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 72.4 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG11 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 73.45 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.32 110.256 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.512 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.01 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.34 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 73.33 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 53.42 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.02 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.512 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.52 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HG ' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 72.33 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 71.44 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.447 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 72.55 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 74.31 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.502 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 72.32 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 71.23 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.55 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 74.23 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.45 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 71.33 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 70' ' ' GLU . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.3 110.624 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 63.13 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 70.33 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.24 110.198 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 74.32 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 HD23 ' A' ' 77' ' ' LEU . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 73.31 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 74.41 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 74.42 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 65.23 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.538 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 73.23 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -101.82 130.75 48.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.02 110.265 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -139.52 105.47 5.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 75.14 110.241 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.429 ' OE1' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -152.26 138.7 18.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 75.11 110.339 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 85' ' ' GLN . 3.9 mm-40 -92.73 148.88 21.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 75.33 110.272 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.51 ' CG ' ' C ' ' A' ' 83' ' ' GLU . 14.1 pt-20 32.67 29.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.108 0.48 . . . . 72.35 111.623 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' GLU . 22.3 mt-30 -146.94 -178.53 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 73.13 110.267 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' HA3' ' OE1' ' A' ' 82' ' ' GLN . . . 76.6 -166.12 54.03 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.561 -1.416 . . . . 53.03 109.561 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.62 11.09 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.123 . . . . 72.4 110.192 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -132.41 110.59 10.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 75.15 110.255 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.442 HG22 ' HD2' ' A' ' 90' ' ' PRO . 5.1 m -166.19 137.53 2.93 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 75.3 110.131 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.442 ' HD2' HG22 ' A' ' 89' ' ' THR . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.964 1.507 . . . . 73.43 110.454 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.359 0.599 . . . . 72.31 110.163 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.402 ' HB3' ' HE3' ' B' ' 2' ' ' LYS . 10.8 mmmt -102.17 90.14 3.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 71.34 110.227 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.449 ' O ' HD12 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -69.47 -28.06 65.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 74.51 110.128 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.95 54.8 0.86 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -0.886 . . . . 73.42 110.065 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 -68.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 74.43 110.223 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -52.51 -25.8 11.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 73.53 110.174 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.53 35.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 71.22 109.613 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -77.18 -38.42 51.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 73.44 109.597 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.75 -55.34 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 75.43 110.025 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.461 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER -53.72 -35.79 61.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 74.34 109.998 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.464 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.43 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.22 110.072 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.1 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.517 ' CG2' ' HG2' ' B' ' 26' ' ' PRO . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.23 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' B' ' 28' ' ' VAL . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.32 110.006 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 70.11 110.1 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.33 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 70.03 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 74.45 110.134 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.491 ' CB ' HG12 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 64.35 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 75.5 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.556 ' CD1' ' CG ' ' A' ' 46' ' ' GLN . 3.9 tp -69.11 -162.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 75.53 110.396 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 41.7 t -83.13 162.2 21.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.447 -0.783 . . . . 74.41 110.351 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.427 ' HA ' HG21 ' B' ' 28' ' ' VAL . 26.8 m -108.15 77.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 64.13 110.089 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.517 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 46.0 Cg_endo -72.45 -50.34 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.954 1.502 . . . . 72.2 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.4 34.89 0.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.441 -1.464 . . . . 74.21 109.441 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.482 ' HA ' ' CB ' ' B' ' 15' ' ' ALA . 86.8 t -49.44 -71.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -1.046 . . . . 74.44 110.188 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' B' ' 28' ' ' VAL . . . 173.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -0.832 . . . . 75.13 110.105 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -103.07 92.13 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 70.13 110.301 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.57 -23.14 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 64.53 110.194 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -78.87 -30.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 73.44 110.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -122.02 -60.08 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 72.01 110.174 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.82 -64.81 0.25 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.558 -1.417 . . . . 52.25 109.558 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 70.33 110.201 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 75.44 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -79.99 -89.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -1.19 . . . . 74.25 110.165 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.1 OUTLIER -86.19 63.8 8.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.183 -0.948 . . . . 63.12 110.202 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.7 tpp -178.76 100.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 73.35 110.365 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 18.5 p80 -114.13 119.64 37.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 75.32 110.2 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.96 126.44 1.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 75.15 110.1 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -142.24 158.24 43.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.902 . . . . 73.01 110.28 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -102.6 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 74.41 110.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.429 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 1.0 OUTLIER -153.4 124.29 7.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 75.44 110.181 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 81' ' ' GLN . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.14 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.42 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.55 ' OG ' ' CD1' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.41 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.523 HD21 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 74.41 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG13 ' CD1' ' B' ' 23' ' ' LEU . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 74.22 109.933 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 73.43 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.492 ' CB ' ' HB2' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.54 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.43 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.53 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 74.2 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.42 110.863 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.11 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.53 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 75.15 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.11 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.51 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 74.22 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.486 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 74.53 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.31 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 74.43 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.51 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.486 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 73.41 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.443 ' HB2' HG22 ' A' ' 37' ' ' VAL . 20.9 t-20 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.2 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 63.31 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 73.45 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.35 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 73.1 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' SG ' ' CG2' ' A' ' 49' ' ' VAL . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 75.43 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.11 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.3 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 75.11 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.23 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.2 110.36 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.43 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.42 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 74.52 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 74.41 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.24 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.524 HD13 ' CB ' ' B' ' 17' ' ' ALA . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.34 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 73.11 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.509 HG13 ' CB ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 75.41 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG13 ' CD1' ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.4 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HB3' HG21 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 72.3 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' CB ' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 70.14 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 63.22 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.42 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.52 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.475 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.51 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.579 ' CG2' ' CB ' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.34 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 74.11 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.501 HG13 ' N ' ' A' ' 61' ' ' GLN . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 73.12 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.501 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.03 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.24 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.493 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 74.14 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.2 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 71.11 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.14 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.35 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.512 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.42 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.12 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.44 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 74.12 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.465 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 75.15 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.22 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 62.21 110.334 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 14' ' ' VAL . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 62.11 109.833 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.551 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 72.12 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 72.24 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.562 ' CE2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.31 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' NE2' ' NE2' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -93.55 136.72 33.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.4 110.147 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.516 ' O ' ' CG1' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -133.21 112.26 11.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 75.31 110.304 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' A' ' 81' ' ' GLN . 4.6 pt20 -151.68 138.7 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 63.54 110.287 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.8 mp0 -78.1 119.55 21.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 54.44 110.264 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -172.51 28.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 72.42 110.264 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' GLU . 9.7 pt20 37.52 47.73 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.64 -0.663 . . . . 74.22 110.776 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 172.02 48.62 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 61.14 109.587 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -153.14 28.61 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -1.154 . . . . 74.42 110.203 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.96 157.22 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 74.13 110.181 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.408 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.2 OUTLIER -87.67 171.81 9.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 74.21 110.163 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 45.6 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 124.105 1.582 . . . . 73.22 110.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.191 0.519 . . . . 74.51 110.276 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 22.84 8.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.876 . . . . 72.34 110.161 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.0 tp -106.37 88.46 2.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 72.45 110.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.5 p -148.94 42.34 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 75.12 110.197 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.0 -34.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 73.2 110.259 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -56.76 -20.65 23.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 74.21 110.231 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -39.27 32.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 74.5 109.735 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.535 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.55 -41.59 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 75.01 109.787 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.406 ' SD ' ' HG3' ' A' ' 81' ' ' GLN . 5.2 ttp -67.75 -47.65 68.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 74.12 110.246 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.464 ' O ' HG23 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.71 -28.16 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.852 . . . . 75.13 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 74.24 110.073 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.05 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.562 ' HA ' ' CE2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 71.12 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.12 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 73.23 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 71.33 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.524 ' CB ' HD13 ' A' ' 48' ' ' ILE . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.2 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' B' ' 14' ' ' VAL . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 64.55 110.1 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 65.42 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 64.4 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.41 110.119 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 54.45 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.469 ' CD1' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -68.23 -162.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 73.54 110.277 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.461 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.7 OUTLIER -82.47 162.25 22.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 34.05 110.359 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' B' ' 28' ' ' VAL . 6.8 p -107.4 83.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 62.13 110.22 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.0 Cg_endo -71.8 -56.66 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.971 1.511 . . . . 71.23 110.533 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.2 36.24 1.94 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.514 -1.435 . . . . 72.4 109.514 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' B' ' 25' ' ' VAL . 57.8 t -64.35 -52.18 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -1.115 . . . . 74.35 110.286 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.98 -1.48 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 74.11 110.279 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 46.93 37.3 4.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 73.04 110.119 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -75.26 -1.05 21.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 73.41 110.268 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 4.9 t 64.36 9.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 73.04 110.298 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -92.81 -179.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.426 -0.796 . . . . 75.03 110.061 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.32 -98.44 0.27 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.496 -1.442 . . . . 52.13 109.496 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.248 -1.148 . . . . 74.14 110.246 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.602 -1.399 . . . . 75.1 109.602 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.58 128.75 42.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.196 . . . . 73.4 110.193 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' ND1' ' CD2' ' A' ' 5' ' ' HIS . 1.6 t-160 -109.7 -141.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 74.51 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.19 71.01 0.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 74.54 110.167 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.519 ' CD2' ' ND1' ' A' ' 3' ' ' HIS . 94.0 m-70 -140.11 123.41 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -0.958 . . . . 74.25 110.268 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.34 121.37 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 73.31 110.177 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -142.31 166.51 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 64.12 110.1 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -102.66 -79.85 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 74.42 110.125 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 -163.76 129.07 2.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 74.15 110.267 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 81' ' ' GLN . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.34 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 79' ' ' TYR . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.32 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.523 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 73.4 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 75.11 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 71.44 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 71.41 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.43 ' HG2' ' HG ' ' A' ' 73' ' ' LEU . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 73.31 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.523 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 64.11 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.42 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.31 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.32 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 74.54 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.4 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 61.12 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.458 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 75.13 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.493 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 74.42 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 64.23 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 63.42 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.04 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 75.22 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.23 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.44 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 74.32 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.21 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 73.42 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 64.1 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.44 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 73.42 110.267 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 75.51 110.128 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.51 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.42 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.44 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.11 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 74.34 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.22 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.45 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' O ' HD22 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.13 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 73.32 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 65.24 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.51 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.11 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.456 ' O ' HG11 ' A' ' 51' ' ' VAL . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 70.34 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.405 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.43 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 63.32 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 72.5 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 75.04 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 73.21 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.4 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.466 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.13 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 ' O ' HG21 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.31 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 74.23 109.87 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.3 110.516 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.34 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.541 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 74.44 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.05 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.02 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.53 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.44 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 73.13 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 65.14 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.4 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.506 HG22 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 74.43 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.44 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 72.13 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.44 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 74.45 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.22 110.33 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.24 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 73.01 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 75.12 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.492 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 73.53 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' CE1' ' NE2' ' A' ' 82' ' ' GLN . 2.1 t-160 -94.55 136.58 34.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.41 110.21 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.453 ' O ' HG12 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -133.52 108.81 8.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 72.14 110.274 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' CE1' ' A' ' 80' ' ' HIS . 3.4 pt20 -161.4 138.71 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 73.03 110.21 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -99.95 118.71 36.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 74.22 110.27 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -155.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 70.23 110.166 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.8 49.81 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.144 -0.972 . . . . 64.1 110.163 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.04 154.01 11.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 65.51 109.528 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.4 mm-40 -134.57 0.87 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -1.155 . . . . 71.1 110.281 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 89' ' ' THR . 60.7 mm-40 38.83 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.442 -0.786 . . . . 54.43 110.963 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.522 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 177.87 61.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 73.14 110.179 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.764 0 O-C-N 123.985 1.519 . . . . 74.32 110.408 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.32 0.581 . . . . 72.43 110.276 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -103.72 65.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 74.45 110.181 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' B' ' 5' ' ' ARG . 3.3 pp -77.13 -28.88 54.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 74.44 110.238 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.41 ' O ' HD11 ' B' ' 3' ' ' LEU . 0.9 OUTLIER 57.18 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 64.42 110.19 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 3' ' ' LEU . 1.1 tmm_? -158.59 -37.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 74.42 110.289 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.3 OUTLIER -56.67 -22.14 32.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 65.33 110.093 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.443 ' CB ' ' HB2' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -78.08 -40.39 38.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 61.02 109.682 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.56 -41.49 24.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.455 -0.778 . . . . 74.31 109.694 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.417 ' HE3' HG11 ' A' ' 50' ' ' VAL . 14.7 ttp -66.74 -47.18 73.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 72.34 110.116 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.498 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.62 -32.28 7.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 71.13 110.049 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.462 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 71.24 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.21 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 62.23 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.22 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 65.12 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 63.24 110.068 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 62.31 110.101 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.31 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 72.25 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 70.31 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.445 ' HB1' HD11 ' B' ' 23' ' ' LEU . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 75.41 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 71.01 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.461 HD12 ' OE1' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -69.89 -162.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 75.34 110.346 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.7 t -82.85 162.16 21.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 74.33 110.251 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.434 HG21 ' CG2' ' B' ' 28' ' ' VAL . 7.6 p -107.46 83.27 1.47 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.4 110.138 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.2 Cg_endo -71.73 -90.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.029 1.541 . . . . 73.54 110.518 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -117.2 52.16 0.7 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.648 -1.381 . . . . 74.44 109.648 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.434 ' CG2' HG21 ' B' ' 25' ' ' VAL . 51.7 t -43.93 -26.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -1.128 . . . . 75.43 110.177 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' B' ' 30' ' ' ARG . . . -91.64 -53.2 4.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 75.51 110.29 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' B' ' 29' ' ' ALA . 15.5 ttt85 56.7 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 75.3 110.089 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' B' ' 30' ' ' ARG . . . 64.81 17.44 10.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 73.2 110.334 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 33' ' ' VAL . 61.4 t -71.51 -28.6 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 74.41 110.176 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 32' ' ' VAL . 10.9 t 60.16 126.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 71.41 110.227 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.79 -147.24 10.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.566 -1.414 . . . . 62.42 109.566 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.289 -1.124 . . . . 72.14 110.205 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.578 -1.409 . . . . 41.24 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -126.0 -45.34 1.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -1.148 . . . . 64.41 110.324 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' SER . 21.4 t-80 60.06 143.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 75.53 110.237 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.8 tpp -177.33 73.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 74.42 110.196 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 82.8 m-70 -116.44 118.68 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 75.41 110.225 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 14.0 m -166.83 121.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 74.1 110.192 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -152.22 163.34 39.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 74.21 110.339 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -109.2 -69.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 75.22 109.946 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -153.07 121.34 6.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 74.21 109.728 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.21 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.31 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.22 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.31 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 75.34 109.953 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.46 ' OE1' ' HB3' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.21 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 64.23 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 74.43 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.53 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.33 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.53 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 73.11 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 71.14 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.506 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.42 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.469 ' O ' HD21 ' A' ' 29' ' ' LEU . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 73.14 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.35 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.22 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.54 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.469 HD21 ' O ' ' A' ' 25' ' ' ILE . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.43 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.525 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 71.5 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.4 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.567 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 74.34 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.43 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 70.34 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.52 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.51 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 75.11 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB3' ' HE2' ' B' ' 9' ' ' MET . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 71.3 110.24 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 75.23 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.24 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.523 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 74.13 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 73.31 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 63.44 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.14 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 44.12 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' O ' HD21 ' A' ' 47' ' ' LEU . 3.7 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 75.51 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 72.21 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.43 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.42 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 75.52 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.41 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.473 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.51 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 72.13 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 73.34 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.03 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.34 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.21 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 74.23 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 64.14 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 61' ' ' GLN . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.5 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.487 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 74.21 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.14 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 64' ' ' GLU . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 71.24 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.538 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 74.13 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.522 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 55.35 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.43 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.01 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.51 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.523 ' CG1' HG21 ' A' ' 72' ' ' VAL . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 70.32 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 74.41 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 71.34 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.523 HG21 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.32 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 72.44 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 64.24 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 74.44 110.393 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.11 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.541 ' HB2' ' CD1' ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 75.52 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 74.42 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.44 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 132.56 36.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.506 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -139.43 111.32 7.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 72.35 110.234 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -154.9 138.7 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 72.23 110.321 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 4.9 tm-20 -83.93 148.79 26.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 74.34 110.216 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.42 -101.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.87 . . . . 73.41 110.184 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -108.76 58.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 65.12 110.15 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.48 135.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 44.5 109.456 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 42.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -1.143 . . . . 71.32 110.271 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 7.9 pt-20 -111.21 135.01 52.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 72.11 110.184 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.416 HG21 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -157.05 58.42 1.56 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 74.51 110.204 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.305 -1.743 0 O-C-N 124.004 1.528 . . . . 71.34 110.366 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.236 0.541 . . . . 72.53 110.343 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -66.53 -46.68 75.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 72.14 110.156 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' B' ' 4' ' ' SER . 0.5 OUTLIER -96.62 -63.46 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 74.44 109.78 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.426 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 10.0 t 59.3 19.84 8.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 70.24 110.253 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.424 ' HG3' ' N ' ' B' ' 6' ' ' ARG . 1.6 tpt180 -153.53 -72.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 75.12 110.273 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.6 ttt85 -57.13 -29.78 63.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 75.21 110.214 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -75.12 -41.25 58.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 74.32 109.66 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.58 -37.61 30.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.455 -0.778 . . . . 73.03 109.749 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 6.2 ttp -67.35 -55.62 13.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 74.4 110.194 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.465 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER -54.46 -27.87 40.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 74.55 110.138 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.463 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 40.14 110.159 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.447 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.24 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 70.41 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.51 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 12' ' ' ASN . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 73.14 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.463 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 74.44 110.066 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 70.11 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 73.52 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.33 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 51.54 110.18 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 72.0 110.237 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.34 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.507 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -64.39 -162.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.51 110.322 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.6 OUTLIER -81.91 162.14 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 62.42 110.23 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 15.9 m -107.81 82.86 1.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 74.42 110.182 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.9 Cg_endo -71.89 -90.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.124 1.592 . . . . 71.42 110.464 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.05 38.76 3.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.58 -1.408 . . . . 74.4 109.58 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.1 t -90.43 -71.15 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -1.151 . . . . 65.2 110.308 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -165.91 73.98 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 71.02 110.217 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 178.48 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 60.34 110.336 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.0 59.14 4.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.536 -0.728 . . . . 71.5 110.185 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.87 -41.58 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 72.33 110.254 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.409 ' O ' HG11 ' B' ' 33' ' ' VAL . 2.1 p -141.69 127.63 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 72.25 110.209 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.82 -118.46 4.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.507 -1.437 . . . . 75.24 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.199 -1.177 . . . . 73.24 110.222 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.616 -1.394 . . . . 70.13 109.616 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 1.7 p -133.82 70.09 1.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.166 . . . . 65.2 110.28 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 2' ' ' SER . 2.1 t60 178.25 72.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -0.888 . . . . 74.24 110.198 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 10.9 ttm -178.71 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 74.3 110.263 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.462 ' O ' HG22 ' A' ' 6' ' ' THR . 52.4 m-70 -115.3 116.26 28.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 74.33 110.237 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -167.25 119.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 63.45 110.073 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.519 ' ND2' HG11 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -152.29 165.46 34.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 74.24 110.495 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.506 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 92.9 m95 -104.98 -69.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.798 . . . . 74.44 109.954 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 121.65 6.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.935 . . . . 74.44 109.989 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 81' ' ' GLN . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.44 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 72.41 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' OG ' ' CG1' ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.31 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.513 HD13 ' CG1' ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 74.24 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 74.11 110.022 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.53 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' OE1' ' HB3' ' A' ' 46' ' ' GLN . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.22 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.33 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 73.21 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.04 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.33 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.529 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 75.1 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 72.55 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.12 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.03 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.47 ' O ' HD23 ' A' ' 29' ' ' LEU . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 73.13 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 65.44 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 75.14 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.1 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.22 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.23 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 75.41 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 72.33 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 71.24 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 75.52 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.54 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.32 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 72.13 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.12 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 71.2 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 75.51 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.34 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 74.43 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.05 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.44 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 50.11 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.461 ' HB3' ' OE1' ' A' ' 16' ' ' GLN . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 74.23 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.35 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 48' ' ' ILE . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.02 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 75.22 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' CG1' ' OG ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 74.0 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.513 ' CG1' HD13 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.03 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.33 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.527 ' HB2' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.21 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 64.21 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 75.25 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 74.24 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.45 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.03 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 53' ' ' ALA . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.21 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.514 ' CG1' ' O ' ' A' ' 57' ' ' GLU . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 74.24 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 75.34 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.31 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 64' ' ' GLU . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 71.21 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.549 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.43 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 60.51 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.522 HG22 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 75.32 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.43 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 73.33 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.22 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.521 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.31 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' HB1' ' A' ' 17' ' ' ALA . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.505 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 73.52 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.32 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 70.52 110.292 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 71.24 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 61.33 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.23 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.506 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.21 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -102.49 126.31 49.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.43 109.857 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -130.4 112.1 12.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 73.31 110.323 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -153.74 138.63 17.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 72.23 110.178 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -94.75 119.09 32.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 75.12 110.244 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 83' ' ' GLU . 1.8 mt-10 65.89 -66.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 72.02 110.039 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 8' ' ' TRP . 0.0 OUTLIER -42.03 147.49 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.531 -0.73 . . . . 74.24 110.32 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 87' ' ' GLU . . . -163.53 -134.76 1.7 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.45 -1.46 . . . . 71.34 109.45 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 25.0 mt-10 61.97 59.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -1.124 . . . . 64.23 110.197 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' CE1' ' A' ' 80' ' ' HIS . 7.1 pt-20 -117.53 140.77 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 74.21 110.295 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 p -87.49 137.66 32.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 74.45 110.198 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.919 1.484 . . . . 74.3 110.442 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.333 0.587 . . . . 73.52 110.228 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -93.41 -9.77 37.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 75.4 110.273 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' B' ' 5' ' ' ARG . 0.9 OUTLIER -79.8 -24.86 41.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 74.12 110.26 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.75 59.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 74.03 110.176 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -174.12 -33.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 75.44 110.23 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -65.0 -18.22 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 74.51 110.199 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -38.53 30.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 64.33 109.722 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.9 OUTLIER -80.61 -42.81 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 72.24 109.748 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 8.4 ttp -67.44 -45.38 76.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.888 . . . . 71.12 110.067 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.465 ' O ' HG21 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -50.69 -27.0 6.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 74.34 110.091 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 74.23 110.148 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.506 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 74.05 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.526 ' CG2' ' HG2' ' B' ' 26' ' ' PRO . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.14 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 72.41 110.09 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.405 ' O ' ' HB1' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.44 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 72.02 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 61.3 110.163 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 71.35 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.32 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 72.54 110.183 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 62.31 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' B' ' 17' ' ' ALA . 0.1 OUTLIER -69.86 -162.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 75.43 110.211 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.43 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 15.5 m -78.18 162.07 26.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 73.32 110.243 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 m -109.86 74.54 0.76 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 74.31 110.379 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.526 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 46.8 Cg_endo -73.16 -90.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.998 1.525 . . . . 72.44 110.376 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -108.68 48.65 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.472 . . . . 72.15 109.421 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' B' ' 29' ' ' ALA . 79.4 t -41.49 -41.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -1.06 . . . . 63.41 110.34 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' B' ' 28' ' ' VAL . . . -176.67 -48.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 75.11 110.176 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -106.44 99.07 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 75.41 110.298 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.65 6.99 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 72.22 110.267 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 34' ' ' GLY . 88.4 t -62.3 -42.06 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 73.43 110.108 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 29.4 m -51.8 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 73.43 110.173 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -174.64 -70.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.607 -1.397 . . . . 75.24 109.607 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.295 -1.121 . . . . 63.11 110.201 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.551 -1.42 . . . . 44.52 109.551 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 3' ' ' HIS . 81.1 p -158.88 -80.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -1.177 . . . . 72.53 110.171 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' N ' ' OG ' ' A' ' 2' ' ' SER . 19.0 m-70 -158.74 162.53 37.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 74.34 110.143 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 4' ' ' MET . 3.0 ptp -159.63 70.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 63.33 110.281 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 23.0 p80 -142.21 119.6 11.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 64.13 110.252 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.35 119.55 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 74.12 110.165 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -142.83 148.94 37.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -0.852 . . . . 74.25 110.249 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 26.8 m95 -103.46 -69.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 72.34 110.093 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -153.56 122.67 6.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 74.43 110.138 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 HG22 ' OE1' ' A' ' 81' ' ' GLN . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 75.43 110.224 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.53 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.493 ' HB2' ' CD2' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.12 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.509 ' HA ' ' CB ' ' A' ' 77' ' ' LEU . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.32 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 76' ' ' SER . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 74.14 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 71.13 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.13 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.51 ' CA ' HD21 ' A' ' 73' ' ' LEU . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 74.34 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.54 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.558 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.35 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 61.43 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.41 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.505 ' O ' ' CD2' ' A' ' 29' ' ' LEU . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.1 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.558 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 73.34 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 74.01 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 73.25 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' CD2' ' O ' ' A' ' 25' ' ' ILE . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.15 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' HB2' HG11 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 74.41 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.54 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.42 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 74.11 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 54.0 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' SG ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.54 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.44 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.54 ' CB ' ' CE ' ' B' ' 9' ' ' MET . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 72.4 110.105 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.448 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 74.32 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 41.35 110.259 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.12 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 73.31 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 71.12 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 53.4 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 73.11 109.661 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' O ' HD22 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 73.13 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.43 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' B' ' 17' ' ' ALA . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.24 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.465 HG11 ' O ' ' A' ' 49' ' ' VAL . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 74.33 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 75.01 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.467 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 74.14 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.31 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.529 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 74.42 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 75.11 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.2 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.31 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 74.11 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.529 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.15 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 53' ' ' ALA . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.21 110.187 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.522 HG13 ' N ' ' A' ' 61' ' ' GLN . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.11 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.522 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 73.44 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.43 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.519 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.32 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.554 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.03 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.53 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.12 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 71.03 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.32 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.21 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 75.33 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.33 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.51 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG22 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.13 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 16' ' ' GLN . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 75.35 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.44 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 74.53 110.251 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.46 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.04 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.509 ' CB ' ' HA ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 75.02 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 74.41 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.567 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.23 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -96.8 127.9 43.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 73.41 110.139 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -137.61 109.69 7.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.864 . . . . 73.21 110.28 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 7.1 pt20 -159.99 138.62 10.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.908 . . . . 54.41 110.24 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.453 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 2.9 tp10 -90.12 119.69 30.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.243 -0.91 . . . . 71.43 110.281 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 1.4 pt-20 177.38 -30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 71.04 110.188 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 50.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 72.4 110.1 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.19 -135.34 4.59 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.436 . . . . 54.43 109.509 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 82' ' ' GLN . 0.8 OUTLIER 49.38 23.2 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 72.14 110.14 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -63.17 152.72 36.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 74.21 110.188 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.11 159.98 31.3 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 73.12 110.18 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.795 0 O-C-N 123.948 1.499 . . . . 74.33 110.349 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 73.34 110.203 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.519 ' O ' ' CD2' ' B' ' 3' ' ' LEU . 12.9 pttp -172.87 143.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 75.32 110.182 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -147.34 141.45 26.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.892 . . . . 72.3 110.266 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' B' ' 3' ' ' LEU . 8.1 t -177.98 -45.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.825 . . . . 72.52 110.078 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.481 ' O ' ' C ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -137.31 -35.73 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 73.14 110.025 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -34.77 -61.87 0.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.689 -0.632 . . . . 75.41 110.991 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 6' ' ' ARG . 0.9 OUTLIER -43.0 -43.66 4.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 65.01 110.379 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -81.22 -45.86 15.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 74.24 110.448 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.54 ' CE ' ' CB ' ' A' ' 38' ' ' ALA . 13.6 ttp -71.53 -55.74 7.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.016 -1.052 . . . . 74.12 109.79 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.3 -25.58 2.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 65.43 109.759 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.454 ' O ' HG23 ' B' ' 14' ' ' VAL . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 71.54 109.827 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.462 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 74.33 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.567 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.32 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.527 ' CG2' ' HG2' ' B' ' 26' ' ' PRO . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 75.32 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.492 ' HA ' ' CG2' ' B' ' 28' ' ' VAL . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 73.01 109.682 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 74.41 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.524 ' CB ' HD11 ' A' ' 48' ' ' ILE . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.45 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.41 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.01 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.34 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.31 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -162.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.42 110.356 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 2.3 m -79.0 162.23 26.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 72.0 110.292 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.453 HG23 ' HB ' ' B' ' 28' ' ' VAL . 2.7 p -107.63 82.81 1.41 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 72.22 110.192 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.527 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 45.1 Cg_endo -72.28 -54.64 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 72.45 110.443 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.23 33.65 2.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.574 -1.41 . . . . 71.13 109.574 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.492 ' CG2' ' HA ' ' B' ' 15' ' ' ALA . 29.2 t -94.49 -79.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 74.15 110.203 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.447 ' O ' ' CB ' ' B' ' 30' ' ' ARG . . . -101.23 -9.87 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 74.43 110.249 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 1.0 OUTLIER 64.96 110.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.12 110.243 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.31 -29.97 68.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 74.51 110.339 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.446 HG23 ' HG2' ' B' ' 30' ' ' ARG . 27.0 m -50.08 -21.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 74.51 110.281 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -151.15 157.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 72.31 110.128 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.81 78.22 0.1 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.496 -1.442 . . . . 70.42 109.496 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.276 -1.132 . . . . 73.35 110.162 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 55.53 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER -89.37 73.44 7.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -1.174 . . . . 73.34 110.147 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 1.7 m80 58.99 118.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 62.51 110.247 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.41 76.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 73.42 110.232 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -124.56 117.86 25.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 64.23 110.279 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 6' ' ' THR . 6.8 t -166.87 126.39 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 70.13 110.154 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.74 168.49 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 73.43 110.338 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.82 -69.66 0.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 63.44 110.095 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.48 124.44 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 62.31 110.194 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.35 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.13 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.519 ' CB ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 73.13 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.506 ' CD1' HG11 ' A' ' 51' ' ' VAL . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.22 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.34 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.2 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.447 ' HG2' ' HB1' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 63.4 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.3 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 75.11 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.43 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 73.05 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' HB2' ' CB ' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 75.14 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.546 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 75.3 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 74.42 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.45 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.498 ' CG1' ' N ' ' A' ' 26' ' ' SER . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.11 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 73.13 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.11 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.54 109.855 179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 74.04 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 70.32 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 28' ' ' GLN . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.31 110.185 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.12 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.13 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.34 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.15 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.41 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.23 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 74.33 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.34 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.41 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.41 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 75.0 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 74.24 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 71.32 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.1 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 64.55 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.11 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.464 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 72.23 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.525 ' CG2' ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 74.35 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG12 ' CB ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.53 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG11 ' CD1' ' A' ' 13' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 75.12 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 74.23 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 75.4 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.14 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.21 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.31 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.34 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.526 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.55 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 74.11 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.494 HG13 ' N ' ' A' ' 61' ' ' GLN . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.41 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.494 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.54 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 72.5 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 75.31 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 74.23 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.01 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG22 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 74.21 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.556 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.54 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.432 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 72.43 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.22 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 74.22 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.51 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.493 ' CG2' HD13 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.41 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.03 110.042 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 72.41 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.21 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.33 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.32 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 71.31 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.57 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.14 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.43 126.42 45.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.3 110.027 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.564 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 pp0? -139.68 112.0 7.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 75.11 110.317 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.496 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.6 pt20 -155.34 138.66 15.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 74.11 110.302 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.463 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 4.4 mm-40 -103.59 135.65 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 72.22 110.207 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 7.5 pt-20 177.62 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 75.53 110.12 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 7.4 mt-30 -156.9 147.03 21.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 74.23 110.231 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 88' ' ' GLU . . . -132.68 174.62 20.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.596 -1.401 . . . . 41.24 109.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 67.05 -59.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.332 -1.099 . . . . 72.34 110.229 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.6 pt-20 34.28 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.703 0.764 . . . . 74.54 111.487 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 47.78 96.39 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 74.32 110.176 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 124.026 1.54 . . . . 73.15 110.41 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.243 0.544 . . . . 70.5 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.78 -138.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 72.13 110.21 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -149.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 71.33 110.18 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.26 -16.07 9.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 74.32 110.298 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -147.84 -55.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 74.12 110.243 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -50.21 -21.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 73.34 110.174 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 35.6 t -81.05 -35.82 31.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 75.11 109.624 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.6 t80 -80.48 -41.49 24.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.498 -0.751 . . . . 72.4 109.911 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.2 ttp -66.86 -50.86 61.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 72.34 110.118 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.68 -29.12 16.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 75.22 110.086 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.459 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 74.13 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 72.42 110.055 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.57 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.41 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.52 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' HA ' ' CG1' ' B' ' 28' ' ' VAL . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.33 110.046 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.04 110.027 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' B' ' 23' ' ' LEU . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.4 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.423 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.21 110.18 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.33 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.5 110.146 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.04 110.227 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 75.41 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.453 ' CD2' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.47 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 73.42 110.518 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.426 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 23.5 t -82.93 158.74 22.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 71.21 110.412 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.472 ' HA ' HG21 ' B' ' 28' ' ' VAL . 15.3 m -107.56 85.18 2.17 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 74.12 109.909 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' B' ' 24' ' ' SER . 43.5 Cg_endo -70.07 -89.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.19 1.626 . . . . 75.13 110.972 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -92.4 -15.48 53.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.175 -1.17 . . . . 73.42 110.175 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' B' ' 15' ' ' ALA . 16.8 m -43.56 -42.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.226 . . . . 72.32 110.299 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.417 ' N ' HG22 ' B' ' 28' ' ' VAL . . . -179.66 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 72.24 110.267 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.427 ' NH1' ' CG ' ' B' ' 30' ' ' ARG . 1.8 mtt-85 63.75 88.59 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 73.54 110.253 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 30' ' ' ARG . . . -42.93 -55.52 3.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 72.2 110.288 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.434 HG11 ' CG2' ' B' ' 33' ' ' VAL . 9.3 p -46.5 -30.1 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 73.32 110.184 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.434 ' CG2' HG11 ' B' ' 32' ' ' VAL . 81.7 t -133.88 83.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 71.32 110.229 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.64 63.63 4.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.487 -1.445 . . . . 74.42 109.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -1.11 . . . . 74.11 110.226 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.529 -1.428 . . . . 63.32 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -92.37 -15.09 27.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -1.168 . . . . 63.52 110.242 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.6 t60 63.03 122.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 74.21 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttt -160.56 71.24 0.43 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 75.34 110.14 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.48 ' ND1' ' HG2' ' A' ' 83' ' ' GLU . 22.9 p80 -142.28 122.36 13.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 71.53 110.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 122.21 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 74.42 110.178 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -143.06 167.0 23.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 74.03 110.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . 0.501 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . 94.1 m95 -110.5 -73.56 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 72.31 110.195 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER -153.41 126.07 8.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 71.23 110.238 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 74.23 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.42 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.533 ' OG ' ' CD2' ' A' ' 79' ' ' TYR . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.34 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' CB ' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.13 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 72.2 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.449 HG23 HG11 ' A' ' 49' ' ' VAL . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 63.35 110.269 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.11 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 74.35 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.528 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 74.01 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.14 111.017 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.528 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.21 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.556 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 75.44 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 63.25 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.32 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 28' ' ' GLN . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.21 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.41 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 74.12 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 62.31 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.462 ' HB3' HG23 ' A' ' 49' ' ' VAL . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 75.33 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.58 ' ND2' ' CG2' ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 75.21 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 65.24 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 75.24 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.41 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.52 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.1 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 75.0 110.095 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.58 ' CG2' ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.44 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.22 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.13 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.04 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.491 ' C ' ' CD ' ' A' ' 43' ' ' PRO . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.41 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 63.12 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.491 ' CD ' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.32 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 74.23 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.31 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 73.1 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 41' ' ' ASP . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 75.34 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.522 HD13 HG21 ' A' ' 48' ' ' ILE . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.35 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.462 HG23 ' HB3' ' A' ' 29' ' ' LEU . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.22 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.51 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.454 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.34 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.14 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.525 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 75.23 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.44 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.31 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.51 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 75.4 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.2 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.457 ' CD2' ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 73.2 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.505 HG13 ' N ' ' A' ' 61' ' ' GLN . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 72.41 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.505 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.33 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' SER . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.1 110.444 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 64' ' ' GLU . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.32 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 75.22 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.529 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.32 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.11 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.12 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.41 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 74.13 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.33 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.02 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG23 HG12 ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.21 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.435 HD23 ' CA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 72.34 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.406 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.54 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.04 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.04 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' CB ' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 73.43 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.42 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 75.04 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 126.36 44.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.54 110.054 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.514 ' CG ' ' O ' ' A' ' 81' ' ' GLN . 1.3 pp0? -135.01 106.9 7.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 65.41 110.323 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.449 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 3.4 pt20 -161.47 138.45 8.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -0.854 . . . . 72.13 110.286 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.48 ' HG2' ' ND1' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -104.19 122.42 45.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 73.43 110.12 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 8.5 pt-20 177.67 -44.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 74.21 110.21 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.446 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 19.9 pt20 -129.3 175.45 8.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 74.32 110.239 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.64 139.31 39.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.512 -1.435 . . . . 64.02 109.512 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.28 -37.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -1.149 . . . . 75.53 110.256 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -107.01 157.05 18.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 75.24 110.178 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.7 p -138.12 83.49 22.44 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 65.02 110.23 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.674 0 O-C-N 123.944 1.497 . . . . 74.33 110.37 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.436 ' O ' ' CB ' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.286 0.565 . . . . 75.3 110.13 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.23 42.26 4.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 73.3 110.242 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.526 ' HG ' ' CB ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -119.17 177.97 4.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.912 . . . . 73.23 110.2 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.82 -71.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 55.0 110.238 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.83 -42.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 75.33 110.181 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -49.63 -21.74 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 75.44 110.243 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' SER . . . . . 0.526 ' CB ' ' HG ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -79.31 -42.37 25.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 71.22 109.833 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.6 t80 -73.65 -39.15 64.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 75.14 109.923 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.446 ' O ' ' HB2' ' B' ' 13' ' ' ALA . 7.4 ttp -67.15 -50.69 60.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 73.45 110.162 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.488 ' O ' ' CG2' ' B' ' 14' ' ' VAL . 0.1 OUTLIER -56.82 -33.32 66.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 72.3 110.099 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.455 ' O ' HG21 ' B' ' 14' ' ' VAL . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 60.24 110.037 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ASN . . . . . 0.427 ' O ' ' HB1' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 72.52 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.572 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 74.2 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . 0.52 ' CG2' ' HG2' ' B' ' 26' ' ' PRO . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 65.2 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' B' ' 28' ' ' VAL . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.41 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.43 110.125 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 48' ' ' ILE . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 63.34 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' B' ' 24' ' ' SER . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 75.54 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 70.3 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 72.31 110.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ALA . . . . . . . . . . . . . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 72.22 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 48' ' ' ILE . 0.4 OUTLIER -68.78 -162.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 75.24 110.277 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.425 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 25.0 m -73.98 162.15 29.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 74.34 110.259 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.417 ' O ' HG23 ' B' ' 25' ' ' VAL . 26.9 m -111.3 73.33 0.98 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 75.44 110.259 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.52 ' HG2' ' CG2' ' B' ' 14' ' ' VAL . 45.8 Cg_endo -73.0 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 73.0 110.474 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.08 8.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 63.52 109.502 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.529 ' CG2' ' HA ' ' B' ' 15' ' ' ALA . 69.0 t -90.97 -21.75 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 75.44 110.285 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.06 18.78 15.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 71.1 110.289 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.465 ' HD3' ' O ' ' B' ' 30' ' ' ARG . 0.3 OUTLIER -124.28 -13.21 7.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 74.52 110.485 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -91.88 63.97 4.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 72.42 110.012 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 1.5 p 170.66 -27.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 74.22 109.54 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' B' ' 34' ' ' GLY . 29.8 t -143.03 171.35 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 74.41 110.063 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . 0.532 ' N ' ' CG1' ' B' ' 33' ' ' VAL . . . 160.84 -30.91 0.35 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.519 -1.433 . . . . 71.43 109.519 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.163 -1.198 . . . . 74.41 110.228 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.222 0.534 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.576 ' OG ' HG12 ' A' ' 50' ' ' VAL . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.532 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.65 ' CD ' ' HB3' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.047 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.047 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.772 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.673 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.857 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD1' HG12 ' A' ' 39' ' ' VAL . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.823 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 46' ' ' GLN . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.085 HD11 HD22 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' OG ' ' A' ' 12' ' ' SER . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.821 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.821 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.747 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB3' ' CD ' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 77' ' ' LEU . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.636 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.237 0.541 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.682 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 1.085 HD22 HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.307 0.575 . . . . 72.52 110.327 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 44.41 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 43.01 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.647 ' OG ' HG12 ' A' ' 50' ' ' VAL . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 62.43 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD23 HD22 ' A' ' 77' ' ' LEU . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 35.31 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 51.22 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.22 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.34 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 61.54 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 72.3 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.44 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.43 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.3 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.41 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 72.22 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 72.42 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.94 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.32 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.888 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.3 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.23 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.45 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.23 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.52 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 73.33 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.54 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 63.04 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 74.1 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 52.21 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.04 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 53.2 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.41 110.106 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 41' ' ' ASP . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 64.22 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 71.44 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 39' ' ' VAL . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.1 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 20.5 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.33 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 42.31 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.04 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 72.51 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.888 HD12 ' CB ' ' A' ' 26' ' ' SER . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 65.25 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.831 HD11 HD22 ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.05 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 74.43 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.647 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.13 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 65.43 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 60.1 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 55.3 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 65.43 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 55.31 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 61.14 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.24 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.624 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 53.22 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 63.45 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.745 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.15 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 74.12 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.34 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 71.41 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.22 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.14 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 72.41 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.579 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 71.13 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 54.41 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 50.12 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 72.44 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.23 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.41 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 71.13 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 51.42 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 75' ' ' VAL . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.21 110.229 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 60.21 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.52 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 64.34 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 65.1 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 54.11 110.163 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.76 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.303 0.573 . . . . 65.11 110.143 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 62.34 110.206 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.21 110.205 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.43 110.219 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.76 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 62.51 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.45 110.109 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 64.45 110.19 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 71.11 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 71.41 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 62.15 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.22 110.12 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.21 110.22 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 71.43 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.831 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 65.44 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.32 0.581 . . . . 65.42 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 72.21 110.23 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 59' ' ' LEU . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 43.33 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 63.41 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.785 HD12 ' N ' ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.43 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' B' ' 21' ' ' ALA . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.04 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.13 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.704 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.43 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.994 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.33 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.54 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.22 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' NE ' ' HA3' ' A' ' 71' ' ' GLY . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.14 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 53.04 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.41 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.44 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.775 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.53 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 71.21 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 64.42 109.848 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.8 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.33 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.15 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.15 110.281 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.35 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.21 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.05 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.34 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 53.43 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.24 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 73.34 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.44 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.24 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.23 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.43 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 53.03 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 62.22 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.804 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 63.11 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 46' ' ' GLN . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 70.14 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.685 HD11 HD22 ' B' ' 23' ' ' LEU . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.24 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.44 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.31 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 52.41 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' A' ' 59' ' ' LEU . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.22 110.222 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 52.3 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.24 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.32 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 54.43 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.43 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.42 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.738 ' O ' HG22 ' A' ' 63' ' ' ILE . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.51 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.55 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 62.51 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 73.12 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 73.14 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 45.1 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.42 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.41 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 70.12 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.31 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.43 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG23 ' CG1' ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.02 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 64.12 110.111 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 61.44 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.41 110.313 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 62.54 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD23 HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 63.33 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 71.13 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 73.12 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.3 110.132 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.711 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.262 0.553 . . . . 53.31 110.082 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 55.54 110.205 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 72.24 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.44 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.711 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 61.03 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 50.42 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 71.24 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.42 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.24 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 64.41 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.12 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.33 110.185 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 64.31 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.302 0.572 . . . . 75.13 110.146 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 51.21 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' HD11 ' A' ' 13' ' ' LEU . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 65.25 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.33 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD11 ' SG ' ' A' ' 11' ' ' CYS . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 72.52 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.41 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.11 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 63.12 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.43 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 62.42 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 70.5 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 61.23 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.53 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 62.51 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.15 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 70.52 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.836 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.33 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 61.13 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 52.14 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.22 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 61.22 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.43 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 71.21 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.14 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 62.24 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.31 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.21 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 55.13 110.194 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' HD12 ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.21 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.01 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.42 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.45 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 54.11 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 55.43 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.33 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.607 ' NE2' ' O ' ' B' ' 21' ' ' ALA . 13.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.35 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.836 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 61.41 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.067 HD11 HD22 ' B' ' 23' ' ' LEU . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.51 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.33 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 53.21 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 64.55 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.2 110.26 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.33 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.21 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.2 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 50.4 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 53.33 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.727 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 72.41 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 64.4 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 63' ' ' ILE . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 60.14 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.523 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.52 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.4 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 60.44 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 63.3 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.23 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 65.22 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.54 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.43 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.01 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.02 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 45.31 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 73.03 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 72.14 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 65.13 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 75' ' ' VAL . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 63.53 110.305 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 71.52 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.31 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.32 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.541 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.2 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.32 110.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.211 0.529 . . . . 73.05 110.141 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.12 110.069 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.24 110.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 10' ' ' LYS . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.33 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 62.02 110.131 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 72.12 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.71 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.21 110.158 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 72.33 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 72.55 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.02 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.04 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 32.42 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 1.067 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.11 110.301 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.6 mt-30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.373 0.606 . . . . 71.43 110.109 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 64.01 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 63.43 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.759 ' HA ' HG12 ' A' ' 50' ' ' VAL . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 55.44 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 72.54 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG11 ' CB ' ' B' ' 21' ' ' ALA . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 43.35 110.11 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.23 110.263 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.32 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.05 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.42 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 50.15 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.42 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 72.5 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.037 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 70.31 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.05 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 69' ' ' VAL . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.44 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.873 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 64.42 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 62.1 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 71.15 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.23 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 51.5 t30 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.43 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 44.02 110.276 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.41 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 63.0 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.11 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.24 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' C ' HG23 ' A' ' 49' ' ' VAL . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.43 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.03 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.53 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.54 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.15 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 61.24 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.04 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.42 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 72.23 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 26' ' ' SER . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 53.22 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.761 HD11 HD22 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.12 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.43 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.32 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.13 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 52.55 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.34 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 40.43 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.13 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.34 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.12 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.669 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 72.41 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 64.12 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 61.21 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.33 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.51 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 74.44 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 63.21 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.35 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.43 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.12 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.11 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 44.13 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.44 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 42.33 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.45 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 42.24 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.618 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.43 110.14 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.01 110.183 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' B' ' 21' ' ' ALA . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 63.13 110.204 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.744 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 51.53 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 71.5 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 71.41 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.24 110.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.75 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.264 0.554 . . . . 61.02 110.132 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.13 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 55.43 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 62.05 110.192 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 64.22 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.415 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 73.54 110.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 63.22 110.091 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.21 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 63.24 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 72.21 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.21 110.227 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 52.22 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 64.11 110.322 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.237 0.542 . . . . 72.03 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.35 110.24 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.35 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 50' ' ' VAL . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.23 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.32 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 41.12 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.42 110.303 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 64.03 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.4 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.42 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 51.14 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.01 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 74.04 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.52 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.12 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.891 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 72.11 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.816 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.4 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.31 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.25 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 63.22 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.53 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.42 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.21 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 74.51 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.12 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.3 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 64.34 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 37' ' ' VAL . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 71.53 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 51.11 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.41 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.21 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.45 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.44 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 71.31 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.21 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.31 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 61.44 110.385 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 52.33 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.89 HD11 HD22 ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.53 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.12 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.44 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 HD11 ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 55.23 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HA ' HD11 ' A' ' 59' ' ' LEU . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.22 110.137 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.901 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.23 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.03 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.32 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 63.41 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 64.32 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.901 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 73.15 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.762 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 71.45 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 63' ' ' ILE . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 71.3 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 55.14 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.45 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.42 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 72.44 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.965 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 64.22 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 54.2 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 64.35 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.03 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.24 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.34 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 61.02 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.576 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.02 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 73.3 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.21 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 72.32 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.24 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.32 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.627 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 73.43 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 73.03 110.168 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.252 0.548 . . . . 75.31 110.151 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 70.44 110.07 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 54.1 110.136 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.04 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.05 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.51 109.934 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 72.31 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 50.4 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 54.5 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.44 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.23 110.186 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 72.43 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 50.02 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.43 110.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.31 0.576 . . . . 64.44 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.03 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.55 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.835 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.12 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 62.51 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 55.24 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 62.21 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.42 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 70.24 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 55.43 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.43 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.34 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 72.51 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.45 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 61.43 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.822 HD13 HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 72.45 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.44 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.41 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.04 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 71.32 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 74.24 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 51.45 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.22 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 63.22 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.04 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.736 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.41 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.671 ' C ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.33 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 74.43 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.43 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 52.23 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 54.05 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.53 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 71.31 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.22 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.51 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 61.43 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.731 ' O ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.11 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 65.03 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 70.32 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.42 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.835 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.43 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 62.34 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.23 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 64.43 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 62.32 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.33 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.32 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.32 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.61 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.34 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 51.45 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 70.15 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.24 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.736 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 65.23 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 74.24 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.569 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 74.52 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.45 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.1 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 73.24 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.12 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 74.43 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.32 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 73.55 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 61.4 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 71.33 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.31 110.206 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.14 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 53.34 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.54 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.55 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 70.31 110.109 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.694 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.227 0.537 . . . . 63.12 109.953 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.32 109.934 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.34 110.102 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 43.1 110.246 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.694 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.33 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.31 109.989 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 63.04 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 64.4 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.13 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.03 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 53.24 110.107 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 40.42 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 73.11 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 64.04 110.359 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.184 0.516 . . . . 65.33 110.308 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.43 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.53 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.703 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 71.45 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 70.43 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' CB ' ' B' ' 21' ' ' ALA . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 55.1 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG23 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 63.32 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.31 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.43 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 64.42 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 70.14 110.964 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.2 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 74.0 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.34 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.41 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 64.25 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.01 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.91 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 61.15 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 70.44 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.51 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 71.11 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.04 110.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.1 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 53.13 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.33 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.04 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 63.11 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 73.31 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 72.22 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 64.3 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.11 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.01 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 71.42 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 61.22 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.44 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.44 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.24 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 26' ' ' SER . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 53.52 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 63.34 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' HG23 ' A' ' 15' ' ' VAL . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 72.34 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.553 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.11 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.31 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 53.25 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 54.31 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 70.23 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.22 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.34 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.05 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.34 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.4 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 72.33 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 60.22 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 52.11 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.23 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.34 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 73.21 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 62.53 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.43 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.923 HG11 HD13 ' A' ' 25' ' ' ILE . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.35 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.34 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.34 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 63.45 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 74.34 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 65.44 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 75' ' ' VAL . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 54.23 110.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 43.43 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 62.02 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 73.14 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.53 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 52.03 110.162 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.677 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.167 0.508 . . . . 51.11 110.047 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.53 110.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 64.51 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.677 HG22 ' O ' ' B' ' 10' ' ' LYS . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 72.23 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.23 110.225 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.3 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.31 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.51 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 63.03 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.52 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.03 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.4 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 54.22 110.32 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 72.42 110.118 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 44.21 110.231 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' HD23 ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 64.13 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.72 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.31 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' B' ' 21' ' ' ALA . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 54.11 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.11 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 65.14 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.987 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 62.53 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 73.45 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.44 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 62.25 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.34 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 73.35 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.14 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 72.42 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 65.22 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.792 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.12 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.33 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 60.43 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.33 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.04 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.13 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.44 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 45.44 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.22 110.211 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 73.42 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 33.52 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 71.23 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.22 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.1 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.42 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 44.11 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 43.13 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 53.54 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 70.04 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.545 HD11 HD22 ' B' ' 23' ' ' LEU . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.15 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 29' ' ' LEU . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 51.25 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 62.54 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 59' ' ' LEU . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.32 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 52.42 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.24 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.02 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.55 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.2 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.31 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 74.35 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 72.21 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.43 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.2 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 53.51 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 73.24 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.13 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 62.44 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 71.24 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 72.32 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 74.21 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 62.51 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.24 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.13 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 72.04 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 63.22 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 72.21 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.22 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.13 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.35 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.33 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.33 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.42 110.098 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.629 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.275 0.56 . . . . 61.1 110.076 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 51.11 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.23 110.183 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.13 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.629 HG13 ' O ' ' B' ' 10' ' ' LYS . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.12 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 72.12 110.108 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 73.33 110.172 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.15 110.172 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.33 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 52.42 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 62.12 110.13 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 71.14 110.234 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.45 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.545 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.51 110.296 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.075 0.464 . . . . 63.25 110.217 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 50.32 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.741 ' SG ' HD11 ' A' ' 13' ' ' LEU . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 50.05 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.684 ' OG ' HG12 ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 53.11 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.23 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG11 ' CB ' ' B' ' 21' ' ' ALA . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 63.52 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.41 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.684 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 71.45 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.3 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.14 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.01 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 74.32 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.549 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.1 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 73.43 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' HG22 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 61.52 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.15 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.961 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.22 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.11 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 70.45 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.14 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 72.14 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 64.11 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.53 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.13 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.41 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.04 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HA ' HG22 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.02 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.42 110.047 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.22 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.31 110.201 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 72.13 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.23 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.22 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.05 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 44.01 109.755 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.873 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.03 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.961 HD12 ' OG ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.21 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.794 HD11 HD22 ' B' ' 23' ' ' LEU . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.02 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 71.5 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG12 ' OG ' ' A' ' 12' ' ' SER . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.03 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.14 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.52 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.24 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.4 ' O ' ' CG ' ' A' ' 55' ' ' ASP . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.24 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.45 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.43 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.34 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 72.11 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 73.51 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.725 ' O ' HG22 ' A' ' 63' ' ' ILE . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 72.13 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 74.4 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 52.22 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.42 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.578 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.53 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 53.25 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 63.23 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.22 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.24 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.22 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.45 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.42 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 54.13 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 74.43 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.22 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 73.43 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.22 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.43 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 55.03 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.45 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.12 110.131 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.692 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 43.43 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.01 110.08 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.1 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.13 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.692 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.32 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 63.12 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.2 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.704 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 65.04 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.419 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.12 110.188 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 64.35 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.41 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 64.52 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 61.3 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 53.22 110.245 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.241 0.543 . . . . 71.24 110.346 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 64.14 110.13 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.44 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.763 ' CB ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.14 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.802 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.1 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.22 109.88 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 61.03 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.21 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.32 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.54 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.41 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.41 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.52 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.43 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.44 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.11 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.912 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.32 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.873 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.44 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.44 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.32 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 64.22 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.31 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 60.25 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.53 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 63.23 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 43.53 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 70.0 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.31 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.13 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.15 110.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.15 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 62.23 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.11 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.04 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 52.34 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 61.1 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.53 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.817 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 71.41 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.32 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.568 HD11 HD13 ' B' ' 23' ' ' LEU . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.21 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.3 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.577 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 72.4 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 59' ' ' LEU . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.12 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.829 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 61.13 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.44 110.238 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.34 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 65.02 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.44 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.711 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 64.33 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.22 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.33 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 62.44 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 61.35 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 72.02 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 40.32 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.55 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 72.12 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 54.21 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.2 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 73.2 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 43.34 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.31 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.33 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 50.02 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 44.43 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 71.41 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.802 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.01 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.83 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.33 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.527 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.32 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.42 110.147 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.822 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.325 0.583 . . . . 71.13 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 34.52 110.101 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.31 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 72.41 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.22 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 61.11 110.047 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.83 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.32 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.55 110.077 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.34 110.061 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 53.31 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 51.35 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.22 110.183 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 63.02 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 64.32 110.215 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.251 0.548 . . . . 63.23 109.995 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 62.22 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.42 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.687 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.34 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 65.23 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.759 HG22 HD12 ' A' ' 48' ' ' ILE . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.01 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 61.22 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 62.44 110.046 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.4 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.42 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.14 110.986 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.22 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.52 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.41 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 41.21 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.04 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.815 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 65.55 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.855 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 64.42 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 71.2 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 72.34 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 62.44 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 61.42 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 54.0 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.13 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 64.21 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.23 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.33 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 53.13 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 71.45 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.13 110.231 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.12 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 63.24 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.634 ' OD1' HG12 ' A' ' 39' ' ' VAL . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 74.13 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.21 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.15 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 55.52 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.31 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.549 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.21 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.855 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 61.53 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.759 HD12 HG22 ' A' ' 14' ' ' VAL . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 63.43 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 71.04 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 53.24 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 13' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 70.1 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 70.14 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.32 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.42 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 70.32 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 61.54 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 54.44 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 53.12 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.24 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.12 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.43 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.1 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 65.03 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 51.52 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 63' ' ' ILE . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 54.42 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.21 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.04 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 71.34 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 60.32 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 33.33 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 45.1 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 71.23 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 54.52 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 64.53 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' B' ' 21' ' ' ALA . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 52.31 110.042 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.34 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.01 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 73.13 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 72.12 110.237 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.182 0.515 . . . . 64.41 110.152 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 71.33 110.084 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 60.23 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.14 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 10' ' ' LYS . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 62.52 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 61.33 110.1 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 70.1 110.197 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.41 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 61.41 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.14 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 53.44 110.096 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.41 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.4 110.461 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.235 0.541 . . . . 63.45 110.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 74.22 110.233 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.842 ' SG ' HD11 ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 62.21 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.713 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.11 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.842 HD11 ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.44 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.846 HG11 ' CB ' ' B' ' 21' ' ' ALA . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 53.32 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 64.4 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 73.14 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.41 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 64.23 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.13 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.42 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.12 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.32 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.31 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 72.33 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 63.31 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.849 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 72.43 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.52 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.3 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.852 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 65.02 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.41 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 51.35 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.12 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 73.41 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.3 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.852 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 62.51 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 44.34 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.54 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.33 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HB ' HD12 ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 64.13 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 63.01 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' HG12 ' A' ' 39' ' ' VAL . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.44 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 61.23 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.55 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.23 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 45.54 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.578 ' O ' HD23 ' A' ' 47' ' ' LEU . 13.1 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 60.43 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 26' ' ' SER . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.45 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 61.02 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 62.13 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG12 ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 64.15 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 62.51 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.527 ' HA ' HD11 ' A' ' 59' ' ' LEU . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.32 110.256 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.01 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.34 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 70.42 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 44.03 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.02 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.52 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 60.44 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.744 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 64.51 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 63.13 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 62.44 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 43.41 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 64.2 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.43 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 72.12 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.45 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 60.34 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.3 110.624 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 52.52 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 60.21 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.24 110.198 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 51.21 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 54.32 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 71.52 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 72.43 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 62.13 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 71.13 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.02 110.265 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.792 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 73.44 109.998 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.43 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.22 110.072 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.1 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.792 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.23 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.32 110.006 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 65.43 110.1 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.33 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 64.14 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 53.23 110.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 51.2 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 54.13 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.836 ' CD2' HD11 ' A' ' 48' ' ' ILE . 3.9 tp . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 73.24 110.396 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.252 0.548 . . . . 74.04 110.181 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.14 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.42 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.33 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.848 HD23 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 63.11 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 71.33 109.933 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 70.33 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.54 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.03 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.43 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 71.13 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.42 110.863 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.11 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 74.5 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.11 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.51 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 53.12 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 72.21 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.82 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.31 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 73.45 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.51 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.858 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 63.11 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 4.6 t30 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.2 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 42.05 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 72.13 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.35 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 72.12 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.858 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 73.43 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.11 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.3 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 54.53 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG12 ' OD1' ' A' ' 41' ' ' ASP . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.23 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.455 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.2 110.36 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.66 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.43 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.42 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 61.32 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 55.13 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.82 HD12 ' CB ' ' A' ' 26' ' ' SER . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.24 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 HD13 ' B' ' 23' ' ' LEU . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.34 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 72.3 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 72.25 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.4 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 51.34 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.864 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 60.21 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 61.2 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.22 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.52 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.51 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.864 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.34 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 73.12 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.739 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 43.22 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.03 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.24 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 64.13 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.583 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.2 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.942 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 63.32 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.14 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.35 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.491 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.42 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.12 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.44 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG23 ' CG1' ' A' ' 69' ' ' VAL . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 44.53 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 74.41 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.22 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 53.42 110.334 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 41.44 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.848 ' CD2' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 62.0 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 64.44 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.31 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.4 110.147 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.717 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.306 0.574 . . . . 74.13 110.036 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 54.21 110.073 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.05 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 65.31 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.12 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 62.44 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 52.21 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.664 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.2 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 44.23 110.1 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 63.12 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 51.15 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.41 110.119 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 44.32 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 62.0 110.277 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.183 0.516 . . . . 74.15 110.267 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.34 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.32 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.853 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 64.44 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 74.3 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 62.13 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 52.42 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 71.13 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 54.14 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.42 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.31 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.32 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.4 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 60.25 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 63.53 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.779 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 71.32 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.797 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 61.22 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 55.11 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.04 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 73.13 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.23 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.44 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 72.22 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.21 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 63.24 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 43.24 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.44 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 37' ' ' VAL . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 62.42 110.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 74.53 110.128 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG12 ' OD2' ' A' ' 41' ' ' ASP . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.51 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.42 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.607 ' OD2' HG12 ' A' ' 39' ' ' VAL . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.44 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.11 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 63.3 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.22 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.45 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD23 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.13 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 26' ' ' SER . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 65.55 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.767 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 63.24 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 49' ' ' VAL . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.51 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.853 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.11 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 62.21 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HA ' HD11 ' A' ' 59' ' ' LEU . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.43 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.772 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 52.12 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 63.43 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 64.32 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 51.2 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.34 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.636 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.13 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.757 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.31 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 4.1 mt-30 -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 72.4 109.87 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' SG ' ' A' ' 35' ' ' CYS . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.3 110.516 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.34 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 73.24 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.972 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.05 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.02 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.53 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.44 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 72.12 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 64.34 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.4 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 72.02 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 71.0 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 72.12 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.22 110.33 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.24 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 70.04 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 71.35 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 71.2 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.41 110.21 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.832 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.269 0.557 . . . . 65.14 110.049 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 64.33 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.21 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 52.02 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.832 HG22 ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.22 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 64.24 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 61.53 110.068 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 52.2 110.101 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.31 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 63.24 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 52.34 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 63.44 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 53.23 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 74.2 110.346 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.33 0.586 . . . . 74.11 109.728 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.12 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 13' ' ' LEU . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.31 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.942 ' C ' HD13 ' A' ' 13' ' ' LEU . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.22 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.942 HD13 ' C ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.31 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 48' ' ' ILE . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 71.33 109.953 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.21 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 55.21 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 62.41 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.53 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.33 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.53 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 71.31 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 52.14 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.42 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.973 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 64.2 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.774 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.35 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.22 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.54 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.828 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.43 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 25.23 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.4 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 72.42 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.43 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 54.23 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.52 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.51 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 63.32 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 52.44 110.24 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' OD1' ' A' ' 41' ' ' ASP . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 73.12 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.24 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.676 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 43.23 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 54.54 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 62.45 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.14 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 42.5 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.5 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 72.33 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.774 HD12 ' CB ' ' A' ' 26' ' ' SER . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 55.24 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.883 HD11 HD22 ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.43 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.828 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.42 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 64.42 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.41 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.51 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 53.3 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 63.5 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.03 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.34 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.21 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.796 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 54.53 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 61.12 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.34 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 72.0 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.14 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 60.32 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 72.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 53.42 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.43 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.01 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.51 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.973 HG11 HD13 ' A' ' 25' ' ' ILE . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 63.15 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 51.44 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 55.32 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.32 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 71.41 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 60.02 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 54.42 110.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.11 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' HD12 ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 61.25 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 62.22 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.44 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.688 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.226 0.536 . . . . 72.44 110.138 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 24.43 110.159 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.474 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.24 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 31.5 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.688 HG22 ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.51 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.405 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 63.54 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 61.54 110.066 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 63.4 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.4 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 72.14 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.33 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 45.04 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 41.4 110.237 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.34 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.51 110.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.242 0.544 . . . . 74.31 109.989 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.44 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 70.52 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.768 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.31 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 63.43 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG11 ' HB1' ' B' ' 21' ' ' ALA . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 73.15 110.022 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.53 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CG ' ' HB3' ' A' ' 74' ' ' ALA . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.22 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.33 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 62.33 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.04 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.33 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 74.32 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 70.51 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.12 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.03 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 69' ' ' VAL . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 62.24 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.81 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 63.14 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 72.11 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.1 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.942 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.22 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.23 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 43.34 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 64.32 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 54.21 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 63.51 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.54 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.13 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 62.41 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.12 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 52.21 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 60.22 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.34 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 71.21 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.05 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.44 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 42.3 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 63.45 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.81 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.35 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.574 HD11 HD22 ' B' ' 23' ' ' LEU . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.02 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 41.34 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 70.44 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.03 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.33 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.559 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.13 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 60.21 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 72.22 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 62.1 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.45 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.03 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.21 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 73.42 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 62.43 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.31 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 62.54 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.2 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 41.04 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 74.15 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.23 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 45.52 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.22 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.31 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 72.54 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB3' ' CG ' ' A' ' 16' ' ' GLN . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.32 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 75' ' ' VAL . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 52.44 110.292 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 54.45 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.697 HD13 HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 53.11 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.23 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.21 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.43 109.857 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.781 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.302 0.572 . . . . 72.31 110.091 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 3.3 m-20 -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 62.34 110.148 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 62.42 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' B' ' 10' ' ' LYS . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.14 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 52.32 110.09 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.15 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 64.01 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 53.32 110.163 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 64.11 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.32 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 64.53 110.183 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 21.53 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 63.25 110.211 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 74.43 110.138 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 72.33 110.224 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.53 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.779 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.12 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 51' ' ' VAL . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.32 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.65 HG11 ' HB1' ' B' ' 21' ' ' ALA . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 53.32 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 65.52 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.13 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 73.22 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.54 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.35 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 51.42 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.41 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.812 HG21 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.1 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.893 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 52.23 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 65.25 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 71.52 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.15 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CG ' HG22 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 52.32 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.41 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.42 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 62.23 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 53.22 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.54 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.44 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 60.14 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG12 ' OD1' ' A' ' 41' ' ' ASP . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 71.2 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 34.45 110.259 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' OD1' HG12 ' A' ' 39' ' ' VAL . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.12 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 71.03 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 64.41 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 44.41 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 52.14 109.661 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 64.22 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.893 HD12 ' CB ' ' A' ' 26' ' ' SER . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.43 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 HD22 ' B' ' 23' ' ' LEU . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.24 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 29' ' ' LEU . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 63.32 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 55.12 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 71.14 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.31 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.862 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 64.44 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 73.01 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.2 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.31 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 63.34 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.862 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.15 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.21 110.187 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.11 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.532 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 55.35 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.43 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.32 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.03 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.978 ' O ' HG23 ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.12 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 70.1 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.32 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.21 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 73.55 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.33 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.51 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.614 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.13 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 61.34 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.44 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 53.42 110.251 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.04 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 61.12 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 73.51 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.23 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 64.23 110.139 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.844 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.21 0.528 . . . . 65.43 109.759 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 64.32 109.827 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.458 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 73.25 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.32 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.844 HG22 ' O ' ' B' ' 10' ' ' LYS . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 73.24 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 71.15 109.682 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 62.43 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.45 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.4 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.01 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.34 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.31 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.42 110.356 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.2 0.524 . . . . 62.31 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.33 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.13 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.639 ' HA ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 51.1 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 77' ' ' LEU . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.22 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.34 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.2 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 62.13 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.094 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.3 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 65.32 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.43 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 64.44 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 63.53 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.094 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 64.22 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 64.02 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.45 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.715 HG21 HG11 ' A' ' 69' ' ' VAL . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.11 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.914 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 70.31 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.11 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.54 109.855 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.933 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 72.13 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 64.25 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.31 110.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.12 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.13 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.34 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.15 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.41 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.23 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 72.32 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.34 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.41 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.41 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 55.02 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 73.42 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 55.55 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.1 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 42.44 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.914 HD12 ' CB ' ' A' ' 26' ' ' SER . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.11 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.684 HD11 HD22 ' B' ' 23' ' ' LEU . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 51.51 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.933 HG21 ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 64.45 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.53 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 64.15 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 72.54 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.535 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 70.15 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.14 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.21 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.31 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.34 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.55 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 53.11 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.31 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.45 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 63.32 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 73.13 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 44.05 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.01 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 65.5 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.54 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 54.51 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.22 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 71.34 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.13 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.41 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.03 110.042 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 63.21 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 77' ' ' LEU . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.11 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.33 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.32 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 63.5 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.14 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.21 110.027 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.773 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.236 0.541 . . . . 75.22 110.086 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 42.1 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 61.14 110.055 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.41 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.52 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.33 110.046 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.04 110.027 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.4 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.21 110.18 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.33 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.21 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.04 110.227 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 74.13 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 72.23 110.518 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.321 0.581 . . . . 71.23 110.238 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 50.43 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' A' ' 59' ' ' LEU . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.42 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.752 ' HA ' HG12 ' A' ' 50' ' ' VAL . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.34 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.13 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 71.12 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 61.52 110.269 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.67 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.11 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 35.12 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 71.42 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.14 111.017 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.21 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 73.32 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 61.13 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.499 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.32 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.12 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.838 ' OG ' HD12 ' A' ' 47' ' ' LEU . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.41 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 71.33 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 51.53 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 74.41 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.965 ' ND2' HG21 ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 73.52 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 43.21 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 60.14 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.41 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.52 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.1 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 72.14 110.095 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.965 HG21 ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.44 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.22 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.13 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.04 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.687 ' OD1' HG12 ' A' ' 39' ' ' VAL . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.41 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 52.23 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.32 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 64.32 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.31 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.772 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 53.2 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.838 HD12 ' OG ' ' A' ' 26' ' ' SER . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 70.02 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.963 HD11 HD22 ' B' ' 23' ' ' LEU . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.35 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.22 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.51 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.34 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.14 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 72.51 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.44 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.31 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.51 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.45 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.2 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.568 HD21 ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 71.31 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 61.43 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.33 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.1 110.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.32 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 73.54 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.32 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.11 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.12 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.32 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 52.51 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.33 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.02 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CG1' ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.21 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 43.44 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.54 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.04 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.04 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 64.33 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.42 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 72.12 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.54 110.054 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.812 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.247 0.546 . . . . 63.31 110.099 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 41.25 110.037 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 65.13 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 70.45 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' VAL . . . . . 0.812 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 52.22 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.41 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.43 110.125 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 60.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ALA . . . . . 0.401 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 53.3 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 64.54 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 54.41 110.152 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 64.24 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 54.41 110.277 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 52.58 -166.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.2 OUTLIER -85.54 124.96 32.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.232 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 1.0 OUTLIER -175.71 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 6' ' ' THR . 1.5 m170 -141.17 124.93 16.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -166.76 123.97 1.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.34 166.09 26.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 19.5 m95 -104.04 -70.93 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -155.51 121.83 5.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.576 ' OG ' HG12 ' A' ' 50' ' ' VAL . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.532 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.65 ' CD ' ' HB3' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.047 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.047 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.772 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.673 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.857 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD1' HG12 ' A' ' 39' ' ' VAL . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.823 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 46' ' ' GLN . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.085 HD11 HD22 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' OG ' ' A' ' 12' ' ' SER . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.821 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.821 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.747 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB3' ' CD ' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 77' ' ' LEU . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.37 129.32 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . 31.3 tp60 -129.45 102.0 6.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' N ' ' CD ' ' A' ' 82' ' ' GLN . 4.7 pm0 -161.58 139.04 8.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -99.73 118.88 37.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.898 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 5.4 pt-20 178.72 -46.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.174 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 47.8 tt0 -166.57 171.25 11.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.136 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . -121.38 133.64 9.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 1.6 pp20? -177.61 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.346 -1.091 . . . . 0.0 110.193 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 34.9 mt-10 -141.06 -164.79 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -117.94 174.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.047 1.551 . . . . 0.0 110.464 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.295 0.569 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -99.42 70.89 1.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.536 HD21 ' HB3' ' B' ' 6' ' ' ARG . 2.1 tt -107.97 109.22 20.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 1.3 t -148.03 64.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.486 ' HD3' ' HB2' ' B' ' 9' ' ' MET . 0.0 OUTLIER -177.73 -32.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.536 ' HB3' HD21 ' B' ' 3' ' ' LEU . 6.0 ttt180 -50.78 -23.19 2.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -78.31 -39.94 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.531 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.7 OUTLIER -80.55 -39.77 27.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.436 -0.79 . . . . 0.0 109.769 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' B' ' 5' ' ' ARG . 1.4 ttp -66.81 -48.71 68.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.636 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -50.49 -29.34 10.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.682 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 1.085 HD22 HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -66.17 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.2 t -82.42 162.06 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.216 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 25' ' ' VAL . 17.4 m -108.26 82.15 1.5 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.0 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.031 1.542 . . . . 0.0 110.422 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.89 21.14 16.46 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 28' ' ' VAL . 64.9 t -108.48 7.91 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -1.134 . . . . 0.0 110.206 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' B' ' 31' ' ' ALA . . . -129.65 -66.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -44.08 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' B' ' 29' ' ' ALA . . . -137.35 6.57 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 32' ' ' VAL . 18.8 m -59.85 -14.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.404 HG12 ' H ' ' B' ' 33' ' ' VAL . 2.9 p -105.99 133.82 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -108.26 -126.74 5.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 2.8 mm100 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.21 -1.17 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 72.22 109.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.09 13.55 9.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -1.168 . . . . 52.44 110.159 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' A' ' 4' ' ' MET . 7.0 p80 -165.33 161.09 18.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 72.35 110.146 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -175.0 84.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 64.23 110.22 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -132.66 123.4 26.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 62.24 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -163.51 118.44 1.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 72.44 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -151.39 172.09 16.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 61.02 110.224 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -102.83 -69.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 71.11 110.218 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.56 122.61 6.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 72.52 110.327 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 44.41 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 43.01 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.647 ' OG ' HG12 ' A' ' 50' ' ' VAL . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 62.43 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD23 HD22 ' A' ' 77' ' ' LEU . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 35.31 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 51.22 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.22 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.34 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 61.54 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 72.3 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.44 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.43 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.3 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.41 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 72.22 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 72.42 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.94 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.32 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.888 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.3 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.23 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.45 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.23 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.52 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 73.33 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.54 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 63.04 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 74.1 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 52.21 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.04 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 53.2 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.41 110.106 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 41' ' ' ASP . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 64.22 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 71.44 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 39' ' ' VAL . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.1 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 20.5 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.33 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 42.31 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.04 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 72.51 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.888 HD12 ' CB ' ' A' ' 26' ' ' SER . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 65.25 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.831 HD11 HD22 ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.05 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 74.43 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.647 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.13 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 65.43 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 60.1 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 55.3 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 65.43 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 55.31 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 61.14 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.24 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.624 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 53.22 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 63.45 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.745 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.15 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 74.12 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.34 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 71.41 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.22 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.14 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 72.41 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.579 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 71.13 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 54.41 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 50.12 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 72.44 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.23 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.41 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 71.13 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 51.42 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 75' ' ' VAL . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.21 110.229 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 60.21 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.52 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 64.34 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 65.1 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 126.49 44.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 54.11 110.163 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.83 107.15 9.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 63.03 110.272 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.53 138.71 9.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 71.45 110.219 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.7 145.32 27.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 75.15 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 21.2 pt-20 -172.63 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 73.15 110.182 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 57.95 95.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 72.45 110.227 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.18 -168.7 27.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.485 -1.446 . . . . 64.11 109.485 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 -36.78 7.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -1.085 . . . . 70.11 110.187 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -111.1 -179.77 3.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 73.13 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -157.66 100.66 1.84 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 62.4 110.188 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 124.043 1.549 . . . . 53.12 110.431 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' B' ' 7' ' ' SER . 24.0 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.316 0.579 . . . . 71.52 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -96.61 90.45 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 63.54 110.351 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.537 HD21 ' OG ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -114.82 -26.96 7.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 70.25 110.439 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 2.6 m -152.26 -72.08 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 74.52 110.255 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 4' ' ' SER . 0.1 OUTLIER 179.89 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.33 -0.856 . . . . 73.5 110.145 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -66.54 -23.07 66.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 71.42 110.198 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.537 ' OG ' HD21 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -80.64 -37.69 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 71.31 109.785 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.472 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.3 t80 -77.54 -39.33 46.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 65.42 109.807 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.619 ' HE3' HG11 ' A' ' 50' ' ' VAL . 8.8 ttp -68.8 -51.18 43.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -0.838 . . . . 71.31 110.189 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.76 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.35 -28.64 55.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 65.11 110.143 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 62.34 110.206 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.21 110.205 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.43 110.219 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.76 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 62.51 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.45 110.109 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 64.45 110.19 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 71.11 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 71.41 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 62.15 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.22 110.12 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.21 110.22 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 71.43 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.831 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.62 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 65.44 110.267 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.499 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 68.2 m -81.49 162.16 23.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 75.24 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' HB ' ' B' ' 28' ' ' VAL . 78.1 t -108.1 82.22 1.46 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 62.32 110.185 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.7 Cg_endo -72.51 -89.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.91 1.479 . . . . 65.32 110.473 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.63 40.87 2.64 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 74.12 109.579 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.933 ' HB ' HG13 ' B' ' 25' ' ' VAL . 64.1 t -107.68 -1.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 74.21 110.236 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.82 -20.28 7.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 60.45 110.266 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.37 116.43 28.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 72.33 110.245 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -132.28 81.63 1.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 71.22 110.28 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 2.1 p 179.5 -32.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 73.33 110.195 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -43.17 106.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.273 -0.892 . . . . 74.43 110.2 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.53 41.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 55.13 109.517 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 35.43 110.152 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.53 -1.428 . . . . 55.34 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -157.48 -43.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 71.25 110.101 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.1 OUTLIER -175.98 -164.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 71.22 110.22 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.505 ' CG ' ' O ' ' A' ' 4' ' ' MET . 3.1 ptt? -177.93 98.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 63.12 110.24 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.668 ' O ' HG23 ' A' ' 6' ' ' THR . 12.1 p80 -122.35 117.94 27.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -0.959 . . . . 73.24 110.174 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -166.77 119.14 0.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 75.04 110.18 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -152.46 154.01 34.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 65.12 110.303 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -110.04 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 74.03 110.135 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -153.56 121.68 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 65.42 110.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 72.21 110.23 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 59' ' ' LEU . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 43.33 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 63.41 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.785 HD12 ' N ' ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.43 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' B' ' 21' ' ' ALA . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.04 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.13 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.704 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.43 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.994 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.33 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.54 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.22 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' NE ' ' HA3' ' A' ' 71' ' ' GLY . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.41 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.14 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 53.04 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.41 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.44 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.775 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.53 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 71.21 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 64.42 109.848 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.8 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.33 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.15 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.15 110.281 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.35 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.21 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.05 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.34 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 53.43 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.24 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 73.34 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.44 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.24 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.23 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.43 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 53.03 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 62.22 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.804 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 63.11 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 46' ' ' GLN . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 70.14 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.685 HD11 HD22 ' B' ' 23' ' ' LEU . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.24 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.44 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.31 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 52.41 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' A' ' 59' ' ' LEU . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.22 110.222 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 52.3 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.24 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' OD1' ' C ' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.32 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 54.43 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.43 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.42 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.738 ' O ' HG22 ' A' ' 63' ' ' ILE . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.51 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.55 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 62.51 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 73.12 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 73.14 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 45.1 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.42 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.41 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 70.12 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.31 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.43 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG23 ' CG1' ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.02 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 64.12 110.111 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 61.44 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.572 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.41 110.313 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 62.54 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.518 HD23 HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 63.33 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 71.13 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 73.12 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 136.48 33.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.3 110.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.5 tp60 -132.44 104.23 6.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 54.41 110.211 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -161.39 138.61 8.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 70.13 110.359 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -104.15 149.05 25.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 62.44 110.117 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -175.18 -75.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 63.02 110.375 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 48.6 tt0 -177.93 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 74.42 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.86 172.2 43.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.585 -1.406 . . . . 63.5 109.585 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -148.32 -39.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.206 . . . . 64.45 110.19 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' THR . 21.5 mt-10 -114.68 151.19 34.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 75.33 110.188 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' GLU . 43.1 p 43.43 69.89 2.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 72.13 110.206 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.8 0 O-C-N 124.047 1.551 . . . . 53.43 110.518 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.41 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.333 0.587 . . . . 70.22 110.123 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' B' ' 1' ' ' MET . 1.1 mmpt? -136.91 160.59 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 64.34 110.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -69.65 58.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 73.33 110.228 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -86.89 64.91 8.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 54.43 110.221 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -39.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 54.04 110.179 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -71.17 -15.44 62.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 73.51 110.235 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.84 -35.52 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 70.22 109.738 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 2.6 t80 -80.4 -43.38 21.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.477 -0.764 . . . . 61.43 109.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 3.1 ttp -65.99 -47.53 74.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 74.41 110.111 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.711 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -53.01 -31.51 41.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 53.31 110.082 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 55.54 110.205 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 72.24 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.44 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.711 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 61.03 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 50.42 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 71.24 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.42 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.24 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 64.41 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.12 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.33 110.185 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 64.31 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -67.08 -162.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 6.7 m -82.74 162.0 21.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 72.44 110.153 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 25' ' ' VAL . 27.3 m -107.94 82.58 1.48 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 74.43 110.245 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.1 Cg_endo -72.05 -89.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.038 1.546 . . . . 61.54 110.473 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.669 ' HA2' HG21 ' B' ' 32' ' ' VAL . . . -91.66 39.75 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.579 -1.408 . . . . 62.43 109.579 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' B' ' 25' ' ' VAL . 57.4 t -77.14 -75.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -1.184 . . . . 73.12 110.185 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' B' ' 30' ' ' ARG . . . -176.87 28.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.296 -0.878 . . . . 52.24 110.362 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' B' ' 29' ' ' ALA . 5.5 mtm-85 -154.38 145.26 22.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 71.22 110.222 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.56 18.91 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 74.12 110.258 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.669 HG21 ' HA2' ' B' ' 27' ' ' GLY . 11.7 p -122.41 -22.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.87 . . . . 64.31 110.248 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.579 HG13 HG13 ' B' ' 32' ' ' VAL . 15.7 m -143.0 148.89 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 74.43 110.228 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.33 12.87 69.98 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.61 -1.396 . . . . 73.31 109.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 71.44 110.261 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.574 -1.41 . . . . 73.3 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' HIS . 6.1 t -76.52 110.51 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -1.119 . . . . 71.52 110.21 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 38.5 m-70 59.61 147.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.45 110.207 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 26.3 ttt -178.4 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 70.01 110.202 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 33.4 p-80 -142.22 120.23 12.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 74.44 110.194 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.7 m -166.74 116.3 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 52.14 110.188 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.67 168.24 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 73.51 110.305 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -111.81 -71.86 0.74 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.851 . . . . 62.45 110.155 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.5 126.39 8.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 75.13 110.146 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 51.21 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' HD11 ' A' ' 13' ' ' LEU . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 65.25 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.33 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD11 ' SG ' ' A' ' 11' ' ' CYS . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 72.52 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.41 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.11 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 63.12 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.43 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 62.42 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 70.5 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 61.23 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.53 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 62.51 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.15 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 70.52 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.836 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.33 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 61.13 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 52.14 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.22 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 61.22 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.43 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 71.21 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.14 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 62.24 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.31 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.21 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 55.13 110.194 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' HD12 ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.21 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.01 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.42 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.45 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 54.11 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 55.43 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.33 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.607 ' NE2' ' O ' ' B' ' 21' ' ' ALA . 13.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.35 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.836 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 61.41 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.067 HD11 HD22 ' B' ' 23' ' ' LEU . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.51 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.33 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 53.21 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 64.55 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.2 110.26 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.33 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.21 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.2 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 50.4 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 53.33 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.727 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 72.41 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 64.4 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 63' ' ' ILE . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 60.14 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.523 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.52 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.4 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 60.44 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 63.3 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.23 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 65.22 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.54 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.43 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.01 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.02 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 45.31 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 73.03 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 72.14 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 65.13 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.622 ' O ' HG13 ' A' ' 75' ' ' VAL . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 63.53 110.305 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 71.52 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.31 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.32 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.2 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 126.39 45.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.32 110.06 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.2 110.59 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 75.04 110.268 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.3 138.71 16.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 72.13 110.287 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' A' ' 5' ' ' HIS . 4.3 mt-10 -102.03 147.52 26.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 75.21 110.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER 174.37 -100.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 64.12 110.192 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -84.75 161.54 19.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 42.33 110.158 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.57 139.73 25.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.529 -1.428 . . . . 61.03 109.529 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -173.06 39.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -1.122 . . . . 65.33 110.259 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 89' ' ' THR . 7.2 pt-20 -76.38 144.62 39.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 63.31 110.146 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -164.2 161.36 16.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 73.42 110.237 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 124.12 1.589 . . . . 55.04 110.426 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 74.34 110.296 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -90.95 -21.38 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 74.03 110.296 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' B' ' 4' ' ' SER . 1.5 tp -93.86 -166.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 74.31 110.17 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' B' ' 3' ' ' LEU . 0.5 OUTLIER 171.74 50.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 73.45 110.214 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -59.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.91 . . . . 71.11 110.226 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.2 ttt-85 -46.49 -29.19 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 72.45 110.29 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.1 t -74.88 -41.89 58.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 71.42 109.831 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.54 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.63 -38.99 28.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 64.01 109.866 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -67.15 -52.93 35.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 70.33 110.171 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.26 -27.01 13.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 73.05 110.141 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.12 110.069 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.24 110.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 10' ' ' LYS . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.33 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 62.02 110.131 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 72.12 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.71 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.21 110.158 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 72.33 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 72.55 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.02 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.04 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 32.42 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 1.067 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.9 -162.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.11 110.301 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 75.3 m -82.86 162.1 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 73.34 110.157 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.656 HG13 ' HB ' ' B' ' 28' ' ' VAL . 12.0 t -108.3 81.91 1.45 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 74.43 110.148 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.6 Cg_endo -72.96 -56.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.043 1.549 . . . . 72.12 110.408 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.04 31.24 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.422 . . . . 74.13 109.544 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.656 ' HB ' HG13 ' B' ' 25' ' ' VAL . 42.8 t -57.31 -29.78 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 71.51 110.304 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.19 -7.03 54.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 71.31 110.241 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mtm-85 -124.99 38.18 4.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 71.24 110.138 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.33 33.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 45.15 110.127 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.532 HG23 HG12 ' B' ' 33' ' ' VAL . 5.3 m -93.68 -40.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -0.843 . . . . 74.44 110.236 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.532 HG12 HG23 ' B' ' 32' ' ' VAL . 8.8 p -154.87 170.21 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 65.31 110.129 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.438 ' N ' HG22 ' B' ' 33' ' ' VAL . . . -112.91 161.52 12.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.569 -1.412 . . . . 63.24 109.569 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 75.13 110.204 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.574 -1.411 . . . . 60.25 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t 47.36 48.31 16.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.317 -1.108 . . . . 74.22 110.143 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -134.43 -68.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 73.34 110.305 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 ttt -175.91 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 53.31 110.224 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -125.48 125.04 42.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.845 . . . . 53.43 110.096 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 m -165.33 104.21 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 73.12 110.358 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -152.28 169.1 23.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 73.13 110.286 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 82.8 m95 -112.77 -73.41 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 74.12 110.155 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 8' ' ' TRP . 2.6 mt-30 -153.6 124.41 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 71.43 110.109 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 64.01 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 63.43 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.759 ' HA ' HG12 ' A' ' 50' ' ' VAL . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 55.44 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 72.54 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG11 ' CB ' ' B' ' 21' ' ' ALA . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 43.35 110.11 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.23 110.263 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.32 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.05 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.42 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 50.15 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.42 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 72.5 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.037 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 70.31 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.05 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 69' ' ' VAL . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.44 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.873 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 64.42 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 62.1 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 71.15 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.23 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 51.5 t30 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.43 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 44.02 110.276 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.41 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 63.0 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.11 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.24 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' C ' HG23 ' A' ' 49' ' ' VAL . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.629 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.43 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.03 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.53 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.54 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.15 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 61.24 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.04 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.42 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 72.23 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 26' ' ' SER . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 53.22 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.761 HD11 HD22 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.12 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.43 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.32 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.13 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 52.55 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.34 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 40.43 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.13 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.34 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.12 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.669 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 72.41 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 64.12 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 61.21 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.33 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.51 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 74.44 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 63.21 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.35 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.43 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.12 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.11 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 44.13 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.44 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 42.33 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.45 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 42.24 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.618 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.43 110.14 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.01 110.183 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' B' ' 21' ' ' ALA . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 63.13 110.204 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.744 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 51.53 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 71.5 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 71.41 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.43 134.73 40.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.24 110.198 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 102.38 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 74.23 110.276 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -158.54 138.65 12.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 73.53 110.21 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.2 132.33 42.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 72.12 110.321 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.61 27.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 62.24 110.161 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.51 58.06 3.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 74.02 110.268 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -46.75 157.52 0.5 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 64.31 109.551 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.51 -1.36 8.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -1.222 . . . . 72.25 110.191 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.56 132.03 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 74.2 110.164 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -89.26 143.68 31.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 74.55 110.157 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 74.1 110.528 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 65.23 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' B' ' 2' ' ' LYS . 5.7 ptpt -141.23 85.69 1.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 74.14 110.231 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.625 HD23 ' N ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -116.43 -173.89 2.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.943 . . . . 64.54 110.189 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -146.67 46.52 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 73.2 110.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.97 -64.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 73.52 110.144 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 25.7 ttt180 -60.43 -16.81 39.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 71.32 110.134 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 43.7 t -80.91 -39.01 26.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 63.45 109.731 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.56 -43.38 39.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.362 -0.836 . . . . 74.54 109.763 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 8.1 ttp -66.23 -54.62 22.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 73.43 110.106 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.75 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.2 OUTLIER -55.25 -33.08 62.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 61.02 110.132 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.13 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 55.43 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 62.05 110.192 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 64.22 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.415 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 73.54 110.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 63.22 110.091 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.21 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 63.24 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 72.21 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.21 110.227 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 52.22 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.65 -162.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 64.11 110.322 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.526 ' H ' HD23 ' B' ' 23' ' ' LEU . 7.3 t -82.76 162.24 21.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 72.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.724 HG13 ' CG2' ' B' ' 28' ' ' VAL . 94.4 t -107.66 82.99 1.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 74.53 110.161 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.3 Cg_endo -72.1 -90.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 63.0 110.394 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.1 34.34 5.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.559 -1.416 . . . . 50.23 109.559 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' B' ' 25' ' ' VAL . 77.2 t -55.57 -17.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -1.218 . . . . 62.22 110.211 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.485 ' O ' ' NE ' ' B' ' 30' ' ' ARG . . . -157.36 -62.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 70.45 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.758 ' HB3' HG22 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -174.58 138.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 64.43 110.179 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -57.71 -17.93 18.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 74.1 110.294 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.758 HG22 ' HB3' ' B' ' 30' ' ' ARG . 16.7 m -43.59 -27.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 73.31 110.288 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.571 ' O ' HG13 ' B' ' 33' ' ' VAL . 12.4 p -77.94 60.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 64.24 110.309 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.14 116.68 3.51 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.502 -1.439 . . . . 53.41 109.502 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.165 . . . . 74.03 110.166 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.608 -1.397 . . . . 64.32 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 156.8 34.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -1.162 . . . . 72.54 110.258 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' MET . 42.2 m80 -97.69 -89.95 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.107 -0.995 . . . . 63.52 110.273 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.406 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 174.68 70.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 73.3 110.164 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 14.0 p80 -138.76 117.72 12.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 74.22 110.273 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 15.2 m -166.8 118.12 0.94 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 70.01 110.269 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -143.01 167.17 22.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 63.52 110.252 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 92.8 m95 -112.79 -69.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 61.55 110.182 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 8' ' ' TRP . 3.3 mm-40 -158.66 127.02 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 72.03 110.122 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 81' ' ' GLN . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.35 110.24 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.35 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 50' ' ' VAL . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.23 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.32 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 41.12 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.42 110.303 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 64.03 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.4 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.42 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 51.14 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.01 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 74.04 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.52 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.12 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.891 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 72.11 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.816 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.4 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.31 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.25 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 63.22 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.53 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.42 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.21 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 74.51 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.12 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.3 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 64.34 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 37' ' ' VAL . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 71.53 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 51.11 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.41 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.21 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.45 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.44 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 71.31 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.21 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.31 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 61.44 110.385 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 52.33 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.89 HD11 HD22 ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.53 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.12 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.44 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 HD11 ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 55.23 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HA ' HD11 ' A' ' 59' ' ' LEU . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.22 110.137 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.901 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.23 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.03 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.32 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 63.41 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 64.32 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.901 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 73.15 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.762 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 71.45 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 63' ' ' ILE . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 71.3 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 55.14 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.45 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.42 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 72.44 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.965 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 64.22 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 54.2 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 64.35 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.03 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.24 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.34 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 61.02 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.576 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.02 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 73.3 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.21 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 72.32 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.24 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.32 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.627 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 73.43 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 136.56 33.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 73.03 110.168 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.2 OUTLIER -133.61 112.26 11.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.297 -0.877 . . . . 71.44 110.179 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.17 138.59 14.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 41.31 110.29 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.99 119.04 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 63.15 110.219 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.2 pt-20 -135.71 -35.78 0.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 74.42 110.21 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.8 mp0 62.81 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.232 -0.917 . . . . 65.31 110.153 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.16 -147.51 5.75 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.565 -1.414 . . . . 75.14 109.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 51.04 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -1.095 . . . . 71.31 110.209 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -139.2 157.93 45.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 72.35 110.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.06 167.38 18.45 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 63.24 110.216 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.303 -1.825 0 O-C-N 124.058 1.557 . . . . 62.12 110.482 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 3' ' ' LEU . 5.6 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.18 0.514 . . . . 74.35 110.215 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.67 -68.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 74.22 110.151 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -145.16 102.19 3.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -0.972 . . . . 72.42 110.232 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.7 40.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 75.13 110.198 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.76 -60.26 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 72.4 110.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -59.51 -19.25 46.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 42.01 110.304 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 53.5 m -80.43 -36.72 33.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 43.13 109.777 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 2.5 t80 -80.63 -43.14 20.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.433 -0.792 . . . . 74.14 109.771 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.2 ttp -67.08 -48.65 67.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 75.53 110.28 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.15 -31.62 32.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 75.31 110.151 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 70.44 110.07 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 54.1 110.136 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.04 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.05 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.51 109.934 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 72.31 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 50.4 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 54.5 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.44 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.23 110.186 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 72.43 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 50.02 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.69 -162.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.43 110.327 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 58.3 p -75.46 162.03 28.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 45.35 110.307 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.747 ' O ' HG13 ' B' ' 25' ' ' VAL . 13.5 p -112.6 73.62 1.49 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 74.24 110.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.792 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.4 Cg_endo -72.97 -90.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.966 1.509 . . . . 51.33 110.471 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.19 75.67 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.581 -1.408 . . . . 54.15 109.581 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' B' ' 25' ' ' VAL . 72.3 t -71.37 -16.82 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -1.193 . . . . 62.25 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' B' ' 25' ' ' VAL . . . -163.1 -58.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 40.11 110.282 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.1 OUTLIER 61.95 74.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 71.01 110.208 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -67.56 -9.35 41.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 42.25 110.192 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.671 ' O ' HG12 ' B' ' 33' ' ' VAL . 13.5 t 61.12 13.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 72.32 110.171 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.671 HG12 ' O ' ' B' ' 32' ' ' VAL . 9.9 p 38.51 35.14 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 73.31 110.53 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 35' ' ' GLN . . . 176.87 95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 63.32 109.559 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' B' ' 34' ' ' GLY . 5.4 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 61.1 110.187 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 5' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.445 . . . . 71.12 109.489 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -153.24 -86.9 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -1.16 . . . . 65.23 110.118 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.3 OUTLIER -150.53 48.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 65.14 110.291 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.0 tmm? 179.37 71.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 71.12 110.16 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 37.6 m80 -130.32 121.48 26.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 73.1 110.258 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -160.23 113.11 2.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 65.33 110.141 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.04 172.11 15.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 43.15 110.236 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 57.6 m95 -102.61 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 74.43 110.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -153.3 121.82 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 64.44 110.053 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' A' ' 81' ' ' GLN . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.03 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.55 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.835 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.12 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 62.51 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 55.24 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 62.21 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.42 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 70.24 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 55.43 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.43 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.34 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 72.51 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.45 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 61.43 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.822 HD13 HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 72.45 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.44 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.41 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.04 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 71.32 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 74.24 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 51.45 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.22 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 63.22 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.04 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.736 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.41 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.671 ' C ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.33 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 37' ' ' VAL . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 74.43 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.43 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 52.23 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 54.05 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.53 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 71.31 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.22 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.51 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 61.43 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.731 ' O ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.11 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 65.03 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 70.32 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.42 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.835 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.43 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 62.34 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.23 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 64.43 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 62.32 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.33 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.32 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.32 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.61 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.34 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 51.45 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 70.15 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.24 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.736 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 65.23 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 74.24 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.569 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 74.52 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.45 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.1 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 73.24 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.12 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 74.43 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.32 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 73.55 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 61.4 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 71.33 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.31 110.206 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.14 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 53.34 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.54 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.55 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -101.04 126.53 47.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 70.31 110.109 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.593 ' CG ' HG13 ' A' ' 10' ' ' VAL . 17.5 pt20 -135.03 111.17 9.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 55.13 110.186 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.43 138.6 8.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 73.45 110.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.82 145.06 30.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 74.34 110.296 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 16.2 pt-20 -170.73 -35.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 45.31 110.223 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -175.82 57.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 75.42 110.28 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -150.61 -137.97 2.78 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 43.21 109.5 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' GLU . 3.7 tp10 66.01 46.49 2.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -1.074 . . . . 75.3 110.246 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' GLU . 2.4 pt-20 -55.53 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.075 -1.016 . . . . 55.24 110.234 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' A' ' 90' ' ' PRO . 1.3 m -42.66 -55.51 7.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 55.1 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 89' ' ' THR . 44.0 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.66 1.347 . . . . 73.25 110.372 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.405 ' O ' ' O ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 73.14 110.175 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' B' ' 1' ' ' MET . 0.2 OUTLIER 59.5 156.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 44.32 110.196 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.734 HD12 ' C ' ' B' ' 3' ' ' LEU . 3.6 pp -100.97 151.96 21.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 65.01 110.199 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.38 23.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 75.51 110.247 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.433 ' CZ ' ' HB2' ' B' ' 5' ' ' ARG . 6.4 tpp85 -159.33 -56.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 72.44 110.222 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -52.31 -23.22 5.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 73.44 110.079 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.416 ' CB ' HD13 ' B' ' 3' ' ' LEU . 1.6 t -77.45 -40.46 43.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 74.33 109.671 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.2 t80 -80.55 -39.4 27.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -0.836 . . . . 75.33 109.707 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.436 ' CG ' ' OE1' ' A' ' 81' ' ' GLN . 1.8 ttp -65.29 -52.19 55.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 72.14 110.193 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.694 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.34 -34.3 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 63.12 109.953 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.32 109.934 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.34 110.102 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 43.1 110.246 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.694 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.33 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.31 109.989 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 63.04 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 64.4 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.13 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.03 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 53.24 110.107 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 40.42 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 73.11 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -69.88 -162.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 64.04 110.359 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 16.5 m -82.94 162.25 21.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 71.41 110.296 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.749 HG13 ' HB ' ' B' ' 28' ' ' VAL . 72.8 t -107.64 82.69 1.39 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 73.14 110.137 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.595 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.1 Cg_endo -71.85 -89.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.092 1.575 . . . . 64.43 110.773 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.58 43.96 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.797 -1.321 . . . . 63.05 109.797 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.749 ' HB ' HG13 ' B' ' 25' ' ' VAL . 37.2 t -73.05 -25.18 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -1.171 . . . . 75.13 109.95 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' B' ' 30' ' ' ARG . . . -125.18 -7.67 7.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 70.53 110.057 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 68.15 96.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 70.44 110.162 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -45.74 -33.53 3.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 65.31 110.244 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' B' ' 30' ' ' ARG . 6.7 m -42.36 -27.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 75.04 110.245 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 31' ' ' ALA . 56.0 t -90.52 108.17 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 43.34 110.205 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.53 61.11 0.44 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.439 -1.464 . . . . 62.43 109.439 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.421 -1.047 . . . . 55.13 110.228 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.612 -1.395 . . . . 60.11 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -141.53 -154.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 74.13 110.248 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -176.08 -167.35 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 71.44 110.217 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.02 72.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 71.22 110.142 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 40.7 m170 -121.53 122.87 40.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 62.41 110.221 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.5 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -154.33 118.95 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 72.2 110.146 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.47 171.69 14.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 52.3 110.232 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -110.72 -76.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 74.23 110.13 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.57 125.29 2.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 65.33 110.308 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.43 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.53 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.703 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 71.45 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 70.43 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' CB ' ' B' ' 21' ' ' ALA . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 55.1 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG23 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 63.32 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.31 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.43 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 64.42 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 70.14 110.964 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.2 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 74.0 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.34 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.41 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 64.25 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.01 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.91 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 61.15 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 70.44 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.51 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 71.11 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.04 110.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.1 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 53.13 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.33 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.04 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 63.11 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 73.31 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 72.22 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 64.3 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.11 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.01 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 71.42 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 61.22 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.44 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.44 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.24 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 26' ' ' SER . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 53.52 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 63.34 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' HG23 ' A' ' 15' ' ' VAL . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 72.34 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.553 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.11 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.31 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 53.25 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 54.31 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 70.23 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.22 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.34 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.05 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.34 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.4 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 72.33 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 60.22 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 52.11 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.23 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.34 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 73.21 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 62.53 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.43 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.923 HG11 HD13 ' A' ' 25' ' ' ILE . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.35 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.34 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.34 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 63.45 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 74.34 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 65.44 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 75' ' ' VAL . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 54.23 110.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 43.43 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 62.02 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 73.14 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.53 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 136.26 35.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 52.03 110.162 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.52 102.07 6.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 72.42 110.184 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -161.5 138.7 8.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 74.55 110.399 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 6' ' ' THR . 1.8 mp0 -80.73 120.37 24.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 75.0 110.227 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 4.0 pt-20 175.21 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.866 . . . . 74.23 110.243 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 33.3 mm-40 56.79 49.91 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 74.53 110.287 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -98.41 -133.42 7.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 65.13 109.52 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 69.36 5.82 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -1.131 . . . . 74.43 110.307 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.5 pt-20 33.62 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.629 0.728 . . . . 73.41 111.431 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER 66.16 68.05 0.66 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.316 -0.865 . . . . 72.45 110.241 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.039 1.547 . . . . 55.14 110.493 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.541 . . . . 74.04 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.41 -72.28 0.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 65.53 110.276 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -119.79 114.48 22.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 74.03 110.185 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -150.9 72.91 1.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 35.2 110.213 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' B' ' 9' ' ' MET . 0.0 OUTLIER -162.57 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 71.11 110.188 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -75.4 -20.92 58.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 75.5 109.98 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.0 t -77.16 -39.92 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 71.23 109.617 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.497 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.1 t80 -80.27 -34.79 36.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 75.13 109.562 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' B' ' 9' ' ' MET . 13.1 ttp -70.16 -55.46 9.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 63.51 110.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.677 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -47.32 -30.17 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 51.11 110.047 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.53 110.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 64.51 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.727 HG21 ' HG2' ' B' ' 26' ' ' PRO . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 72.23 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.23 110.225 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.3 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.31 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.51 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 63.03 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.52 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.03 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.4 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -62.9 -162.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 54.22 110.32 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.4 OUTLIER -81.74 161.7 23.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.388 -0.82 . . . . 73.21 110.179 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 25' ' ' VAL . 32.8 m -109.25 78.67 1.08 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 71.14 110.206 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.727 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.9 Cg_endo -72.96 -57.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.991 1.521 . . . . 61.4 110.52 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 30' ' ' ARG . . . -89.58 -35.96 7.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.546 -1.422 . . . . 73.3 109.546 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 54.9 t -46.32 -43.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -1.109 . . . . 72.24 110.128 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.65 -8.0 51.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 73.32 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' B' ' 34' ' ' GLY . 9.4 mtp180 55.85 78.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 72.55 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 0.62 57.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 74.13 110.187 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.435 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 61.1 t -54.58 -39.84 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 75.42 110.222 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.1 p -179.61 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 74.14 110.144 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' B' ' 30' ' ' ARG . . . 136.32 -69.57 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.411 . . . . 60.03 109.571 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.273 -1.133 . . . . 73.01 110.234 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.656 -1.378 . . . . 65.33 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 -3.78 7.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.312 -1.111 . . . . 73.25 110.228 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' MET . 33.4 p80 -122.91 162.77 21.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 41.05 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.1 ttt -179.17 70.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 74.4 110.247 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' O ' ' OG1' ' A' ' 6' ' ' THR . 15.9 p80 -127.83 118.64 24.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 75.23 110.206 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 21.2 m -166.81 123.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 75.11 110.222 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -152.28 168.67 24.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 62.01 110.201 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -108.61 -69.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 75.12 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.91 121.67 5.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 72.42 110.118 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 44.21 110.231 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' HD23 ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 64.13 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.72 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.31 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' B' ' 21' ' ' ALA . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 54.11 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.11 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 65.14 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.987 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 62.53 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 73.45 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.44 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 62.25 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.34 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 73.35 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.14 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 72.42 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 65.22 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.792 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.12 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.33 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 60.43 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.33 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.04 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.13 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.44 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 45.44 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.22 110.211 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 37' ' ' VAL . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 73.42 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 33.52 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 71.23 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.22 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.1 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.42 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 44.11 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 43.13 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 53.54 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 70.04 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.545 HD11 HD22 ' B' ' 23' ' ' LEU . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.15 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 29' ' ' LEU . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 51.25 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 62.54 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 59' ' ' LEU . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.32 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 52.42 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.24 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.02 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.55 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.2 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.31 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 74.35 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 72.21 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.43 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.2 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 53.51 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 73.24 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.13 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 62.44 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 71.24 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 72.32 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 74.21 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 62.51 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.24 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.13 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 72.04 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 63.22 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 72.21 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.645 ' O ' HG13 ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.22 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.13 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.35 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.33 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.33 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.53 135.27 34.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.42 110.098 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.629 ' O ' HG13 ' A' ' 10' ' ' VAL . 18.3 tp60 -129.62 101.97 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 71.24 110.301 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -161.41 138.7 8.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 71.34 110.27 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 3.5 mm-40 -90.37 118.93 30.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 63.41 110.212 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 6.2 pt-20 175.7 -162.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 45.01 110.176 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 67.2 tp60 -87.07 50.93 2.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 63.12 110.205 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.449 ' HA2' ' OE2' ' A' ' 87' ' ' GLU . . . -101.91 -143.08 13.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.467 -1.453 . . . . 71.32 109.467 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' OE2' ' HA2' ' A' ' 86' ' ' GLY . 1.4 pm0 -179.48 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -1.183 . . . . 72.13 110.221 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 2.8 pt-20 -47.24 123.54 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 71.14 110.175 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 157.57 46.22 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 74.42 110.157 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 123.871 1.458 . . . . 75.44 110.41 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.265 0.555 . . . . 60.42 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.85 102.7 2.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.917 . . . . 72.05 110.21 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -78.73 -77.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 71.41 110.313 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 3' ' ' LEU . 0.6 OUTLIER 42.19 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 62.1 110.267 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -137.49 -59.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 52.55 110.354 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -30.65 60.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 73.14 110.261 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.6 t -75.45 -40.41 57.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 70.41 109.765 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.537 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.56 -38.81 28.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 74.11 109.739 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 50' ' ' VAL . 7.2 ttp -65.94 -54.27 28.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 74.23 110.231 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.629 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -53.02 -31.86 43.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 61.1 110.076 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 51.11 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.23 110.183 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.13 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.629 HG13 ' O ' ' B' ' 10' ' ' LYS . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.12 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 72.12 110.108 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 73.33 110.172 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.15 110.172 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.33 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 52.42 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 62.12 110.13 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 71.14 110.234 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.45 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.545 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -63.85 -162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.51 110.296 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.3 t -82.74 162.04 21.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 62.11 110.33 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' B' ' 28' ' ' VAL . 15.4 m -109.05 80.24 1.29 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 65.12 110.212 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.594 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.2 Cg_endo -73.03 -56.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.964 1.507 . . . . 74.15 110.465 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.15 -9.28 57.16 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.465 -1.454 . . . . 61.33 109.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 28' ' ' VAL . 98.3 t -80.92 6.35 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -1.118 . . . . 73.5 110.256 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.89 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 75.05 110.189 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 2.9 mtm180 -68.73 -142.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.305 -0.872 . . . . 71.12 110.146 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 59.64 16.15 5.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 71.1 110.194 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 8.6 p -118.71 -10.7 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.892 . . . . 72.05 110.298 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 5.9 t 61.83 103.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 73.01 110.192 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 35' ' ' GLN . . . -143.08 17.99 2.33 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.542 -1.423 . . . . 75.41 109.542 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' B' ' 34' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 73.52 110.184 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.41 . . . . 62.12 109.574 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 56.29 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 71.43 110.282 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' MET . 8.1 t-160 57.03 28.0 14.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 73.41 110.193 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.2 ttm 175.82 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 73.5 110.201 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 5' ' ' HIS . 17.0 p80 -131.71 118.22 19.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 72.24 110.349 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.551 HG23 ' O ' ' A' ' 6' ' ' THR . 6.3 t -166.72 124.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 73.35 110.281 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -152.54 157.02 40.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 73.44 110.317 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.438 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 69.2 m95 -107.17 -70.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 61.52 110.161 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -157.37 121.82 4.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 63.25 110.217 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 81' ' ' GLN . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 50.32 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.741 ' SG ' HD11 ' A' ' 13' ' ' LEU . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 50.05 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.684 ' OG ' HG12 ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 53.11 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.23 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG11 ' CB ' ' B' ' 21' ' ' ALA . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 63.52 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.41 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.684 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 71.45 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.3 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.14 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.01 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 74.32 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.549 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.1 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 73.43 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' HG22 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 61.52 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.15 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.961 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.22 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.11 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 70.45 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.14 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 72.14 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 64.11 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.53 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.13 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.41 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.04 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HA ' HG22 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.02 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.42 110.047 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.22 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.31 110.201 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 72.13 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.23 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.22 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.05 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 44.01 109.755 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.873 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.03 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.961 HD12 ' OG ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.21 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.794 HD11 HD22 ' B' ' 23' ' ' LEU . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.02 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 71.5 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG12 ' OG ' ' A' ' 12' ' ' SER . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.03 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.14 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.52 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.24 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.24 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.45 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.43 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.34 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 72.11 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 73.51 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.725 ' O ' HG22 ' A' ' 63' ' ' ILE . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 72.13 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 74.4 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 52.22 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.42 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.53 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 53.25 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 63.23 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.22 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.24 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.22 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.45 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.42 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 54.13 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 74.43 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.22 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 73.43 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.22 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.43 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 55.03 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.45 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.19 136.27 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.12 110.131 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.656 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -130.57 103.04 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 63.41 110.258 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.3 138.71 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 64.42 110.253 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -85.69 118.74 25.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 70.3 110.198 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 179.94 30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.872 . . . . 75.02 110.316 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 20.7 mm100 60.19 49.74 7.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 75.22 110.078 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -103.57 169.77 18.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.421 . . . . 62.32 109.549 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 5.2 tt0 69.48 38.75 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 74.44 110.228 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.857 ' O ' HG23 ' A' ' 89' ' ' THR . 22.5 mt-10 -151.17 -164.89 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 74.12 110.136 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -179.84 130.14 0.25 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.952 . . . . 61.45 110.118 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 123.841 1.443 . . . . 73.13 110.422 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.213 0.53 . . . . 74.31 110.177 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -106.53 -89.57 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 74.42 110.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.717 HD12 ' C ' ' B' ' 3' ' ' LEU . 3.4 pp -96.36 136.79 36.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.845 . . . . 70.21 110.14 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.26 45.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 73.43 110.278 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -145.22 -51.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 73.05 110.217 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 8.9 ttt180 -55.87 -19.47 11.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 53.33 110.211 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -38.04 28.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 71.11 109.698 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.536 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.58 -41.06 24.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 61.13 109.852 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.411 ' HB3' ' HE2' ' B' ' 9' ' ' MET . 11.7 ttp -66.92 -48.92 67.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 61.4 110.195 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.692 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.99 -30.52 25.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 43.43 110.11 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.01 110.08 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.1 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.13 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.692 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.32 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 63.12 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.2 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.704 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 65.04 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.419 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.12 110.188 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 64.35 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.41 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 64.52 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 61.3 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.92 -162.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 53.22 110.245 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.7 t -82.4 161.99 22.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 62.14 110.246 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 25' ' ' VAL . 31.5 m -109.33 81.86 1.86 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 63.51 110.254 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.8 Cg_endo -72.7 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 73.1 110.477 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.23 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.57 -1.412 . . . . 73.23 109.57 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.41 -47.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -1.168 . . . . 70.33 110.225 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 30' ' ' ARG . . . -117.93 -74.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 74.42 110.192 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.664 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 2.5 mtp-105 -60.61 -142.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 75.14 110.181 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 65.86 25.44 11.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 73.32 110.236 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 30' ' ' ARG . 23.4 t -122.93 -25.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 43.14 110.185 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.432 HG23 ' H ' ' B' ' 33' ' ' VAL . 20.3 t -52.06 107.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 52.01 110.29 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -146.06 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 72.41 109.589 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 5.5 mt-30 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.304 -1.115 . . . . 74.32 110.148 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.535 -1.426 . . . . 74.53 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.75 -147.14 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 65.02 110.198 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.0 OUTLIER 60.94 86.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 71.44 110.219 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.2 ttm -179.56 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 75.3 110.365 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 11.4 p80 -114.25 118.32 33.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 72.24 110.143 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.89 128.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 43.24 110.012 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.14 170.02 16.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 72.44 110.145 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 82.7 m95 -109.22 -71.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 75.32 110.225 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 126.98 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 71.24 110.346 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 81' ' ' GLN . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 64.14 110.13 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.44 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.763 ' CB ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.14 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.802 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.1 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.22 109.88 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 61.03 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.21 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.32 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.54 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.41 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.41 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.52 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.43 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.44 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.11 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.912 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.32 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.873 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.44 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.44 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.32 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 64.22 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.31 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 60.25 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.53 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 63.23 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 43.53 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 70.0 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.31 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.13 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.15 110.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.15 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 62.23 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.11 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.04 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 52.34 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 61.1 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.53 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.817 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 71.41 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.32 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.568 HD11 HD13 ' B' ' 23' ' ' LEU . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.21 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.3 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.577 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 72.4 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 59' ' ' LEU . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.12 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.829 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 61.13 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 8' ' ' TRP . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.44 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.34 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 65.02 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.44 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.711 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 64.33 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.22 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.33 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 62.44 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 61.35 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 72.02 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 40.32 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.55 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 72.12 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 54.21 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.2 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 73.2 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 43.34 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.31 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.33 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 50.02 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 44.43 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 71.41 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.802 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.01 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.83 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.33 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.527 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.32 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -100.11 132.97 45.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.42 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.673 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.59 111.01 7.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 64.42 110.159 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -156.68 138.64 14.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 74.33 110.376 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -103.56 145.96 29.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 62.55 110.184 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -167.36 -169.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 71.11 110.233 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 3.2 pt20 -105.65 143.09 34.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 65.3 110.289 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 87' ' ' GLU . . . 48.53 -173.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.549 -1.42 . . . . 74.22 109.549 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' GLY . 1.9 mt-10 42.91 54.19 4.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -1.158 . . . . 72.53 110.224 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 89' ' ' THR . 6.2 mt-10 -69.76 143.66 52.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 64.5 110.174 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -158.15 134.86 6.56 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.143 -0.973 . . . . 73.44 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.0 1.527 . . . . 70.24 110.412 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.29 0.567 . . . . 63.04 110.253 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' B' ' 3' ' ' LEU . 2.0 ptpt -145.58 -41.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 72.13 110.234 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.965 HD21 ' HB3' ' B' ' 7' ' ' SER . 2.6 tt -94.34 116.25 28.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.211 -0.93 . . . . 73.52 110.118 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.09 30.49 2.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 75.51 110.117 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 -63.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 62.35 110.22 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.1 OUTLIER -48.57 -23.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 74.13 110.253 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.965 ' HB3' HD21 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -80.05 -35.74 36.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 72.5 109.731 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.7 t80 -80.61 -41.53 23.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 64.21 109.763 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.2 ttp -67.93 -47.52 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 64.24 110.031 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.822 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.94 -31.67 63.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 71.13 110.107 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 34.52 110.101 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.31 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 72.41 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.22 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 61.11 110.047 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.83 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.32 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.55 110.077 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 24' ' ' SER . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.34 110.061 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 53.31 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 51.35 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.22 110.183 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 63.02 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.04 -163.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 64.32 110.215 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.449 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 0.5 OUTLIER -79.48 162.26 25.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 71.44 110.172 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 25' ' ' VAL . 20.8 m -112.16 71.74 1.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 63.53 110.244 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.726 ' HG2' HG21 ' B' ' 14' ' ' VAL . 44.8 Cg_endo -72.48 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.942 1.496 . . . . 71.43 110.562 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 29' ' ' ALA . . . -43.35 -26.61 0.63 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 73.12 109.732 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' B' ' 25' ' ' VAL . 63.8 t -42.39 -26.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 71.41 110.297 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 27' ' ' GLY . . . -111.3 -39.2 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 75.22 110.232 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.23 46.02 19.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 64.4 110.249 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -84.96 -1.37 56.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 52.13 110.256 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 34' ' ' GLY . 3.5 t 64.19 11.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.915 . . . . 62.41 110.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.9 t 65.11 -66.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.603 -0.686 . . . . 61.11 110.265 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -171.73 69.16 0.12 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.493 -1.443 . . . . 63.21 109.493 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' B' ' 34' ' ' GLY . 10.7 tp60 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.24 -1.153 . . . . 64.32 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 73.04 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.04 -39.2 3.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -1.062 . . . . 64.54 110.234 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 4' ' ' MET . 60.9 m-70 -118.97 120.68 37.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 75.41 110.148 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 178.65 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 62.22 110.307 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.402 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 11.8 p80 -114.37 116.26 28.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 75.31 110.194 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.8 m -167.34 125.96 1.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 60.53 110.175 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 32.6 m120 -142.22 146.45 35.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 72.3 110.23 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -103.94 -69.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.885 . . . . 75.4 109.97 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 -152.96 121.56 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 63.23 109.995 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 62.22 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.42 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.687 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.34 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 65.23 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.759 HG22 HD12 ' A' ' 48' ' ' ILE . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.01 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 61.22 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 62.44 110.046 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.4 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.42 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.14 110.986 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.22 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.52 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.41 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 41.21 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.04 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.815 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 65.55 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.855 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 64.42 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 71.2 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 72.34 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 62.44 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 61.42 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 54.0 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.13 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 64.21 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.23 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.33 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 53.13 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 71.45 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.13 110.231 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.12 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 63.24 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.634 ' OD1' HG12 ' A' ' 39' ' ' VAL . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 74.13 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.21 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.15 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 55.52 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.31 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.549 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.21 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.855 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 61.53 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.759 HD12 HG22 ' A' ' 14' ' ' VAL . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 63.43 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 71.04 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 53.24 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 13' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 70.1 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 70.14 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.32 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.42 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 70.32 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 61.54 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 54.44 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 53.12 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.24 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.12 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.43 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.1 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 65.03 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 51.52 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 63' ' ' ILE . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 54.42 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.21 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.04 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 71.34 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 60.32 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 33.33 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 45.1 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 71.23 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 54.52 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.675 ' O ' HG13 ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 64.53 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' B' ' 21' ' ' ALA . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 52.31 110.042 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.34 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.01 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 73.13 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -93.59 136.59 33.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 72.12 110.237 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.6 112.27 8.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.888 . . . . 72.14 110.388 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.08 138.84 17.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 70.42 110.234 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 44.6 mt-10 -96.36 136.72 36.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 63.35 110.234 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.52 -172.67 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 71.52 110.187 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.37 163.56 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 72.03 110.218 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.44 139.97 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.619 -1.392 . . . . 73.32 109.619 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.64 55.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 75.34 110.285 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 4.9 pt-20 -106.46 -164.39 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 65.25 110.23 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 110.09 30.58 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.382 -0.824 . . . . 73.33 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 123.933 1.491 . . . . 70.44 110.433 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.267 0.556 . . . . 73.15 110.222 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.45 85.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 74.33 110.218 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.67 -53.59 4.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 73.03 110.158 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -176.06 -63.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 64.33 110.312 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.481 ' C ' ' CD ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -163.49 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 73.11 110.245 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -69.16 -20.48 64.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 71.42 110.145 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -78.79 -39.99 34.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 53.31 109.806 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.51 -41.18 24.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.873 . . . . 65.43 109.853 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.48 -53.24 51.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 72.41 110.291 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.76 -33.45 10.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.912 . . . . 64.41 110.152 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 71.33 110.084 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 60.23 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.14 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 10' ' ' LYS . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 62.52 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 61.33 110.1 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 70.1 110.197 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.41 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 61.41 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.14 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 53.44 110.096 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.41 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -69.96 -162.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.4 110.461 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 7.5 p -79.72 162.43 25.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 72.34 110.105 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.829 HG23 ' HB ' ' B' ' 28' ' ' VAL . 4.2 p -108.45 78.33 0.85 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 74.44 110.243 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.566 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.6 Cg_endo -72.66 -89.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.024 1.539 . . . . 71.2 110.534 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.47 -11.64 83.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.59 -1.404 . . . . 64.44 109.59 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.829 ' HB ' HG23 ' B' ' 25' ' ' VAL . 57.8 t -58.87 -17.12 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 75.13 110.131 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.07 -27.89 6.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 64.13 110.175 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -91.77 23.66 3.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -0.855 . . . . 73.13 110.353 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.33 -2.04 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 72.22 110.274 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.16 -17.95 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.228 -0.92 . . . . 73.42 110.158 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.26 -72.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 74.04 110.256 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.29 153.24 14.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.52 -1.432 . . . . 73.4 109.52 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.227 -1.161 . . . . 72.43 110.242 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.499 -1.44 . . . . 74.42 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -93.27 70.7 4.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -1.16 . . . . 73.23 110.159 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 146.13 42.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 73.14 110.241 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.16 70.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 53.44 110.206 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 27.9 p80 -142.55 120.22 11.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 74.32 110.22 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -163.44 112.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 43.33 110.247 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -150.93 171.57 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 72.43 110.213 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.95 -74.37 0.66 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 75.44 110.24 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.44 125.96 2.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 63.45 110.196 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 74.22 110.233 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.842 ' SG ' HD11 ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 62.21 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.713 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.11 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.842 HD11 ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.44 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.846 HG11 ' CB ' ' B' ' 21' ' ' ALA . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 53.32 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 64.4 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 73.14 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.41 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 64.23 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.13 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.42 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.12 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.32 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.31 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 72.33 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 63.31 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.849 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 72.43 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.52 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.3 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.852 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 65.02 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.41 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 51.35 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.12 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 73.41 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.3 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.852 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 62.51 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 44.34 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.54 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.33 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HB ' HD12 ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 64.13 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 63.01 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' HG12 ' A' ' 39' ' ' VAL . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.44 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 61.23 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.55 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.23 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 45.54 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.578 ' O ' HD23 ' A' ' 47' ' ' LEU . 13.1 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 60.43 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 26' ' ' SER . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.45 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 61.02 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 62.13 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG12 ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 64.15 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 62.51 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.527 ' HA ' HD11 ' A' ' 59' ' ' LEU . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.32 110.256 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.01 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.34 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 70.42 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 44.03 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.02 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.52 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 60.44 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.744 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 64.51 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 63.13 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 62.44 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 43.41 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 64.2 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.43 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 72.12 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.45 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 60.34 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.3 110.624 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 52.52 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 60.21 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.24 110.198 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 51.21 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.584 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 54.32 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 71.52 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 72.43 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 62.13 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 71.13 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -101.82 130.75 48.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.02 110.265 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -139.52 105.47 5.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 62.2 110.241 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' OE1' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -152.26 138.7 18.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 75.11 110.339 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 85' ' ' GLN . 3.9 mm-40 -92.73 148.88 21.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 75.33 110.272 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 14.1 pt-20 32.67 29.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.108 0.48 . . . . 72.35 111.623 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' GLU . 22.3 mt-30 -146.94 -178.53 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 73.13 110.267 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.452 ' HA3' ' OE1' ' A' ' 82' ' ' GLN . . . 76.6 -166.12 54.03 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.561 -1.416 . . . . 53.03 109.561 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.62 11.09 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.123 . . . . 72.04 110.192 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -132.41 110.59 10.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 75.15 110.255 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 84' ' ' GLU . 5.1 m -166.19 137.53 2.93 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 75.3 110.131 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.964 1.507 . . . . 64.4 110.454 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.359 0.599 . . . . 72.31 110.163 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -102.17 90.14 3.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 71.34 110.227 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -28.06 65.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 74.51 110.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.95 54.8 0.86 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -0.886 . . . . 73.42 110.065 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 -68.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 74.43 110.223 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -52.51 -25.8 11.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 73.53 110.174 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.53 35.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 64.32 109.613 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.524 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -77.18 -38.42 51.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 65.51 109.597 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.75 -55.34 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 51.33 110.025 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.792 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -53.72 -35.79 61.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 73.44 109.998 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.43 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.22 110.072 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.1 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.792 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.23 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.32 110.006 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 65.43 110.1 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.33 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 64.14 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 53.23 110.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 51.2 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 54.13 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.836 ' CD2' HD11 ' A' ' 48' ' ' ILE . 3.9 tp -69.11 -162.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 73.24 110.396 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 41.7 t -83.13 162.2 21.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.447 -0.783 . . . . 74.41 110.351 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 25' ' ' VAL . 26.8 m -108.15 77.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 63.42 110.089 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.746 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.0 Cg_endo -72.45 -50.34 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.954 1.502 . . . . 72.2 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.4 34.89 0.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.441 -1.464 . . . . 74.21 109.441 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.712 HG22 ' HA ' ' B' ' 15' ' ' ALA . 86.8 t -49.44 -71.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -1.046 . . . . 72.54 110.188 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' B' ' 28' ' ' VAL . . . 173.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -0.832 . . . . 53.04 110.105 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -103.07 92.13 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 70.13 110.301 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.57 -23.14 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 64.53 110.194 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.762 HG23 HG23 ' B' ' 33' ' ' VAL . 15.3 m -78.87 -30.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 73.44 110.188 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.762 HG23 HG23 ' B' ' 32' ' ' VAL . 51.3 t -122.02 -60.08 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 72.01 110.174 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.82 -64.81 0.25 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.558 -1.417 . . . . 45.41 109.558 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 70.33 110.201 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 75.44 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -79.99 -89.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -1.19 . . . . 74.25 110.165 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.1 OUTLIER -86.19 63.8 8.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.183 -0.948 . . . . 61.45 110.202 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.7 tpp -178.76 100.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 73.35 110.365 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.661 ' O ' HG23 ' A' ' 6' ' ' THR . 18.5 p80 -114.13 119.64 37.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 75.32 110.2 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -166.96 126.44 1.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 75.15 110.1 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 10' ' ' VAL . 14.7 t-20 -142.24 158.24 43.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.902 . . . . 71.32 110.28 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -102.6 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 72.44 110.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.4 124.29 7.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 74.04 110.181 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.14 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.42 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.33 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.848 HD23 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 63.11 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 71.33 109.933 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 70.33 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.54 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.03 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.43 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 71.13 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.42 110.863 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.11 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 74.5 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.11 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.51 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 53.12 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 72.21 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.82 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.31 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 73.45 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.51 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.858 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 63.11 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 4.6 t30 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.2 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 42.05 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 72.13 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.35 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 72.12 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.858 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 73.43 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.11 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.3 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 54.53 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG12 ' OD1' ' A' ' 41' ' ' ASP . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.23 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.455 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.2 110.36 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.66 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.43 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.42 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 61.32 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 55.13 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.82 HD12 ' CB ' ' A' ' 26' ' ' SER . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.24 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 HD13 ' B' ' 23' ' ' LEU . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.34 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 72.3 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 72.25 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.4 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 51.34 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.864 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 60.21 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 61.2 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.22 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.52 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.51 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.864 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.34 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 73.12 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.739 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 43.22 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.03 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.24 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 64.13 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.2 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.942 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 63.32 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.14 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.35 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.491 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.42 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.12 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.44 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG23 ' CG1' ' A' ' 69' ' ' VAL . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 44.53 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 74.41 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.22 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 53.42 110.334 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 41.44 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.848 ' CD2' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 62.0 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 64.44 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.31 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.55 136.72 33.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.4 110.147 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.629 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -133.21 112.26 11.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 74.02 110.304 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' A' ' 81' ' ' GLN . 15.4 pt20 -151.68 138.7 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 61.11 110.287 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.8 mp0 -78.1 119.55 21.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 52.44 110.264 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -172.51 28.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 62.33 110.264 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' GLU . 9.7 pt20 37.52 47.73 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.64 -0.663 . . . . 72.03 110.776 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 172.02 48.62 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 43.23 109.587 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -153.14 28.61 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -1.154 . . . . 74.42 110.203 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.96 157.22 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 74.13 110.181 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.2 OUTLIER -87.67 171.81 9.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 54.1 110.163 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 45.6 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 124.105 1.582 . . . . 72.14 110.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.191 0.519 . . . . 74.51 110.276 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 22.84 8.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.876 . . . . 72.34 110.161 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.0 tp -106.37 88.46 2.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 72.45 110.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.5 p -148.94 42.34 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 75.12 110.197 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.0 -34.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 52.0 110.259 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -56.76 -20.65 23.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 74.21 110.231 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -39.27 32.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 52.2 109.735 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.535 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.55 -41.59 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 75.01 109.787 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.428 ' SD ' ' HG3' ' A' ' 81' ' ' GLN . 5.2 ttp -67.75 -47.65 68.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 71.41 110.246 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.717 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.71 -28.16 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.852 . . . . 74.13 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 54.21 110.073 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.05 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 65.31 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.12 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 62.44 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 52.21 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.664 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.2 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 44.23 110.1 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 63.12 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 51.15 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.41 110.119 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 44.32 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.627 HD23 ' H ' ' B' ' 24' ' ' SER . 0.2 OUTLIER -68.23 -162.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 62.0 110.277 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.627 ' H ' HD23 ' B' ' 23' ' ' LEU . 0.7 OUTLIER -82.47 162.25 22.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 31.44 110.359 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.856 HG23 ' HB ' ' B' ' 28' ' ' VAL . 6.8 p -107.4 83.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 55.5 110.22 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.0 Cg_endo -71.8 -56.66 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.971 1.511 . . . . 71.23 110.533 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.2 36.24 1.94 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.514 -1.435 . . . . 62.21 109.514 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 25' ' ' VAL . 57.8 t -64.35 -52.18 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -1.115 . . . . 74.35 110.286 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.98 -1.48 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 74.11 110.279 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 46.93 37.3 4.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 72.14 110.119 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -75.26 -1.05 21.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 73.41 110.268 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 4.9 t 64.36 9.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 73.04 110.298 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.633 HG22 ' H ' ' B' ' 34' ' ' GLY . 7.5 p -92.81 -179.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.426 -0.796 . . . . 71.41 110.061 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.633 ' H ' HG22 ' B' ' 33' ' ' VAL . . . -79.32 -98.44 0.27 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.496 -1.442 . . . . 52.13 109.496 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.248 -1.148 . . . . 74.14 110.246 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.602 -1.399 . . . . 62.34 109.602 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.58 128.75 42.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.196 . . . . 71.32 110.193 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' ND1' ' CD2' ' A' ' 5' ' ' HIS . 1.6 t-160 -109.7 -141.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 74.51 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.19 71.01 0.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 74.54 110.167 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.519 ' CD2' ' ND1' ' A' ' 3' ' ' HIS . 94.0 m-70 -140.11 123.41 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -0.958 . . . . 74.25 110.268 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.34 121.37 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 73.31 110.177 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -142.31 166.51 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 53.41 110.1 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -102.66 -79.85 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 74.42 110.125 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 -163.76 129.07 2.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 74.15 110.267 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 81' ' ' GLN . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.34 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.32 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.853 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 64.44 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.707 HD12 ' N ' ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 74.3 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 62.13 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 52.42 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 71.13 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 54.14 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.42 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.31 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.32 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 73.14 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.4 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 60.25 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 63.53 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.779 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 71.32 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.797 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 61.22 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 55.11 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.04 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 73.13 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.23 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.44 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 72.22 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.21 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 63.24 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 43.24 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.44 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.582 ' O ' HG23 ' A' ' 37' ' ' VAL . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 62.42 110.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 74.53 110.128 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG12 ' OD2' ' A' ' 41' ' ' ASP . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.51 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.42 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.607 ' OD2' HG12 ' A' ' 39' ' ' VAL . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.44 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.11 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 63.3 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.22 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.45 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD23 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.13 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 26' ' ' SER . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 65.55 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.767 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 63.24 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 49' ' ' VAL . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.51 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.853 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.11 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 62.21 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HA ' HD11 ' A' ' 59' ' ' LEU . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.43 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.772 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 52.12 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 63.43 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 64.32 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 51.2 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.34 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.636 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.13 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.757 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.31 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 4.1 mt-30 -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 72.4 109.87 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' SG ' ' A' ' 35' ' ' CYS . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.3 110.516 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.34 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 73.24 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.972 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.05 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.02 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.53 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.44 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 72.12 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 64.34 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.4 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 72.02 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 71.0 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 72.12 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.22 110.33 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.24 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 70.04 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 71.35 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 71.2 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -94.55 136.58 34.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.41 110.21 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.681 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -133.52 108.81 8.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 72.14 110.274 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -161.4 138.71 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 72.42 110.21 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -99.95 118.71 36.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 74.22 110.27 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -155.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 70.23 110.166 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.8 49.81 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.144 -0.972 . . . . 64.1 110.163 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.04 154.01 11.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 65.51 109.528 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.4 mm-40 -134.57 0.87 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -1.155 . . . . 54.33 110.281 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.831 ' O ' HG23 ' A' ' 89' ' ' THR . 60.7 mm-40 38.83 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.442 -0.786 . . . . 54.43 110.963 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 177.87 61.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 73.14 110.179 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.764 0 O-C-N 123.985 1.519 . . . . 71.44 110.408 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.32 0.581 . . . . 72.43 110.276 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -103.72 65.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 74.45 110.181 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.734 HD12 ' C ' ' B' ' 3' ' ' LEU . 3.3 pp -77.13 -28.88 54.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 74.44 110.238 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.578 ' C ' HD12 ' B' ' 3' ' ' LEU . 0.9 OUTLIER 57.18 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 64.42 110.19 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 3' ' ' LEU . 1.1 tmm_? -158.59 -37.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 74.42 110.289 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.3 OUTLIER -56.67 -22.14 32.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 64.23 110.093 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -78.08 -40.39 38.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 61.02 109.682 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.539 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.56 -41.49 24.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.455 -0.778 . . . . 61.41 109.694 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.7 ttp -66.74 -47.18 73.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 72.34 110.116 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.832 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.62 -32.28 7.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 65.14 110.049 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' B' ' 30' ' ' ARG . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 64.33 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.21 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 52.02 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.832 HG22 ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.22 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 64.24 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 61.53 110.068 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 52.2 110.101 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.31 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 63.24 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 52.34 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 63.44 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 53.23 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -69.89 -162.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 74.2 110.346 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.7 t -82.85 162.16 21.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 74.11 110.251 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.763 HG23 ' CG2' ' B' ' 28' ' ' VAL . 7.6 p -107.46 83.27 1.47 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.31 110.138 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.556 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.2 Cg_endo -71.73 -90.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.029 1.541 . . . . 71.31 110.518 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -117.2 52.16 0.7 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.648 -1.381 . . . . 74.44 109.648 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.763 ' CG2' HG23 ' B' ' 25' ' ' VAL . 51.7 t -43.93 -26.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -1.128 . . . . 71.41 110.177 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' B' ' 30' ' ' ARG . . . -91.64 -53.2 4.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 71.23 110.29 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 15.5 ttt85 56.7 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 75.3 110.089 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 64.81 17.44 10.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 61.42 110.334 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 33' ' ' VAL . 61.4 t -71.51 -28.6 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 71.54 110.176 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 32' ' ' VAL . 10.9 t 60.16 126.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 52.2 110.227 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.79 -147.24 10.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.566 -1.414 . . . . 62.31 109.566 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.289 -1.124 . . . . 72.14 110.205 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.578 -1.409 . . . . 35.45 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -126.0 -45.34 1.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -1.148 . . . . 61.42 110.324 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' SER . 21.4 t-80 60.06 143.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 71.13 110.237 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.8 tpp -177.33 73.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 73.21 110.196 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.487 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 82.8 m-70 -116.44 118.68 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 75.41 110.225 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 14.0 m -166.83 121.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 74.1 110.192 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -152.22 163.34 39.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 62.52 110.339 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -109.2 -69.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 65.13 109.946 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -153.07 121.34 6.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 74.11 109.728 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.12 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 13' ' ' LEU . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.31 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.942 ' C ' HD13 ' A' ' 13' ' ' LEU . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.22 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.942 HD13 ' C ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.31 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 48' ' ' ILE . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 71.33 109.953 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.21 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 55.21 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 62.41 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.53 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.33 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.53 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 71.31 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 52.14 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.42 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.973 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 64.2 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.774 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.35 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.22 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.54 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.828 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.43 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 25.23 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.4 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 72.42 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.43 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 54.23 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.52 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.51 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 63.32 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 52.44 110.24 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' OD1' ' A' ' 41' ' ' ASP . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 73.12 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.24 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.676 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 43.23 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 54.54 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 62.45 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.14 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 42.5 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.5 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 72.33 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD12 ' CB ' ' A' ' 26' ' ' SER . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 55.24 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.883 HD11 HD22 ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.43 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.828 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.42 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 64.42 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.41 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.51 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 53.3 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 63.5 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.03 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.34 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.21 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.796 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 54.53 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 61.12 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.34 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 72.0 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.14 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 60.32 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 72.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 53.42 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.43 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.01 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.51 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.973 HG11 HD13 ' A' ' 25' ' ' ILE . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 63.15 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 51.44 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 55.32 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.32 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 71.41 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 60.02 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 75' ' ' VAL . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 54.42 110.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.11 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' HD12 ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 61.25 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 62.22 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.44 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 132.56 36.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.528 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -139.43 111.32 7.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 72.35 110.234 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -154.9 138.7 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 72.23 110.321 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 4.9 tm-20 -83.93 148.79 26.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 74.34 110.216 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.42 -101.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.87 . . . . 73.21 110.184 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -108.76 58.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 63.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.48 135.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 33.45 109.456 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 42.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -1.143 . . . . 53.51 110.271 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 89' ' ' THR . 7.9 pt-20 -111.21 135.01 52.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 72.11 110.184 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -157.05 58.42 1.56 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 64.11 110.204 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.305 -1.743 0 O-C-N 124.004 1.528 . . . . 54.1 110.366 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.236 0.541 . . . . 72.53 110.343 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -66.53 -46.68 75.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 72.14 110.156 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.705 ' H ' HD12 ' B' ' 3' ' ' LEU . 0.5 OUTLIER -96.62 -63.46 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 63.4 109.78 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 10.0 t 59.3 19.84 8.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 70.24 110.253 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 6' ' ' ARG . 1.6 tpt180 -153.53 -72.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 61.5 110.273 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.6 ttt85 -57.13 -29.78 63.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 75.21 110.214 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -75.12 -41.25 58.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 74.32 109.66 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.518 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.58 -37.61 30.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.455 -0.778 . . . . 73.03 109.749 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.409 ' HE1' HG11 ' A' ' 50' ' ' VAL . 6.2 ttp -67.35 -55.62 13.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 63.55 110.194 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.688 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -54.46 -27.87 40.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 72.44 110.138 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 24.43 110.159 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.474 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.24 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 31.5 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.688 HG22 ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.51 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.405 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 63.54 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 61.54 110.066 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 63.4 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.4 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 72.14 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.33 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 45.04 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 41.4 110.237 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.34 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -64.39 -162.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.51 110.322 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.6 OUTLIER -81.91 162.14 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 62.42 110.23 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 25' ' ' VAL . 15.9 m -107.81 82.86 1.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 74.42 110.182 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.9 Cg_endo -71.89 -90.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.124 1.592 . . . . 71.42 110.464 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.05 38.76 3.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.58 -1.408 . . . . 74.4 109.58 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.1 t -90.43 -71.15 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -1.151 . . . . 51.51 110.308 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -165.91 73.98 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 71.02 110.217 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 178.48 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 52.41 110.336 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.0 59.14 4.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.536 -0.728 . . . . 71.5 110.185 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.87 -41.58 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 72.32 110.254 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.69 127.63 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 72.25 110.209 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.82 -118.46 4.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.507 -1.437 . . . . 75.24 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.199 -1.177 . . . . 73.24 110.222 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.616 -1.394 . . . . 70.13 109.616 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 1.7 p -133.82 70.09 1.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.166 . . . . 53.23 110.28 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 2' ' ' SER . 2.1 t60 178.25 72.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -0.888 . . . . 74.24 110.198 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 10.9 ttm -178.71 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 52.15 110.263 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' THR . 34.1 m80 -115.3 116.26 28.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 62.32 110.237 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -167.25 119.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 61.03 110.073 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -152.29 165.46 34.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 74.24 110.495 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.593 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 92.9 m95 -104.98 -69.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.798 . . . . 74.44 109.954 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 121.65 6.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.935 . . . . 74.31 109.989 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.44 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 70.52 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.768 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.31 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 63.43 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG11 ' HB1' ' B' ' 21' ' ' ALA . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 73.15 110.022 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.53 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CG ' ' HB3' ' A' ' 74' ' ' ALA . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.22 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.33 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 62.33 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.04 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.33 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 74.32 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 70.51 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.12 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.03 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 69' ' ' VAL . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 62.24 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.81 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 63.14 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 72.11 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.1 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.942 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.22 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.23 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 43.34 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 64.32 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 54.21 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 63.51 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.54 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.13 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 62.41 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.12 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 52.21 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 60.22 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.34 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 71.21 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.05 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.44 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 42.3 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 63.45 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.81 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.35 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.574 HD11 HD22 ' B' ' 23' ' ' LEU . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.02 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 41.34 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 70.44 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.03 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.33 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.559 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.13 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 60.21 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 72.22 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 62.1 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.45 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.03 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.21 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 73.42 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 62.43 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.31 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 62.54 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.2 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 41.04 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 74.15 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.23 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 45.52 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.22 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.31 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 72.54 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB3' ' CG ' ' A' ' 16' ' ' GLN . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.32 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' O ' HG13 ' A' ' 75' ' ' VAL . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 52.44 110.292 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 54.45 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.697 HD13 HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 53.11 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.23 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.21 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.49 126.31 49.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.43 109.857 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -130.4 112.1 12.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 73.31 110.323 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' NE2' ' HA2' ' A' ' 86' ' ' GLY . 11.4 pt20 -153.74 138.63 17.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 72.23 110.178 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -94.75 119.09 32.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 75.12 110.244 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 83' ' ' GLU . 1.8 mt-10 65.89 -66.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 72.02 110.039 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.593 ' NE2' ' O ' ' A' ' 8' ' ' TRP . 1.1 tm0? -42.03 147.49 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.531 -0.73 . . . . 74.24 110.32 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' GLU . . . -163.53 -134.76 1.7 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.45 -1.46 . . . . 71.34 109.45 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 25.0 mt-10 61.97 59.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -1.124 . . . . 61.54 110.197 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 88' ' ' GLU . 7.1 pt-20 -117.53 140.77 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 63.45 110.295 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 p -87.49 137.66 32.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 74.45 110.198 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.919 1.484 . . . . 74.3 110.442 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.333 0.587 . . . . 71.24 110.228 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -93.41 -9.77 37.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 75.4 110.273 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.616 ' O ' HD23 ' B' ' 3' ' ' LEU . 0.9 OUTLIER -79.8 -24.86 41.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 64.31 110.26 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.75 59.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 72.45 110.176 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -174.12 -33.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 73.44 110.23 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -65.0 -18.22 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 74.51 110.199 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -38.53 30.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 64.33 109.722 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 0.9 OUTLIER -80.61 -42.81 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 72.24 109.748 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.435 ' SD ' ' NE2' ' A' ' 81' ' ' GLN . 8.4 ttp -67.44 -45.38 76.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.888 . . . . 71.12 110.067 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.781 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -50.69 -27.0 6.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 72.31 110.091 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 3.3 m-20 -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 62.34 110.148 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 62.42 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' B' ' 10' ' ' LYS . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.14 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 52.32 110.09 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.15 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 64.01 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 24' ' ' SER . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 53.32 110.163 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 64.11 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.32 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 64.53 110.183 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 21.53 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -69.86 -162.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 63.25 110.211 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.452 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 15.5 m -78.18 162.07 26.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 72.05 110.243 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 25' ' ' VAL . 21.4 m -109.86 74.54 0.76 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 74.31 110.379 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.637 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.8 Cg_endo -73.16 -90.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.998 1.525 . . . . 72.12 110.376 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -108.68 48.65 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.472 . . . . 52.01 109.421 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' GLY . 79.4 t -41.49 -41.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -1.06 . . . . 62.45 110.34 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 28' ' ' VAL . . . -176.67 -48.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 51.43 110.176 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -106.44 99.07 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 73.15 110.298 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.65 6.99 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 71.23 110.267 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 34' ' ' GLY . 88.4 t -62.3 -42.06 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 61.33 110.108 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 33' ' ' VAL . 29.4 m -51.8 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 73.43 110.173 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -174.64 -70.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.607 -1.397 . . . . 75.24 109.607 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.295 -1.121 . . . . 63.11 110.201 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.551 -1.42 . . . . 44.52 109.551 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 3' ' ' HIS . 81.1 p -158.88 -80.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -1.177 . . . . 54.11 110.171 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' N ' ' OG ' ' A' ' 2' ' ' SER . 19.0 m-70 -158.74 162.53 37.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 74.34 110.143 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 4' ' ' MET . 3.0 ptp -159.63 70.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 63.25 110.281 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 23.0 p80 -142.21 119.6 11.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 63.4 110.252 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.35 119.55 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 74.12 110.165 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -142.83 148.94 37.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -0.852 . . . . 74.25 110.249 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.536 ' CD1' ' N ' ' A' ' 8' ' ' TRP . 26.8 m95 -103.46 -69.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 72.34 110.093 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -153.56 122.67 6.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 74.43 110.138 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG13 ' HG3' ' A' ' 81' ' ' GLN . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 72.33 110.224 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.53 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.779 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.12 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 51' ' ' VAL . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.32 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.65 HG11 ' HB1' ' B' ' 21' ' ' ALA . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 53.32 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 65.52 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.13 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 73.22 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.54 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.35 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 51.42 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.41 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.812 HG21 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.1 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.893 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 52.23 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 65.25 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 71.52 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.15 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CG ' HG22 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 52.32 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.41 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.42 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 62.23 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 53.22 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.54 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 37' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.44 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.892 ' HB1' ' HE2' ' B' ' 9' ' ' MET . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 60.14 110.105 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG12 ' OD1' ' A' ' 41' ' ' ASP . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 71.2 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 34.45 110.259 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' OD1' HG12 ' A' ' 39' ' ' VAL . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.12 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 71.03 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 64.41 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 44.41 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 52.14 109.661 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 64.22 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.893 HD12 ' CB ' ' A' ' 26' ' ' SER . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.43 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 HD22 ' B' ' 23' ' ' LEU . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.24 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 29' ' ' LEU . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 63.32 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 55.12 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 71.14 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.31 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.862 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 64.44 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 73.01 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.2 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.31 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 63.34 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.862 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.15 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.21 110.187 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.11 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.532 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 55.35 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.43 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.32 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.03 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.978 ' O ' HG23 ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.12 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 70.1 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.32 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.21 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 73.55 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.33 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.51 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.614 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.13 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 61.34 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.44 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 75' ' ' VAL . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 53.42 110.251 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.04 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 61.12 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 73.51 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.23 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -96.8 127.9 43.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 64.23 110.139 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.588 ' HG3' HG13 ' A' ' 10' ' ' VAL . 0.8 OUTLIER -137.61 109.69 7.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.864 . . . . 73.21 110.28 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 7.1 pt20 -159.99 138.62 10.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.908 . . . . 40.04 110.24 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 2.9 tp10 -90.12 119.69 30.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.243 -0.91 . . . . 54.23 110.281 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 1.4 pt-20 177.38 -30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 64.11 110.188 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 50.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 72.4 110.1 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.19 -135.34 4.59 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.436 . . . . 54.43 109.509 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 82' ' ' GLN . 0.8 OUTLIER 49.38 23.2 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 60.42 110.14 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' THR . 6.3 pt-20 -63.17 152.72 36.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 74.21 110.188 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -155.11 159.98 31.3 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 73.12 110.18 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.795 0 O-C-N 123.948 1.499 . . . . 70.1 110.349 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 34.41 110.203 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.941 ' O ' HD22 ' B' ' 3' ' ' LEU . 12.9 pttp -172.87 143.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 75.32 110.182 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.941 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -147.34 141.45 26.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.892 . . . . 52.04 110.266 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 3' ' ' LEU . 8.1 t -177.98 -45.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.825 . . . . 62.01 110.078 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' B' ' 9' ' ' MET . 0.2 OUTLIER -137.31 -35.73 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 63.33 110.025 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -34.77 -61.87 0.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.689 -0.632 . . . . 75.41 110.991 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 6' ' ' ARG . 0.9 OUTLIER -43.0 -43.66 4.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 64.2 110.379 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -81.22 -45.86 15.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 72.44 110.448 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.892 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 13.6 ttp -71.53 -55.74 7.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.016 -1.052 . . . . 71.24 109.79 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.844 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.3 -25.58 2.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 65.43 109.759 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 64.32 109.827 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.458 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 73.25 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.32 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.844 HG22 ' O ' ' B' ' 10' ' ' LYS . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 73.24 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 71.15 109.682 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 62.43 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.45 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.4 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.01 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.34 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.31 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.0 -162.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.42 110.356 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 2.3 m -79.0 162.23 26.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 72.0 110.292 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.747 HG23 ' HB ' ' B' ' 28' ' ' VAL . 2.7 p -107.63 82.81 1.41 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 72.22 110.192 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.786 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.1 Cg_endo -72.28 -54.64 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 63.34 110.443 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.23 33.65 2.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.574 -1.41 . . . . 71.13 109.574 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' B' ' 25' ' ' VAL . 29.2 t -94.49 -79.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 65.24 110.203 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.55 ' N ' HG12 ' B' ' 28' ' ' VAL . . . -101.23 -9.87 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 74.43 110.249 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 1.0 OUTLIER 64.96 110.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.12 110.243 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.31 -29.97 68.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 74.51 110.339 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.517 ' C ' HG13 ' B' ' 33' ' ' VAL . 27.0 m -50.08 -21.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 72.54 110.281 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.517 HG13 ' C ' ' B' ' 32' ' ' VAL . 32.8 m -151.15 157.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 62.0 110.128 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.81 78.22 0.1 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.496 -1.442 . . . . 63.31 109.496 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.276 -1.132 . . . . 61.02 110.162 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 55.53 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER -89.37 73.44 7.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -1.174 . . . . 73.34 110.147 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 1.7 m80 58.99 118.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 62.51 110.247 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.41 76.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 73.42 110.232 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -124.56 117.86 25.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 62.12 110.279 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 6' ' ' THR . 6.8 t -166.87 126.39 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 70.11 110.154 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.74 168.49 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 54.32 110.338 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.82 -69.66 0.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 63.44 110.095 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.48 124.44 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 62.31 110.194 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.33 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.13 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.639 ' HA ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 51.1 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 77' ' ' LEU . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.22 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.34 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.2 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 62.13 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.094 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.3 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 65.32 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.43 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 64.44 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 63.53 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.094 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 64.22 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 64.02 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.45 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.715 HG21 HG11 ' A' ' 69' ' ' VAL . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.11 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.914 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 70.31 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.11 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.54 109.855 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.933 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 72.13 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 64.25 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.31 110.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.12 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.13 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.34 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.15 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.41 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.23 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 72.32 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.34 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.41 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.41 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 55.02 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 73.42 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 55.55 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.1 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 42.44 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.914 HD12 ' CB ' ' A' ' 26' ' ' SER . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.11 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.684 HD11 HD22 ' B' ' 23' ' ' LEU . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 51.51 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.933 HG21 ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 64.45 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.53 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 64.15 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 72.54 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 70.15 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.14 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.21 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.31 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.34 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.55 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 53.11 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.31 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.45 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 63.32 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 73.13 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 44.05 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.01 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 65.5 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.54 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 54.51 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.22 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 71.34 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.13 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.41 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.03 110.042 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 63.21 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 77' ' ' LEU . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.11 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.33 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.32 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 63.5 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 81' ' ' GLN . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.14 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.43 126.42 45.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.21 110.027 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.571 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 pp0? -139.68 112.0 7.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 55.34 110.317 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.496 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.6 pt20 -155.34 138.66 15.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 74.11 110.302 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 4.4 mm-40 -103.59 135.65 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 72.22 110.207 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 7.5 pt-20 177.62 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 74.32 110.12 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 7.4 mt-30 -156.9 147.03 21.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 74.23 110.231 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 88' ' ' GLU . . . -132.68 174.62 20.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.596 -1.401 . . . . 41.24 109.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 67.05 -59.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.332 -1.099 . . . . 72.34 110.229 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.6 pt-20 34.28 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.703 0.764 . . . . 64.04 111.487 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 47.78 96.39 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 71.24 110.176 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 124.026 1.54 . . . . 73.15 110.41 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.243 0.544 . . . . 70.5 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.78 -138.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 72.13 110.21 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -149.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 71.33 110.18 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.26 -16.07 9.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 74.32 110.298 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -147.84 -55.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 65.21 110.243 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -50.21 -21.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 73.34 110.174 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 35.6 t -81.05 -35.82 31.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 75.11 109.624 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.6 t80 -80.48 -41.49 24.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.498 -0.751 . . . . 45.31 109.911 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.2 ttp -66.86 -50.86 61.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 72.34 110.118 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.773 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.68 -29.12 16.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 75.22 110.086 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 42.1 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 61.14 110.055 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.41 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.52 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' CG1' ' B' ' 28' ' ' VAL . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.33 110.046 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.04 110.027 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.4 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.21 110.18 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.33 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.21 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.04 110.227 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 74.13 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.47 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 72.23 110.518 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 23.5 t -82.93 158.74 22.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 53.42 110.412 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 25' ' ' VAL . 15.3 m -107.56 85.18 2.17 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 74.12 109.909 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.644 ' HG2' HG21 ' B' ' 14' ' ' VAL . 43.5 Cg_endo -70.07 -89.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.19 1.626 . . . . 75.13 110.972 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -92.4 -15.48 53.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.175 -1.17 . . . . 73.42 110.175 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.491 HG23 ' N ' ' B' ' 29' ' ' ALA . 16.8 m -43.56 -42.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.226 . . . . 72.23 110.299 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.491 ' N ' HG23 ' B' ' 28' ' ' VAL . . . -179.66 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 53.1 110.267 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.427 ' NH1' ' CG ' ' B' ' 30' ' ' ARG . 1.8 mtt-85 63.75 88.59 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 72.21 110.253 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 30' ' ' ARG . . . -42.93 -55.52 3.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 45.13 110.288 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.925 HG13 HG23 ' B' ' 33' ' ' VAL . 9.3 p -46.5 -30.1 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 71.32 110.184 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.925 HG23 HG13 ' B' ' 32' ' ' VAL . 81.7 t -133.88 83.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 71.12 110.229 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.64 63.63 4.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.487 -1.445 . . . . 72.42 109.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -1.11 . . . . 64.42 110.226 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.529 -1.428 . . . . 63.32 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -92.37 -15.09 27.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -1.168 . . . . 44.52 110.242 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.6 t60 63.03 122.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 74.21 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttt -160.56 71.24 0.43 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 75.11 110.14 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 83' ' ' GLU . 22.9 p80 -142.28 122.36 13.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 54.51 110.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 122.21 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 73.23 110.178 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -143.06 167.0 23.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 74.03 110.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.518 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . 94.1 m95 -110.5 -73.56 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 72.31 110.195 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -153.41 126.07 8.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 71.23 110.238 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 50.43 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' A' ' 59' ' ' LEU . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.42 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.752 ' HA ' HG12 ' A' ' 50' ' ' VAL . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.34 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.13 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 71.12 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 61.52 110.269 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.67 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.11 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 35.12 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 71.42 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.14 111.017 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.21 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 73.32 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 61.13 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.499 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.32 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.12 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.838 ' OG ' HD12 ' A' ' 47' ' ' LEU . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.41 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 71.33 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 51.53 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 74.41 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.965 ' ND2' HG21 ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 73.52 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 43.21 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 60.14 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.41 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.52 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.1 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 72.14 110.095 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.965 HG21 ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.44 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.22 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.13 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.04 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.687 ' OD1' HG12 ' A' ' 39' ' ' VAL . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.41 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 52.23 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.32 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 64.32 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.31 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.772 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 53.2 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.838 HD12 ' OG ' ' A' ' 26' ' ' SER . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 70.02 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.963 HD11 HD22 ' B' ' 23' ' ' LEU . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.35 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.22 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.51 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.34 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.14 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 72.51 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.44 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.31 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.51 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.45 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.2 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.568 HD21 ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 71.31 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 61.43 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.33 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.1 110.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.32 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 73.54 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.32 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.11 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.12 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.32 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 52.51 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.33 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.02 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CG1' ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.21 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 43.44 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.54 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.04 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.04 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 64.33 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.42 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 72.12 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 126.36 44.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.54 110.054 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.514 ' CG ' ' O ' ' A' ' 81' ' ' GLN . 1.3 pp0? -135.01 106.9 7.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 65.41 110.323 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 3.4 pt20 -161.47 138.45 8.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -0.854 . . . . 62.41 110.286 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' HG2' ' ND1' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -104.19 122.42 45.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 73.43 110.12 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 85' ' ' GLN . 8.5 pt-20 177.67 -44.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 74.21 110.21 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 19.9 pt20 -129.3 175.45 8.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 74.32 110.239 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.64 139.31 39.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.512 -1.435 . . . . 64.02 109.512 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.28 -37.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -1.149 . . . . 75.53 110.256 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -107.01 157.05 18.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 75.24 110.178 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.7 p -138.12 83.49 22.44 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 62.43 110.23 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.674 0 O-C-N 123.944 1.497 . . . . 74.03 110.37 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.436 ' O ' ' CB ' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.286 0.565 . . . . 72.13 110.13 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.23 42.26 4.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 73.3 110.242 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.531 ' HG ' ' CB ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -119.17 177.97 4.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.912 . . . . 73.23 110.2 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.82 -71.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 41.23 110.238 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.83 -42.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 75.33 110.181 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -49.63 -21.74 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 73.44 110.243 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 7' ' ' SER . . . . . 0.531 ' CB ' ' HG ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -79.31 -42.37 25.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 53.11 109.833 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PHE . . . . . 0.45 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.6 t80 -73.65 -39.15 64.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 75.14 109.923 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.4 ttp -67.15 -50.69 60.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 63.24 110.162 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.812 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -56.82 -33.32 66.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 63.31 110.099 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 41.25 110.037 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 65.13 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 70.45 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' VAL . . . . . 0.812 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 52.22 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.923 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.41 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.43 110.125 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 60.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ALA . . . . . 0.401 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 53.3 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 64.54 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 54.41 110.152 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 64.24 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -68.78 -162.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 54.41 110.277 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 25.0 m -73.98 162.15 29.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 74.34 110.259 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 25' ' ' VAL . 26.9 m -111.3 73.33 0.98 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 63.45 110.259 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.8 Cg_endo -73.0 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 61.45 110.474 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.08 8.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 63.52 109.502 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.923 HG22 ' HA ' ' B' ' 15' ' ' ALA . 69.0 t -90.97 -21.75 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 75.44 110.285 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.06 18.78 15.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 71.1 110.289 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' B' ' 30' ' ' ARG . 0.3 OUTLIER -124.28 -13.21 7.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 74.52 110.485 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.519 ' C ' HG12 ' B' ' 32' ' ' VAL . . . -91.88 63.97 4.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 72.42 110.012 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.741 HG22 HG23 ' B' ' 33' ' ' VAL . 1.5 p 170.66 -27.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 72.33 109.54 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' VAL . . . . . 0.741 HG23 HG22 ' B' ' 32' ' ' VAL . 29.8 t -143.03 171.35 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 73.3 110.063 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' HG12 ' B' ' 33' ' ' VAL . . . 160.84 -30.91 0.35 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.519 -1.433 . . . . 71.43 109.519 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.163 -1.198 . . . . 74.41 110.228 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.222 0.534 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.576 ' OG ' HG12 ' A' ' 50' ' ' VAL . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.532 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.65 ' CD ' ' HB3' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.047 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.047 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.772 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.673 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.857 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD1' HG12 ' A' ' 39' ' ' VAL . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.823 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 46' ' ' GLN . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.085 HD11 HD22 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' OG ' ' A' ' 12' ' ' SER . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.821 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.821 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.747 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB3' ' CD ' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 77' ' ' LEU . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.636 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.237 0.541 . . . . 0.0 110.049 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.682 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 1.085 HD22 HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.307 0.575 . . . . 72.519999999999996 110.327 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 44.409999999999997 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 43.009999999999998 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.647 ' OG ' HG12 ' A' ' 50' ' ' VAL . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 62.43 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 HD23 HD22 ' A' ' 77' ' ' LEU . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 35.310000000000002 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 51.219999999999999 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.219999999999999 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.340000000000003 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 61.539999999999999 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 72.299999999999997 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.439999999999998 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.430000000000007 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.538 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.299999999999997 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.409999999999997 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 72.219999999999999 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 72.420000000000002 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.94 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.319999999999993 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.888 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.299999999999997 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.230000000000004 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.450000000000003 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.229999999999997 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.519999999999996 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 73.329999999999998 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.540000000000006 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 63.039999999999999 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 74.099999999999994 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 52.210000000000001 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.040000000000006 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 53.200000000000003 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.409999999999997 110.106 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 41' ' ' ASP . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 64.219999999999999 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 71.439999999999998 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 39' ' ' VAL . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.099999999999994 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 20.5 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.329999999999998 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 42.310000000000002 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.040000000000006 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 72.510000000000005 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.888 HD12 ' CB ' ' A' ' 26' ' ' SER . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 65.25 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.831 HD11 HD22 ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.049999999999997 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 74.430000000000007 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.647 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.129999999999995 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 65.430000000000007 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 60.100000000000001 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 55.299999999999997 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 65.430000000000007 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 55.310000000000002 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 61.140000000000001 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.239999999999995 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.624 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 53.219999999999999 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 63.450000000000003 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.745 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.150000000000006 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 74.120000000000005 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.340000000000003 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 71.409999999999997 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.219999999999999 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.140000000000001 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 72.409999999999997 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.579 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 71.129999999999995 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 54.409999999999997 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 50.119999999999997 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 72.439999999999998 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.229999999999997 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.409999999999997 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 71.129999999999995 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 51.420000000000002 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 75' ' ' VAL . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.209999999999994 110.229 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 60.210000000000001 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.519999999999996 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 64.340000000000003 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 65.099999999999994 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 54.109999999999999 110.163 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.76 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.303 0.573 . . . . 65.109999999999999 110.143 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 62.340000000000003 110.206 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.209999999999994 110.205 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.430000000000007 110.219 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.76 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 62.509999999999998 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.450000000000003 110.109 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 64.450000000000003 110.19 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 71.109999999999999 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 71.409999999999997 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 62.149999999999999 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.219999999999999 110.12 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.210000000000001 110.22 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 71.430000000000007 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.831 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 65.439999999999998 110.267 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.32 0.581 . . . . 65.420000000000002 110.133 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 72.209999999999994 110.23 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 59' ' ' LEU . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 43.329999999999998 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 63.409999999999997 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.430000000000007 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' B' ' 21' ' ' ALA . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.040000000000006 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.129999999999995 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.704 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.430000000000007 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.994 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.329999999999998 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.540000000000006 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.219999999999999 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' NE ' ' HA3' ' A' ' 71' ' ' GLY . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.409999999999997 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.140000000000001 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 53.039999999999999 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.409999999999997 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.439999999999998 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.775 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.530000000000001 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 71.209999999999994 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 64.420000000000002 109.848 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.8 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.329999999999998 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.150000000000006 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.150000000000006 110.281 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.349999999999994 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.209999999999994 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.049999999999997 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.340000000000003 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 53.43 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.239999999999995 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 73.340000000000003 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.439999999999998 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.240000000000002 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.230000000000004 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.430000000000007 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 53.030000000000001 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 62.219999999999999 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.804 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 63.109999999999999 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 46' ' ' GLN . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 70.140000000000001 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.685 HD11 HD22 ' B' ' 23' ' ' LEU . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.239999999999995 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.439999999999998 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.310000000000002 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 52.409999999999997 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' A' ' 59' ' ' LEU . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.219999999999999 110.222 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 52.299999999999997 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.240000000000002 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.319999999999993 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 54.43 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.420000000000002 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.738 ' O ' HG22 ' A' ' 63' ' ' ILE . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.510000000000005 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.549999999999997 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 62.509999999999998 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 73.120000000000005 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 73.140000000000001 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 45.100000000000001 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.420000000000002 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.409999999999997 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 70.120000000000005 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.310000000000002 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.430000000000007 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.505 HG23 ' CG1' ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.019999999999996 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 64.120000000000005 110.111 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 61.439999999999998 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.409999999999997 110.313 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 62.539999999999999 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.518 HD23 HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 63.329999999999998 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 71.129999999999995 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 73.120000000000005 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.299999999999997 110.132 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.711 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.262 0.553 . . . . 53.310000000000002 110.082 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 55.539999999999999 110.205 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 72.239999999999995 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.439999999999998 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.711 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 61.030000000000001 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 50.420000000000002 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 71.239999999999995 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.420000000000002 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.239999999999995 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 64.409999999999997 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.120000000000005 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.329999999999998 110.185 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 64.310000000000002 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.302 0.572 . . . . 75.129999999999995 110.146 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 51.210000000000001 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' HD11 ' A' ' 13' ' ' LEU . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 65.25 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.329999999999998 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD11 ' SG ' ' A' ' 11' ' ' CYS . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 72.519999999999996 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.409999999999997 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.109999999999999 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 63.119999999999997 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.430000000000007 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 62.420000000000002 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 70.5 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 61.229999999999997 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.530000000000001 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 62.509999999999998 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.150000000000006 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 70.519999999999996 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.836 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.329999999999998 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 61.130000000000003 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 52.140000000000001 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.219999999999999 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 61.219999999999999 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.430000000000007 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 71.209999999999994 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.140000000000001 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 62.240000000000002 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.310000000000002 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.209999999999994 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 55.130000000000003 110.194 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' HD12 ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.209999999999994 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.010000000000005 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.420000000000002 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.450000000000003 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 54.109999999999999 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 55.43 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.329999999999998 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 47' ' ' LEU . 2.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.349999999999994 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.836 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 61.409999999999997 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.067 HD11 HD22 ' B' ' 23' ' ' LEU . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.510000000000005 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.329999999999998 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 53.210000000000001 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 64.549999999999997 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.200000000000003 110.26 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.329999999999998 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.209999999999994 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.200000000000003 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 50.399999999999999 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 53.329999999999998 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.727 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 72.409999999999997 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 64.400000000000006 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 63' ' ' ILE . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 60.140000000000001 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.523 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.519999999999996 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.400000000000006 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 60.439999999999998 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 63.299999999999997 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.230000000000004 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 65.219999999999999 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.540000000000006 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.430000000000007 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.010000000000005 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.019999999999996 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 45.310000000000002 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 73.030000000000001 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 72.140000000000001 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 65.129999999999995 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 63.530000000000001 110.305 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 71.519999999999996 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.310000000000002 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.319999999999993 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.541 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.200000000000003 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.319999999999993 110.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.211 0.529 . . . . 73.049999999999997 110.141 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.120000000000005 110.069 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.239999999999995 110.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 10' ' ' LYS . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.329999999999998 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 62.020000000000003 110.131 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 72.120000000000005 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.71 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.209999999999994 110.158 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 72.329999999999998 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 72.549999999999997 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.019999999999996 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.040000000000006 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 32.420000000000002 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 1.067 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.109999999999999 110.301 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.6 mt-30 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.373 0.606 . . . . 71.430000000000007 110.109 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 64.010000000000005 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 63.43 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.759 ' HA ' HG12 ' A' ' 50' ' ' VAL . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 55.439999999999998 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 72.540000000000006 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG11 ' CB ' ' B' ' 21' ' ' ALA . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 43.350000000000001 110.11 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.230000000000004 110.263 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.319999999999993 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.049999999999997 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.420000000000002 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 50.149999999999999 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.420000000000002 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 72.5 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.037 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 70.310000000000002 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.049999999999997 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 69' ' ' VAL . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.439999999999998 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.873 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 64.420000000000002 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 62.100000000000001 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 71.150000000000006 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.230000000000004 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 13.3 t-20 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.430000000000007 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 44.020000000000003 110.276 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.409999999999997 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 63.0 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.109999999999999 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.239999999999995 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' C ' HG23 ' A' ' 49' ' ' VAL . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 37' ' ' VAL . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.430000000000007 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.030000000000001 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.530000000000001 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.540000000000006 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.150000000000006 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 61.240000000000002 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.420000000000002 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 72.230000000000004 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 26' ' ' SER . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 53.219999999999999 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.761 HD11 HD22 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.120000000000005 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.430000000000007 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.319999999999993 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.129999999999995 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 52.549999999999997 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.340000000000003 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 40.43 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.129999999999995 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.340000000000003 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.120000000000005 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.669 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 72.409999999999997 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 64.120000000000005 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 61.210000000000001 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.329999999999998 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.510000000000005 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 74.439999999999998 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 63.210000000000001 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.350000000000001 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.430000000000007 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.120000000000005 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.109999999999999 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 44.130000000000003 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.439999999999998 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 42.329999999999998 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.450000000000003 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 42.240000000000002 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.618 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.430000000000007 110.14 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.010000000000005 110.183 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' B' ' 21' ' ' ALA . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 63.130000000000003 110.204 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.744 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 51.530000000000001 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 71.5 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 71.409999999999997 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.239999999999995 110.198 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.75 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.264 0.554 . . . . 61.020000000000003 110.132 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.129999999999995 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 55.43 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 62.049999999999997 110.192 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 64.219999999999999 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.415 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 73.540000000000006 110.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 63.219999999999999 110.091 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.210000000000001 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 63.240000000000002 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 72.209999999999994 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.209999999999994 110.227 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 52.219999999999999 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 64.109999999999999 110.322 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.237 0.542 . . . . 72.030000000000001 110.122 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.349999999999994 110.24 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.349999999999994 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 50' ' ' VAL . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.230000000000004 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.319999999999993 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 41.119999999999997 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.420000000000002 110.303 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 64.030000000000001 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.400000000000006 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.420000000000002 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 51.140000000000001 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.010000000000005 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 74.040000000000006 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.519999999999996 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.120000000000005 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.891 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 72.109999999999999 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.816 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.399999999999999 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.310000000000002 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.25 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 63.219999999999999 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.530000000000001 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.420000000000002 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.209999999999994 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 74.510000000000005 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.119999999999997 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.299999999999997 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 64.340000000000003 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' VAL . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 51.109999999999999 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.409999999999997 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.210000000000001 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.450000000000003 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.439999999999998 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 71.310000000000002 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.209999999999994 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.310000000000002 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 61.439999999999998 110.385 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 52.329999999999998 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.89 HD11 HD22 ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.530000000000001 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.120000000000005 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.439999999999998 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 HD11 ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 55.229999999999997 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HA ' HD11 ' A' ' 59' ' ' LEU . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.219999999999999 110.137 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.901 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.229999999999997 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.030000000000001 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 63.409999999999997 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 64.319999999999993 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.901 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 73.150000000000006 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.762 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 71.450000000000003 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 63' ' ' ILE . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 71.299999999999997 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 55.140000000000001 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.450000000000003 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.420000000000002 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 72.439999999999998 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.965 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 64.219999999999999 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.563 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 54.200000000000003 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 64.349999999999994 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.030000000000001 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.239999999999995 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.340000000000003 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 61.020000000000003 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.576 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.019999999999996 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 73.299999999999997 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.209999999999994 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 72.319999999999993 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.239999999999995 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.319999999999993 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.627 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 73.430000000000007 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 73.030000000000001 110.168 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.252 0.548 . . . . 75.310000000000002 110.151 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 70.439999999999998 110.07 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 54.100000000000001 110.136 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.040000000000006 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.049999999999997 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.510000000000005 109.934 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 72.310000000000002 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 50.399999999999999 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 54.5 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.439999999999998 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.230000000000004 110.186 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 72.430000000000007 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 50.020000000000003 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.430000000000007 110.327 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.31 0.576 . . . . 64.439999999999998 110.053 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.030000000000001 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.549999999999997 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.835 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.120000000000005 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 62.509999999999998 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 55.240000000000002 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 62.210000000000001 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.420000000000002 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 70.239999999999995 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 55.43 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.340000000000003 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 72.510000000000005 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.450000000000003 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 61.43 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.822 HD13 HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 72.450000000000003 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.439999999999998 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.409999999999997 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.040000000000006 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 71.319999999999993 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 74.239999999999995 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 51.450000000000003 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.219999999999999 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 63.219999999999999 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.039999999999999 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.736 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.409999999999997 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.671 ' C ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.329999999999998 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 37' ' ' VAL . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 74.430000000000007 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.430000000000007 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 52.229999999999997 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 54.049999999999997 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.530000000000001 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 71.310000000000002 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.219999999999999 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.510000000000005 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 61.43 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.731 ' O ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.109999999999999 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 65.030000000000001 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 70.319999999999993 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.420000000000002 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.835 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.430000000000007 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 62.340000000000003 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 64.430000000000007 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 62.32 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.329999999999998 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.319999999999993 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.319999999999993 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.61 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.340000000000003 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 51.450000000000003 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 70.150000000000006 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.239999999999995 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.736 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 65.230000000000004 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 74.239999999999995 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.569 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 74.519999999999996 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.450000000000003 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.099999999999994 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 73.239999999999995 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.120000000000005 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 74.430000000000007 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.319999999999993 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 73.549999999999997 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 61.399999999999999 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 71.329999999999998 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.310000000000002 110.206 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.140000000000001 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 53.340000000000003 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.540000000000006 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.549999999999997 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 70.310000000000002 110.109 179.831 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.694 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.227 0.537 . . . . 63.119999999999997 109.953 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.319999999999993 109.934 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.340000000000003 110.102 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 43.100000000000001 110.246 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.694 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.329999999999998 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.310000000000002 109.989 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 63.039999999999999 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 64.400000000000006 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.129999999999995 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.030000000000001 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 53.240000000000002 110.107 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 40.420000000000002 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 73.109999999999999 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 64.040000000000006 110.359 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.184 0.516 . . . . 65.329999999999998 110.308 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.430000000000007 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.530000000000001 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.703 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 71.450000000000003 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 70.430000000000007 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' CB ' ' B' ' 21' ' ' ALA . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 55.100000000000001 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG23 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 63.32 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.310000000000002 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.430000000000007 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 64.420000000000002 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 70.140000000000001 110.964 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.200000000000003 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 74.0 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.340000000000003 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.409999999999997 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 64.25 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.010000000000005 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.91 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 61.149999999999999 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 70.439999999999998 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.510000000000005 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 71.109999999999999 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.039999999999999 110.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.100000000000001 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 53.130000000000003 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.329999999999998 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.039999999999999 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 63.109999999999999 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 73.310000000000002 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 72.219999999999999 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 64.299999999999997 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.109999999999999 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.010000000000005 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 71.420000000000002 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 61.219999999999999 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.439999999999998 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.439999999999998 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.239999999999995 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 26' ' ' SER . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 53.520000000000003 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 63.340000000000003 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' HG23 ' A' ' 15' ' ' VAL . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 72.340000000000003 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.553 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.109999999999999 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.310000000000002 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 53.25 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 54.310000000000002 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 70.230000000000004 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.219999999999999 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.340000000000003 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.049999999999997 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.340000000000003 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.400000000000006 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 72.329999999999998 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 60.219999999999999 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 52.109999999999999 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.230000000000004 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.340000000000003 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 73.209999999999994 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.575 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 62.530000000000001 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.526 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.430000000000007 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 65' ' ' SER . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.349999999999994 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.340000000000003 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.340000000000003 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.499 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 63.450000000000003 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 74.340000000000003 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 65.439999999999998 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 54.229999999999997 110.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 43.43 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 62.020000000000003 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 73.140000000000001 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.530000000000001 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 52.030000000000001 110.162 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.677 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.167 0.508 . . . . 51.109999999999999 110.047 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.530000000000001 110.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 64.510000000000005 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.677 HG22 ' O ' ' B' ' 10' ' ' LYS . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 72.230000000000004 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.230000000000004 110.225 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.299999999999997 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.310000000000002 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.509999999999998 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 63.030000000000001 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.520000000000003 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.030000000000001 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.400000000000006 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 54.219999999999999 110.32 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.3 0.572 . . . . 72.420000000000002 110.118 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 44.210000000000001 110.231 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' HD23 ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 64.129999999999995 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.72 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.310000000000002 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' B' ' 21' ' ' ALA . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 54.109999999999999 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.109999999999999 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 65.140000000000001 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.987 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 62.530000000000001 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 73.450000000000003 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.439999999999998 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 62.25 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.340000000000003 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 73.349999999999994 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.140000000000001 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 72.420000000000002 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 65.219999999999999 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.792 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.120000000000005 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.329999999999998 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 60.43 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.329999999999998 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.040000000000006 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.129999999999995 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.439999999999998 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 45.439999999999998 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.219999999999999 110.211 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 73.420000000000002 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 33.520000000000003 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 71.230000000000004 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.219999999999999 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.099999999999994 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.420000000000002 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 44.109999999999999 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 43.130000000000003 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 53.539999999999999 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 70.040000000000006 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.545 HD11 HD22 ' B' ' 23' ' ' LEU . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.150000000000006 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 29' ' ' LEU . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 51.25 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 62.539999999999999 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 59' ' ' LEU . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.319999999999993 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 52.420000000000002 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.239999999999995 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.019999999999996 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.549999999999997 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.200000000000003 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.310000000000002 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 74.349999999999994 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 72.209999999999994 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.430000000000007 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.200000000000003 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 53.509999999999998 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.129999999999995 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 62.439999999999998 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 71.239999999999995 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 72.319999999999993 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 74.209999999999994 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 62.509999999999998 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.239999999999995 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.130000000000003 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 72.040000000000006 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 63.219999999999999 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 72.209999999999994 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.219999999999999 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.129999999999995 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.349999999999994 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.329999999999998 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.420000000000002 110.098 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.629 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.275 0.56 . . . . 61.100000000000001 110.076 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 51.109999999999999 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.230000000000004 110.183 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.129999999999995 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.629 HG13 ' O ' ' B' ' 10' ' ' LYS . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.120000000000005 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 72.120000000000005 110.108 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 73.329999999999998 110.172 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.150000000000006 110.172 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.329999999999998 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 52.420000000000002 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 62.119999999999997 110.13 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 71.140000000000001 110.234 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.450000000000003 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.545 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.510000000000005 110.296 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.075 0.464 . . . . 63.25 110.217 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 50.32 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.741 ' SG ' HD11 ' A' ' 13' ' ' LEU . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 50.049999999999997 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.684 ' OG ' HG12 ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 53.109999999999999 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.230000000000004 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.678 HG11 ' CB ' ' B' ' 21' ' ' ALA . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 63.520000000000003 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.409999999999997 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.684 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 71.450000000000003 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.299999999999997 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.140000000000001 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.009999999999998 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 74.319999999999993 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.549 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.099999999999994 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 73.430000000000007 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' HG22 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 61.520000000000003 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.150000000000006 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.961 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.219999999999999 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.109999999999999 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 70.450000000000003 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.140000000000001 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 72.140000000000001 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 64.109999999999999 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.530000000000001 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.129999999999995 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.409999999999997 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HA ' HG22 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.019999999999996 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.420000000000002 110.047 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.219999999999999 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.310000000000002 110.201 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 72.129999999999995 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.230000000000004 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.219999999999999 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.049999999999997 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 44.009999999999998 109.755 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.873 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.030000000000001 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.961 HD12 ' OG ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.209999999999994 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.794 HD11 HD22 ' B' ' 23' ' ' LEU . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.019999999999996 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 71.5 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.684 HG12 ' OG ' ' A' ' 12' ' ' SER . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.030000000000001 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.140000000000001 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.519999999999996 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.239999999999995 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.239999999999995 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.450000000000003 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.430000000000007 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.340000000000003 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 72.109999999999999 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 73.510000000000005 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.725 ' O ' HG22 ' A' ' 63' ' ' ILE . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 72.129999999999995 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 52.219999999999999 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.420000000000002 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.578 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.530000000000001 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 53.25 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 63.229999999999997 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.219999999999999 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.239999999999995 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.219999999999999 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.450000000000003 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.420000000000002 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 54.130000000000003 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 74.430000000000007 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.219999999999999 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 73.430000000000007 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.219999999999999 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.430000000000007 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 55.030000000000001 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.120000000000005 110.131 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.692 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 43.43 110.11 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.010000000000005 110.08 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.099999999999994 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.129999999999995 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.692 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.319999999999993 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 63.119999999999997 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.200000000000003 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.704 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 65.040000000000006 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.419 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.120000000000005 110.188 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 64.349999999999994 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.409999999999997 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 64.519999999999996 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 61.299999999999997 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 53.219999999999999 110.245 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.241 0.543 . . . . 71.239999999999995 110.346 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 64.140000000000001 110.13 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.439999999999998 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.763 ' CB ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.802 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.099999999999994 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.219999999999999 109.88 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 61.030000000000001 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.209999999999994 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.319999999999993 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.540000000000006 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.409999999999997 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.409999999999997 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.519999999999996 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.430000000000007 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.439999999999998 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.109999999999999 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.912 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.319999999999993 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.873 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.439999999999998 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.439999999999998 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.319999999999993 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 64.219999999999999 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.310000000000002 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 60.25 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.530000000000001 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 63.229999999999997 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 43.530000000000001 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 70.0 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.310000000000002 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.129999999999995 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.150000000000006 110.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.150000000000006 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 62.229999999999997 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.109999999999999 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.040000000000006 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 52.340000000000003 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 61.100000000000001 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.530000000000001 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.817 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 71.409999999999997 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.319999999999993 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.568 HD11 HD13 ' B' ' 23' ' ' LEU . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.209999999999994 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.299999999999997 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.577 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 72.400000000000006 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 59' ' ' LEU . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.120000000000005 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.829 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 61.130000000000003 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.439999999999998 110.238 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.340000000000003 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 65.019999999999996 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.439999999999998 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.711 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 64.329999999999998 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.219999999999999 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.329999999999998 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 62.439999999999998 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 61.350000000000001 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 72.019999999999996 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 40.32 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.549999999999997 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 72.120000000000005 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 54.210000000000001 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.200000000000003 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 73.200000000000003 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 43.340000000000003 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.310000000000002 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.329999999999998 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 50.020000000000003 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 44.43 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 71.409999999999997 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.802 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.010000000000005 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.83 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.329999999999998 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.527 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.319999999999993 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.420000000000002 110.147 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.822 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.325 0.583 . . . . 71.129999999999995 110.107 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 34.520000000000003 110.101 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.310000000000002 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 72.409999999999997 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.219999999999999 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 61.109999999999999 110.047 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.83 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.319999999999993 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 110.077 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.340000000000003 110.061 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 53.310000000000002 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 51.350000000000001 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.219999999999999 110.183 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 63.020000000000003 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 64.319999999999993 110.215 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.251 0.548 . . . . 63.229999999999997 109.995 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 62.219999999999999 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.420000000000002 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.687 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.340000000000003 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 65.230000000000004 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.759 HG22 HD12 ' A' ' 48' ' ' ILE . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.010000000000005 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 61.219999999999999 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 62.439999999999998 110.046 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.400000000000006 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.420000000000002 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.140000000000001 110.986 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.219999999999999 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.519999999999996 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.409999999999997 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 41.210000000000001 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.040000000000006 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.815 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 65.549999999999997 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.855 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 64.420000000000002 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 71.200000000000003 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 72.340000000000003 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 62.439999999999998 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 61.420000000000002 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 54.0 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.129999999999995 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 64.209999999999994 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.230000000000004 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.329999999999998 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 53.130000000000003 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 71.450000000000003 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.129999999999995 110.231 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.634 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.120000000000005 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 63.240000000000002 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.634 ' OD1' HG12 ' A' ' 39' ' ' VAL . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 74.129999999999995 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.209999999999994 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.150000000000006 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 55.520000000000003 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.310000000000002 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.549 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.209999999999994 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.855 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 61.530000000000001 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.759 HD12 HG22 ' A' ' 14' ' ' VAL . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 63.43 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 71.040000000000006 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 53.240000000000002 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 13' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 70.099999999999994 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 70.140000000000001 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.319999999999993 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.420000000000002 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 70.319999999999993 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 61.539999999999999 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 54.439999999999998 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 53.119999999999997 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.239999999999995 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.120000000000005 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.430000000000007 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.099999999999994 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 65.030000000000001 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 51.520000000000003 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 63' ' ' ILE . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 54.420000000000002 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.209999999999994 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.040000000000006 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 71.340000000000003 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 60.32 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 33.329999999999998 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 45.100000000000001 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 71.230000000000004 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 54.520000000000003 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 64.530000000000001 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' B' ' 21' ' ' ALA . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 52.310000000000002 110.042 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.340000000000003 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.010000000000005 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 73.129999999999995 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 72.120000000000005 110.237 -179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.182 0.515 . . . . 64.409999999999997 110.152 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 71.329999999999998 110.084 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 60.229999999999997 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.140000000000001 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 10' ' ' LYS . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 62.520000000000003 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 61.329999999999998 110.1 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 70.099999999999994 110.197 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.409999999999997 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 61.409999999999997 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.140000000000001 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 53.439999999999998 110.096 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.409999999999997 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.400000000000006 110.461 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.235 0.541 . . . . 63.450000000000003 110.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 74.219999999999999 110.233 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.842 ' SG ' HD11 ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 62.210000000000001 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.713 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.109999999999999 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.842 HD11 ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.439999999999998 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.846 HG11 ' CB ' ' B' ' 21' ' ' ALA . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 53.32 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 64.400000000000006 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 73.140000000000001 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.409999999999997 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 64.230000000000004 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.129999999999995 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.420000000000002 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.120000000000005 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.310000000000002 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 72.329999999999998 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 63.310000000000002 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.849 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 72.430000000000007 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.520000000000003 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.299999999999997 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.852 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 65.019999999999996 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.409999999999997 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 51.350000000000001 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.120000000000005 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 73.409999999999997 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.299999999999997 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.852 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 62.509999999999998 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 44.340000000000003 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.540000000000006 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.329999999999998 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HB ' HD12 ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 64.129999999999995 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 63.009999999999998 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' HG12 ' A' ' 39' ' ' VAL . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.439999999999998 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 61.229999999999997 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.549999999999997 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.230000000000004 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 45.539999999999999 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.722 ' NE2' ' HB1' ' B' ' 21' ' ' ALA . 6.9 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 60.43 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 26' ' ' SER . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.450000000000003 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 61.020000000000003 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 62.130000000000003 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG12 ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 64.150000000000006 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 62.509999999999998 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.527 ' HA ' HD11 ' A' ' 59' ' ' LEU . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.319999999999993 110.256 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.010000000000005 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.340000000000003 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 70.420000000000002 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 44.030000000000001 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.019999999999996 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.519999999999996 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 60.439999999999998 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.744 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 64.510000000000005 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 63.130000000000003 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 62.439999999999998 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 43.409999999999997 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 64.200000000000003 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.430000000000007 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 72.120000000000005 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.450000000000003 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 60.340000000000003 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.299999999999997 110.624 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 52.520000000000003 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 60.210000000000001 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.239999999999995 110.198 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 51.210000000000001 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 54.32 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 71.519999999999996 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 72.430000000000007 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 62.130000000000003 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 71.129999999999995 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.019999999999996 110.265 -179.924 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.792 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.326 0.584 . . . . 73.439999999999998 109.998 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.219999999999999 110.072 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.099999999999994 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.792 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.230000000000004 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.319999999999993 110.006 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 65.430000000000007 110.1 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.329999999999998 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 64.140000000000001 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 53.229999999999997 110.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 51.200000000000003 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 54.130000000000003 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.836 ' CD2' HD11 ' A' ' 48' ' ' ILE . 3.9 tp . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 73.239999999999995 110.396 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.429 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.252 0.548 . . . . 74.040000000000006 110.181 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.140000000000001 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.420000000000002 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.329999999999998 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.848 HD23 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 63.109999999999999 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 71.329999999999998 109.933 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 70.329999999999998 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.540000000000006 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.03 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.430000000000007 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 71.129999999999995 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.420000000000002 110.863 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.109999999999999 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 74.5 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.109999999999999 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.510000000000005 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 53.119999999999997 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 72.209999999999994 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.82 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.310000000000002 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 73.450000000000003 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.510000000000005 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.858 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 63.109999999999999 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.9 t-20 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.200000000000003 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 42.049999999999997 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 72.129999999999995 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.349999999999994 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 72.120000000000005 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.858 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 73.430000000000007 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.109999999999999 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.299999999999997 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 54.530000000000001 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.66 HG12 ' OD1' ' A' ' 41' ' ' ASP . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.230000000000004 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.455 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.200000000000003 110.36 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.66 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.430000000000007 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.420000000000002 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 61.32 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 55.130000000000003 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.82 HD12 ' CB ' ' A' ' 26' ' ' SER . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.239999999999995 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 HD13 ' B' ' 23' ' ' LEU . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.340000000000003 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 72.299999999999997 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 72.25 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.399999999999999 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 51.340000000000003 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.864 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 60.210000000000001 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 61.200000000000003 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.219999999999999 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.519999999999996 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.510000000000005 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.864 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.340000000000003 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 73.120000000000005 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.739 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 43.219999999999999 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.030000000000001 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.239999999999995 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 64.129999999999995 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.583 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.200000000000003 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.942 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 63.32 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.140000000000001 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.349999999999994 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.491 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.420000000000002 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.120000000000005 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.439999999999998 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.536 HG23 ' CG1' ' A' ' 69' ' ' VAL . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 44.530000000000001 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 74.409999999999997 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.219999999999999 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 53.420000000000002 110.334 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 41.439999999999998 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.848 ' CD2' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 62.0 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 64.439999999999998 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.310000000000002 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.429 ' NE2' ' NE2' ' A' ' 9' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.400000000000006 110.147 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.717 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.036 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 54.210000000000001 110.073 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.049999999999997 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 65.310000000000002 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.120000000000005 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 62.439999999999998 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 52.210000000000001 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.664 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.200000000000003 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 44.229999999999997 110.1 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 63.119999999999997 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 51.149999999999999 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.409999999999997 110.119 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 44.32 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 62.0 110.277 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.183 0.516 . . . . 74.150000000000006 110.267 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.340000000000003 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.319999999999993 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.853 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 64.439999999999998 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 74.299999999999997 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 62.130000000000003 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 52.420000000000002 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 71.129999999999995 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 54.140000000000001 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.420000000000002 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.310000000000002 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.319999999999993 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 73.140000000000001 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.400000000000006 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 60.25 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 63.530000000000001 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.779 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 71.319999999999993 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.797 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 61.219999999999999 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 55.109999999999999 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.040000000000006 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 73.129999999999995 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.439999999999998 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 72.219999999999999 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.209999999999994 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 63.240000000000002 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 43.240000000000002 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.439999999999998 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 37' ' ' VAL . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 62.420000000000002 110.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 74.530000000000001 110.128 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.607 HG12 ' OD2' ' A' ' 41' ' ' ASP . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.510000000000005 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.420000000000002 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.607 ' OD2' HG12 ' A' ' 39' ' ' VAL . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.439999999999998 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.109999999999999 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 63.299999999999997 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.219999999999999 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.450000000000003 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD23 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.129999999999995 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 26' ' ' SER . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 65.549999999999997 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.767 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 63.240000000000002 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 49' ' ' VAL . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.509999999999998 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.853 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.109999999999999 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 62.210000000000001 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HA ' HD11 ' A' ' 59' ' ' LEU . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.430000000000007 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.772 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 52.119999999999997 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 63.43 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 64.319999999999993 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 51.200000000000003 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.340000000000003 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.636 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.129999999999995 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.757 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.310000000000002 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 72.400000000000006 109.87 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' SG ' ' A' ' 35' ' ' CYS . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.299999999999997 110.516 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.340000000000003 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 73.239999999999995 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.972 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.049999999999997 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.019999999999996 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.530000000000001 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 72.120000000000005 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 64.340000000000003 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.399999999999999 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 72.019999999999996 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 71.0 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 72.120000000000005 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.219999999999999 110.33 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 70.040000000000006 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 71.349999999999994 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 71.200000000000003 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.409999999999997 110.21 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.832 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.269 0.557 . . . . 65.140000000000001 110.049 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.412 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 64.329999999999998 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.210000000000001 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 52.020000000000003 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.832 HG22 ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.219999999999999 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 64.239999999999995 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 61.530000000000001 110.068 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 52.200000000000003 110.101 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.310000000000002 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 63.240000000000002 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 52.340000000000003 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 63.439999999999998 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 53.229999999999997 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 74.200000000000003 110.346 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 121.33 0.586 . . . . 74.109999999999999 109.728 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.120000000000005 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 13' ' ' LEU . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.310000000000002 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.942 ' C ' HD13 ' A' ' 13' ' ' LEU . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.219999999999999 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.942 HD13 ' C ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.310000000000002 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 48' ' ' ILE . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.953 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.209999999999994 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 55.210000000000001 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 62.409999999999997 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.530000000000001 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.329999999999998 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.530000000000001 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 71.310000000000002 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 52.140000000000001 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.420000000000002 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.973 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 64.200000000000003 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.774 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.349999999999994 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.219999999999999 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.540000000000006 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.828 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.430000000000007 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 25.23 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.399999999999999 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 72.420000000000002 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.430000000000007 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 54.229999999999997 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.519999999999996 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.510000000000005 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 63.32 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 52.439999999999998 110.24 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' OD1' ' A' ' 41' ' ' ASP . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 73.120000000000005 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.239999999999995 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.676 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 43.229999999999997 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 54.539999999999999 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 62.450000000000003 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.140000000000001 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 42.5 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.7 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 72.329999999999998 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.774 HD12 ' CB ' ' A' ' 26' ' ' SER . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 55.240000000000002 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.883 HD11 HD22 ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.430000000000007 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.828 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.420000000000002 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 64.420000000000002 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.409999999999997 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.510000000000005 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 53.299999999999997 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 63.5 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.030000000000001 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.340000000000003 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.209999999999994 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.796 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 54.530000000000001 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 61.119999999999997 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.340000000000003 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 72.0 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.140000000000001 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 60.32 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 72.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 53.420000000000002 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.430000000000007 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.010000000000005 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.510000000000005 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.973 HG11 HD13 ' A' ' 25' ' ' ILE . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 63.149999999999999 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 51.439999999999998 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 55.32 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.319999999999993 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 71.409999999999997 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 60.020000000000003 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 54.420000000000002 110.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.109999999999999 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' HD12 ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 61.25 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 62.219999999999999 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.439999999999998 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.688 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.226 0.536 . . . . 72.439999999999998 110.138 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 24.43 110.159 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.474 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.239999999999995 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 31.5 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.688 HG22 ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.510000000000005 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.405 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 63.539999999999999 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 61.539999999999999 110.066 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 63.399999999999999 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.4 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 72.140000000000001 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.329999999999998 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 45.039999999999999 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 41.399999999999999 110.237 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.340000000000003 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.509999999999998 110.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.242 0.544 . . . . 74.310000000000002 109.989 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.439999999999998 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 70.519999999999996 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.768 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.310000000000002 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 63.43 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.675 HG11 ' HB1' ' B' ' 21' ' ' ALA . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 73.150000000000006 110.022 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.530000000000001 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CG ' ' HB3' ' A' ' 74' ' ' ALA . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.219999999999999 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.329999999999998 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 62.329999999999998 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.040000000000006 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.329999999999998 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 74.319999999999993 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 70.510000000000005 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.120000000000005 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.030000000000001 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 69' ' ' VAL . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 62.240000000000002 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.81 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 63.140000000000001 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 72.109999999999999 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.099999999999994 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.942 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.219999999999999 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.230000000000004 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 43.340000000000003 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 64.319999999999993 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 54.210000000000001 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 63.509999999999998 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.540000000000006 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.129999999999995 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 62.409999999999997 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.120000000000005 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 52.210000000000001 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 60.219999999999999 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.340000000000003 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 71.209999999999994 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.049999999999997 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.439999999999998 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 42.299999999999997 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 63.450000000000003 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.81 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.349999999999994 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.574 HD11 HD22 ' B' ' 23' ' ' LEU . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.019999999999996 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 41.340000000000003 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 70.439999999999998 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.030000000000001 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.329999999999998 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.559 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.129999999999995 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 60.210000000000001 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 72.219999999999999 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 62.100000000000001 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.450000000000003 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.030000000000001 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.209999999999994 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 73.420000000000002 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 62.43 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.310000000000002 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 62.539999999999999 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.200000000000003 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 41.039999999999999 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 74.150000000000006 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.230000000000004 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 45.520000000000003 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.219999999999999 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.310000000000002 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 72.540000000000006 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB3' ' CG ' ' A' ' 16' ' ' GLN . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.319999999999993 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 52.439999999999998 110.292 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 54.450000000000003 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.697 HD13 HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 53.109999999999999 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.209999999999994 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.430000000000007 109.857 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.781 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.302 0.572 . . . . 72.310000000000002 110.091 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 62.340000000000003 110.148 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 62.420000000000002 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' B' ' 10' ' ' LYS . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.140000000000001 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 52.32 110.09 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.149999999999999 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 64.010000000000005 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 53.32 110.163 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 64.109999999999999 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.319999999999993 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 64.530000000000001 110.183 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 21.530000000000001 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 63.25 110.211 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.289 0.566 . . . . 74.430000000000007 110.138 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 72.329999999999998 110.224 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.530000000000001 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.779 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.120000000000005 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 51' ' ' VAL . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.319999999999993 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.65 HG11 ' HB1' ' B' ' 21' ' ' ALA . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 53.32 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 65.519999999999996 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.129999999999995 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 73.219999999999999 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.540000000000006 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.349999999999994 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 51.420000000000002 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.409999999999997 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.812 HG21 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.099999999999994 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.893 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 52.229999999999997 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 65.25 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 71.519999999999996 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.150000000000006 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CG ' HG22 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 52.32 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.409999999999997 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.420000000000002 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 62.229999999999997 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 53.219999999999999 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.540000000000006 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 37' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.439999999999998 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 60.140000000000001 110.105 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.605 HG12 ' OD1' ' A' ' 41' ' ' ASP . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 71.200000000000003 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 34.450000000000003 110.259 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' OD1' HG12 ' A' ' 39' ' ' VAL . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.120000000000005 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 71.030000000000001 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 64.409999999999997 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 44.409999999999997 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 52.140000000000001 109.661 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 64.219999999999999 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.893 HD12 ' CB ' ' A' ' 26' ' ' SER . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.430000000000007 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 HD22 ' B' ' 23' ' ' LEU . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 29' ' ' LEU . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 63.32 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 55.119999999999997 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 71.140000000000001 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.310000000000002 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.862 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 64.439999999999998 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 73.010000000000005 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.200000000000003 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.310000000000002 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 63.340000000000003 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.862 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.150000000000006 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.209999999999994 110.187 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.109999999999999 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.532 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 55.350000000000001 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.430000000000007 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.319999999999993 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.030000000000001 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.978 ' O ' HG23 ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.120000000000005 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 70.099999999999994 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.319999999999993 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.209999999999994 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 73.549999999999997 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.329999999999998 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.510000000000005 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.614 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.129999999999995 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 61.340000000000003 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.439999999999998 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 75' ' ' VAL . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 53.420000000000002 110.251 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.040000000000006 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 61.119999999999997 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 73.510000000000005 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.230000000000004 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 64.230000000000004 110.139 -179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.844 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.21 0.528 . . . . 65.430000000000007 109.759 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 64.319999999999993 109.827 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.458 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 73.25 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.319999999999993 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.844 HG22 ' O ' ' B' ' 10' ' ' LYS . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 73.239999999999995 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 71.150000000000006 109.682 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 62.43 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.450000000000003 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.399999999999999 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.010000000000005 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.340000000000003 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.310000000000002 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.420000000000002 110.356 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.2 0.524 . . . . 62.310000000000002 110.194 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.329999999999998 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.129999999999995 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.639 ' HA ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 51.100000000000001 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 77' ' ' LEU . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.219999999999999 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.340000000000003 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.200000000000003 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 62.130000000000003 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.094 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.299999999999997 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 65.319999999999993 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.430000000000007 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 64.439999999999998 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.544 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 63.530000000000001 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.094 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 64.219999999999999 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 64.019999999999996 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.450000000000003 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.715 HG21 HG11 ' A' ' 69' ' ' VAL . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.109999999999999 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.914 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 70.310000000000002 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.109999999999999 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.540000000000006 109.855 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.933 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 72.129999999999995 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 64.25 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.310000000000002 110.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.120000000000005 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.130000000000003 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.340000000000003 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.150000000000006 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.409999999999997 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.230000000000004 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 72.319999999999993 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.340000000000003 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.409999999999997 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.409999999999997 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 55.020000000000003 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 73.420000000000002 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 55.549999999999997 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.099999999999994 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 42.439999999999998 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.914 HD12 ' CB ' ' A' ' 26' ' ' SER . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.109999999999999 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.684 HD11 HD22 ' B' ' 23' ' ' LEU . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 51.509999999999998 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.933 HG21 ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 64.450000000000003 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.530000000000001 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 64.150000000000006 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 72.540000000000006 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.535 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 70.150000000000006 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.140000000000001 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.209999999999994 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.310000000000002 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.340000000000003 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.549999999999997 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 53.109999999999999 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.310000000000002 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.450000000000003 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 63.32 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 73.129999999999995 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 44.049999999999997 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.010000000000005 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 65.5 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.540000000000006 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 54.509999999999998 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.219999999999999 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 71.340000000000003 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.129999999999995 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.409999999999997 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.030000000000001 110.042 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 63.210000000000001 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 77' ' ' LEU . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.109999999999999 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.329999999999998 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.319999999999993 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 63.5 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.548 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.140000000000001 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.209999999999994 110.027 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.773 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.236 0.541 . . . . 75.219999999999999 110.086 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 42.100000000000001 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 61.140000000000001 110.055 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.409999999999997 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.519999999999996 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.329999999999998 110.046 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.040000000000006 110.027 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.400000000000006 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.209999999999994 110.18 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.329999999999998 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.210000000000001 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.040000000000006 110.227 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 74.129999999999995 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 72.230000000000004 110.518 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.514 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.321 0.581 . . . . 71.230000000000004 110.238 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.468 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 50.43 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' A' ' 59' ' ' LEU . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.420000000000002 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.752 ' HA ' HG12 ' A' ' 50' ' ' VAL . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.340000000000003 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.129999999999995 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 71.120000000000005 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 61.520000000000003 110.269 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.67 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.109999999999999 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 35.119999999999997 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 71.420000000000002 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.140000000000001 111.017 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.209999999999994 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 73.319999999999993 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 61.130000000000003 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.499 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.319999999999993 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.120000000000005 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.838 ' OG ' HD12 ' A' ' 47' ' ' LEU . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.409999999999997 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 71.329999999999998 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 51.530000000000001 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 74.409999999999997 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.965 ' ND2' HG21 ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 73.519999999999996 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 43.210000000000001 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 60.140000000000001 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.409999999999997 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.519999999999996 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.099999999999994 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 72.140000000000001 110.095 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.965 HG21 ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.439999999999998 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.219999999999999 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.129999999999995 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.687 ' OD1' HG12 ' A' ' 39' ' ' VAL . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.409999999999997 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 52.229999999999997 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.319999999999993 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 64.319999999999993 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.310000000000002 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.772 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 53.200000000000003 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.838 HD12 ' OG ' ' A' ' 26' ' ' SER . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 70.019999999999996 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.963 HD11 HD22 ' B' ' 23' ' ' LEU . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.349999999999994 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.219999999999999 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.510000000000005 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.340000000000003 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.140000000000001 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 72.510000000000005 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.439999999999998 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.310000000000002 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.509999999999998 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.450000000000003 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.200000000000003 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.568 HD21 ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 71.310000000000002 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 61.43 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.329999999999998 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.099999999999994 110.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.319999999999993 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 73.540000000000006 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.319999999999993 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.109999999999999 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.120000000000005 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.319999999999993 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 52.509999999999998 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.329999999999998 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.020000000000003 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CG1' ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.209999999999994 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 43.439999999999998 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.540000000000006 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.040000000000006 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.040000000000006 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 64.329999999999998 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.420000000000002 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 72.120000000000005 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.540000000000006 110.054 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.812 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.247 0.546 . . . . 63.310000000000002 110.099 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 41.25 110.037 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 65.129999999999995 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 70.450000000000003 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . 0.812 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 52.219999999999999 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.409999999999997 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.430000000000007 110.125 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 60.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ALA . . . . . 0.401 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 53.299999999999997 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 64.540000000000006 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 54.409999999999997 110.152 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 64.239999999999995 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 54.409999999999997 110.277 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.3 m 52.58 -166.99 0.06 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -1.131 . . . . 0.0 110.218 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.2 OUTLIER -85.54 124.96 32.69 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.23 -0.919 . . . . 0.0 110.232 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.4 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 1.0 OUTLIER -175.71 80.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.743 ' O ' HG23 ' A' ' 6' ' ' THR . 1.5 m170 -141.17 124.93 16.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.92 . . . . 0.0 110.204 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.2 OUTLIER -166.76 123.97 1.28 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.202 179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.34 166.09 26.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.238 -0.914 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' A' ' 8' ' ' TRP . 19.5 m95 -104.04 -70.93 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.296 -0.877 . . . . 0.0 110.186 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -155.51 121.83 5.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.199 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.6 p -165.17 142.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.241 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 19.3 p -142.58 171.1 14.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 0.0 110.154 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.576 ' OG ' HG12 ' A' ' 50' ' ' VAL . 73.4 m -105.02 121.59 44.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -0.902 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.532 HD23 ' CB ' ' A' ' 77' ' ' LEU . 4.3 mp -109.64 139.43 44.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.235 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.43 ' HB ' ' O ' ' A' ' 76' ' ' SER . 34.4 t -98.83 100.76 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 110.119 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.95 128.97 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.341 -0.849 . . . . 0.0 110.276 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.65 ' CD ' ' HB3' ' A' ' 74' ' ' ALA . 10.4 tt0 -109.26 111.78 23.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.194 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.047 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.2 168.74 19.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.881 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.6 148.19 0.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.966 . . . . 0.0 109.601 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.54 -47.23 39.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 111.083 -179.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -92.09 -5.34 52.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.767 -1.208 . . . . 0.0 110.421 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.74 -50.45 17.37 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.047 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.69 -40.96 63.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.746 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 21.0 t -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 120.588 -1.32 . . . . 0.0 108.442 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.51 ' O ' HG22 ' A' ' 27' ' ' THR . 62.1 m-20 -71.96 -58.97 2.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.557 -0.714 . . . . 0.0 111.107 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.772 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.35 -49.16 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.402 -0.812 . . . . 0.0 111.477 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.673 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -52.25 -52.72 50.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.833 -1.167 . . . . 0.0 109.938 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.76 -33.39 61.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.779 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.4 ' N ' ' CG2' ' A' ' 27' ' ' THR . 0.8 OUTLIER -61.64 -44.18 97.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.443 -0.786 . . . . 0.0 109.897 179.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.857 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -50.95 -36.48 39.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.343 -0.848 . . . . 0.0 109.99 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 8.1 t-20 -68.83 -25.94 64.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.209 -0.932 . . . . 0.0 110.016 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.55 -28.11 61.69 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.298 -0.876 . . . . 0.0 110.198 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -73.48 154.99 89.79 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 110.268 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.17 -56.75 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.992 1.522 . . . . 0.0 110.418 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.1 -58.94 9.24 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.857 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -72.82 143.14 47.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -1.127 . . . . 0.0 110.122 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.3 OUTLIER -155.8 128.71 8.01 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 0.0 110.208 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 78.3 t -71.84 120.16 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 0.0 110.2 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.57 -51.11 5.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.174 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.734 ' HB ' HD12 ' A' ' 48' ' ' ILE . 16.7 t -120.65 120.39 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 110.117 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.32 12.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -0.922 . . . . 0.0 110.261 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' OD1' HG12 ' A' ' 39' ' ' VAL . 1.5 m-20 -133.25 148.15 51.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 110.136 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.71 54.38 0.41 Allowed Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.361 -0.837 . . . . 0.0 111.225 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 44.7 Cg_endo -70.68 -38.79 5.37 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.629 1.331 . . . . 0.0 109.797 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.4 t -149.43 14.5 0.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.494 -0.754 . . . . 0.0 110.1 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.01 28.14 11.38 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.823 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.1 pt20 -130.2 137.71 50.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -1.179 . . . . 0.0 110.364 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.823 HD23 ' O ' ' A' ' 46' ' ' GLN . 14.4 mt -123.09 159.81 27.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.24 -0.912 . . . . 0.0 110.14 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.085 HD11 HD22 ' B' ' 23' ' ' LEU . 46.0 mt -98.87 124.72 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -132.15 128.75 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' OG ' ' A' ' 12' ' ' SER . 13.2 m -96.24 146.17 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 0.0 110.164 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 13' ' ' LEU . 9.3 p -136.19 139.28 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 25.4 pt-20 -123.52 147.7 46.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 110.161 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.821 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.3 176.38 12.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.57 -46.71 19.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.251 -0.905 . . . . 0.0 110.222 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -155.3 -171.71 3.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 110.26 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' HG12 ' A' ' 60' ' ' ILE . 37.2 m -60.8 -41.17 95.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -0.933 . . . . 0.0 110.135 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 14.1 mm-40 -49.24 -46.98 46.73 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.236 -0.915 . . . . 0.0 110.174 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.821 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -74.8 -33.66 62.26 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.804 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -62.0 -44.53 96.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.209 179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.747 ' O ' HG22 ' A' ' 63' ' ' ILE . 22.2 pt -66.56 -28.68 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.905 . . . . 0.0 109.57 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 17.3 tt0 -52.65 -45.51 66.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.411 -0.806 . . . . 0.0 109.906 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.2 m -56.87 -41.63 78.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.864 . . . . 0.0 110.679 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.5 tt -52.41 -36.73 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.131 -0.981 . . . . 0.0 110.32 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.2 mt-10 -52.33 -33.33 42.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.036 -1.04 . . . . 0.0 109.774 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.9 t -68.91 -55.76 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.357 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.533 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.81 -42.14 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.843 . . . . 0.0 111.01 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.84 -41.0 88.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.057 -1.027 . . . . 0.0 110.49 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.578 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 10.2 t30 -76.26 -20.39 57.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 110.708 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 25.4 t -67.19 124.52 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.019 . . . . 0.0 109.995 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.25 -49.72 68.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.0 110.542 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.26 -32.89 5.34 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG23 ' CG1' ' A' ' 69' ' ' VAL . 27.3 t -80.46 115.97 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -1.153 . . . . 0.0 110.324 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.34 -19.54 16.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.278 -0.889 . . . . 0.0 110.066 179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB3' ' CD ' ' A' ' 16' ' ' GLN . . . -151.14 171.61 17.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.547 HG22 HD23 ' A' ' 77' ' ' LEU . 2.6 p -155.83 118.49 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.215 -0.928 . . . . 0.0 110.23 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.12 93.1 3.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.547 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -103.94 104.98 15.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 110.245 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.2 t -138.33 91.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 110.277 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 85.0 t80 -179.26 114.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.34 -0.85 . . . . 0.0 110.225 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.37 129.32 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.215 -0.928 . . . . 0.0 110.104 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.621 ' O ' HG13 ' A' ' 10' ' ' VAL . 4.2 tp-100 -129.45 102.0 6.21 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 110.292 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.482 ' CD ' ' N ' ' A' ' 82' ' ' GLN . 4.7 pm0 -161.58 139.04 8.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 0.0 110.37 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.3 OUTLIER -99.73 118.88 37.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.262 -0.898 . . . . 0.0 110.21 -179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 5.4 pt-20 178.72 -46.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.174 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.417 ' CG ' ' N ' ' A' ' 86' ' ' GLY . 47.8 tt0 -166.57 171.25 11.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 110.136 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . -121.38 133.64 9.65 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.457 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 1.6 pp20? -177.61 30.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.346 -1.091 . . . . 0.0 110.193 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' HG3' ' HG3' ' A' ' 87' ' ' GLU . 34.9 mt-10 -141.06 -164.79 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 0.0 110.239 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.1 OUTLIER -117.94 174.46 2.6 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.221 -0.924 . . . . 0.0 110.191 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 46.6 Cg_endo . . . . . 0 C--N 1.305 -1.739 0 O-C-N 124.047 1.551 . . . . 0.0 110.464 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.295 0.569 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -99.42 70.89 1.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 110.221 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.536 HD21 ' HB3' ' B' ' 6' ' ' ARG . 2.1 tt -107.97 109.22 20.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.267 -0.896 . . . . 0.0 110.171 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 1.3 t -148.03 64.12 1.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 110.222 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.486 ' HD3' ' HB2' ' B' ' 9' ' ' MET . 0.0 OUTLIER -177.73 -32.05 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.261 -0.9 . . . . 0.0 110.283 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.536 ' HB3' HD21 ' B' ' 3' ' ' LEU . 6.0 ttt180 -50.78 -23.19 2.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.212 -0.93 . . . . 0.0 110.238 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 9.5 t -78.31 -39.94 38.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.803 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.531 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.7 OUTLIER -80.55 -39.77 27.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.436 -0.79 . . . . 0.0 109.769 179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB2' ' HD3' ' B' ' 5' ' ' ARG . 1.4 ttp -66.81 -48.71 68.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 110.149 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.636 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -50.49 -29.34 10.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 0.0 110.049 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.46 -45.32 84.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.287 -0.883 . . . . 0.0 110.134 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 3.5 m-20 -82.87 -39.87 21.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.921 . . . . 0.0 110.188 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.23 -48.14 71.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 110.231 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.7 m -59.86 -33.0 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.272 -0.892 . . . . 0.0 110.181 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -32.62 74.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.28 -0.888 . . . . 0.0 110.123 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.94 -14.03 22.01 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.904 . . . . 0.0 110.182 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.682 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.26 -24.13 15.37 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 110.175 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -84.73 -51.13 7.03 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.171 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.55 -10.52 59.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.284 -0.885 . . . . 0.0 110.223 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.64 -52.61 2.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.197 -0.939 . . . . 0.0 110.188 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.682 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 14.36 13.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.93 . . . . 0.0 110.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.65 25.88 51.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 1.085 HD22 HD11 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -66.17 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -1.17 . . . . 0.0 110.28 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.494 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.2 t -82.42 162.06 22.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 110.216 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.522 HG23 ' O ' ' B' ' 25' ' ' VAL . 17.4 m -108.26 82.15 1.5 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.874 . . . . 0.0 110.194 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.494 ' HD3' ' O ' ' B' ' 24' ' ' SER . 46.0 Cg_endo -72.87 -54.51 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.031 1.542 . . . . 0.0 110.422 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -113.89 21.14 16.46 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.624 HG12 ' O ' ' B' ' 28' ' ' VAL . 64.9 t -108.48 7.91 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -1.134 . . . . 0.0 110.206 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' B' ' 31' ' ' ALA . . . -129.65 -66.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 0.0 110.21 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -44.08 94.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.286 -0.884 . . . . 0.0 110.17 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' B' ' 29' ' ' ALA . . . -137.35 6.57 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.195 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.427 ' H ' HG22 ' B' ' 32' ' ' VAL . 18.8 m -59.85 -14.49 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.272 -0.893 . . . . 0.0 110.209 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.404 HG12 ' H ' ' B' ' 33' ' ' VAL . 2.9 p -105.99 133.82 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.24 -0.912 . . . . 0.0 110.186 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -108.26 -126.74 5.48 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 2.8 mm100 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.21 -1.17 . . . . 0.0 110.243 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 72.219999999999999 109.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.09 13.55 9.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.214 -1.168 . . . . 52.439999999999998 110.159 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' A' ' 4' ' ' MET . 7.0 p80 -165.33 161.09 18.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 72.349999999999994 110.146 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.408 ' HG2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -175.0 84.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.22 -0.925 . . . . 64.230000000000004 110.22 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.2 m-70 -132.66 123.4 26.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.183 -0.948 . . . . 62.240000000000002 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.9 m -163.51 118.44 1.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.226 -0.921 . . . . 72.439999999999998 110.204 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -151.39 172.09 16.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 61.020000000000003 110.224 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -102.83 -69.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.256 -0.902 . . . . 71.109999999999999 110.218 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -153.56 122.61 6.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 72.519999999999996 110.327 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 2.5 p -159.34 141.75 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 44.409999999999997 110.188 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.9 p -138.93 171.17 14.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.221 -0.925 . . . . 43.009999999999998 110.262 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.647 ' OG ' HG12 ' A' ' 50' ' ' VAL . 1.9 t -104.96 115.7 30.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.068 -1.02 . . . . 62.43 110.235 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 HD23 HD22 ' A' ' 77' ' ' LEU . 2.5 mp -100.91 137.23 39.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 35.310000000000002 110.246 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 76' ' ' SER . 26.5 t -99.21 99.93 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.171 -0.956 . . . . 51.219999999999999 110.155 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 54.5 t -78.09 125.83 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.298 -0.876 . . . . 75.219999999999999 110.231 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -108.37 111.63 23.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.158 -0.964 . . . . 73.340000000000003 110.229 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.13 168.82 18.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 61.539999999999999 109.913 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.83 148.53 0.24 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 72.299999999999997 109.72 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.3 -47.15 36.73 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 70.439999999999998 110.983 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 20' ' ' GLU . 2.7 tp10 -92.01 -5.43 52.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.827 -1.171 . . . . 75.430000000000007 110.341 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.538 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.78 -50.03 18.75 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.046 -1.034 . . . . 63.299999999999997 108.26 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.87 -40.0 59.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 120.224 -0.59 . . . . 73.409999999999997 110.838 -179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.54 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.63 -40.52 62.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 118.506 -1.278 . . . . 72.219999999999999 108.555 179.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.518 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.2 -58.89 3.04 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.511 -0.743 . . . . 72.420000000000002 111.058 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.94 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -78.57 -49.92 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.429 -0.794 . . . . 72.319999999999993 111.466 -178.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.888 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 t -52.15 -52.92 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.951 -1.093 . . . . 73.299999999999997 110.16 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.3 t -54.3 -33.27 58.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 75.230000000000004 109.978 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 1.3 mm-40 -61.73 -44.07 97.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.248 -0.908 . . . . 72.450000000000003 109.756 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.927 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.27 -35.35 36.89 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.839 . . . . 63.229999999999997 109.978 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.537 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 5.1 t30 -73.94 -22.88 59.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 71.519999999999996 110.12 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.36 -28.11 61.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.263 -0.898 . . . . 73.329999999999998 110.306 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -74.33 151.46 87.71 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.175 -0.953 . . . . 73.540000000000006 110.234 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.6 Cg_endo -73.01 -44.09 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.046 1.551 . . . . 63.039999999999999 110.439 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.41 -60.86 4.48 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.526 -1.43 . . . . 74.099999999999994 109.526 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.536 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -77.06 147.42 36.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -1.101 . . . . 52.210000000000001 110.318 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 5.1 mm-40 -153.65 128.19 9.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 73.040000000000006 110.189 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 71.7 t -68.33 120.08 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 53.200000000000003 110.264 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.06 -53.71 4.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.243 -0.911 . . . . 73.409999999999997 110.106 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.566 HG12 ' OD2' ' A' ' 41' ' ' ASP . 11.8 t -120.5 120.52 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.462 -0.774 . . . . 64.219999999999999 110.131 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.0 p -106.64 101.85 11.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.94 . . . . 71.439999999999998 110.208 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.566 ' OD2' HG12 ' A' ' 39' ' ' VAL . 35.7 m-20 -133.41 148.22 51.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 74.099999999999994 110.127 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.99 54.3 0.43 Allowed Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.354 -0.841 . . . . 20.5 111.156 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.1 Cg_endo -70.51 -38.89 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.664 1.35 . . . . 61.329999999999998 109.803 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' A' ' 44' ' ' SER . 0.3 OUTLIER -148.28 13.9 0.98 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.362 -0.836 . . . . 42.310000000000002 110.128 179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 94.03 27.8 11.83 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.612 -1.395 . . . . 71.040000000000006 109.612 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.3 pt20 -130.29 136.15 48.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.157 -1.202 . . . . 72.510000000000005 110.421 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.888 HD12 ' CB ' ' A' ' 26' ' ' SER . 50.6 mt -121.1 159.82 24.96 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.225 -0.922 . . . . 65.25 110.05 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.831 HD11 HD22 ' B' ' 23' ' ' LEU . 13.8 mt -99.96 123.33 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 74.049999999999997 110.217 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.927 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.5 p -132.56 126.75 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.305 -0.872 . . . . 74.430000000000007 110.139 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.647 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.7 m -101.88 143.36 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 71.129999999999995 110.234 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.8 p -133.14 145.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 65.430000000000007 110.133 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.529 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 2.2 pt-20 -128.71 145.92 51.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.858 . . . . 60.100000000000001 110.234 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.624 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -157.88 -177.9 6.91 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.269 -0.895 . . . . 55.299999999999997 110.189 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -46.89 -49.95 19.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 65.430000000000007 110.151 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -155.41 -168.71 2.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 55.310000000000002 110.164 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 60' ' ' ILE . 11.1 t -63.39 -35.22 79.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 61.140000000000001 110.176 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.8 tt0 -48.48 -49.69 34.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.253 -0.904 . . . . 73.239999999999995 110.227 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.624 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 54.3 m -75.11 -32.57 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 53.219999999999999 110.118 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -62.88 -44.7 95.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 63.450000000000003 110.109 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.745 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.9 pt -66.6 -28.79 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 73.150000000000006 109.723 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -52.67 -45.46 66.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.885 . . . . 74.120000000000005 109.802 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 65' ' ' SER . 39.9 m -56.81 -41.41 77.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 71.340000000000003 110.425 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -49.55 -36.59 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.212 -0.93 . . . . 71.409999999999997 110.237 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.579 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 30.7 mt-10 -52.33 -33.31 42.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 70.219999999999999 109.828 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.953 ' O ' HG23 ' A' ' 69' ' ' VAL . 5.3 m -69.01 -55.34 11.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.365 -0.834 . . . . 74.140000000000001 110.437 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.9 m -65.37 -41.83 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.337 -0.852 . . . . 72.409999999999997 111.081 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.579 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.33 -41.08 90.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.053 -1.03 . . . . 71.129999999999995 110.493 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.563 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 8.7 t-20 -75.86 -20.68 57.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.195 -0.941 . . . . 54.409999999999997 110.446 -179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.953 HG23 ' O ' ' A' ' 65' ' ' SER . 37.7 t -68.48 120.46 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.014 . . . . 50.119999999999997 109.873 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.72 -39.79 81.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.234 -0.916 . . . . 72.439999999999998 110.468 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -54.1 -31.59 48.9 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.511 -1.436 . . . . 55.229999999999997 109.511 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 69' ' ' VAL . 25.4 t -77.81 116.78 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -1.131 . . . . 75.409999999999997 110.424 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -97.92 -21.48 16.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.906 . . . . 71.129999999999995 110.079 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -151.95 173.58 14.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.36 -0.838 . . . . 51.420000000000002 110.142 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 75' ' ' VAL . 3.3 p -159.41 118.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 75.209999999999994 110.229 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.9 OUTLIER -124.69 100.83 6.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.244 -0.91 . . . . 60.210000000000001 110.173 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 13' ' ' LEU . 0.6 OUTLIER -109.85 105.0 14.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.294 -0.879 . . . . 71.519999999999996 110.242 -179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.5 t -139.48 94.0 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -0.919 . . . . 64.340000000000003 110.205 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.515 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 88.1 t80 -179.86 109.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 65.099999999999994 110.084 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 126.49 44.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.895 . . . . 54.109999999999999 110.163 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.83 107.15 9.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 63.030000000000001 110.272 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.53 138.71 9.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 71.450000000000003 110.219 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -99.7 145.32 27.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.32 -0.863 . . . . 75.150000000000006 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 85' ' ' GLN . 21.2 pt-20 -172.63 -38.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.236 -0.915 . . . . 73.150000000000006 110.182 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 57.95 95.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.277 -0.889 . . . . 72.450000000000003 110.227 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -76.18 -168.7 27.06 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.485 -1.446 . . . . 64.109999999999999 109.485 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 -36.78 7.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.355 -1.085 . . . . 70.109999999999999 110.187 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -111.1 -179.77 3.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.206 -0.934 . . . . 73.129999999999995 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 95.3 m -157.66 100.66 1.84 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.237 -0.914 . . . . 62.399999999999999 110.188 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.763 0 O-C-N 124.043 1.549 . . . . 53.119999999999997 110.431 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' B' ' 7' ' ' SER . 24.0 mtt . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.316 0.579 . . . . 71.519999999999996 110.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 11.4 mmtp -96.61 90.45 5.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.128 -0.982 . . . . 63.539999999999999 110.351 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.537 HD21 ' OG ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -114.82 -26.96 7.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.325 -0.859 . . . . 70.25 110.439 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' B' ' 5' ' ' ARG . 2.6 m -152.26 -72.08 0.15 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 74.519999999999996 110.255 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' B' ' 4' ' ' SER . 0.1 OUTLIER 179.89 -31.3 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.33 -0.856 . . . . 73.5 110.145 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -66.54 -23.07 66.17 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.309 -0.869 . . . . 71.420000000000002 110.198 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.537 ' OG ' HD21 ' B' ' 3' ' ' LEU . 0.4 OUTLIER -80.64 -37.69 30.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.218 -0.927 . . . . 71.310000000000002 109.785 179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.472 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 1.3 t80 -77.54 -39.33 46.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.402 -0.811 . . . . 65.420000000000002 109.807 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.619 ' HE3' HG11 ' A' ' 50' ' ' VAL . 8.8 ttp -68.8 -51.18 43.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.359 -0.838 . . . . 71.310000000000002 110.189 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.76 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.35 -28.64 55.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.902 . . . . 65.109999999999999 110.143 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.1 -48.81 78.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.893 . . . . 62.340000000000003 110.206 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -82.85 -38.06 23.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.146 -0.971 . . . . 74.209999999999994 110.205 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.98 -47.68 82.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.911 . . . . 65.430000000000007 110.219 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.76 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.5 m -59.69 -31.45 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 62.509999999999998 110.207 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.24 71.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.31 -0.869 . . . . 74.450000000000003 110.109 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.485 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.02 -13.94 20.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 64.450000000000003 110.19 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.9 -24.46 14.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.213 -0.93 . . . . 71.109999999999999 110.187 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -85.41 -52.64 5.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 71.409999999999997 110.168 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.52 -10.59 59.61 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 62.149999999999999 110.187 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -109.47 -52.67 2.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.261 -0.899 . . . . 53.219999999999999 110.12 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.94 14.81 12.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 50.210000000000001 110.22 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.55 55.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.484 -1.446 . . . . 71.430000000000007 109.484 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.831 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.62 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.316 -1.108 . . . . 65.439999999999998 110.267 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.499 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 68.2 m -81.49 162.16 23.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 75.239999999999995 110.213 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.933 HG13 ' HB ' ' B' ' 28' ' ' VAL . 78.1 t -108.1 82.22 1.46 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.261 -0.899 . . . . 62.32 110.185 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.7 Cg_endo -72.51 -89.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.91 1.479 . . . . 65.319999999999993 110.473 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.63 40.87 2.64 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.579 -1.408 . . . . 74.120000000000005 109.579 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.933 ' HB ' HG13 ' B' ' 25' ' ' VAL . 64.1 t -107.68 -1.72 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -1.133 . . . . 74.209999999999994 110.236 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -120.82 -20.28 7.02 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.899 . . . . 60.450000000000003 110.266 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mpp_? -115.37 116.43 28.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 72.329999999999998 110.245 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -132.28 81.63 1.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 71.219999999999999 110.28 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 2.1 p 179.5 -32.33 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.216 -0.927 . . . . 73.329999999999998 110.195 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.2 t -43.17 106.79 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.273 -0.892 . . . . 74.430000000000007 110.2 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 151.53 41.79 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 55.130000000000003 109.517 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.289 -1.124 . . . . 35.43 110.152 -179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.53 -1.428 . . . . 55.340000000000003 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -157.48 -43.93 0.07 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -1.177 . . . . 71.25 110.101 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' MET . 0.1 OUTLIER -175.98 -164.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 71.219999999999999 110.22 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.505 ' O ' ' CG ' ' A' ' 4' ' ' MET . 3.1 ptt? -177.93 98.87 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 63.119999999999997 110.24 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.668 ' O ' HG23 ' A' ' 6' ' ' THR . 12.1 p80 -122.35 117.94 27.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.165 -0.959 . . . . 73.239999999999995 110.174 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -166.77 119.14 0.98 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -0.862 . . . . 75.040000000000006 110.18 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -152.46 154.01 34.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.167 -0.958 . . . . 65.120000000000005 110.303 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -110.04 -69.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.25 -0.906 . . . . 74.030000000000001 110.135 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -153.56 121.68 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 65.420000000000002 110.133 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.7 p -164.42 142.35 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.235 -0.916 . . . . 72.209999999999994 110.23 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.554 ' SG ' HD23 ' A' ' 59' ' ' LEU . 9.5 p -142.37 171.14 14.46 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.258 -0.901 . . . . 43.329999999999998 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.576 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -105.0 120.39 41.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.318 -0.864 . . . . 63.409999999999997 110.213 179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.785 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.1 mp -106.95 141.53 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.155 -0.966 . . . . 70.430000000000007 110.228 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG11 ' CB ' ' B' ' 21' ' ' ALA . 21.5 t -99.98 99.22 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 72.040000000000006 110.193 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.3 t -78.05 128.86 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 73.129999999999995 110.226 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.704 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 24.9 tp60 -111.34 112.84 24.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.430000000000007 110.354 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.994 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.65 19.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 64.329999999999998 109.757 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 3.9 tmtt? -43.68 147.89 0.4 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.185 -0.947 . . . . 73.540000000000006 109.693 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -47.21 38.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.295 -0.878 . . . . 63.25 111.104 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.3 mt-10 -91.87 -5.46 53.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.775 -1.203 . . . . 61.219999999999999 110.448 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' NE ' ' HA3' ' A' ' 71' ' ' GLY . 1.5 mmm180 -74.78 -50.91 15.59 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.175 -1.046 . . . . 74.409999999999997 108.175 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.994 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.89 -40.67 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.213 -0.595 . . . . 74.140000000000001 110.838 -179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 26.6 p -52.45 -40.43 62.23 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.61 -1.306 . . . . 53.039999999999999 108.392 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 27' ' ' THR . 22.4 t70 -72.02 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.606 -0.684 . . . . 75.409999999999997 111.085 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.846 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.68 -48.94 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -0.879 . . . . 63.439999999999998 111.497 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.775 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.32 -52.39 53.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.862 -1.149 . . . . 75.530000000000001 109.984 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.9 t -55.35 -33.27 63.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.111 -0.993 . . . . 71.209999999999994 109.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -44.41 97.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.453 -0.78 . . . . 64.420000000000002 109.848 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.8 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.22 -35.14 35.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 74.329999999999998 110.008 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 21.0 t-20 -71.08 -24.8 62.38 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 74.150000000000006 110.184 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.46 -28.06 61.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.248 -0.907 . . . . 72.150000000000006 110.281 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -75.78 152.47 84.92 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 74.349999999999994 110.25 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 -53.27 0.14 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.04 1.547 . . . . 71.209999999999994 110.405 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.44 -62.57 5.23 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.499 -1.44 . . . . 62.049999999999997 109.499 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.55 144.92 43.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.279 -1.13 . . . . 71.340000000000003 110.173 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 6.4 mt-10 -157.31 129.94 7.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 53.43 110.124 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.415 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 83.4 t -70.29 120.19 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 74.239999999999995 110.233 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.44 -48.12 7.31 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.18 -0.95 . . . . 73.340000000000003 110.05 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 16.2 t -120.51 120.33 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.389 -0.819 . . . . 75.5 110.077 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.76 99.78 9.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 51.439999999999998 110.23 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 64.3 m-20 -133.88 148.03 51.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.412 -0.805 . . . . 61.240000000000002 110.285 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.82 54.25 0.41 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.373 -0.829 . . . . 74.230000000000004 111.196 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.7 Cg_endo -70.67 -38.65 5.55 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.591 1.311 . . . . 74.430000000000007 109.896 179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.3 t -149.46 14.91 0.88 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.485 -0.759 . . . . 53.030000000000001 110.023 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 28.46 13.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 62.219999999999999 109.606 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.804 ' O ' HD23 ' A' ' 47' ' ' LEU . 9.6 pt20 -130.18 136.53 49.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.092 -1.24 . . . . 63.109999999999999 110.343 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 46' ' ' GLN . 16.1 mt -122.85 159.7 27.6 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.264 -0.898 . . . . 70.140000000000001 110.153 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.685 HD11 HD22 ' B' ' 23' ' ' LEU . 22.7 mt -100.46 124.6 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 75.239999999999995 110.134 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 7.6 p -130.27 125.56 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.207 -0.933 . . . . 74.439999999999998 110.141 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.9 m -98.4 141.68 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 75.310000000000002 110.212 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -134.05 146.51 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 52.409999999999997 110.234 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.444 ' HA ' HD11 ' A' ' 59' ' ' LEU . 13.7 pt-20 -126.43 147.74 49.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 74.219999999999999 110.222 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.865 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.63 179.58 9.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 52.299999999999997 110.251 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -46.1 -49.46 16.51 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 62.240000000000002 110.22 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.416 ' C ' ' OD1' ' A' ' 55' ' ' ASP . 45.7 p-10 -155.31 -168.94 3.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 62.25 110.2 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -60.83 -40.97 94.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.263 -0.898 . . . . 71.319999999999993 110.227 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.517 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.8 mt-10 -49.32 -49.96 41.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 54.43 110.259 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.564 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 4.0 m -71.43 -33.49 69.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 74.430000000000007 110.113 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.865 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.3 OUTLIER -64.46 -44.39 91.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.171 -0.956 . . . . 74.420000000000002 110.121 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.738 ' O ' HG22 ' A' ' 63' ' ' ILE . 21.7 pt -66.63 -28.11 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 74.510000000000005 109.685 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.525 ' N ' HG13 ' A' ' 60' ' ' ILE . 4.1 tt0 -52.12 -45.42 64.94 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.339 -0.851 . . . . 74.549999999999997 109.76 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' SER . 16.1 m -56.65 -41.57 77.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.328 -0.858 . . . . 62.509999999999998 110.444 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.738 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.8 tt -50.12 -36.42 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.947 . . . . 73.120000000000005 110.229 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 4.1 mm-40 -52.13 -33.22 39.06 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.153 -0.967 . . . . 73.140000000000001 109.805 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.927 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.6 m -68.84 -55.43 11.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 61.0 110.364 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.529 HG23 ' N ' ' A' ' 67' ' ' ARG . 34.0 m -65.38 -41.88 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.315 -0.866 . . . . 45.100000000000001 111.11 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.588 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -66.68 -41.0 88.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.119 -0.988 . . . . 65.420000000000002 110.44 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 6.2 t30 -76.03 -20.47 57.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.099 -1.001 . . . . 74.409999999999997 110.458 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.927 HG23 ' O ' ' A' ' 65' ' ' SER . 24.9 t -68.89 122.97 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.07 -1.019 . . . . 70.120000000000005 109.897 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -57.82 -45.77 85.66 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 74.310000000000002 110.564 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.544 ' HA3' ' NE ' ' A' ' 21' ' ' ARG . . . -46.48 -32.97 5.72 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.539 -1.424 . . . . 71.430000000000007 109.539 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.505 HG23 ' CG1' ' A' ' 69' ' ' VAL . 32.5 t -79.72 116.61 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -1.076 . . . . 73.019999999999996 110.326 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -97.34 -20.42 17.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 64.120000000000005 110.111 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -150.92 173.57 14.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.241 -0.912 . . . . 61.439999999999998 110.136 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.3 p -158.96 118.43 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.056 -1.027 . . . . 65.409999999999997 110.313 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.4 OUTLIER -126.26 98.28 5.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.157 -0.964 . . . . 62.539999999999999 110.191 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.518 HD23 HG22 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -111.05 104.86 13.45 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.215 -0.928 . . . . 63.329999999999998 110.23 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 38.4 t -140.49 93.11 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.948 . . . . 71.129999999999995 110.136 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 85.7 t80 -179.31 117.83 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 73.120000000000005 110.185 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.48 136.48 33.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.208 -0.932 . . . . 62.299999999999997 110.132 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.471 ' O ' HG13 ' A' ' 10' ' ' VAL . 43.5 tp60 -132.44 104.23 6.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 54.409999999999997 110.211 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -161.39 138.61 8.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.309 -0.869 . . . . 70.129999999999995 110.359 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -104.15 149.05 25.59 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.433 -0.792 . . . . 62.439999999999998 110.117 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -175.18 -75.35 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 63.020000000000003 110.375 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 9.5 tt0 -177.93 84.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.092 -1.005 . . . . 74.420000000000002 110.16 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -168.86 172.2 43.13 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.585 -1.406 . . . . 63.5 109.585 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -148.32 -39.24 0.17 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.149 -1.206 . . . . 64.450000000000003 110.19 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 89' ' ' THR . 21.5 mt-10 -114.68 151.19 34.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 75.329999999999998 110.188 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 88' ' ' GLU . 43.1 p 43.43 69.89 2.12 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.322 -0.861 . . . . 72.129999999999995 110.206 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.304 -1.8 0 O-C-N 124.047 1.551 . . . . 53.43 110.518 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.41 ' C ' ' HG2' ' B' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.333 0.587 . . . . 70.219999999999999 110.123 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' B' ' 1' ' ' MET . 1.1 mmpt? -136.91 160.59 38.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 64.340000000000003 110.168 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -69.65 58.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 73.329999999999998 110.228 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -86.89 64.91 8.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 54.43 110.221 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 -39.88 0.06 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 54.039999999999999 110.179 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -71.17 -15.44 62.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 73.510000000000005 110.235 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -82.84 -35.52 26.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.33 -0.856 . . . . 70.219999999999999 109.738 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 2.6 t80 -80.4 -43.38 21.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.477 -0.764 . . . . 61.43 109.862 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 3.1 ttp -65.99 -47.53 74.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.234 -0.916 . . . . 74.409999999999997 110.111 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.711 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -53.01 -31.51 41.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.276 -0.89 . . . . 53.310000000000002 110.082 179.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.27 -46.7 88.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.239 -0.913 . . . . 55.539999999999999 110.205 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.2 OUTLIER -82.83 -40.16 20.71 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.136 -0.978 . . . . 72.239999999999995 110.095 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.502 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -54.93 -48.74 72.73 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.271 -0.893 . . . . 74.439999999999998 110.26 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.711 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.7 m -59.22 -31.06 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 61.030000000000001 110.192 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -30.25 71.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.299 -0.876 . . . . 50.420000000000002 110.162 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.5 -13.84 20.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 71.239999999999995 110.198 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -24.48 16.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 51.420000000000002 110.208 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -86.09 -53.35 5.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 64.239999999999995 110.228 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.68 -10.5 59.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -0.892 . . . . 64.409999999999997 110.184 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.98 -54.81 2.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 74.120000000000005 110.223 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -91.88 16.58 10.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 61.329999999999998 110.185 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.35 26.92 52.22 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.537 -1.425 . . . . 64.310000000000002 109.537 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.685 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -67.08 -162.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -1.15 . . . . 73.25 110.327 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.487 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 6.7 m -82.74 162.0 21.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.444 -0.785 . . . . 72.439999999999998 110.153 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 25' ' ' VAL . 27.3 m -107.94 82.58 1.48 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 74.430000000000007 110.245 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.1 Cg_endo -72.05 -89.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.038 1.546 . . . . 61.539999999999999 110.473 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.669 ' HA2' HG21 ' B' ' 32' ' ' VAL . . . -91.66 39.75 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.579 -1.408 . . . . 62.43 109.579 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.533 HG21 ' HA ' ' B' ' 25' ' ' VAL . 57.4 t -77.14 -75.85 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.187 -1.184 . . . . 73.120000000000005 110.185 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.48 ' O ' ' HG2' ' B' ' 30' ' ' ARG . . . -176.87 28.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.296 -0.878 . . . . 52.240000000000002 110.362 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' B' ' 29' ' ' ALA . 5.5 mtm-85 -154.38 145.26 22.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 71.219999999999999 110.222 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . 53.56 18.91 1.55 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 74.120000000000005 110.258 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.669 HG21 ' HA2' ' B' ' 27' ' ' GLY . 11.7 p -122.41 -22.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.309 -0.87 . . . . 64.310000000000002 110.248 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.579 HG13 HG13 ' B' ' 32' ' ' VAL . 15.7 m -143.0 148.89 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 74.430000000000007 110.228 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.33 12.87 69.98 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.61 -1.396 . . . . 73.310000000000002 109.61 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.316 -1.108 . . . . 71.439999999999998 110.261 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.574 -1.41 . . . . 73.299999999999997 109.574 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 3' ' ' HIS . 6.1 t -76.52 110.51 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.298 -1.119 . . . . 71.519999999999996 110.21 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.462 ' O ' ' O ' ' A' ' 2' ' ' SER . 38.5 m-70 59.61 147.16 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.287 -0.883 . . . . 72.450000000000003 110.207 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 26.3 ttt -178.4 92.67 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.351 -0.843 . . . . 70.010000000000005 110.202 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.451 ' HB2' ' OE1' ' A' ' 83' ' ' GLU . 33.4 p-80 -142.22 120.23 12.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.28 -0.888 . . . . 74.439999999999998 110.194 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.7 m -166.74 116.3 0.89 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.301 -0.874 . . . . 52.140000000000001 110.188 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.67 168.24 24.94 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.186 -0.946 . . . . 73.510000000000005 110.305 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 13.0 m95 -111.81 -71.86 0.74 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.339 -0.851 . . . . 62.450000000000003 110.155 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -153.5 126.39 8.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 75.129999999999995 110.146 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 2.2 p -160.9 142.33 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.119 -0.988 . . . . 51.210000000000001 110.263 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.539 ' SG ' HD11 ' A' ' 13' ' ' LEU . 23.6 p -139.04 171.05 14.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.273 -0.892 . . . . 65.25 110.239 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 79' ' ' TYR . 19.3 t -105.01 116.28 31.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.281 -0.887 . . . . 72.329999999999998 110.179 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD11 ' SG ' ' A' ' 11' ' ' CYS . 2.6 mp -103.82 133.8 48.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 72.519999999999996 110.249 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 1.025 HG11 ' HB1' ' B' ' 21' ' ' ALA . 61.4 t -99.11 100.96 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.259 -0.901 . . . . 75.409999999999997 110.173 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 99.1 t -78.2 121.93 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.337 -0.852 . . . . 73.109999999999999 110.27 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 8.3 tt0 -105.03 110.35 22.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.241 -0.912 . . . . 63.119999999999997 110.036 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.0 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.159 -0.963 . . . . 73.430000000000007 110.012 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.548 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.4 tttt -42.93 148.53 0.25 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.909 . . . . 62.420000000000002 109.671 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.35 -47.33 37.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.365 -0.834 . . . . 70.5 111.064 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.14 -5.3 52.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.76 -1.212 . . . . 61.229999999999997 110.373 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.548 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.82 -50.28 17.71 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.001 . . . . 75.530000000000001 108.299 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.9 -40.47 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.201 -0.6 . . . . 62.509999999999998 110.872 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.2 OUTLIER -52.38 -40.72 62.41 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.482 -1.287 . . . . 75.150000000000006 108.49 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.485 ' O ' HG22 ' A' ' 27' ' ' THR . 34.5 m-20 -72.09 -58.79 3.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.518 -0.739 . . . . 75.25 110.971 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -78.83 -49.82 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.406 -0.809 . . . . 70.519999999999996 111.444 -178.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.836 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.23 -53.01 48.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.789 -1.195 . . . . 73.329999999999998 110.098 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.544 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.6 t -54.96 -33.33 62.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.084 -1.01 . . . . 61.130000000000003 109.98 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.55 -44.13 97.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 52.140000000000001 109.886 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.928 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.9 mm? -51.26 -31.85 22.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.365 -0.834 . . . . 75.219999999999999 109.917 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 21.2 t30 -72.23 -26.15 61.91 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 61.219999999999999 110.073 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.53 -28.1 61.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.376 -0.827 . . . . 74.430000000000007 110.19 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.97 151.14 96.24 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 75.25 110.265 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.89 -51.58 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.055 1.555 . . . . 71.209999999999994 110.489 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.09 -58.49 7.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.506 -1.438 . . . . 75.140000000000001 109.506 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -73.44 145.66 45.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.238 -1.154 . . . . 62.240000000000002 110.153 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -155.06 128.47 8.43 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.275 -0.891 . . . . 73.310000000000002 110.257 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 84.6 t -70.59 120.24 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 73.209999999999994 110.216 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.63 -53.38 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.937 . . . . 55.130000000000003 110.194 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' HB ' HD12 ' A' ' 48' ' ' ILE . 22.7 t -120.65 120.31 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 71.209999999999994 110.127 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.64 103.86 13.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 71.010000000000005 110.277 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.0 OUTLIER -133.56 148.13 51.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.328 -0.857 . . . . 70.420000000000002 110.195 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.37 0.42 Allowed Pre-proline 0 C--N 1.301 -1.513 0 O-C-N 121.392 -0.817 . . . . 75.450000000000003 111.113 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.6 -38.89 5.43 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.754 1.397 . . . . 54.109999999999999 109.866 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.62 15.35 0.77 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.405 -0.809 . . . . 55.43 110.132 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.04 29.38 9.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.584 -1.406 . . . . 75.329999999999998 109.584 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.485 ' O ' HD23 ' A' ' 47' ' ' LEU . 2.3 pt20 -130.34 137.66 50.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.116 -1.226 . . . . 75.349999999999994 110.334 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.836 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.6 mt -125.38 159.8 30.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.236 -0.915 . . . . 61.409999999999997 110.164 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.067 HD11 HD22 ' B' ' 23' ' ' LEU . 37.7 mt -100.54 126.57 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.188 -0.945 . . . . 73.510000000000005 110.163 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.928 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.8 p -133.31 124.39 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.867 . . . . 73.329999999999998 110.274 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 11' ' ' CYS . 4.1 m -97.26 141.08 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.3 -0.875 . . . . 53.210000000000001 110.241 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.504 HG12 ' CD1' ' A' ' 13' ' ' LEU . 7.6 p -134.46 137.64 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.263 -0.898 . . . . 64.549999999999997 110.222 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.41 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 8.4 pt-20 -121.95 145.47 48.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 73.200000000000003 110.26 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.727 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -154.84 -177.9 6.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 72.329999999999998 110.224 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -47.51 -49.88 24.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.253 -0.905 . . . . 71.209999999999994 110.239 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -155.54 -168.4 2.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 72.200000000000003 110.194 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' HG12 ' A' ' 60' ' ' ILE . 70.4 m -61.42 -41.36 97.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 50.399999999999999 110.174 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' O ' HG12 ' A' ' 60' ' ' ILE . 71.8 mt-10 -48.54 -47.98 38.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.261 -0.899 . . . . 53.329999999999998 110.208 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.727 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -72.9 -33.68 66.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.2 -0.938 . . . . 72.409999999999997 110.205 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.701 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.99 -44.35 85.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.315 -0.866 . . . . 64.400000000000006 110.162 -179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.733 ' O ' HG22 ' A' ' 63' ' ' ILE . 28.6 pt -66.42 -28.59 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.121 -0.987 . . . . 60.140000000000001 109.577 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.523 ' N ' HG13 ' A' ' 60' ' ' ILE . 29.9 tp60 -52.44 -45.51 66.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.377 -0.827 . . . . 73.519999999999996 109.869 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' SER . 42.6 m -56.62 -40.83 76.03 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 74.400000000000006 110.527 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.733 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.23 -36.09 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 60.439999999999998 110.307 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.7 pt-20 -52.19 -32.84 38.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.054 -1.029 . . . . 63.299999999999997 109.73 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.967 ' O ' HG23 ' A' ' 69' ' ' VAL . 3.1 m -69.14 -55.66 10.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 74.230000000000004 110.475 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -64.79 -42.03 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.405 -0.809 . . . . 65.219999999999999 111.12 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.58 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.29 -40.96 90.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.161 -0.962 . . . . 75.540000000000006 110.438 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.58 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.5 t30 -75.91 -20.63 57.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.099 -1.001 . . . . 74.430000000000007 110.587 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.967 HG23 ' O ' ' A' ' 65' ' ' SER . 38.8 t -67.98 122.55 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 72.010000000000005 110.002 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.0 -45.07 87.41 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.193 -0.942 . . . . 75.019999999999996 110.439 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.71 -31.79 23.83 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.564 -1.415 . . . . 45.310000000000002 109.564 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' CG1' ' A' ' 69' ' ' VAL . 35.9 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -1.146 . . . . 73.030000000000001 110.256 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.26 -19.61 16.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.298 -0.876 . . . . 72.140000000000001 110.074 179.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -151.63 173.34 14.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 65.129999999999995 110.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 75' ' ' VAL . 10.7 p -158.68 118.56 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.876 . . . . 63.530000000000001 110.305 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -121.36 99.5 6.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 71.519999999999996 110.18 179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -113.05 105.04 13.0 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 73.310000000000002 110.328 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.8 t -145.48 94.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 72.319999999999993 110.31 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.541 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 87.1 t80 -178.2 107.89 0.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.327 -0.858 . . . . 73.200000000000003 110.265 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.23 126.39 45.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.143 -0.973 . . . . 74.319999999999993 110.06 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.2 110.59 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.187 -0.946 . . . . 75.040000000000006 110.268 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -154.3 138.71 16.74 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 72.129999999999995 110.287 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.451 ' OE1' ' HB2' ' A' ' 5' ' ' HIS . 4.3 mt-10 -102.03 147.52 26.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.855 . . . . 75.209999999999994 110.153 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.7 OUTLIER 174.37 -100.79 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 64.120000000000005 110.192 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 -84.75 161.54 19.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 42.329999999999998 110.158 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -75.57 139.73 25.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.529 -1.428 . . . . 61.030000000000001 109.529 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -173.06 39.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -1.122 . . . . 65.329999999999998 110.259 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.637 ' O ' HG23 ' A' ' 89' ' ' THR . 7.2 pt-20 -76.38 144.62 39.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.128 -0.983 . . . . 63.310000000000002 110.146 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -164.2 161.36 16.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.367 -0.833 . . . . 73.420000000000002 110.237 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.304 -1.807 0 O-C-N 124.12 1.589 . . . . 55.039999999999999 110.426 179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.283 0.563 . . . . 74.340000000000003 110.296 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -90.95 -21.38 21.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.908 . . . . 74.030000000000001 110.296 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.446 ' O ' ' CB ' ' B' ' 4' ' ' SER . 1.5 tp -93.86 -166.23 1.46 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.276 -0.89 . . . . 74.310000000000002 110.17 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' B' ' 3' ' ' LEU . 0.5 OUTLIER 171.74 50.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.885 . . . . 73.450000000000003 110.214 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.18 -59.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.243 -0.91 . . . . 71.109999999999999 110.226 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.2 ttt-85 -46.49 -29.19 1.65 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.229 -0.919 . . . . 72.450000000000003 110.29 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 8.1 t -74.88 -41.89 58.92 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 71.420000000000002 109.831 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.54 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.63 -38.99 28.23 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.429 -0.794 . . . . 64.010000000000005 109.866 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 6.2 ttp -67.15 -52.93 35.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.247 -0.908 . . . . 70.329999999999998 110.171 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.623 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.26 -27.01 13.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 73.049999999999997 110.141 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -64.74 -48.57 74.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.303 -0.873 . . . . 70.120000000000005 110.069 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.459 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.8 m-80 -82.89 -37.42 24.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.314 -0.866 . . . . 64.239999999999995 110.194 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.541 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.52 -48.3 72.11 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 72.0 110.26 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.623 HG22 ' O ' ' B' ' 10' ' ' LYS . 30.0 m -59.21 -30.77 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.36 -0.837 . . . . 71.329999999999998 110.1 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.27 -31.95 73.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 62.020000000000003 110.131 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.431 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.58 -14.07 20.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -0.938 . . . . 72.120000000000005 110.16 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.71 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.51 -22.61 16.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.336 -0.853 . . . . 72.209999999999994 110.158 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.57 -51.69 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.875 . . . . 72.329999999999998 110.196 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.39 -10.48 59.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.265 -0.897 . . . . 72.549999999999997 110.181 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.68 -52.69 2.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 72.019999999999996 110.197 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 1.025 ' HB1' HG11 ' A' ' 14' ' ' VAL . . . -90.45 13.55 15.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -0.928 . . . . 74.040000000000006 110.275 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.86 27.08 49.45 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.564 -1.414 . . . . 32.420000000000002 109.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 1.067 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.9 -162.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -1.188 . . . . 75.109999999999999 110.301 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.492 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 75.3 m -82.86 162.1 21.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 73.340000000000003 110.157 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.656 HG13 ' HB ' ' B' ' 28' ' ' VAL . 12.0 t -108.3 81.91 1.45 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 74.430000000000007 110.148 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.532 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.6 Cg_endo -72.96 -56.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.043 1.549 . . . . 72.120000000000005 110.408 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.04 31.24 2.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.422 . . . . 74.129999999999995 109.544 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.656 ' HB ' HG13 ' B' ' 25' ' ' VAL . 42.8 t -57.31 -29.78 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.224 -1.162 . . . . 71.510000000000005 110.304 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.19 -7.03 54.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.303 -0.873 . . . . 71.310000000000002 110.241 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 29.2 mtm-85 -124.99 38.18 4.25 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.209 -0.932 . . . . 71.239999999999995 110.138 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -146.33 33.23 0.98 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.276 -0.89 . . . . 45.149999999999999 110.127 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.532 HG23 HG12 ' B' ' 33' ' ' VAL . 5.3 m -93.68 -40.01 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.352 -0.843 . . . . 74.439999999999998 110.236 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.532 HG12 HG23 ' B' ' 32' ' ' VAL . 8.8 p -154.87 170.21 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 65.310000000000002 110.129 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.438 ' N ' HG22 ' B' ' 33' ' ' VAL . . . -112.91 161.52 12.66 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.569 -1.412 . . . . 63.240000000000002 109.569 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.229 -1.159 . . . . 75.129999999999995 110.204 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.574 -1.411 . . . . 60.25 109.574 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 t 47.36 48.31 16.48 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.317 -1.108 . . . . 74.219999999999999 110.143 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -134.43 -68.46 0.55 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.202 -0.936 . . . . 73.340000000000003 110.305 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.2 ttt -175.91 72.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.27 -0.894 . . . . 53.310000000000002 110.224 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 m80 -125.48 125.04 42.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.349 -0.845 . . . . 53.43 110.096 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.5 m -165.33 104.21 0.74 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.148 -0.97 . . . . 73.120000000000005 110.358 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -152.28 169.1 23.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.861 . . . . 73.129999999999995 110.286 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' O ' ' HG3' ' A' ' 9' ' ' GLN . 82.8 m95 -112.77 -73.41 0.67 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.362 -0.836 . . . . 74.120000000000005 110.155 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 8' ' ' TRP . 2.6 mt-30 -153.6 124.41 7.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 71.430000000000007 110.109 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 p -164.79 141.33 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.238 -0.914 . . . . 64.010000000000005 110.062 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.478 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 19.4 p -138.27 171.18 14.77 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 63.43 110.146 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.759 ' HA ' HG12 ' A' ' 50' ' ' VAL . 66.3 p -104.86 116.45 32.02 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.13 -0.981 . . . . 55.439999999999998 110.125 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.744 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.4 mp -100.88 138.99 37.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 72.540000000000006 110.298 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG11 ' CB ' ' B' ' 21' ' ' ALA . 99.4 t -98.83 99.98 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.414 -0.804 . . . . 43.350000000000001 110.11 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 47.9 t -77.92 118.86 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 73.230000000000004 110.263 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.6 tt0 -104.6 109.8 21.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 74.319999999999993 110.05 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.037 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.97 168.85 18.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 74.049999999999997 109.959 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -42.13 146.5 0.29 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.841 . . . . 74.420000000000002 109.761 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -47.16 37.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 50.149999999999999 111.04 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -91.92 -5.51 53.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.71 -1.244 . . . . 71.420000000000002 110.688 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.55 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.99 -50.34 16.9 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.061 -1.089 . . . . 72.5 108.061 177.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.037 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.72 -39.5 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 120.28 -0.568 . . . . 70.310000000000002 110.733 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.6 -40.31 62.56 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.592 -1.317 . . . . 65.049999999999997 108.37 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 27' ' ' THR . 8.7 t70 -71.74 -58.77 3.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.538 -0.726 . . . . 71.25 111.014 179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.522 HD12 HG11 ' A' ' 69' ' ' VAL . 6.4 pt -80.26 -49.75 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 73.439999999999998 111.822 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.873 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.0 t -51.04 -50.79 57.94 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.028 -1.045 . . . . 64.420000000000002 109.533 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.36 -33.08 67.42 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.634 -0.827 . . . . 62.100000000000001 109.835 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.0 OUTLIER -61.59 -44.48 96.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.887 . . . . 71.150000000000006 109.942 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.808 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.19 -36.01 39.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.243 -0.911 . . . . 75.230000000000004 110.007 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.521 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 13.3 t-20 -68.5 -25.76 65.12 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 74.430000000000007 110.176 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.45 -28.12 61.79 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 44.020000000000003 110.276 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -76.18 151.31 83.65 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.382 -0.824 . . . . 74.409999999999997 110.231 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 -52.32 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.032 1.543 . . . . 63.0 110.322 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.52 -61.88 5.85 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.529 -1.428 . . . . 75.109999999999999 109.529 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.808 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.3 t -77.71 142.53 38.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.132 -1.216 . . . . 74.239999999999995 110.195 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' C ' HG23 ' A' ' 49' ' ' VAL . 2.0 mt-10 -155.42 127.5 7.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 75.0 110.225 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 37' ' ' VAL . 18.8 m -66.7 119.97 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.183 -0.948 . . . . 74.430000000000007 110.271 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.94 -48.21 7.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.263 -0.898 . . . . 73.030000000000001 110.027 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 10.9 t -120.5 120.37 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.387 -0.821 . . . . 55.530000000000001 110.115 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.74 101.4 10.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -0.911 . . . . 75.540000000000006 110.433 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.521 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 89.6 m-20 -133.48 148.16 51.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 74.5 110.067 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -114.38 50.0 0.53 Allowed Pre-proline 0 C--N 1.303 -1.427 0 O-C-N 121.378 -0.826 . . . . 72.150000000000006 111.292 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -72.0 -43.37 1.21 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.759 1.399 . . . . 61.240000000000002 109.947 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 46' ' ' GLN . 1.9 m -134.39 0.42 3.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.366 -0.834 . . . . 75.040000000000006 110.362 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 101.4 24.9 8.53 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.658 -1.377 . . . . 74.420000000000002 109.658 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.468 ' O ' HD23 ' A' ' 47' ' ' LEU . 1.6 pt20 -130.25 134.39 47.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -1.144 . . . . 72.230000000000004 110.344 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' OG ' ' A' ' 26' ' ' SER . 25.9 mt -116.04 156.81 25.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.208 -0.932 . . . . 53.219999999999999 110.158 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.761 HD11 HD22 ' B' ' 23' ' ' LEU . 25.2 mt -95.72 125.5 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.275 -0.891 . . . . 74.120000000000005 110.014 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.0 p -131.73 125.17 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 73.430000000000007 110.236 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -100.26 142.76 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.911 . . . . 64.319999999999993 110.096 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG13 ' HG ' ' A' ' 59' ' ' LEU . 11.2 p -131.88 139.04 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 75.129999999999995 110.171 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -118.56 146.9 44.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 52.549999999999997 110.216 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.827 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.4 174.91 14.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -0.896 . . . . 65.340000000000003 110.183 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -46.72 -45.58 19.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 40.43 110.231 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 23.2 p-10 -155.26 -174.43 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -0.936 . . . . 74.129999999999995 110.324 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.512 ' O ' HG23 ' A' ' 60' ' ' ILE . 5.5 m -60.76 -33.55 73.11 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.375 -0.828 . . . . 74.340000000000003 110.133 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -53.44 -49.77 66.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.943 . . . . 74.120000000000005 110.089 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.669 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 19.2 m -73.76 -28.06 61.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.179 -0.95 . . . . 72.409999999999997 110.197 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.827 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -69.65 -44.37 70.71 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 64.120000000000005 110.165 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 34.7 pt -66.46 -28.49 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.866 . . . . 61.210000000000001 109.663 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' N ' HG13 ' A' ' 60' ' ' ILE . 20.5 mm-40 -52.39 -45.3 65.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.354 -0.841 . . . . 74.329999999999998 109.991 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.2 m -56.52 -41.06 76.1 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.342 -0.849 . . . . 71.510000000000005 110.639 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.2 -36.47 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.137 -0.977 . . . . 74.439999999999998 110.289 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -52.29 -32.69 38.77 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.094 -1.004 . . . . 63.210000000000001 109.73 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.907 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -68.98 -55.8 9.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.882 . . . . 44.350000000000001 110.202 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.571 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -66.88 -43.54 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.351 -0.843 . . . . 73.430000000000007 110.865 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.85 -40.29 91.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.138 -0.976 . . . . 71.120000000000005 110.364 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.59 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 21.0 t-20 -76.03 -20.38 57.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.063 -1.023 . . . . 72.109999999999999 110.484 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.907 HG23 ' O ' ' A' ' 65' ' ' SER . 17.3 t -68.86 127.4 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.105 -0.997 . . . . 44.130000000000003 109.791 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.34 -47.12 83.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.144 -0.972 . . . . 73.439999999999998 110.609 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.16 -30.83 4.2 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.589 -1.404 . . . . 42.329999999999998 109.589 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.3 t -79.99 115.0 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -1.114 . . . . 71.450000000000003 110.342 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.46 ' HG ' ' HG2' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -98.22 -19.33 17.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.328 -0.858 . . . . 42.240000000000002 110.035 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.618 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -145.6 171.98 13.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.295 -0.878 . . . . 71.430000000000007 110.14 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.3 p -163.12 114.48 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 75.010000000000005 110.183 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.513 ' HB2' ' HB2' ' B' ' 21' ' ' ALA . 65.7 m -122.46 99.53 6.46 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.234 -0.916 . . . . 63.130000000000003 110.204 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.744 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.9 OUTLIER -109.3 99.0 8.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 51.530000000000001 110.255 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 39.1 t -138.66 93.24 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 71.5 110.18 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.478 ' O ' ' CB ' ' A' ' 11' ' ' CYS . 74.6 t80 -178.28 111.71 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.26 -0.9 . . . . 71.409999999999997 110.202 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.438 ' CE1' ' NE2' ' A' ' 82' ' ' GLN . 0.8 OUTLIER -97.43 134.73 40.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 73.239999999999995 110.198 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.22 102.38 6.19 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.209 -0.932 . . . . 74.230000000000004 110.276 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.438 ' NE2' ' CE1' ' A' ' 80' ' ' HIS . 3.5 pt20 -158.54 138.65 12.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 73.530000000000001 110.21 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.2 132.33 42.08 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.333 -0.855 . . . . 72.120000000000005 110.321 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.61 27.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 62.240000000000002 110.161 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 59.51 58.06 3.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.348 -0.845 . . . . 74.019999999999996 110.268 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -46.75 157.52 0.5 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.42 . . . . 64.310000000000002 109.551 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -124.51 -1.36 8.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -1.222 . . . . 72.25 110.191 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.56 132.03 47.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 74.200000000000003 110.164 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 18.5 p -89.26 143.68 31.3 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 74.549999999999997 110.157 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.022 1.538 . . . . 74.099999999999994 110.528 179.842 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.264 0.554 . . . . 65.230000000000004 110.153 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.426 ' O ' ' HG3' ' B' ' 2' ' ' LYS . 5.7 ptpt -141.23 85.69 1.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.268 -0.895 . . . . 74.140000000000001 110.231 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.625 HD23 ' N ' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -116.43 -173.89 2.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.192 -0.943 . . . . 64.540000000000006 110.189 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 45.4 t -146.67 46.52 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.257 -0.902 . . . . 73.200000000000003 110.157 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.97 -64.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.302 -0.874 . . . . 73.519999999999996 110.144 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 25.7 ttt180 -60.43 -16.81 39.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.246 -0.909 . . . . 71.319999999999993 110.134 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 43.7 t -80.91 -39.01 26.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 63.450000000000003 109.731 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -76.56 -43.38 39.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.362 -0.836 . . . . 74.540000000000006 109.763 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 8.1 ttp -66.23 -54.62 22.91 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 73.430000000000007 110.106 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.75 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.2 OUTLIER -55.25 -33.08 62.85 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 61.020000000000003 110.132 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.94 -45.89 91.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.889 . . . . 72.129999999999995 110.128 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -40.15 20.66 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.326 -0.859 . . . . 55.43 110.174 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.98 -50.53 70.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 62.049999999999997 110.192 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.75 HG22 ' O ' ' B' ' 10' ' ' LYS . 33.2 m -59.4 -33.81 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 64.219999999999999 110.139 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.415 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.21 -31.13 72.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 73.540000000000006 110.061 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.87 -13.9 26.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -0.854 . . . . 63.219999999999999 110.091 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.46 -23.17 14.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 72.5 110.16 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -88.96 -49.63 6.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 61.210000000000001 110.041 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.31 -10.46 59.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.399 -0.813 . . . . 63.240000000000002 110.205 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.97 -55.21 2.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.285 -0.884 . . . . 72.209999999999994 110.189 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.38 15.2 11.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.908 . . . . 65.209999999999994 110.227 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.71 28.84 57.4 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.548 -1.421 . . . . 52.219999999999999 109.548 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.761 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.65 -162.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.389 -1.066 . . . . 64.109999999999999 110.322 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.526 ' H ' HD23 ' B' ' 23' ' ' LEU . 7.3 t -82.76 162.24 21.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 72.0 110.158 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.724 HG13 ' CG2' ' B' ' 28' ' ' VAL . 94.4 t -107.66 82.99 1.46 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.141 -0.974 . . . . 74.530000000000001 110.161 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.3 Cg_endo -72.1 -90.17 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.973 1.512 . . . . 63.0 110.394 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.1 34.34 5.85 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.559 -1.416 . . . . 50.229999999999997 109.559 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.724 ' CG2' HG13 ' B' ' 25' ' ' VAL . 77.2 t -55.57 -17.36 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.13 -1.218 . . . . 62.219999999999999 110.211 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.485 ' O ' ' NE ' ' B' ' 30' ' ' ARG . . . -157.36 -62.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.925 . . . . 70.450000000000003 110.272 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.758 ' HB3' HG22 ' B' ' 32' ' ' VAL . 0.0 OUTLIER -174.58 138.17 0.51 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 64.430000000000007 110.179 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -57.71 -17.93 18.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 74.099999999999994 110.294 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.758 HG22 ' HB3' ' B' ' 30' ' ' ARG . 16.7 m -43.59 -27.07 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 73.310000000000002 110.288 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.571 ' O ' HG13 ' B' ' 33' ' ' VAL . 12.4 p -77.94 60.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.26 -0.9 . . . . 64.239999999999995 110.309 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 112.14 116.68 3.51 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.502 -1.439 . . . . 53.409999999999997 109.502 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.219 -1.165 . . . . 74.030000000000001 110.166 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.608 -1.397 . . . . 64.319999999999993 109.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.73 156.8 34.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -1.162 . . . . 72.540000000000006 110.258 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.406 ' O ' ' CB ' ' A' ' 4' ' ' MET . 42.2 m80 -97.69 -89.95 0.28 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.107 -0.995 . . . . 63.520000000000003 110.273 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.406 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 174.68 70.51 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.269 -0.894 . . . . 73.299999999999997 110.164 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 14.0 p80 -138.76 117.72 12.47 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.291 -0.881 . . . . 74.219999999999999 110.273 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 15.2 m -166.8 118.12 0.94 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.17 -0.956 . . . . 70.010000000000005 110.269 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -143.01 167.17 22.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.172 -0.955 . . . . 63.520000000000003 110.252 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 9' ' ' GLN . 92.8 m95 -112.79 -69.7 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 61.549999999999997 110.182 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 8' ' ' TRP . 3.3 mm-40 -158.66 127.02 5.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.895 . . . . 72.030000000000001 110.122 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 81' ' ' GLN . 3.5 p -158.56 142.31 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.877 . . . . 73.349999999999994 110.24 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.6 p -136.39 171.51 14.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.293 -0.88 . . . . 75.349999999999994 110.128 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.602 ' HA ' HG12 ' A' ' 50' ' ' VAL . 34.9 p -104.67 117.24 33.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 65.230000000000004 110.069 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD11 HG12 ' A' ' 51' ' ' VAL . 3.7 mp -100.8 136.61 40.39 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.224 -0.922 . . . . 74.319999999999993 110.285 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' B' ' 21' ' ' ALA . 39.4 t -99.08 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.373 -0.829 . . . . 41.119999999999997 109.936 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 66.4 t -78.05 119.59 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.275 -0.89 . . . . 74.420000000000002 110.303 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -103.31 109.81 21.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.151 -0.968 . . . . 74.25 110.135 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.84 168.75 19.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.865 . . . . 64.030000000000001 109.901 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.97 148.6 0.24 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.244 -0.91 . . . . 73.400000000000006 109.725 179.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.68 -47.12 41.02 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 54.420000000000002 110.899 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.07 -5.42 52.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.847 -1.158 . . . . 51.140000000000001 110.397 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.542 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.77 -50.51 17.04 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.136 -1.061 . . . . 74.010000000000005 108.136 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.88 -41.29 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 120.169 -0.612 . . . . 74.040000000000006 110.769 -179.665 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' A' ' 27' ' ' THR . 57.5 m -52.52 -40.3 62.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.613 -1.304 . . . . 73.519999999999996 108.362 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 27' ' ' THR . 25.6 t70 -72.05 -58.84 3.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.638 -0.664 . . . . 72.120000000000005 111.099 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.891 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.67 -48.97 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.39 -0.819 . . . . 72.109999999999999 111.481 -178.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.816 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -52.19 -52.59 51.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.866 -1.146 . . . . 61.399999999999999 110.019 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.4 t -54.59 -33.36 60.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -0.986 . . . . 75.310000000000002 109.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.68 -44.3 97.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.502 -0.749 . . . . 72.25 109.838 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.834 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.11 -28.05 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 63.219999999999999 110.03 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.527 ' HB2' ' CG1' ' A' ' 37' ' ' VAL . 46.2 t30 -77.63 -21.42 52.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.18 -0.95 . . . . 65.530000000000001 110.089 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.27 -28.12 61.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 72.420000000000002 110.263 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -78.9 151.8 76.67 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.193 -0.942 . . . . 75.209999999999994 110.233 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.81 -52.52 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.981 1.516 . . . . 74.510000000000005 110.324 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.58 -60.45 8.48 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.443 -1.463 . . . . 53.119999999999997 109.443 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.7 OUTLIER -77.7 142.67 38.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.294 -1.121 . . . . 70.299999999999997 110.244 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -153.55 124.61 7.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 64.340000000000003 110.14 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 37' ' ' VAL . 28.9 m -64.3 120.18 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.164 -0.96 . . . . 71.530000000000001 110.246 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.72 -51.44 5.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.322 -0.861 . . . . 51.109999999999999 110.096 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 18.0 t -120.47 120.33 62.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.282 -0.886 . . . . 72.409999999999997 110.052 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 40' ' ' SER . 12.9 p -106.84 100.23 9.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 55.210000000000001 110.279 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.512 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 98.9 m-20 -133.27 148.05 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.291 -0.88 . . . . 74.450000000000003 110.282 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.421 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.03 53.76 0.42 Allowed Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.38 -0.825 . . . . 74.439999999999998 111.309 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.2 Cg_endo -70.8 -39.22 4.7 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.704 1.37 . . . . 71.310000000000002 109.85 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -148.27 14.22 0.99 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 70.209999999999994 109.977 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.05 29.05 12.06 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.628 -1.389 . . . . 64.310000000000002 109.628 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.3 pt20 -130.23 132.17 45.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -1.226 . . . . 61.439999999999998 110.385 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.6 mt -119.02 159.8 23.2 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 52.329999999999998 110.098 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.89 HD11 HD22 ' B' ' 23' ' ' LEU . 14.5 mt -100.74 124.25 54.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 75.530000000000001 110.157 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.834 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.6 p -130.89 125.67 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.283 -0.885 . . . . 64.120000000000005 110.129 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 12' ' ' SER . 10.5 m -98.16 146.95 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.852 . . . . 73.439999999999998 110.126 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 HG12 HD11 ' A' ' 13' ' ' LEU . 9.8 p -140.77 146.8 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.127 -0.983 . . . . 55.229999999999997 110.168 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.518 ' HA ' HD11 ' A' ' 59' ' ' LEU . 2.7 pt-20 -123.15 145.77 48.32 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.908 . . . . 74.219999999999999 110.137 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.901 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -153.53 175.84 12.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 52.229999999999997 110.217 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -46.01 -47.66 16.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 70.030000000000001 110.281 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -155.18 -168.04 2.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.319999999999993 110.25 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -63.59 -35.13 79.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 63.409999999999997 110.186 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 13.0 tt0 -58.08 -44.63 87.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 64.319999999999993 110.146 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.901 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -74.37 -33.53 63.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.29 -0.881 . . . . 73.150000000000006 110.161 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.762 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -62.63 -44.38 96.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 71.450000000000003 109.983 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.781 ' O ' HG22 ' A' ' 63' ' ' ILE . 23.5 pt -66.52 -28.13 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.879 . . . . 71.299999999999997 109.511 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -52.02 -45.5 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.807 . . . . 55.140000000000001 109.595 179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.1 m -56.78 -40.96 76.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 75.450000000000003 110.415 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.781 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.2 tt -49.24 -35.86 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.322 -0.861 . . . . 75.420000000000002 110.286 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 9.3 pt-20 -51.52 -32.89 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.003 -1.061 . . . . 72.439999999999998 109.809 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.965 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -69.12 -55.72 9.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.378 -0.826 . . . . 64.219999999999999 110.168 179.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.563 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.0 m -67.32 -43.08 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 54.200000000000003 111.104 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.84 -40.17 94.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.172 -0.955 . . . . 64.349999999999994 110.549 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.591 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 13.8 t30 -75.83 -20.52 58.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.122 -0.986 . . . . 75.030000000000001 110.507 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.965 HG23 ' O ' ' A' ' 65' ' ' SER . 41.1 t -67.56 121.01 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.085 -1.009 . . . . 74.239999999999995 109.843 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.3 mm-40 -53.55 -45.99 70.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.197 -0.94 . . . . 75.340000000000003 110.429 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -50.1 -32.02 19.65 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.548 -1.421 . . . . 61.020000000000003 109.548 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.576 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.38 116.75 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.381 -1.07 . . . . 73.019999999999996 110.441 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -100.54 -21.63 15.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.317 -0.864 . . . . 73.299999999999997 110.242 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.07 173.54 13.75 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.125 -0.984 . . . . 74.209999999999994 110.183 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.655 HG13 ' O ' ' A' ' 75' ' ' VAL . 9.5 p -158.8 118.69 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 72.319999999999993 110.29 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -119.15 101.1 7.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 72.239999999999995 110.093 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.2 104.98 12.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.2 -0.937 . . . . 71.319999999999993 110.389 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.627 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 33.1 t -146.17 93.39 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 73.25 110.256 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.484 ' HB3' ' OG ' ' A' ' 12' ' ' SER . 88.4 t80 -179.64 117.95 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.22 -0.925 . . . . 73.430000000000007 110.141 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 136.56 33.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.222 -0.924 . . . . 73.030000000000001 110.168 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.646 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -133.61 112.26 11.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.297 -0.877 . . . . 71.439999999999998 110.179 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -156.17 138.59 14.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 41.310000000000002 110.29 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.99 119.04 17.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 63.149999999999999 110.219 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.2 pt-20 -135.71 -35.78 0.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.252 -0.905 . . . . 74.420000000000002 110.21 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 1.8 mp0 62.81 99.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.232 -0.917 . . . . 65.310000000000002 110.153 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.16 -147.51 5.75 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.565 -1.414 . . . . 75.140000000000001 109.565 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.87 51.04 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.339 -1.095 . . . . 71.310000000000002 110.209 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -139.2 157.93 45.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.289 -0.882 . . . . 72.349999999999994 110.155 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -140.06 167.38 18.45 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 63.240000000000002 110.216 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.303 -1.825 0 O-C-N 124.058 1.557 . . . . 62.119999999999997 110.482 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.496 ' O ' ' N ' ' B' ' 3' ' ' LEU . 5.6 mtp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.18 0.514 . . . . 74.349999999999994 110.215 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.67 -68.45 0.12 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.341 -0.849 . . . . 74.219999999999999 110.151 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.525 ' HA ' HD22 ' B' ' 3' ' ' LEU . 0.2 OUTLIER -145.16 102.19 3.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.145 -0.972 . . . . 72.420000000000002 110.232 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.7 40.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 75.129999999999995 110.198 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.76 -60.26 0.51 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.172 -0.955 . . . . 72.400000000000006 110.23 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -59.51 -19.25 46.71 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.295 -0.878 . . . . 42.009999999999998 110.304 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 53.5 m -80.43 -36.72 33.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 43.130000000000003 109.777 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.403 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 2.5 t80 -80.63 -43.14 20.96 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.433 -0.792 . . . . 74.140000000000001 109.771 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.2 ttp -67.08 -48.65 67.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 75.530000000000001 110.28 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.802 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.15 -31.62 32.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 75.310000000000002 110.151 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.82 -47.22 86.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 70.439999999999998 110.07 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m120 -82.85 -37.18 24.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 54.100000000000001 110.136 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.72 -47.73 84.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -0.945 . . . . 71.040000000000006 110.194 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.802 HG22 ' O ' ' B' ' 10' ' ' LYS . 34.3 m -59.13 -30.22 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -0.907 . . . . 72.049999999999997 110.111 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.554 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.04 -32.45 74.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 72.510000000000005 109.934 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -99.74 -13.96 19.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.182 -0.948 . . . . 72.310000000000002 109.974 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -102.27 -21.41 14.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 50.399999999999999 110.085 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -86.6 -51.31 6.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.822 . . . . 54.5 110.124 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.35 -10.31 58.67 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 64.439999999999998 110.092 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.09 -52.52 2.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 75.230000000000004 110.186 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.15 13.88 13.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 72.430000000000007 110.171 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.89 25.65 53.23 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.594 -1.402 . . . . 50.020000000000003 109.594 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.89 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -66.69 -162.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -1.159 . . . . 72.430000000000007 110.327 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.428 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 58.3 p -75.46 162.03 28.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.341 -0.849 . . . . 45.350000000000001 110.307 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.747 HG13 ' O ' ' B' ' 25' ' ' VAL . 13.5 p -112.6 73.62 1.49 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.88 . . . . 74.239999999999995 110.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.792 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.4 Cg_endo -72.97 -90.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.966 1.509 . . . . 51.329999999999998 110.471 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.56 -8.19 75.67 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.581 -1.408 . . . . 54.149999999999999 109.581 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.668 ' HB ' HG23 ' B' ' 25' ' ' VAL . 72.3 t -71.37 -16.82 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.171 -1.193 . . . . 62.25 110.187 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.429 ' HB3' HG22 ' B' ' 25' ' ' VAL . . . -163.1 -58.37 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 40.109999999999999 110.282 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.527 ' O ' HG23 ' B' ' 32' ' ' VAL . 0.1 OUTLIER 61.95 74.3 0.44 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.3 -0.875 . . . . 71.010000000000005 110.208 -180.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -67.56 -9.35 41.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 42.25 110.192 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.671 ' O ' HG12 ' B' ' 33' ' ' VAL . 13.5 t 61.12 13.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.371 -0.831 . . . . 72.319999999999993 110.171 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.671 HG12 ' O ' ' B' ' 32' ' ' VAL . 9.9 p 38.51 35.14 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.259 0.552 . . . . 73.310000000000002 110.53 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 35' ' ' GLN . . . 176.87 95.1 0.1 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.559 -1.416 . . . . 63.32 109.559 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' B' ' 34' ' ' GLY . 5.4 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.221 -1.164 . . . . 61.100000000000001 110.187 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 5' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.489 -1.445 . . . . 71.120000000000005 109.489 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.9 p -153.24 -86.9 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.228 -1.16 . . . . 65.230000000000004 110.118 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.3 OUTLIER -150.53 48.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.284 -0.885 . . . . 65.140000000000001 110.291 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.437 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.0 tmm? 179.37 71.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.258 -0.901 . . . . 71.120000000000005 110.16 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.496 ' CE1' ' HA3' ' A' ' 1' ' ' GLY . 37.6 m80 -130.32 121.48 26.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.177 -0.952 . . . . 73.099999999999994 110.258 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.1 m -160.23 113.11 2.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.192 -0.943 . . . . 65.329999999999998 110.141 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -150.04 172.11 15.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 43.149999999999999 110.236 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.446 ' N ' ' CD1' ' A' ' 8' ' ' TRP . 57.6 m95 -102.61 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.26 -0.9 . . . . 74.430000000000007 110.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -153.3 121.82 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.351 -0.843 . . . . 64.439999999999998 110.053 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG13 ' CG ' ' A' ' 81' ' ' GLN . 2.8 p -161.51 142.47 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.254 -0.903 . . . . 72.030000000000001 110.141 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' SG ' ' CD2' ' A' ' 59' ' ' LEU . 21.3 p -132.77 171.2 14.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 71.549999999999997 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.835 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -104.97 114.97 29.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.345 -0.847 . . . . 74.120000000000005 110.165 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.706 HD23 HD22 ' A' ' 77' ' ' LEU . 2.0 mp -100.92 135.78 41.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 62.509999999999998 110.357 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' SER . 98.1 t -98.87 100.8 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.332 -0.855 . . . . 55.240000000000002 109.94 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.7 t -78.06 118.81 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 62.210000000000001 110.305 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.555 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 7.0 tt0 -104.77 109.79 21.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.101 -0.999 . . . . 73.0 110.207 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.71 19.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 63.420000000000002 110.006 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.543 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER -42.82 148.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 70.239999999999995 109.664 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.8 m -48.2 -47.19 35.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 55.43 110.933 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -91.95 -5.26 53.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.786 -1.196 . . . . 72.430000000000007 110.465 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.543 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.0 OUTLIER -74.68 -50.59 17.04 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.223 -1.028 . . . . 74.340000000000003 108.223 177.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.73 -40.74 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 CA-C-N 115.906 -0.588 . . . . 72.510000000000005 110.848 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.535 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.59 -40.51 62.71 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.575 -1.328 . . . . 73.450000000000003 108.294 179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 18.0 t0 -72.33 -58.77 3.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.475 -0.766 . . . . 61.43 111.022 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.822 HD13 HG11 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -79.29 -49.64 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 O-C-N 121.339 -0.85 . . . . 72.450000000000003 111.472 -178.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.734 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.29 -52.8 50.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.827 -1.171 . . . . 73.439999999999998 110.036 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.8 t -53.63 -33.29 54.62 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.996 . . . . 74.409999999999997 109.754 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.52 -44.06 97.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 71.040000000000006 109.915 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.1 mm? -51.27 -32.76 25.73 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.414 -0.804 . . . . 71.319999999999993 110.023 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.605 ' CG ' HG22 ' A' ' 37' ' ' VAL . 44.6 t-20 -70.93 -26.37 63.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.332 -0.855 . . . . 74.239999999999995 110.111 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.64 -28.14 61.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.164 -0.96 . . . . 51.450000000000003 110.205 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.68 152.09 93.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.189 -0.945 . . . . 74.219999999999999 110.224 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.95 -46.62 0.38 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.162 1.611 . . . . 63.219999999999999 110.423 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.79 -53.47 4.27 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.531 -1.428 . . . . 51.039999999999999 109.531 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.736 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.0 OUTLIER -72.38 146.7 46.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.285 -1.126 . . . . 64.409999999999997 110.159 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.671 ' C ' HG23 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -159.94 131.22 5.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 75.329999999999998 110.263 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 37' ' ' VAL . 25.8 m -71.46 120.22 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 74.430000000000007 110.218 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.65 -47.4 7.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 74.430000000000007 110.242 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 17.3 t -120.36 120.45 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 52.229999999999997 110.176 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 40' ' ' SER . 5.0 p -106.53 105.1 14.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.248 -0.908 . . . . 54.049999999999997 110.279 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -133.06 147.27 52.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.44 -0.788 . . . . 72.530000000000001 109.886 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -125.6 44.7 1.2 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.156 -0.965 . . . . 71.310000000000002 111.676 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 42' ' ' ALA . 46.8 Cg_endo -73.81 -40.41 1.43 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.719 1.378 . . . . 74.219999999999999 109.666 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.94 -25.21 3.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.463 -0.773 . . . . 75.510000000000005 109.987 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 121.62 28.2 1.63 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.676 -1.37 . . . . 61.43 109.676 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.731 ' O ' HD23 ' A' ' 47' ' ' LEU . 5.9 pt20 -130.39 135.54 48.13 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.182 -1.187 . . . . 75.109999999999999 110.517 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' CB ' ' A' ' 26' ' ' SER . 11.1 mt -118.81 159.71 23.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.292 -0.88 . . . . 65.030000000000001 110.036 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 13.2 mt -104.09 124.37 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.187 -0.946 . . . . 70.319999999999993 110.231 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.996 HG21 ' HB3' ' A' ' 29' ' ' LEU . 12.9 p -131.24 129.41 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 72.420000000000002 110.271 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.835 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.3 m -101.28 149.15 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.318 -0.864 . . . . 75.430000000000007 110.181 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.527 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.4 p -137.99 142.09 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 62.340000000000003 110.274 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 1.3 pm0 -121.53 145.89 47.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 74.230000000000004 110.156 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.07 176.53 12.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 64.430000000000007 110.276 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -45.65 -48.17 14.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -0.906 . . . . 62.32 110.237 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -155.35 -172.73 4.27 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.295 -0.878 . . . . 64.329999999999998 110.239 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.458 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.9 m -60.71 -38.68 85.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.318 -0.864 . . . . 73.319999999999993 110.241 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 tt0 -48.93 -45.33 41.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.403 -0.811 . . . . 72.319999999999993 110.16 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.61 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 3.2 m -77.61 -33.63 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.315 -0.865 . . . . 75.340000000000003 110.222 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.527 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -63.48 -44.54 94.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 51.450000000000003 110.18 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.737 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.4 pt -66.55 -28.41 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.89 . . . . 70.150000000000006 109.701 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.517 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -52.36 -45.09 65.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.419 -0.801 . . . . 73.239999999999995 109.87 179.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.736 HG21 ' SG ' ' A' ' 35' ' ' CYS . 23.5 m -56.39 -40.83 75.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.244 -0.91 . . . . 65.230000000000004 110.499 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.737 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -49.17 -36.17 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.262 -0.899 . . . . 74.239999999999995 110.24 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.569 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.1 pp20? -52.04 -32.57 35.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.044 -1.035 . . . . 74.519999999999996 109.718 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.969 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.9 t -69.01 -55.68 10.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.33 -0.856 . . . . 75.450000000000003 110.395 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.86 -42.42 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.42 -0.8 . . . . 75.099999999999994 111.062 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.32 -40.63 93.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.08 -1.012 . . . . 73.239999999999995 110.468 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.587 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 3.9 t-20 -76.05 -20.49 57.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.109 -0.994 . . . . 74.120000000000005 110.572 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.969 HG23 ' O ' ' A' ' 65' ' ' SER . 39.3 t -67.78 125.08 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.251 -0.905 . . . . 65.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.91 -49.86 76.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.199 -0.938 . . . . 74.430000000000007 110.54 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.7 -32.79 5.97 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.589 -1.405 . . . . 71.319999999999993 109.589 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.673 HG23 ' CG1' ' A' ' 69' ' ' VAL . 42.5 t -76.98 116.33 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -1.081 . . . . 73.549999999999997 110.322 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.604 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.52 -21.88 15.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 61.399999999999999 110.17 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.59 173.59 13.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -0.839 . . . . 71.329999999999998 110.26 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.9 p -162.22 118.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.394 -0.816 . . . . 74.310000000000002 110.206 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 15.9 m -124.93 100.69 6.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 62.140000000000001 110.342 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.706 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -110.3 104.77 13.62 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.265 -0.897 . . . . 53.340000000000003 110.229 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 32.7 t -140.01 93.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.183 -0.948 . . . . 74.540000000000006 110.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.45 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.3 t80 -178.41 107.71 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.859 . . . . 65.549999999999997 110.241 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -101.04 126.53 47.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 70.310000000000002 110.109 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.593 ' CG ' HG13 ' A' ' 10' ' ' VAL . 17.5 pt20 -135.03 111.17 9.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.924 . . . . 55.130000000000003 110.186 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.43 138.6 8.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.186 -0.946 . . . . 73.450000000000003 110.371 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.82 145.06 30.65 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.463 -0.773 . . . . 74.340000000000003 110.296 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 85' ' ' GLN . 16.2 pt-20 -170.73 -35.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.252 -0.905 . . . . 45.310000000000002 110.223 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' N ' ' HG3' ' A' ' 84' ' ' GLU . 0.9 OUTLIER -175.82 57.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 75.420000000000002 110.28 -179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.455 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -150.61 -137.97 2.78 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.5 -1.44 . . . . 43.210000000000001 109.5 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 88' ' ' GLU . 3.7 tp10 66.01 46.49 2.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -1.074 . . . . 75.299999999999997 110.246 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 87' ' ' GLU . 2.4 pt-20 -55.53 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.075 -1.016 . . . . 55.240000000000002 110.234 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.549 ' HB ' ' HD3' ' A' ' 90' ' ' PRO . 1.3 m -42.66 -55.51 7.04 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.311 -0.868 . . . . 55.100000000000001 110.284 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 89' ' ' THR . 44.0 Cg_endo . . . . . 0 C--N 1.308 -1.574 0 O-C-N 123.66 1.347 . . . . 73.25 110.372 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.405 ' O ' ' O ' ' B' ' 2' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.27 0.557 . . . . 73.140000000000001 110.175 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' B' ' 1' ' ' MET . 0.2 OUTLIER 59.5 156.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 44.32 110.196 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.734 ' C ' HD12 ' B' ' 3' ' ' LEU . 3.6 pp -100.97 151.96 21.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -0.919 . . . . 65.010000000000005 110.199 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.38 23.61 0.24 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.267 -0.896 . . . . 75.510000000000005 110.247 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.433 ' CZ ' ' HB2' ' B' ' 5' ' ' ARG . 6.4 tpp85 -159.33 -56.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.217 -0.927 . . . . 72.439999999999998 110.222 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -52.31 -23.22 5.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.185 -0.947 . . . . 73.439999999999998 110.079 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.416 ' CB ' HD13 ' B' ' 3' ' ' LEU . 1.6 t -77.45 -40.46 43.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 74.329999999999998 109.671 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.468 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 1.2 t80 -80.55 -39.4 27.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -0.836 . . . . 75.329999999999998 109.707 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.436 ' CG ' ' OE1' ' A' ' 81' ' ' GLN . 1.8 ttp -65.29 -52.19 55.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.324 -0.86 . . . . 72.140000000000001 110.193 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.694 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -52.34 -34.3 46.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 63.119999999999997 109.953 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.73 91.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 64.319999999999993 109.934 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.4 m-20 -82.81 -39.39 21.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 75.340000000000003 110.102 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.8 -48.4 72.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 43.100000000000001 110.246 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.694 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.9 m -58.36 -30.96 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 75.329999999999998 110.119 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.29 -32.75 74.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 62.310000000000002 109.989 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.17 -13.9 29.9 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.344 -0.848 . . . . 63.039999999999999 110.028 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.687 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.67 -23.59 15.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.285 -0.884 . . . . 64.400000000000006 109.986 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.3 -51.2 7.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 74.129999999999995 110.054 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.6 59.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 74.030000000000001 110.051 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -109.54 -52.62 2.75 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 53.240000000000002 110.107 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.72 13.51 15.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.871 . . . . 40.420000000000002 109.996 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.41 27.22 47.0 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.656 -1.378 . . . . 73.109999999999999 109.656 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.445 HD11 ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -69.88 -162.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -1.152 . . . . 64.040000000000006 110.359 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.5 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 16.5 m -82.94 162.25 21.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 71.409999999999997 110.296 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.749 HG13 ' HB ' ' B' ' 28' ' ' VAL . 72.8 t -107.64 82.69 1.39 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.36 -0.837 . . . . 73.140000000000001 110.137 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.595 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.1 Cg_endo -71.85 -89.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.092 1.575 . . . . 64.430000000000007 110.773 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.58 43.96 1.59 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.797 -1.321 . . . . 63.049999999999997 109.797 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.749 ' HB ' HG13 ' B' ' 25' ' ' VAL . 37.2 t -73.05 -25.18 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.21 -1.171 . . . . 75.129999999999995 109.95 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.468 ' O ' ' CB ' ' B' ' 30' ' ' ARG . . . -125.18 -7.67 7.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.323 -0.86 . . . . 70.530000000000001 110.057 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.468 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 68.15 96.51 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.175 -0.953 . . . . 70.439999999999998 110.162 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' B' ' 32' ' ' VAL . . . -45.74 -33.53 3.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 65.310000000000002 110.244 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.451 ' CG2' ' HB3' ' B' ' 30' ' ' ARG . 6.7 m -42.36 -27.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 75.040000000000006 110.245 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' B' ' 31' ' ' ALA . 56.0 t -90.52 108.17 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 43.340000000000003 110.205 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -148.53 61.11 0.44 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.439 -1.464 . . . . 62.43 109.439 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.421 -1.047 . . . . 55.130000000000003 110.228 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.612 -1.395 . . . . 60.109999999999999 109.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 85.9 p -141.53 -154.81 0.54 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.269 -1.136 . . . . 74.129999999999995 110.248 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -176.08 -167.35 0.22 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.207 -0.933 . . . . 71.439999999999998 110.217 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.02 72.27 0.16 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.3 -0.875 . . . . 71.219999999999999 110.142 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 83' ' ' GLU . 40.7 m170 -121.53 122.87 40.66 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.25 -0.906 . . . . 62.409999999999997 110.221 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.5 ' N ' ' OE1' ' A' ' 83' ' ' GLU . 0.2 OUTLIER -154.33 118.95 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 72.200000000000003 110.146 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.47 171.69 14.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 52.299999999999997 110.232 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.2 m95 -110.72 -76.33 0.61 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.208 -0.932 . . . . 74.230000000000004 110.13 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.57 125.29 2.81 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.289 -0.882 . . . . 65.329999999999998 110.308 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.524 ' HB ' ' CB ' ' A' ' 52' ' ' GLU . 1.9 p -167.51 141.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 73.430000000000007 110.223 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.5 p -139.4 171.06 14.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 63.530000000000001 110.247 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.703 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -105.03 118.14 35.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 71.450000000000003 110.158 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 77' ' ' LEU . 2.7 mp -103.09 138.08 40.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.322 -0.861 . . . . 70.430000000000007 110.348 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.568 HG11 ' CB ' ' B' ' 21' ' ' ALA . 26.2 t -99.01 100.19 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.264 -0.897 . . . . 55.100000000000001 110.101 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG23 ' CG1' ' A' ' 49' ' ' VAL . 60.0 t -77.98 128.1 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.2 -0.938 . . . . 63.32 110.258 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tp60 -110.08 112.28 24.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 74.310000000000002 110.333 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.04 168.72 19.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.327 -0.858 . . . . 71.430000000000007 109.891 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.539 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.8 ttmt -43.46 148.51 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 64.420000000000002 109.621 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.424 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.32 -47.29 36.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -0.937 . . . . 70.140000000000001 110.964 -179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -91.95 -5.37 53.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.816 -1.177 . . . . 71.200000000000003 110.418 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.539 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.68 -50.23 18.37 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.048 -1.033 . . . . 74.0 108.274 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.092 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.67 -39.98 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 120.18 -0.608 . . . . 70.340000000000003 110.818 -179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.6 t -52.56 -40.49 62.61 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.533 -1.267 . . . . 75.409999999999997 108.497 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 27' ' ' THR . 1.5 m-20 -71.86 -58.97 3.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.481 -0.762 . . . . 64.25 111.108 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.923 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.99 -49.08 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.38 -0.825 . . . . 71.010000000000005 111.503 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.91 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.8 t -52.03 -52.67 49.33 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.649 -1.282 . . . . 61.149999999999999 109.936 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -56.18 -33.15 65.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.13 -0.982 . . . . 70.439999999999998 109.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.4 mm-40 -61.5 -44.18 97.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 71.510000000000005 109.845 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.723 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.34 -35.25 37.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.311 -0.868 . . . . 71.109999999999999 110.003 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -71.06 -24.62 62.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.908 . . . . 52.039999999999999 110.217 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.48 -20.08 60.78 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 62.100000000000001 110.239 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -85.68 152.22 56.71 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.225 -0.922 . . . . 53.130000000000003 110.28 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.2 Cg_endo -72.8 -53.89 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 73.329999999999998 110.522 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -61.79 -62.87 5.29 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.598 -1.401 . . . . 54.039999999999999 109.598 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.723 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.2 t -75.7 142.94 42.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.179 -1.189 . . . . 75.25 110.241 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 35' ' ' CYS . 5.0 mt-10 -153.55 127.73 9.08 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.278 -0.889 . . . . 63.109999999999999 110.082 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 93.8 t -67.92 120.11 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.2 -0.937 . . . . 73.310000000000002 110.213 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.93 -51.01 5.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 72.219999999999999 110.118 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 21.8 t -122.77 120.23 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -0.859 . . . . 64.299999999999997 110.12 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.73 102.76 12.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.278 -0.889 . . . . 74.109999999999999 110.162 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.32 148.0 51.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.375 -0.828 . . . . 71.010000000000005 110.302 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.77 54.04 0.41 Allowed Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.268 -0.895 . . . . 71.420000000000002 111.227 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -70.67 -38.92 5.23 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.646 1.34 . . . . 61.219999999999999 109.834 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 29.0 t -148.75 14.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.67 . . . . 70.439999999999998 110.07 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.93 28.7 10.63 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.697 -1.361 . . . . 71.439999999999998 109.697 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.9 pt20 -130.28 137.49 50.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.185 -1.185 . . . . 64.239999999999995 110.375 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.91 HD12 ' CB ' ' A' ' 26' ' ' SER . 67.3 mt -124.19 155.91 37.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.34 -0.85 . . . . 53.520000000000003 110.061 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.886 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -95.33 126.31 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.161 -0.962 . . . . 63.340000000000003 110.133 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.587 ' CG1' HG23 ' A' ' 15' ' ' VAL . 1.8 p -130.68 128.32 63.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.223 -0.923 . . . . 72.340000000000003 110.322 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 12' ' ' SER . 17.7 m -102.18 142.73 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.245 -0.909 . . . . 63.43 110.123 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.553 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.7 p -133.56 138.84 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.213 -0.929 . . . . 71.109999999999999 110.182 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.524 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 11.0 pt-20 -125.2 147.45 49.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 75.310000000000002 110.148 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.531 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -159.39 -177.95 6.8 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.897 . . . . 53.25 110.138 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -46.81 -49.92 19.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 54.310000000000002 110.184 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 26.8 p-10 -155.47 -169.12 3.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.202 -0.936 . . . . 70.230000000000004 110.214 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -61.99 -32.15 72.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 74.219999999999999 110.189 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 2.1 tt0 -52.0 -51.18 59.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.201 -0.937 . . . . 74.340000000000003 110.162 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 21.9 m -73.6 -30.5 63.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.302 -0.874 . . . . 70.049999999999997 110.168 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -62.68 -44.3 96.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.866 . . . . 73.340000000000003 110.272 179.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 14.1 pt -66.81 -28.47 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 73.400000000000006 109.517 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' N ' HG13 ' A' ' 60' ' ' ILE . 16.0 tt0 -52.66 -45.44 66.75 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.408 -0.807 . . . . 72.329999999999998 109.859 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 45.1 m -56.78 -41.44 77.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.444 -0.785 . . . . 60.219999999999999 110.491 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -50.31 -36.79 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.197 -0.94 . . . . 52.109999999999999 110.177 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.575 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 20.7 mt-10 -52.74 -33.32 47.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.146 -0.972 . . . . 74.230000000000004 109.861 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.923 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -69.15 -53.89 17.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.465 -0.772 . . . . 75.340000000000003 110.359 179.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -67.72 -40.96 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.456 -0.778 . . . . 73.209999999999994 111.131 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.575 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 ppt_? -66.68 -40.52 88.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.004 -1.06 . . . . 62.530000000000001 110.631 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.526 ' HB2' ' NE ' ' A' ' 67' ' ' ARG . 7.5 t-20 -76.27 -20.54 57.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.045 -1.034 . . . . 73.430000000000007 110.627 -179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.923 HG23 ' O ' ' A' ' 65' ' ' SER . 36.0 t -69.59 121.99 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.024 -1.048 . . . . 72.349999999999994 109.896 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.5 -44.23 93.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.243 -0.91 . . . . 74.340000000000003 110.673 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.47 -33.05 8.0 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 109.509 -1.436 . . . . 73.340000000000003 109.509 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.499 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.5 t -76.69 116.71 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.275 -1.132 . . . . 63.450000000000003 110.428 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -98.3 -20.08 17.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 74.340000000000003 109.996 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -151.99 173.47 14.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.398 -0.814 . . . . 65.439999999999998 110.108 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.2 p -157.16 118.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -0.962 . . . . 54.229999999999997 110.289 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -123.73 100.82 6.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.216 -0.927 . . . . 43.43 110.084 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.57 ' HB3' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -110.77 104.96 13.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 62.020000000000003 110.263 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 47.0 t -143.32 92.19 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.355 -0.841 . . . . 73.140000000000001 110.102 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.543 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 91.9 t80 -179.28 109.1 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.331 -0.856 . . . . 61.530000000000001 110.262 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.85 136.26 35.38 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.151 -0.968 . . . . 52.030000000000001 110.162 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.52 102.07 6.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.895 . . . . 72.420000000000002 110.184 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -161.5 138.7 8.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 74.549999999999997 110.399 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 6' ' ' THR . 1.8 mp0 -80.73 120.37 24.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.363 -0.836 . . . . 75.0 110.227 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 4.0 pt-20 175.21 -28.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -0.866 . . . . 74.230000000000004 110.243 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 33.3 mm-40 56.79 49.91 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.339 -0.851 . . . . 74.530000000000001 110.287 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -98.41 -133.42 7.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.52 -1.432 . . . . 65.129999999999995 109.52 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.504 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 0.1 OUTLIER 69.36 5.82 5.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -1.131 . . . . 74.430000000000007 110.307 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.5 pt-20 33.62 100.03 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.629 0.728 . . . . 73.409999999999997 111.431 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.465 ' CB ' ' O ' ' A' ' 88' ' ' GLU . 0.5 OUTLIER 66.16 68.05 0.66 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.316 -0.865 . . . . 72.450000000000003 110.241 179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 C--N 1.306 -1.695 0 O-C-N 124.039 1.547 . . . . 55.140000000000001 110.493 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.237 0.541 . . . . 74.040000000000006 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.41 -72.28 0.62 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 65.530000000000001 110.276 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' B' ' 3' ' ' LEU . 0.2 OUTLIER -119.79 114.48 22.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.294 -0.879 . . . . 74.030000000000001 110.185 179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.2 t -150.9 72.91 1.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.864 . . . . 35.200000000000003 110.213 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' B' ' 9' ' ' MET . 0.0 OUTLIER -162.57 -36.25 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.219 -0.926 . . . . 71.109999999999999 110.188 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 ttp85 -75.4 -20.92 58.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.901 . . . . 75.5 109.98 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.0 t -77.16 -39.92 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.317 -0.864 . . . . 71.230000000000004 109.617 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.497 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 1.1 t80 -80.27 -34.79 36.7 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.478 -0.764 . . . . 75.129999999999995 109.562 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.463 ' HE2' ' HB3' ' B' ' 9' ' ' MET . 13.1 ttp -70.16 -55.46 9.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.315 -0.865 . . . . 63.509999999999998 110.114 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.677 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -47.32 -30.17 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 51.109999999999999 110.047 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -49.4 74.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.401 -0.812 . . . . 73.530000000000001 110.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.457 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.7 OUTLIER -82.82 -36.74 25.27 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.257 -0.902 . . . . 70.25 110.124 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.48 -48.69 71.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 64.510000000000005 110.214 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.727 HG21 ' HG2' ' B' ' 26' ' ' PRO . 24.5 m -59.17 -30.19 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 72.230000000000004 110.194 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.77 -32.07 73.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.853 . . . . 74.230000000000004 110.225 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.63 -13.44 22.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 75.299999999999997 110.189 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.34 -23.85 14.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -0.883 . . . . 74.310000000000002 110.141 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.474 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.44 -48.95 9.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.174 -0.954 . . . . 62.509999999999998 110.155 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.36 59.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.318 -0.863 . . . . 63.030000000000001 110.26 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.51 -52.79 2.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.295 -0.878 . . . . 61.520000000000003 110.228 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.84 16.87 8.54 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 74.030000000000001 110.242 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.59 23.56 36.29 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.508 -1.437 . . . . 74.400000000000006 109.508 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.886 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -62.9 -162.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.184 -1.186 . . . . 54.219999999999999 110.32 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.4 OUTLIER -81.74 161.7 23.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.388 -0.82 . . . . 73.209999999999994 110.179 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.674 HG23 ' O ' ' B' ' 25' ' ' VAL . 32.8 m -109.25 78.67 1.08 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.181 -0.949 . . . . 71.140000000000001 110.206 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.727 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.9 Cg_endo -72.96 -57.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.991 1.521 . . . . 61.399999999999999 110.52 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.406 ' O ' ' N ' ' B' ' 30' ' ' ARG . . . -89.58 -35.96 7.64 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.546 -1.422 . . . . 73.299999999999997 109.546 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' B' ' 25' ' ' VAL . 54.9 t -46.32 -43.13 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -1.109 . . . . 72.239999999999995 110.128 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.65 -8.0 51.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.2 -0.938 . . . . 73.319999999999993 110.204 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.47 ' NH2' ' O ' ' B' ' 34' ' ' GLY . 9.4 mtp180 55.85 78.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.097 -1.002 . . . . 72.549999999999997 110.267 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -91.58 0.62 57.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 74.129999999999995 110.187 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.435 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 61.1 t -54.58 -39.84 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.286 -0.884 . . . . 75.420000000000002 110.222 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.1 p -179.61 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 74.140000000000001 110.144 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.47 ' O ' ' NH2' ' B' ' 30' ' ' ARG . . . 136.32 -69.57 0.51 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.571 -1.411 . . . . 60.030000000000001 109.571 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.273 -1.133 . . . . 73.010000000000005 110.234 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.656 -1.378 . . . . 65.329999999999998 109.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.72 -3.78 7.14 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.312 -1.111 . . . . 73.25 110.228 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 4' ' ' MET . 22.2 p-80 -122.91 162.77 21.6 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 41.049999999999997 110.194 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 3.1 ttt -179.17 70.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.155 -0.966 . . . . 74.400000000000006 110.247 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.503 ' CD2' ' O ' ' A' ' 5' ' ' HIS . 9.9 p-80 -127.83 118.64 24.08 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.339 -0.851 . . . . 75.230000000000004 110.206 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 21.2 m -166.81 123.13 1.2 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.342 -0.849 . . . . 75.109999999999999 110.222 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -152.28 168.67 24.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.932 . . . . 62.009999999999998 110.201 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -108.61 -69.71 0.84 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.207 -0.933 . . . . 75.120000000000005 110.174 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -153.91 121.67 5.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 72.420000000000002 110.118 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 81' ' ' GLN . 2.7 p -162.08 140.88 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.144 -0.973 . . . . 44.210000000000001 110.231 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.635 ' SG ' HD23 ' A' ' 59' ' ' LEU . 6.5 p -142.66 171.18 14.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 64.129999999999995 110.136 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.72 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.4 m -105.05 114.48 28.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.310000000000002 110.133 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 77' ' ' LEU . 3.8 mp -101.09 138.03 38.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 65.5 110.362 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.469 HG11 ' CB ' ' B' ' 21' ' ' ALA . 32.3 t -99.22 100.2 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.879 . . . . 54.109999999999999 110.088 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 52.3 t -78.1 128.95 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 75.109999999999999 110.186 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.469 ' HB3' ' O ' ' A' ' 74' ' ' ALA . 1.2 tt0 -107.48 111.03 23.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.217 -0.927 . . . . 65.140000000000001 110.322 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.987 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.75 168.84 18.8 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.276 -0.89 . . . . 62.530000000000001 109.75 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.23 147.6 0.35 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.927 . . . . 73.450000000000003 109.772 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.6 t -49.44 -47.28 48.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.111 -0.993 . . . . 65.439999999999998 111.114 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -91.2 -6.17 53.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.769 -1.207 . . . . 62.25 110.37 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 6.8 mmm180 -74.95 -51.97 12.36 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.703 -1.221 . . . . 73.340000000000003 107.703 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.987 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.3 OUTLIER -55.55 -42.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 115.862 -0.608 . . . . 73.349999999999994 110.537 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.2 p -52.64 -40.12 62.46 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.572 -1.33 . . . . 73.140000000000001 108.223 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.524 ' O ' HG22 ' A' ' 27' ' ' THR . 1.8 m-20 -71.98 -58.88 3.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.462 -0.774 . . . . 72.420000000000002 111.034 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.866 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.59 -48.98 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.396 -0.815 . . . . 65.219999999999999 111.497 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.792 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.7 t -52.22 -52.66 51.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 74.120000000000005 109.926 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 23' ' ' SER . 4.1 t -54.13 -33.26 57.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.15 -0.969 . . . . 73.329999999999998 109.819 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -61.67 -44.23 97.36 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.467 -0.771 . . . . 60.43 109.839 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.14 -32.01 21.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.461 -0.775 . . . . 75.329999999999998 110.02 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.518 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 45.6 t-20 -68.7 -27.31 65.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 72.5 110.042 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.6 -28.17 61.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.289 -0.882 . . . . 75.040000000000006 110.134 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -65.15 148.82 97.62 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 73.129999999999995 110.258 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.18 -39.4 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.96 1.505 . . . . 74.439999999999998 110.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.96 -55.39 2.96 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.609 -1.396 . . . . 45.439999999999998 109.609 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.5 t -75.98 148.4 38.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.376 -1.073 . . . . 54.43 110.252 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.1 OUTLIER -158.21 130.17 6.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.218 -0.926 . . . . 63.219999999999999 110.211 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 37' ' ' VAL . 17.4 m -72.89 120.28 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.262 -0.898 . . . . 73.420000000000002 110.164 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.78 -50.85 5.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.285 -0.884 . . . . 33.520000000000003 110.102 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 13.6 t -120.37 120.36 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.325 -0.86 . . . . 71.230000000000004 110.078 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 40' ' ' SER . 18.2 p -106.95 100.25 9.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 63.43 110.368 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 62.2 m-20 -134.86 147.9 49.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 74.219999999999999 110.182 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.76 55.78 0.43 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.4 -0.813 . . . . 64.099999999999994 111.201 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.0 Cg_endo -70.53 -38.18 6.43 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.626 1.33 . . . . 65.420000000000002 109.872 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 58.6 m -148.45 13.9 0.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.482 -0.761 . . . . 44.109999999999999 110.116 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.69 27.84 12.2 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.545 -1.422 . . . . 43.130000000000003 109.545 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.781 ' O ' HD23 ' A' ' 47' ' ' LEU . 20.5 pt20 -130.37 136.27 48.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.137 -1.213 . . . . 53.539999999999999 110.401 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.9 mt -121.15 157.08 30.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.167 -0.958 . . . . 70.040000000000006 110.043 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.545 HD11 HD22 ' B' ' 23' ' ' LEU . 12.0 mt -98.91 122.94 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.248 -0.908 . . . . 75.150000000000006 110.184 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 29' ' ' LEU . 5.1 p -130.88 128.95 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.163 -0.961 . . . . 51.25 110.072 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.0 m -101.84 143.25 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 62.539999999999999 110.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 59' ' ' LEU . 14.3 p -135.83 144.79 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.371 -0.831 . . . . 75.319999999999993 110.079 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HA ' HD11 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -122.47 143.05 49.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 52.420000000000002 110.222 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.837 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -153.85 175.99 12.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.179 -0.951 . . . . 74.239999999999995 110.174 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -45.55 -48.35 14.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 75.019999999999996 110.26 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' OD2' ' HG3' ' A' ' 57' ' ' GLU . 14.5 p-10 -155.44 -169.63 3.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.216 -0.927 . . . . 71.549999999999997 110.133 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 60' ' ' ILE . 12.6 t -62.78 -34.13 76.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.313 -0.867 . . . . 74.200000000000003 110.254 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 5.9 mt-10 -55.19 -46.72 75.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 72.310000000000002 110.194 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.671 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.8 m -74.32 -33.53 63.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 74.349999999999994 110.272 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.837 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.58 -44.41 86.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.271 -0.893 . . . . 72.209999999999994 110.17 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 35.9 pt -66.58 -28.45 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.843 . . . . 73.430000000000007 109.675 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.509 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 11.5 tt0 -52.48 -45.5 66.16 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.313 -0.867 . . . . 75.200000000000003 109.826 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.6 m -56.86 -41.05 77.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.336 -0.853 . . . . 53.509999999999998 110.578 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.5 tt -49.38 -36.19 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 73.239999999999995 110.428 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.3 pp20? -52.1 -32.51 35.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.04 -1.037 . . . . 73.129999999999995 109.81 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 44.3 p -69.26 -55.41 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.296 -0.878 . . . . 62.439999999999998 110.472 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.539 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.6 m -65.76 -42.51 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.356 -0.84 . . . . 71.239999999999995 111.257 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -65.21 -40.92 94.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.044 -1.035 . . . . 72.319999999999993 110.6 -179.675 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.509 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 23.8 t-20 -75.88 -20.24 58.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.121 -0.987 . . . . 74.209999999999994 110.739 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.64 123.57 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.916 -1.115 . . . . 62.509999999999998 109.862 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -54.77 -49.41 70.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.147 -0.971 . . . . 72.239999999999995 110.539 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.28 -32.89 5.37 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.691 -1.364 . . . . 54.130000000000003 109.691 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.441 HG23 ' CG1' ' A' ' 69' ' ' VAL . 39.8 t -78.98 116.58 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -1.209 . . . . 72.040000000000006 110.309 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.74 -22.43 15.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.945 . . . . 63.219999999999999 110.068 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -151.87 172.74 15.73 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.283 -0.886 . . . . 72.209999999999994 110.203 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.645 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.4 p -155.06 117.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.337 -0.852 . . . . 61.219999999999999 110.202 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.437 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -121.97 93.23 3.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.955 . . . . 72.129999999999995 110.119 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -107.14 103.9 13.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.225 -0.922 . . . . 74.349999999999994 110.229 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.2 t -139.74 92.51 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 74.329999999999998 110.215 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.472 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 76.9 t80 -179.65 117.54 0.06 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.302 -0.874 . . . . 75.329999999999998 110.19 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.53 135.27 34.21 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 75.420000000000002 110.098 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.629 ' O ' HG13 ' A' ' 10' ' ' VAL . 18.3 tp60 -129.62 101.97 6.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.111 -0.993 . . . . 71.239999999999995 110.301 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -161.41 138.7 8.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 71.340000000000003 110.27 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 3.5 mm-40 -90.37 118.93 30.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 63.409999999999997 110.212 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 6.2 pt-20 175.7 -162.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 45.009999999999998 110.176 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 67.2 tp60 -87.07 50.93 2.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.212 -0.93 . . . . 63.119999999999997 110.205 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.449 ' HA2' ' OE2' ' A' ' 87' ' ' GLU . . . -101.91 -143.08 13.1 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.467 -1.453 . . . . 71.319999999999993 109.467 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' OE2' ' HA2' ' A' ' 86' ' ' GLY . 1.4 pm0 -179.48 47.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -1.183 . . . . 72.129999999999995 110.221 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 88' ' ' GLU . 2.8 pt-20 -47.24 123.54 5.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 71.140000000000001 110.175 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.0 157.57 46.22 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 74.420000000000002 110.157 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 C--N 1.305 -1.723 0 O-C-N 123.871 1.458 . . . . 75.439999999999998 110.41 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.265 0.555 . . . . 60.420000000000002 110.195 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.85 102.7 2.7 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.917 . . . . 72.049999999999997 110.21 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.504 ' HA ' HD22 ' B' ' 3' ' ' LEU . 0.2 OUTLIER -78.73 -77.15 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.334 -0.854 . . . . 71.409999999999997 110.313 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 3' ' ' LEU . 0.6 OUTLIER 42.19 29.67 0.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 62.100000000000001 110.267 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -137.49 -59.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 52.549999999999997 110.354 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -30.65 60.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -0.856 . . . . 73.140000000000001 110.261 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 17.6 t -75.45 -40.41 57.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 70.409999999999997 109.765 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.537 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.56 -38.81 28.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.444 -0.785 . . . . 74.109999999999999 109.739 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.471 ' HE3' HG11 ' A' ' 50' ' ' VAL . 7.2 ttp -65.94 -54.27 28.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.197 -0.939 . . . . 74.230000000000004 110.231 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.629 ' O ' HG13 ' B' ' 14' ' ' VAL . 0.3 OUTLIER -53.02 -31.86 43.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 61.100000000000001 110.076 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 14' ' ' VAL . . . -63.23 -47.2 83.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 51.109999999999999 110.152 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.7 -36.1 26.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.328 -0.858 . . . . 73.230000000000004 110.183 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -57.24 -47.98 80.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 73.129999999999995 110.257 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.629 HG13 ' O ' ' B' ' 10' ' ' LYS . 27.1 m -58.96 -29.87 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.216 -0.928 . . . . 73.120000000000005 110.137 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -65.54 -31.55 72.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 72.120000000000005 110.108 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -100.31 -13.83 18.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 73.329999999999998 110.172 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.68 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -96.61 -21.47 17.62 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 72.150000000000006 110.172 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.421 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -87.38 -51.6 5.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 73.329999999999998 110.184 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.36 -10.47 59.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 52.420000000000002 110.207 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.66 -52.73 2.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 62.119999999999997 110.13 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.19 14.64 15.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 71.140000000000001 110.234 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 24.13 47.05 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.55 -1.42 . . . . 53.450000000000003 109.55 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.545 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -63.85 -162.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.315 -1.109 . . . . 72.510000000000005 110.296 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.3 t -82.74 162.04 21.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.409 -0.807 . . . . 62.109999999999999 110.33 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HB ' ' B' ' 28' ' ' VAL . 15.4 m -109.05 80.24 1.29 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 65.120000000000005 110.212 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.594 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.2 Cg_endo -73.03 -56.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.964 1.507 . . . . 74.150000000000006 110.465 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.15 -9.28 57.16 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.465 -1.454 . . . . 61.329999999999998 109.465 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.58 HG12 ' O ' ' B' ' 28' ' ' VAL . 98.3 t -80.92 6.35 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -1.118 . . . . 73.5 110.256 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.89 -53.44 0.26 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 75.049999999999997 110.189 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 2.9 mtm180 -68.73 -142.81 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.305 -0.872 . . . . 71.120000000000005 110.146 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 59.64 16.15 5.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 71.099999999999994 110.194 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HB ' ' B' ' 33' ' ' VAL . 8.6 p -118.71 -10.7 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.892 . . . . 72.049999999999997 110.298 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 5.9 t 61.83 103.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 73.010000000000005 110.192 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' B' ' 35' ' ' GLN . . . -143.08 17.99 2.33 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.542 -1.423 . . . . 75.409999999999997 109.542 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.461 ' O ' ' O ' ' B' ' 34' ' ' GLY . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.23 -1.159 . . . . 73.519999999999996 110.184 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.574 -1.41 . . . . 62.119999999999997 109.574 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 56.29 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 71.430000000000007 110.282 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 4' ' ' MET . 8.1 t-160 57.03 28.0 14.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 73.409999999999997 110.193 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.2 ttm 175.82 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.258 -0.901 . . . . 73.5 110.201 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.513 ' O ' ' ND1' ' A' ' 5' ' ' HIS . 17.0 p80 -131.71 118.22 19.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 72.239999999999995 110.349 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.551 ' O ' HG23 ' A' ' 6' ' ' THR . 6.3 t -166.72 124.86 1.37 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 73.349999999999994 110.281 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -152.54 157.02 40.48 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 73.439999999999998 110.317 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.438 ' O ' ' OE1' ' A' ' 9' ' ' GLN . 69.2 m95 -107.17 -70.25 0.8 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 61.520000000000003 110.161 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.3 OUTLIER -157.37 121.82 4.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.304 -0.872 . . . . 63.25 110.217 180.0 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 81' ' ' GLN . 2.1 p -160.68 142.48 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.384 -0.822 . . . . 50.32 110.26 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.741 ' SG ' HD11 ' A' ' 13' ' ' LEU . 21.0 p -143.24 167.52 21.93 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.288 -0.882 . . . . 50.049999999999997 109.748 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.684 ' OG ' HG12 ' A' ' 50' ' ' VAL . 21.7 m -104.63 121.39 43.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.328 -0.857 . . . . 53.109999999999999 110.447 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 13' ' ' LEU . 6.0 mp -104.62 137.18 42.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.167 -0.958 . . . . 71.230000000000004 110.092 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.678 HG11 ' CB ' ' B' ' 21' ' ' ALA . 19.8 t -98.72 99.65 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 63.520000000000003 109.973 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 73.3 t -78.03 119.77 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 74.409999999999997 110.32 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.684 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 3.1 tp60 -102.14 109.61 21.36 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.284 -0.885 . . . . 71.450000000000003 109.971 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.095 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.88 168.71 19.13 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.309 -0.87 . . . . 73.299999999999997 109.981 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.03 148.97 0.22 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.301 -0.874 . . . . 72.140000000000001 109.795 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -48.7 -47.17 41.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 53.009999999999998 111.013 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -92.26 -5.22 52.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.81 -1.181 . . . . 74.319999999999993 110.497 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.549 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.75 -50.64 16.66 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.964 -1.085 . . . . 73.099999999999994 108.155 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.095 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.81 -40.36 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 120.385 -0.526 . . . . 73.430000000000007 110.853 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.9 m -52.55 -40.5 62.6 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.658 -1.276 . . . . 75.25 108.482 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.502 ' O ' HG22 ' A' ' 27' ' ' THR . 97.8 m-20 -71.97 -58.96 3.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.521 -0.737 . . . . 61.520000000000003 111.047 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.764 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -78.72 -49.47 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 121.329 -0.857 . . . . 72.150000000000006 111.5 -178.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.961 ' OG ' HD12 ' A' ' 47' ' ' LEU . 3.6 t -52.09 -52.94 48.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.815 -1.178 . . . . 75.219999999999999 110.02 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.4 t -55.6 -33.37 63.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.133 -0.98 . . . . 74.109999999999999 109.963 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 3.5 mt-30 -61.31 -44.35 97.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.41 -0.806 . . . . 75.0 109.944 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.8 mm? -51.13 -26.38 6.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.865 . . . . 70.450000000000003 110.07 -179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.2 t-20 -74.83 -27.43 60.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.177 -0.952 . . . . 75.140000000000001 110.002 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.56 -28.07 61.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 72.140000000000001 110.203 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -69.7 151.31 96.52 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 64.109999999999999 110.256 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.35 -53.61 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.072 1.564 . . . . 70.530000000000001 110.353 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.98 -57.48 8.63 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.507 -1.437 . . . . 75.129999999999995 109.507 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.534 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -77.61 147.11 35.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.305 -1.114 . . . . 54.409999999999997 110.055 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -158.32 130.76 7.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 75.040000000000006 110.212 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.458 ' HA ' HG22 ' A' ' 49' ' ' VAL . 64.8 t -67.09 120.18 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 75.019999999999996 110.252 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.551 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.73 -54.78 3.73 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.304 -0.873 . . . . 72.420000000000002 110.047 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 48' ' ' ILE . 10.9 t -120.71 120.7 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -0.823 . . . . 73.219999999999999 110.035 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 100.61 10.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.224 -0.922 . . . . 72.310000000000002 110.201 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.1 m-20 -133.41 148.2 51.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.377 -0.827 . . . . 72.129999999999995 110.048 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.47 53.07 0.37 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.34 -0.85 . . . . 71.230000000000004 111.41 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.9 Cg_endo -71.63 -39.54 3.47 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.613 1.323 . . . . 63.219999999999999 109.616 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 t -147.53 12.93 1.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.457 -0.777 . . . . 73.049999999999997 110.173 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.406 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 93.15 27.68 13.14 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.755 -1.338 . . . . 44.009999999999998 109.755 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.873 ' O ' HD23 ' A' ' 47' ' ' LEU . 12.4 pt20 -130.44 137.73 49.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.208 -1.172 . . . . 74.030000000000001 110.429 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.961 HD12 ' OG ' ' A' ' 26' ' ' SER . 11.3 mt -124.07 159.81 29.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 73.209999999999994 110.153 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.794 HD11 HD22 ' B' ' 23' ' ' LEU . 13.9 mt -94.65 123.65 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.876 . . . . 65.019999999999996 110.084 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 37' ' ' VAL . 20.0 t -127.82 131.62 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.329 -0.857 . . . . 71.5 110.774 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.684 HG12 ' OG ' ' A' ' 12' ' ' SER . 8.7 m -102.5 145.42 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.06 -1.025 . . . . 74.030000000000001 110.173 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.3 p -141.42 137.16 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 72.140000000000001 110.159 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 1.3 pt-20 -124.67 147.63 48.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.857 . . . . 72.519999999999996 110.104 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.88 179.41 9.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.936 . . . . 72.239999999999995 110.241 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -46.14 -49.44 16.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 74.239999999999995 110.24 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CG ' ' O ' ' A' ' 54' ' ' GLU . 7.3 m-20 -155.52 -170.22 3.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.202 -0.937 . . . . 72.450000000000003 110.197 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -61.28 -38.38 86.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 75.430000000000007 110.194 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 1.0 OUTLIER -51.31 -48.6 62.28 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.34 -0.85 . . . . 65.340000000000003 110.157 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 1.8 m -72.9 -33.59 66.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.247 -0.908 . . . . 72.109999999999999 110.271 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 53' ' ' ALA . 1.1 mp -63.16 -44.44 95.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.292 -0.88 . . . . 73.510000000000005 110.222 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.725 ' O ' HG22 ' A' ' 63' ' ' ILE . 24.8 pt -66.64 -28.71 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 72.129999999999995 109.629 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.526 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.57 -45.52 66.49 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.31 -0.869 . . . . 74.400000000000006 109.838 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 65' ' ' SER . 90.2 m -56.45 -41.39 76.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 52.219999999999999 110.485 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.0 tt -49.61 -36.54 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 73.420000000000002 110.11 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 5.6 mm-40 -52.51 -33.36 44.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.978 -1.076 . . . . 73.530000000000001 109.629 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 4.0 m -69.15 -55.75 9.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.322 -0.861 . . . . 53.25 110.371 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.552 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.48 -42.38 93.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.39 -0.818 . . . . 63.229999999999997 111.044 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.4 -40.55 93.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.073 -1.017 . . . . 74.219999999999999 110.53 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 27.8 t30 -75.75 -20.27 58.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.003 -1.061 . . . . 72.239999999999995 110.628 -179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 46.8 t -66.99 127.39 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.044 -1.035 . . . . 70.219999999999999 109.831 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -60.74 -49.77 76.15 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 60.450000000000003 110.635 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -32.91 5.22 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.515 -1.434 . . . . 73.420000000000002 109.515 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 HG23 ' CG1' ' A' ' 69' ' ' VAL . 46.6 t -76.54 116.68 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -1.176 . . . . 54.130000000000003 110.441 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -99.99 -19.18 16.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.312 -0.868 . . . . 74.430000000000007 110.004 179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -150.47 173.58 13.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.396 -0.815 . . . . 75.219999999999999 110.089 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.512 HG22 HD23 ' A' ' 77' ' ' LEU . 2.3 p -156.42 118.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 73.430000000000007 110.315 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -122.99 99.18 6.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.299 -0.876 . . . . 75.219999999999999 110.113 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 HD23 HG22 ' A' ' 75' ' ' VAL . 0.5 OUTLIER -111.21 104.9 13.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 73.430000000000007 110.29 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 30.1 t -146.39 92.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.177 -0.952 . . . . 55.030000000000001 110.162 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 88.6 t80 -178.76 117.64 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.172 -0.955 . . . . 74.450000000000003 110.247 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -97.19 136.27 37.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 74.120000000000005 110.131 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.656 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -130.57 103.04 6.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 63.409999999999997 110.258 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.3 138.71 8.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 64.420000000000002 110.253 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -85.69 118.74 25.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.275 -0.891 . . . . 70.299999999999997 110.198 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER 179.94 30.25 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.304 -0.872 . . . . 75.019999999999996 110.316 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.42 ' HB2' ' O ' ' A' ' 84' ' ' GLU . 20.7 mm100 60.19 49.74 7.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 75.219999999999999 110.078 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . -103.57 169.77 18.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.549 -1.421 . . . . 62.32 109.549 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 86' ' ' GLY . 5.2 tt0 69.48 38.75 1.72 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 74.439999999999998 110.228 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.857 ' O ' HG23 ' A' ' 89' ' ' THR . 22.5 mt-10 -151.17 -164.89 2.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.955 . . . . 74.120000000000005 110.136 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.857 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -179.84 130.14 0.25 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.178 -0.952 . . . . 61.450000000000003 110.118 179.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.678 0 O-C-N 123.841 1.443 . . . . 73.129999999999995 110.422 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.213 0.53 . . . . 74.310000000000002 110.177 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -106.53 -89.57 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.263 -0.898 . . . . 74.420000000000002 110.197 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.717 ' C ' HD12 ' B' ' 3' ' ' LEU . 3.4 pp -96.36 136.79 36.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.347 -0.845 . . . . 70.209999999999994 110.14 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.26 45.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 73.430000000000007 110.278 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -145.22 -51.6 0.26 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.189 -0.945 . . . . 73.049999999999997 110.217 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 8.9 ttt180 -55.87 -19.47 11.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 53.329999999999998 110.211 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.84 -38.04 28.94 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.184 -0.948 . . . . 71.109999999999999 109.698 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.536 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.58 -41.06 24.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.421 -0.799 . . . . 61.130000000000003 109.852 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.411 ' HB3' ' HE2' ' B' ' 9' ' ' MET . 11.7 ttp -66.92 -48.92 67.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.23 -0.919 . . . . 61.399999999999999 110.195 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.692 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.99 -30.52 25.38 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.912 . . . . 43.43 110.11 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.2 97.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.263 -0.898 . . . . 75.010000000000005 110.08 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.7 t-20 -82.74 -42.51 17.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.286 -0.884 . . . . 74.099999999999994 110.314 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -53.74 -47.72 70.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.278 -0.889 . . . . 73.129999999999995 110.269 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.692 HG22 ' O ' ' B' ' 10' ' ' LYS . 35.8 m -60.39 -30.03 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -0.953 . . . . 65.319999999999993 110.252 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.07 -31.81 73.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 63.119999999999997 110.126 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -98.96 -13.63 19.86 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.331 -0.856 . . . . 72.200000000000003 110.193 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.704 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.3 -24.58 15.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.247 -0.908 . . . . 65.040000000000006 110.212 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.419 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -84.79 -50.82 7.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 74.120000000000005 110.188 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.49 -10.3 58.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 64.349999999999994 110.132 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -112.71 -52.73 2.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.157 -0.965 . . . . 74.409999999999997 110.224 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.704 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.64 14.32 13.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 64.519999999999996 110.105 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.28 24.15 43.7 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.577 -1.409 . . . . 61.299999999999997 109.577 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.794 HD22 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -63.92 -162.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -1.124 . . . . 53.219999999999999 110.245 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 1.7 t -82.4 161.99 22.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.448 -0.783 . . . . 62.140000000000001 110.246 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.647 HG23 ' O ' ' B' ' 25' ' ' VAL . 31.5 m -109.33 81.86 1.86 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.214 -0.929 . . . . 63.509999999999998 110.254 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.618 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.8 Cg_endo -72.7 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 73.099999999999994 110.477 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.23 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.57 -1.412 . . . . 73.230000000000004 109.57 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -91.41 -47.34 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.214 -1.168 . . . . 70.329999999999998 110.225 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 30' ' ' ARG . . . -117.93 -74.26 0.61 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.186 -0.946 . . . . 74.420000000000002 110.192 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.664 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 2.5 mtp-105 -60.61 -142.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 75.140000000000001 110.181 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 65.86 25.44 11.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.926 . . . . 73.319999999999993 110.236 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 30' ' ' ARG . 23.4 t -122.93 -25.57 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 43.140000000000001 110.185 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.432 HG23 ' H ' ' B' ' 33' ' ' VAL . 20.3 t -52.06 107.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 52.009999999999998 110.29 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' B' ' 35' ' ' GLN . . . -146.06 -75.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.589 -1.404 . . . . 72.409999999999997 109.589 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' B' ' 34' ' ' GLY . 5.5 mt-30 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.304 -1.115 . . . . 74.319999999999993 110.148 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.535 -1.426 . . . . 74.530000000000001 109.535 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.75 -147.14 0.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.234 -1.156 . . . . 65.019999999999996 110.198 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.0 OUTLIER 60.94 86.78 0.1 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 71.439999999999998 110.219 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.2 ttm -179.56 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 75.299999999999997 110.365 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.418 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 11.4 p80 -114.25 118.32 33.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 72.239999999999995 110.143 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -166.89 128.09 1.63 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.374 -0.829 . . . . 43.240000000000002 110.012 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -142.14 170.02 16.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.286 -0.884 . . . . 72.439999999999998 110.145 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.481 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 82.7 m95 -109.22 -71.46 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 75.319999999999993 110.225 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.95 126.98 8.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.185 -0.947 . . . . 71.239999999999995 110.346 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 81' ' ' GLN . 1.7 p -158.84 134.72 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 64.140000000000001 110.13 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 79' ' ' TYR . 9.3 p -142.85 171.56 13.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 74.439999999999998 110.188 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.763 ' CB ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -104.51 112.92 26.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 74.140000000000001 110.034 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.802 HD23 ' CB ' ' A' ' 77' ' ' LEU . 2.7 mp -100.75 137.07 39.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.326 -0.859 . . . . 74.099999999999994 110.54 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.3 t -98.77 101.49 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -0.853 . . . . 75.219999999999999 109.88 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -77.74 128.83 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.281 -0.887 . . . . 61.030000000000001 110.274 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -108.46 112.36 24.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 75.209999999999994 110.185 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.056 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.96 168.99 18.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.263 -0.898 . . . . 72.319999999999993 109.827 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 1.7 tptt -41.46 147.2 0.18 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.839 . . . . 74.540000000000006 109.815 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.16 -47.2 45.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 71.409999999999997 111.067 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -92.02 -5.53 52.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.715 -1.241 . . . . 74.409999999999997 110.498 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.6 mmm180 -75.01 -50.43 16.57 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.006 -1.059 . . . . 74.519999999999996 108.197 177.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.056 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.68 -42.24 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 120.338 -0.545 . . . . 74.430000000000007 110.899 -179.473 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 6.2 t -52.34 -40.47 61.98 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 118.365 -1.334 . . . . 72.439999999999998 108.256 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.52 ' O ' HG22 ' A' ' 27' ' ' THR . 0.5 OUTLIER -72.12 -59.01 2.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.621 -0.674 . . . . 72.109999999999999 111.154 179.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.912 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.76 -48.94 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.37 -0.831 . . . . 74.319999999999993 111.479 -178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.873 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.9 OUTLIER -51.84 -52.76 47.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.744 -1.223 . . . . 63.439999999999998 109.778 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.29 -33.39 63.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.05 -1.031 . . . . 74.439999999999998 109.817 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.49 -44.33 97.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 74.319999999999993 109.928 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.533 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.15 -33.33 26.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 64.219999999999999 110.111 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -68.28 -28.15 66.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.189 -0.945 . . . . 74.310000000000002 110.095 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.58 -28.08 61.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 60.25 110.162 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -64.12 147.97 96.04 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.296 -0.877 . . . . 75.530000000000001 110.233 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.45 -36.14 4.22 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.996 1.524 . . . . 63.229999999999997 110.319 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.91 -61.79 1.65 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.549 -1.421 . . . . 43.530000000000001 109.549 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.533 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.4 t -71.06 150.17 45.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.259 -1.141 . . . . 70.0 110.268 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.68 130.21 6.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 71.310000000000002 110.291 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 t -72.68 120.14 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 73.129999999999995 110.257 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.82 -50.32 6.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 65.150000000000006 110.182 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 25.3 t -120.94 120.14 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.361 -0.837 . . . . 74.150000000000006 110.05 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.78 99.95 9.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.235 -0.916 . . . . 62.229999999999997 110.274 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 1.5 m-20 -133.46 148.13 51.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.332 -0.855 . . . . 74.109999999999999 110.213 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.7 54.18 0.4 Allowed Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.345 -0.847 . . . . 73.040000000000006 111.268 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.7 Cg_endo -70.82 -38.9 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.583 1.307 . . . . 52.340000000000003 109.843 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.0 t -148.56 13.71 0.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.488 -0.758 . . . . 61.100000000000001 110.239 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.79 28.61 11.94 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.813 -1.315 . . . . 70.530000000000001 109.813 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.817 ' O ' HD23 ' A' ' 47' ' ' LEU . 6.8 pt20 -130.33 135.33 47.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.156 . . . . 71.409999999999997 110.357 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD12 ' CB ' ' A' ' 26' ' ' SER . 14.7 mt -122.32 157.48 31.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.204 -0.935 . . . . 72.319999999999993 110.106 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.568 HD11 HD13 ' B' ' 23' ' ' LEU . 14.2 mt -98.88 123.98 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.163 -0.961 . . . . 72.209999999999994 110.19 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' CG2' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -131.43 127.51 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.965 . . . . 73.299999999999997 110.384 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.763 HG12 ' CB ' ' A' ' 12' ' ' SER . 4.8 m -102.01 147.83 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 63.25 110.18 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.577 HG13 ' HG ' ' A' ' 59' ' ' LEU . 12.6 p -138.29 143.94 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.22 -0.925 . . . . 72.400000000000006 110.233 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 59' ' ' LEU . 12.9 pt-20 -122.21 146.12 47.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 64.120000000000005 110.189 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.829 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -157.28 174.55 15.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 61.130000000000003 110.132 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 8' ' ' TRP . 14.4 tt0 -45.8 -47.1 15.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.261 -0.899 . . . . 74.439999999999998 110.238 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 55' ' ' ASP . 39.6 p-10 -155.5 -169.95 3.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.338 -0.851 . . . . 72.340000000000003 110.21 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 60' ' ' ILE . 10.9 t -63.46 -32.37 73.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.872 . . . . 65.019999999999996 110.149 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 49.3 mm-40 -56.85 -47.07 81.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 75.439999999999998 110.201 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.711 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 8.4 m -73.91 -32.11 63.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 64.329999999999998 110.158 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.829 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -66.43 -44.52 82.67 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.289 -0.882 . . . . 73.219999999999999 110.18 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 36.1 pt -66.51 -28.53 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.279 -0.888 . . . . 75.329999999999998 109.604 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.503 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -52.49 -45.6 66.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 62.439999999999998 109.707 179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.5 m -56.84 -40.95 77.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.401 -0.812 . . . . 61.350000000000001 110.478 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.0 -36.01 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.203 -0.936 . . . . 72.5 110.379 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.595 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.2 pt-20 -51.76 -33.18 33.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.159 -0.963 . . . . 72.019999999999996 109.914 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.987 ' O ' HG23 ' A' ' 69' ' ' VAL . 17.2 t -69.34 -54.64 13.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.356 -0.84 . . . . 40.32 110.532 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 32.8 m -67.2 -41.95 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 73.549999999999997 111.301 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -64.28 -40.41 95.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.094 -1.004 . . . . 72.120000000000005 110.481 -179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 10.4 t30 -76.06 -20.18 57.96 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.058 -1.026 . . . . 54.210000000000001 110.406 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.987 HG23 ' O ' ' A' ' 65' ' ' SER . 39.8 t -66.9 120.89 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.04 -1.038 . . . . 72.200000000000003 109.907 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -55.53 -49.89 71.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.212 -0.93 . . . . 73.200000000000003 110.594 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.81 5.4 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.639 -1.384 . . . . 43.340000000000003 109.639 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.701 HG23 ' CG1' ' A' ' 69' ' ' VAL . 20.4 t -80.55 116.76 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.331 -1.099 . . . . 63.310000000000002 110.229 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.686 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.59 -23.72 14.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.189 -0.944 . . . . 74.329999999999998 110.253 179.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' N ' ' HG ' ' A' ' 73' ' ' LEU . . . -150.02 173.61 13.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -0.873 . . . . 50.020000000000003 110.241 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.638 HG13 ' O ' ' A' ' 75' ' ' VAL . 13.3 p -157.58 118.7 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 44.43 110.266 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -119.06 101.09 7.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.19 -0.943 . . . . 71.409999999999997 110.139 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.802 ' CB ' HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -113.3 105.05 12.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.143 -0.973 . . . . 74.010000000000005 110.273 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.83 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 45.4 t -139.59 92.53 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 73.329999999999998 110.279 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.527 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 89.1 t80 -178.75 113.65 0.06 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.374 -0.828 . . . . 72.319999999999993 110.195 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -100.11 132.97 45.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.116 -0.99 . . . . 71.420000000000002 110.147 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.673 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -139.59 111.01 7.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 64.420000000000002 110.159 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -156.68 138.64 14.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 74.329999999999998 110.376 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -103.56 145.96 29.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.291 -0.88 . . . . 62.549999999999997 110.184 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.422 ' OE1' ' O ' ' A' ' 85' ' ' GLN . 0.6 OUTLIER -167.36 -169.71 1.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.097 -1.002 . . . . 71.109999999999999 110.233 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.422 ' O ' ' OE1' ' A' ' 84' ' ' GLU . 3.2 pt20 -105.65 143.09 34.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.232 -0.918 . . . . 65.299999999999997 110.289 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 87' ' ' GLU . . . 48.53 -173.7 0.04 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.549 -1.42 . . . . 74.219999999999999 109.549 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 86' ' ' GLY . 1.9 mt-10 42.91 54.19 4.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -1.158 . . . . 72.530000000000001 110.224 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.472 ' O ' HG23 ' A' ' 89' ' ' THR . 6.2 mt-10 -69.76 143.66 52.95 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 64.5 110.174 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -158.15 134.86 6.56 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.143 -0.973 . . . . 73.439999999999998 110.258 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.687 0 O-C-N 124.0 1.527 . . . . 70.239999999999995 110.412 -179.96 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.29 0.567 . . . . 63.039999999999999 110.253 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' B' ' 3' ' ' LEU . 2.0 ptpt -145.58 -41.39 0.22 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 72.129999999999995 110.234 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.965 HD21 ' HB3' ' B' ' 7' ' ' SER . 2.6 tt -94.34 116.25 28.6 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.211 -0.93 . . . . 73.519999999999996 110.118 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.09 30.49 2.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.267 -0.896 . . . . 75.510000000000005 110.117 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 -63.81 0.17 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 62.350000000000001 110.22 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.1 OUTLIER -48.57 -23.76 1.1 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -0.923 . . . . 74.129999999999995 110.253 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.965 ' HB3' HD21 ' B' ' 3' ' ' LEU . 0.1 OUTLIER -80.05 -35.74 36.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 72.5 109.731 179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.438 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.7 t80 -80.61 -41.53 23.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 64.209999999999994 109.763 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.2 ttp -67.93 -47.52 68.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.16 -0.962 . . . . 64.239999999999995 110.031 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.822 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -55.94 -31.67 63.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 71.129999999999995 110.107 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.19 90.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.173 -0.954 . . . . 34.520000000000003 110.101 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.1 m-20 -82.52 -39.32 22.56 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 75.310000000000002 110.05 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.7 81.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 72.409999999999997 110.255 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.822 HG22 ' O ' ' B' ' 10' ' ' LYS . 28.1 m -59.44 -30.93 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 71.219999999999999 110.154 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.03 -32.53 74.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 61.109999999999999 110.047 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.83 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -93.77 -13.95 26.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.333 -0.855 . . . . 73.319999999999993 110.022 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.722 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.1 -21.27 13.93 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.226 -0.921 . . . . 75.549999999999997 110.077 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' B' ' 24' ' ' SER . . . -84.45 -51.07 7.21 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.176 -0.952 . . . . 62.340000000000003 110.061 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.79 -10.52 59.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.925 . . . . 53.310000000000002 110.062 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.08 -52.74 2.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 51.350000000000001 110.106 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.7 13.56 12.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 40.219999999999999 110.183 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.7 22.63 40.86 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.579 -1.408 . . . . 63.020000000000003 109.579 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.568 HD13 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -70.04 -163.14 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -1.163 . . . . 64.319999999999993 110.215 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.449 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 0.5 OUTLIER -79.48 162.26 25.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 71.439999999999998 110.172 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.718 HG23 ' O ' ' B' ' 25' ' ' VAL . 20.8 m -112.16 71.74 1.11 Allowed Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.203 -0.936 . . . . 63.530000000000001 110.244 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.726 ' HG2' HG21 ' B' ' 14' ' ' VAL . 44.8 Cg_endo -72.48 -89.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.942 1.496 . . . . 71.430000000000007 110.562 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' B' ' 29' ' ' ALA . . . -43.35 -26.61 0.63 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.732 -1.347 . . . . 73.120000000000005 109.732 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' B' ' 25' ' ' VAL . 63.8 t -42.39 -26.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -1.071 . . . . 71.409999999999997 110.297 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' B' ' 27' ' ' GLY . . . -111.3 -39.2 4.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 75.219999999999999 110.232 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 57.23 46.02 19.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.282 -0.886 . . . . 64.400000000000006 110.249 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -84.96 -1.37 56.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 52.130000000000003 110.256 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' B' ' 34' ' ' GLY . 3.5 t 64.19 11.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.237 -0.915 . . . . 62.409999999999997 110.054 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' B' ' 32' ' ' VAL . 3.9 t 65.11 -66.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.603 -0.686 . . . . 61.109999999999999 110.265 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -171.73 69.16 0.12 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.493 -1.443 . . . . 63.210000000000001 109.493 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.413 ' C ' ' O ' ' B' ' 34' ' ' GLY . 10.7 tp60 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.24 -1.153 . . . . 64.319999999999993 110.195 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.6 -1.4 . . . . 73.040000000000006 109.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.04 -39.2 3.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.395 -1.062 . . . . 64.540000000000006 110.234 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' A' ' 4' ' ' MET . 60.9 m-70 -118.97 120.68 37.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.319 -0.863 . . . . 75.409999999999997 110.148 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.416 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 178.65 84.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 62.219999999999999 110.307 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.402 ' CD2' ' H ' ' A' ' 5' ' ' HIS . 11.8 p80 -114.37 116.26 28.64 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.895 . . . . 75.310000000000002 110.194 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.8 m -167.34 125.96 1.32 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.303 -0.873 . . . . 60.530000000000001 110.175 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 83' ' ' GLU . 32.6 m120 -142.22 146.45 35.21 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 72.299999999999997 110.23 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -103.94 -69.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.885 . . . . 75.400000000000006 109.97 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 55' ' ' ASP . 2.1 mt-30 -152.96 121.56 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.885 . . . . 63.229999999999997 109.995 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.6 p -158.39 142.52 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 62.219999999999999 110.288 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.1 p -140.54 171.93 13.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.384 -0.822 . . . . 71.420000000000002 109.976 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.687 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 p -104.08 117.5 34.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 73.340000000000003 110.012 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 77' ' ' LEU . 2.9 mp -100.79 140.37 35.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.156 -0.965 . . . . 65.230000000000004 110.495 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.759 HG22 HD12 ' A' ' 48' ' ' ILE . 99.1 t -98.87 100.42 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.403 -0.81 . . . . 74.010000000000005 109.921 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.428 HG23 HG12 ' A' ' 49' ' ' VAL . 11.8 t -77.71 120.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 61.219999999999999 110.367 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -102.22 109.88 21.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.85 . . . . 62.439999999999998 110.046 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.78 168.83 18.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.26 -0.9 . . . . 75.400000000000006 109.891 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.32 148.27 0.32 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.345 -0.847 . . . . 71.420000000000002 109.727 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -48.56 -47.2 39.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -0.888 . . . . 75.140000000000001 110.986 -179.283 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -92.14 -5.31 52.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.778 -1.201 . . . . 73.219999999999999 110.531 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.8 mmm180 -74.8 -50.71 16.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.124 -1.065 . . . . 74.519999999999996 108.124 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.69 -40.77 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 120.234 -0.586 . . . . 74.409999999999997 110.858 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.541 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.1 OUTLIER -52.49 -40.38 62.31 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 120.613 -1.304 . . . . 41.210000000000001 108.484 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 89.4 m-20 -71.98 -58.86 3.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.494 -0.754 . . . . 74.040000000000006 111.009 179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.815 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.22 -49.22 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.404 -0.81 . . . . 65.549999999999997 111.403 -178.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.855 ' CB ' HD12 ' A' ' 47' ' ' LEU . 4.6 t -52.11 -52.7 49.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.793 -1.192 . . . . 64.420000000000002 110.055 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -55.21 -33.38 63.0 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.117 -0.99 . . . . 71.200000000000003 109.894 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.46 -44.45 97.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.367 -0.833 . . . . 72.340000000000003 109.826 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.32 -35.98 40.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 62.439999999999998 110.018 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 37' ' ' VAL . 1.0 OUTLIER -68.39 -25.99 65.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.119 -0.988 . . . . 61.420000000000002 110.111 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.15 61.78 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.134 -0.978 . . . . 54.0 110.139 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -75.31 151.14 85.51 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.87 . . . . 72.129999999999995 110.241 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.33 -55.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.995 1.524 . . . . 64.209999999999994 110.481 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.85 -60.73 7.94 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.523 -1.431 . . . . 74.230000000000004 109.523 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -74.63 149.8 39.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -1.183 . . . . 74.329999999999998 110.34 -179.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -159.52 130.7 6.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 53.130000000000003 110.241 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 90.0 t -68.94 126.86 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.328 -0.858 . . . . 71.450000000000003 110.356 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.516 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -91.34 -57.88 2.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 72.129999999999995 110.231 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.634 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.0 t -123.44 121.28 62.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 71.120000000000005 109.651 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.3 103.76 13.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.145 -0.972 . . . . 63.240000000000002 110.457 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.634 ' OD1' HG12 ' A' ' 39' ' ' VAL . 2.0 m-20 -133.32 148.62 51.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.473 -0.767 . . . . 74.129999999999995 109.873 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -110.95 52.4 0.32 Allowed Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.26 -0.9 . . . . 72.209999999999994 111.682 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -71.77 -40.09 2.99 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.55 1.29 . . . . 73.150000000000006 109.584 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.17 12.56 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.488 -0.757 . . . . 55.520000000000003 110.011 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 90.92 31.8 9.63 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.772 -1.331 . . . . 64.310000000000002 109.772 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.549 ' O ' HD23 ' A' ' 47' ' ' LEU . 24.0 pt20 -130.4 130.82 44.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.148 -1.207 . . . . 73.209999999999994 110.616 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.855 HD12 ' CB ' ' A' ' 26' ' ' SER . 30.4 mt -121.3 160.09 24.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 61.530000000000001 109.97 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.759 HD12 HG22 ' A' ' 14' ' ' VAL . 1.4 mm -98.01 128.78 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 63.43 110.206 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 29' ' ' LEU . 13.6 p -130.06 126.94 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 71.040000000000006 110.188 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.687 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -102.2 146.74 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 53.240000000000002 110.314 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 13' ' ' LEU . 12.8 p -140.99 138.04 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 70.099999999999994 110.141 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 5.8 pm0 -118.48 147.7 43.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 70.140000000000001 110.316 -179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.66 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -156.72 173.68 16.6 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 71.319999999999993 110.073 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -45.65 -46.71 14.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 74.420000000000002 110.205 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 35.8 p-10 -155.34 -170.37 3.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 70.319999999999993 110.181 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.4 m -63.5 -36.95 85.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 61.539999999999999 110.175 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' O ' HG12 ' A' ' 60' ' ' ILE . 51.9 tp10 -49.11 -44.93 42.75 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.198 -0.939 . . . . 54.439999999999998 110.259 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.66 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 12.8 m -78.82 -33.69 45.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.209 -0.932 . . . . 73.25 110.298 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.4 OUTLIER -62.34 -44.21 97.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.259 -0.9 . . . . 53.119999999999997 110.213 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.761 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.5 pt -66.59 -28.89 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 74.239999999999995 109.523 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.454 ' N ' HG13 ' A' ' 60' ' ' ILE . 15.6 tt0 -52.84 -45.25 67.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.323 -0.86 . . . . 74.120000000000005 109.869 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 65' ' ' SER . 40.7 m -56.58 -41.53 77.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 75.430000000000007 110.669 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.761 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.9 tp -49.61 -36.61 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.223 -0.923 . . . . 75.099999999999994 110.12 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.58 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 78.6 mt-10 -52.63 -33.62 47.58 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.15 -0.969 . . . . 65.030000000000001 109.847 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.975 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -69.17 -55.73 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.429 -0.795 . . . . 51.520000000000003 110.208 179.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.623 HG21 HD12 ' A' ' 63' ' ' ILE . 28.5 m -67.47 -42.78 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.421 -0.8 . . . . 54.420000000000002 111.045 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -64.37 -40.38 95.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.169 -0.957 . . . . 64.209999999999994 110.592 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.585 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 7.1 t-20 -76.0 -20.56 57.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.018 -1.051 . . . . 75.040000000000006 110.675 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 65' ' ' SER . 40.9 t -67.63 122.34 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 71.340000000000003 109.78 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.45 -48.32 77.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 60.32 110.79 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.62 -32.93 5.91 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.532 -1.427 . . . . 33.329999999999998 109.532 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.558 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.8 t -80.44 116.89 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.286 -1.126 . . . . 45.100000000000001 110.454 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.809 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.1 -23.18 14.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 71.230000000000004 110.241 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -148.37 173.57 12.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 54.520000000000003 110.198 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.675 HG13 ' O ' ' A' ' 75' ' ' VAL . 8.6 p -162.48 118.51 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.252 -0.905 . . . . 64.530000000000001 110.282 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' B' ' 21' ' ' ALA . 0.2 OUTLIER -123.36 101.19 7.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 52.310000000000002 110.042 179.912 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 13' ' ' LEU . 0.7 OUTLIER -111.38 105.2 13.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.187 -0.945 . . . . 72.340000000000003 110.39 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 41.6 t -142.59 92.5 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 72.010000000000005 110.181 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.555 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 54.9 t80 179.08 117.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.894 . . . . 73.129999999999995 110.307 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -93.59 136.59 33.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.218 -0.926 . . . . 72.120000000000005 110.237 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.598 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -138.6 112.27 8.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.28 -0.888 . . . . 72.140000000000001 110.388 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -153.08 138.84 17.93 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.202 -0.936 . . . . 70.420000000000002 110.234 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 44.6 mt-10 -96.36 136.72 36.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.265 -0.897 . . . . 63.350000000000001 110.234 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -165.52 -172.67 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 71.519999999999996 110.187 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -57.37 163.56 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 72.030000000000001 110.218 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.44 139.97 2.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.619 -1.392 . . . . 73.319999999999993 109.619 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.64 55.67 1.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -1.113 . . . . 75.340000000000003 110.285 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 90' ' ' PRO . 4.9 pt-20 -106.46 -164.39 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.324 -0.86 . . . . 65.25 110.23 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.2 110.09 30.58 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.382 -0.824 . . . . 73.329999999999998 110.177 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 88' ' ' GLU . 46.0 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 123.933 1.491 . . . . 70.439999999999998 110.433 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.267 0.556 . . . . 73.150000000000006 110.222 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 45.45 85.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 74.329999999999998 110.218 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.67 -53.59 4.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 73.030000000000001 110.158 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 23.7 p -176.06 -63.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.348 -0.845 . . . . 64.329999999999998 110.312 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.481 ' C ' ' CD ' ' B' ' 5' ' ' ARG . 0.0 OUTLIER -163.49 -38.52 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.339 -0.851 . . . . 73.109999999999999 110.245 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.7 OUTLIER -69.16 -20.48 64.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.298 -0.876 . . . . 71.420000000000002 110.145 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 31.2 t -78.79 -39.99 34.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 53.310000000000002 109.806 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.53 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.51 -41.18 24.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.304 -0.873 . . . . 65.430000000000007 109.853 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.48 -53.24 51.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.348 -0.845 . . . . 72.409999999999997 110.291 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.594 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.76 -33.45 10.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.912 . . . . 64.409999999999997 110.152 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -60.05 -44.97 94.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.314 -0.866 . . . . 71.329999999999998 110.084 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -82.81 -37.73 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 60.229999999999997 110.145 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.14 -48.64 75.85 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.269 -0.894 . . . . 64.140000000000001 110.275 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 10' ' ' LYS . 32.2 m -59.26 -32.23 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 62.520000000000003 110.154 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.807 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.19 -32.02 73.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.293 -0.879 . . . . 61.329999999999998 110.1 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.94 20.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.358 -0.838 . . . . 70.099999999999994 110.197 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -101.34 -24.37 14.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 65.409999999999997 110.102 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.439 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -82.8 -49.05 10.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -0.871 . . . . 61.409999999999997 110.126 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.56 -10.46 59.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.358 -0.839 . . . . 72.140000000000001 110.079 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.37 -52.61 2.74 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.373 -0.83 . . . . 54.43 110.1 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.23 14.18 13.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.308 -0.87 . . . . 53.439999999999998 110.096 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.61 27.9 55.49 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.515 -1.434 . . . . 61.409999999999997 109.515 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -69.96 -162.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -1.125 . . . . 75.400000000000006 110.461 -179.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 7.5 p -79.72 162.43 25.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.476 -0.765 . . . . 72.340000000000003 110.105 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.829 HG23 ' HB ' ' B' ' 28' ' ' VAL . 4.2 p -108.45 78.33 0.85 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 74.439999999999998 110.243 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.566 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.6 Cg_endo -72.66 -89.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.024 1.539 . . . . 71.200000000000003 110.534 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -80.47 -11.64 83.92 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.59 -1.404 . . . . 64.439999999999998 109.59 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.829 ' HB ' HG23 ' B' ' 25' ' ' VAL . 57.8 t -58.87 -17.12 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.195 -1.179 . . . . 75.129999999999995 110.131 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.07 -27.89 6.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 64.129999999999995 110.175 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -91.77 23.66 3.51 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.331 -0.855 . . . . 73.129999999999995 110.353 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -89.33 -2.04 58.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 72.219999999999999 110.274 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 33.6 m -112.16 -17.95 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.228 -0.92 . . . . 73.420000000000002 110.158 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.26 -72.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.343 -0.848 . . . . 74.040000000000006 110.256 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.29 153.24 14.87 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.52 -1.432 . . . . 73.400000000000006 109.52 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.227 -1.161 . . . . 72.430000000000007 110.242 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.499 -1.44 . . . . 74.420000000000002 109.499 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -93.27 70.7 4.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.228 -1.16 . . . . 73.230000000000004 110.159 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.73 146.13 42.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 73.140000000000001 110.241 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -166.16 70.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.209 -0.932 . . . . 53.439999999999998 110.206 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.44 ' CG ' ' O ' ' A' ' 5' ' ' HIS . 27.9 p80 -142.55 120.22 11.83 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 74.319999999999993 110.22 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.4 m -163.44 112.52 1.28 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.253 -0.904 . . . . 43.329999999999998 110.247 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -150.93 171.57 17.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 72.430000000000007 110.213 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -107.95 -74.37 0.66 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 75.439999999999998 110.24 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -162.44 125.96 2.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 63.450000000000003 110.196 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 52' ' ' GLU . 2.2 p -158.56 142.21 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.895 . . . . 74.219999999999999 110.233 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.842 ' SG ' HD11 ' A' ' 13' ' ' LEU . 26.9 p -142.74 170.97 14.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.372 -0.83 . . . . 62.210000000000001 110.188 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.713 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -105.48 114.56 28.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.193 -0.942 . . . . 72.109999999999999 110.212 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.842 HD11 ' SG ' ' A' ' 11' ' ' CYS . 5.5 mp -103.19 136.66 42.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 71.439999999999998 110.23 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.846 HG11 ' CB ' ' B' ' 21' ' ' ALA . 8.7 t -98.76 99.91 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.317 -0.864 . . . . 53.32 110.259 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 37.5 t -78.38 125.4 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 64.400000000000006 110.185 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 46' ' ' GLN . 2.0 tt0 -108.63 111.92 23.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 73.140000000000001 110.247 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.83 168.85 18.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 75.409999999999997 109.85 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.6 OUTLIER -41.98 146.57 0.27 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 64.230000000000004 109.883 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.34 -47.06 37.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -0.831 . . . . 75.129999999999995 111.185 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 -5.6 52.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.844 -1.16 . . . . 72.420000000000002 110.46 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 7.8 mmm180 -74.92 -49.96 18.46 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.063 -1.023 . . . . 73.120000000000005 108.347 177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -55.52 -40.42 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 110.909 -179.537 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.6 OUTLIER -52.61 -40.54 62.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.625 -1.297 . . . . 73.310000000000002 108.42 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.525 ' O ' HG22 ' A' ' 27' ' ' THR . 1.6 m-20 -72.28 -58.93 3.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.51 -0.744 . . . . 72.329999999999998 111.014 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.929 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.36 -49.39 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.499 -0.751 . . . . 63.310000000000002 111.467 -178.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.849 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.6 t -52.24 -52.55 51.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.684 -1.26 . . . . 72.430000000000007 110.013 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.7 t -54.3 -33.32 58.48 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.108 -0.995 . . . . 61.520000000000003 109.825 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -44.32 97.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 72.299999999999997 109.888 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.852 HD12 ' SG ' ' A' ' 35' ' ' CYS . 3.0 mm? -51.08 -31.77 20.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.788 . . . . 65.019999999999996 110.104 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.465 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 64.2 t-20 -75.36 -23.35 57.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.329 -0.857 . . . . 55.409999999999997 110.016 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.47 -28.17 61.8 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.258 -0.901 . . . . 51.350000000000001 110.219 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -78.21 153.78 79.62 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 72.120000000000005 110.234 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.4 -55.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.036 1.546 . . . . 73.409999999999997 110.352 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -58.98 11.68 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 73.299999999999997 109.478 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.852 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.82 144.1 37.33 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -1.104 . . . . 62.509999999999998 110.203 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 7.2 mm-40 -154.28 127.36 8.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.887 . . . . 44.340000000000003 110.239 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 94.9 t -72.34 120.43 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.287 -0.883 . . . . 64.540000000000006 110.351 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.9 -49.9 6.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 64.329999999999998 110.187 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.683 ' HB ' HD12 ' A' ' 48' ' ' ILE . 21.5 t -120.88 120.1 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 64.129999999999995 110.033 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.456 ' O ' ' OG ' ' A' ' 40' ' ' SER . 11.2 p -107.06 100.88 10.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.35 -0.844 . . . . 63.009999999999998 110.551 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' OD2' HG12 ' A' ' 39' ' ' VAL . 67.8 m-20 -133.37 147.86 51.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 73.439999999999998 110.07 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -115.07 49.84 0.59 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.316 -0.865 . . . . 61.229999999999997 111.404 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 47.3 Cg_endo -72.16 -44.06 0.96 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.613 1.323 . . . . 72.549999999999997 109.904 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m -126.77 -20.8 4.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 72.230000000000004 110.481 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 122.43 17.21 3.63 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.724 -1.35 . . . . 45.539999999999999 109.724 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.722 ' NE2' ' HB1' ' B' ' 21' ' ' ALA . 6.9 pt20 -126.7 137.83 53.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 60.43 110.187 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.849 HD12 ' CB ' ' A' ' 26' ' ' SER . 15.2 mt -115.88 158.95 22.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.157 -0.964 . . . . 74.450000000000003 110.22 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.836 HD11 ' CD2' ' B' ' 23' ' ' LEU . 37.2 mt -96.04 121.42 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.922 . . . . 61.020000000000003 110.212 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 29' ' ' LEU . 8.4 p -131.88 125.48 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 62.130000000000003 110.151 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG12 ' OG ' ' A' ' 12' ' ' SER . 14.2 m -98.81 143.88 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 64.150000000000006 110.147 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.466 HG13 ' HG ' ' A' ' 59' ' ' LEU . 8.8 p -133.45 142.57 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.157 -0.964 . . . . 62.509999999999998 110.241 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.527 ' HA ' HD11 ' A' ' 59' ' ' LEU . 11.4 pt-20 -125.6 147.56 49.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.27 -0.894 . . . . 73.319999999999993 110.256 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -157.42 179.69 9.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 75.010000000000005 110.182 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -45.69 -49.9 14.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 74.340000000000003 110.262 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -155.42 -168.1 2.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 70.420000000000002 110.232 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 t -63.79 -32.83 74.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.234 -0.916 . . . . 44.030000000000001 110.189 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.455 ' O ' HG12 ' A' ' 60' ' ' ILE . 17.0 tt0 -52.91 -45.86 67.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.847 . . . . 74.019999999999996 110.246 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.528 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 10.5 m -78.49 -32.64 48.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 72.519999999999996 110.116 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD11 ' HA ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -62.79 -44.45 96.14 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.321 -0.862 . . . . 60.439999999999998 110.24 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.744 ' O ' HG22 ' A' ' 63' ' ' ILE . 47.9 pt -66.75 -28.7 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -0.953 . . . . 64.510000000000005 109.563 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.463 ' N ' HG13 ' A' ' 60' ' ' ILE . 1.8 tt0 -52.6 -45.4 66.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.294 -0.879 . . . . 63.130000000000003 109.794 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.9 m -56.7 -41.57 77.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.293 -0.879 . . . . 62.439999999999998 110.626 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.744 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -50.22 -36.62 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.17 -0.956 . . . . 43.409999999999997 110.116 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.577 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 71.0 mt-10 -52.6 -33.26 45.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.933 -1.105 . . . . 64.200000000000003 109.723 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.964 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -68.93 -55.75 10.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 73.430000000000007 110.299 179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.55 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.0 m -65.66 -42.39 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.419 -0.801 . . . . 72.120000000000005 111.029 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -65.5 -40.54 93.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.149 -0.97 . . . . 75.25 110.457 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 14.1 t-20 -76.02 -20.61 57.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.134 -0.979 . . . . 72.450000000000003 110.607 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.964 HG23 ' O ' ' A' ' 65' ' ' SER . 38.7 t -67.36 127.28 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.058 -1.026 . . . . 60.340000000000003 110.076 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -62.94 -49.1 76.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.874 . . . . 73.299999999999997 110.624 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.36 -32.96 5.53 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.651 -1.38 . . . . 52.520000000000003 109.651 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG23 ' CG1' ' A' ' 69' ' ' VAL . 49.5 t -74.93 116.65 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.388 -1.066 . . . . 60.210000000000001 110.277 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -99.63 -19.43 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.199 -0.938 . . . . 75.239999999999995 110.198 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -152.02 173.75 14.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.231 -0.918 . . . . 51.210000000000001 110.275 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.1 p -157.86 118.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 54.32 110.175 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 14' ' ' VAL . 1.4 m -124.12 101.04 7.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.169 -0.957 . . . . 71.519999999999996 110.245 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -111.69 105.09 13.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.331 -0.856 . . . . 72.430000000000007 110.156 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.514 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 52.8 t -138.29 91.84 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.282 -0.886 . . . . 62.130000000000003 110.233 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 66.0 t80 -178.29 109.1 0.05 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.322 -0.861 . . . . 71.129999999999995 110.084 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -101.82 130.75 48.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.187 -0.946 . . . . 74.019999999999996 110.265 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -139.52 105.47 5.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 62.200000000000003 110.241 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' OE1' ' HA3' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -152.26 138.7 18.56 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 75.109999999999999 110.339 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.566 ' O ' ' N ' ' A' ' 85' ' ' GLN . 3.9 mm-40 -92.73 148.88 21.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 75.329999999999998 110.272 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 14.1 pt-20 32.67 29.9 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.108 0.48 . . . . 72.349999999999994 111.623 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.566 ' N ' ' O ' ' A' ' 83' ' ' GLU . 22.3 mt-30 -146.94 -178.53 6.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.238 -0.914 . . . . 73.129999999999995 110.267 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.452 ' HA3' ' OE1' ' A' ' 82' ' ' GLN . . . 76.6 -166.12 54.03 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.561 -1.416 . . . . 53.030000000000001 109.561 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -88.62 11.09 18.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.29 -1.123 . . . . 72.040000000000006 110.192 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -132.41 110.59 10.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.318 -0.864 . . . . 75.150000000000006 110.255 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 84' ' ' GLU . 5.1 m -166.19 137.53 2.93 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.252 -0.905 . . . . 75.299999999999997 110.131 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.305 -1.718 0 O-C-N 123.964 1.507 . . . . 64.400000000000006 110.454 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.359 0.599 . . . . 72.310000000000002 110.163 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -102.17 90.14 3.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 71.340000000000003 110.227 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -28.06 65.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 74.510000000000005 110.128 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.95 54.8 0.86 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.283 -0.886 . . . . 73.420000000000002 110.065 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.76 -68.73 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.237 -0.915 . . . . 74.430000000000007 110.223 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 1.4 ttt85 -52.51 -25.8 11.29 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.221 -0.924 . . . . 73.530000000000001 110.174 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.53 35.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.215 -0.928 . . . . 64.319999999999993 109.613 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.524 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -77.18 -38.42 51.7 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.34 -0.85 . . . . 65.510000000000005 109.597 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 5.2 ttp -64.75 -55.34 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.251 -0.906 . . . . 51.329999999999998 110.025 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.792 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -53.72 -35.79 61.57 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 73.439999999999998 109.998 179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -62.05 -42.52 99.27 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 75.430000000000007 109.927 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.463 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.3 m-20 -82.89 -41.48 18.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -0.869 . . . . 75.219999999999999 110.072 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.3 -47.61 75.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.298 -0.876 . . . . 64.099999999999994 110.173 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.792 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.7 m -58.51 -31.12 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.27 -0.894 . . . . 75.230000000000004 110.097 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.712 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.21 -31.97 73.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.87 . . . . 75.319999999999993 110.006 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.514 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -92.16 -13.98 29.8 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 74.25 109.985 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.733 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.07 -22.58 13.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.448 -0.782 . . . . 65.430000000000007 110.1 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.448 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -83.83 -51.18 7.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.858 . . . . 75.329999999999998 109.992 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.56 -9.48 58.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.17 -0.956 . . . . 64.140000000000001 110.044 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.07 -52.53 2.78 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.265 -0.897 . . . . 53.229999999999997 110.134 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.846 ' CB ' HG11 ' A' ' 14' ' ' VAL . . . -89.14 14.78 10.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.245 -0.909 . . . . 51.200000000000003 110.025 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.6 25.13 49.87 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.307 -1.517 . . . . 54.130000000000003 109.307 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.836 ' CD2' HD11 ' A' ' 48' ' ' ILE . 3.9 tp -69.11 -162.93 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -1.099 . . . . 73.239999999999995 110.396 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 41.7 t -83.13 162.2 21.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.447 -0.783 . . . . 74.409999999999997 110.351 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 25' ' ' VAL . 26.8 m -108.15 77.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 63.420000000000002 110.089 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.746 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.0 Cg_endo -72.45 -50.34 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.954 1.502 . . . . 72.200000000000003 110.448 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -153.4 34.89 0.76 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.441 -1.464 . . . . 74.209999999999994 109.441 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.712 HG22 ' HA ' ' B' ' 15' ' ' ALA . 86.8 t -49.44 -71.49 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.421 -1.046 . . . . 72.540000000000006 110.188 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' B' ' 28' ' ' VAL . . . 173.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.369 -0.832 . . . . 53.039999999999999 110.105 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -103.07 92.13 4.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 70.129999999999995 110.301 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.57 -23.14 7.22 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 64.530000000000001 110.194 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.762 HG23 HG23 ' B' ' 33' ' ' VAL . 15.3 m -78.87 -30.07 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 73.439999999999998 110.188 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.762 HG23 HG23 ' B' ' 32' ' ' VAL . 51.3 t -122.02 -60.08 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 72.010000000000005 110.174 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.82 -64.81 0.25 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.558 -1.417 . . . . 45.409999999999997 109.558 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.106 -1.232 . . . . 70.329999999999998 110.201 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.535 -1.426 . . . . 75.439999999999998 109.535 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.5 m -79.99 -89.31 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -1.19 . . . . 74.25 110.165 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.1 OUTLIER -86.19 63.8 8.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.183 -0.948 . . . . 61.450000000000003 110.202 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 4.7 tpp -178.76 100.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 73.349999999999994 110.365 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.661 ' O ' HG23 ' A' ' 6' ' ' THR . 18.5 p80 -114.13 119.64 37.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 75.319999999999993 110.2 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -166.96 126.44 1.45 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.223 -0.923 . . . . 75.150000000000006 110.1 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 10' ' ' VAL . 14.7 t-20 -142.24 158.24 43.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.902 . . . . 71.319999999999993 110.28 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -102.6 -69.54 0.79 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 72.439999999999998 110.069 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.429 ' NE2' ' NE2' ' A' ' 80' ' ' HIS . 1.0 OUTLIER -153.4 124.29 7.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 74.040000000000006 110.181 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.1 p -158.39 142.16 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.311 -0.868 . . . . 65.140000000000001 110.141 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 9.5 p -142.63 171.86 13.48 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 71.420000000000002 110.123 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -104.18 115.49 30.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 71.329999999999998 109.97 179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.848 HD23 ' CD2' ' A' ' 77' ' ' LEU . 1.6 mp -100.84 136.85 40.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 63.109999999999999 110.521 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.1 t -101.25 100.48 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.284 -0.885 . . . . 71.329999999999998 109.933 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.4 t -78.04 125.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 70.329999999999998 110.293 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.738 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -104.47 111.41 24.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 74.540000000000006 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.03 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.71 168.86 18.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -0.956 . . . . 74.430000000000007 109.959 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -43.61 148.13 0.37 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.087 -1.008 . . . . 71.129999999999995 109.602 179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.0 OUTLIER -48.44 -47.1 38.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.11 -0.994 . . . . 72.420000000000002 110.863 -179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.2 -5.23 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.787 -1.196 . . . . 73.109999999999999 110.456 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.547 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.61 -50.91 16.06 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.07 -1.085 . . . . 74.5 108.07 177.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.03 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.85 -40.99 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 115.905 -0.589 . . . . 75.109999999999999 110.777 -179.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.542 ' O ' ' CG2' ' A' ' 27' ' ' THR . 9.4 t -52.41 -40.41 62.1 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.638 -1.289 . . . . 74.510000000000005 108.413 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 27' ' ' THR . 0.6 OUTLIER -71.98 -59.03 2.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.468 -0.77 . . . . 53.119999999999997 111.087 179.17 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.879 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.27 -49.27 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 O-C-N 121.416 -0.802 . . . . 72.209999999999994 111.461 -178.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.82 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -52.31 -52.63 51.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.857 -1.152 . . . . 72.310000000000002 110.066 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.542 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -54.63 -33.33 60.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 73.450000000000003 110.039 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -61.8 -44.21 97.31 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 74.510000000000005 109.718 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.858 HD12 ' SG ' ' A' ' 35' ' ' CYS . 2.9 mm? -51.28 -35.27 36.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 63.109999999999999 110.041 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 20.9 t-20 -68.76 -26.44 65.23 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.279 -0.888 . . . . 64.200000000000003 110.02 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.38 -28.2 61.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.248 -0.907 . . . . 42.049999999999997 110.255 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.86 151.62 86.61 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.896 . . . . 72.129999999999995 110.229 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.14 -54.23 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.008 1.531 . . . . 73.349999999999994 110.461 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -62.65 -62.24 5.73 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.538 -1.425 . . . . 72.120000000000005 109.538 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.858 ' SG ' HD12 ' A' ' 29' ' ' LEU . 3.6 t -75.88 147.13 39.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -1.164 . . . . 73.430000000000007 110.223 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -159.67 130.83 5.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 75.109999999999999 110.126 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.5 t -72.8 120.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.18 -0.95 . . . . 73.299999999999997 110.257 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.65 6.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 54.530000000000001 109.949 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.66 HG12 ' OD1' ' A' ' 41' ' ' ASP . 10.6 t -120.46 120.58 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 72.230000000000004 109.958 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.455 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -106.74 102.31 11.69 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.35 -0.844 . . . . 51.200000000000003 110.36 -179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.66 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.5 m-20 -133.22 148.0 52.01 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.406 -0.809 . . . . 52.43 110.095 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.97 53.81 0.42 Allowed Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.321 -0.862 . . . . 65.430000000000007 111.319 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 46.6 Cg_endo -70.59 -39.19 5.14 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.682 1.359 . . . . 74.420000000000002 109.785 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.462 ' OG ' ' OE1' ' A' ' 46' ' ' GLN . 88.7 p -148.47 14.36 0.97 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.556 -0.715 . . . . 61.32 109.954 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.0 28.87 11.13 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.585 -1.406 . . . . 55.130000000000003 109.585 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' OE1' ' OG ' ' A' ' 44' ' ' SER . 6.1 pt20 -130.37 135.39 47.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.182 -1.187 . . . . 74.5 110.481 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.82 HD12 ' CB ' ' A' ' 26' ' ' SER . 70.0 mt -121.66 154.8 36.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.342 -0.849 . . . . 71.239999999999995 109.894 179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.598 HD11 HD13 ' B' ' 23' ' ' LEU . 24.3 mt -94.87 122.24 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 74.340000000000003 110.246 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.53 131.39 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 72.299999999999997 110.191 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.6 m -101.94 151.22 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.293 -0.879 . . . . 72.25 110.218 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.783 HG12 HD11 ' A' ' 13' ' ' LEU . 10.0 p -141.91 142.19 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 51.399999999999999 110.152 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -125.69 147.64 49.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.927 . . . . 51.340000000000003 110.223 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.864 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -158.85 176.28 12.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 60.210000000000001 110.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.62 -47.86 14.75 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 61.200000000000003 110.239 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -155.39 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 73.219999999999999 110.205 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.5 p -65.98 -36.95 84.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 74.519999999999996 110.188 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 60' ' ' ILE . 4.6 mt-10 -49.15 -48.14 45.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.33 -0.856 . . . . 72.510000000000005 110.218 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.864 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 m -75.29 -33.61 61.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -0.913 . . . . 71.340000000000003 110.208 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -61.71 -44.69 96.43 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.903 . . . . 73.120000000000005 110.128 179.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.739 ' O ' HG22 ' A' ' 63' ' ' ILE . 30.5 pt -66.43 -28.72 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 43.219999999999999 109.659 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.524 ' N ' HG13 ' A' ' 60' ' ' ILE . 35.1 tt0 -52.52 -45.37 66.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.399 -0.813 . . . . 72.030000000000001 109.871 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.456 ' O ' ' HB2' ' A' ' 65' ' ' SER . 38.8 m -56.93 -40.87 77.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 74.239999999999995 110.513 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.739 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.3 tt -49.06 -36.28 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.905 . . . . 64.129999999999995 110.453 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.8 pt-20 -52.23 -32.85 38.7 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.032 -1.042 . . . . 72.200000000000003 109.844 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.942 ' O ' HG23 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -69.12 -54.8 13.06 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.343 -0.848 . . . . 63.32 110.372 179.529 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.3 m -66.8 -42.1 88.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.398 -0.814 . . . . 73.140000000000001 111.148 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.6 OUTLIER -65.32 -40.6 93.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.042 -1.036 . . . . 72.349999999999994 110.51 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.491 ' N ' ' HD2' ' A' ' 67' ' ' ARG . 9.5 t30 -75.95 -20.55 57.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.992 -1.067 . . . . 73.5 110.439 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.942 HG23 ' O ' ' A' ' 65' ' ' SER . 33.0 t -69.07 119.61 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.104 -0.998 . . . . 75.420000000000002 109.849 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.07 -46.18 82.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.336 -0.852 . . . . 73.120000000000005 110.659 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -45.96 -32.98 4.93 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.543 -1.423 . . . . 61.439999999999998 109.543 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.536 HG23 ' CG1' ' A' ' 69' ' ' VAL . 43.7 t -78.32 115.79 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.246 -1.15 . . . . 44.530000000000001 110.371 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.697 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.88 -19.04 16.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 74.409999999999997 110.203 179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -147.15 173.7 12.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.3 -0.875 . . . . 74.219999999999999 110.142 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.2 p -157.46 119.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.257 -0.902 . . . . 53.420000000000002 110.334 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 m -126.92 95.73 4.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.314 -0.866 . . . . 41.439999999999998 109.833 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.848 ' CD2' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -114.99 97.74 6.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 62.0 110.518 -179.687 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 40.3 t -138.42 93.86 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.148 -0.97 . . . . 64.439999999999998 110.261 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' HA ' ' B' ' 13' ' ' ALA . 59.0 t80 -179.79 117.85 0.06 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 75.310000000000002 110.265 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.429 ' NE2' ' NE2' ' A' ' 9' ' ' GLN . 0.1 OUTLIER -93.55 136.72 33.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 73.400000000000006 110.147 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.629 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -133.21 112.26 11.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.95 . . . . 74.019999999999996 110.304 -179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' A' ' 81' ' ' GLN . 4.6 pt20 -151.68 138.7 19.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.217 -0.927 . . . . 61.109999999999999 110.287 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 83' ' ' GLU . 1.8 mp0 -78.1 119.55 21.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 52.439999999999998 110.264 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' O ' ' CG ' ' A' ' 85' ' ' GLN . 0.1 OUTLIER -172.51 28.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 62.329999999999998 110.264 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' GLU . 9.7 pt20 37.52 47.73 0.8 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.64 -0.663 . . . . 72.030000000000001 110.776 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -72.46 172.02 48.62 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.587 -1.405 . . . . 43.229999999999997 109.587 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -153.14 28.61 0.51 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.238 -1.154 . . . . 74.420000000000002 110.203 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -47.96 157.22 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 74.129999999999995 110.181 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 90' ' ' PRO . 0.2 OUTLIER -87.67 171.81 9.03 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 54.100000000000001 110.163 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 89' ' ' THR . 45.6 Cg_endo . . . . . 0 C--N 1.307 -1.656 0 O-C-N 124.105 1.582 . . . . 72.140000000000001 110.444 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.191 0.519 . . . . 74.510000000000005 110.276 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 22.84 8.67 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.299 -0.876 . . . . 72.340000000000003 110.161 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 19.0 tp -106.37 88.46 2.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 72.450000000000003 110.125 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 39.5 p -148.94 42.34 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.885 . . . . 75.120000000000005 110.197 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.0 -34.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 52.0 110.259 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -56.76 -20.65 23.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.909 . . . . 74.209999999999994 110.231 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.43 -39.27 32.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.32 -0.862 . . . . 52.200000000000003 109.735 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.535 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.55 -41.59 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.464 -0.772 . . . . 75.010000000000005 109.787 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.428 ' SD ' ' HG3' ' A' ' 81' ' ' GLN . 5.2 ttp -67.75 -47.65 68.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.891 . . . . 71.409999999999997 110.246 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.717 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.71 -28.16 5.69 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.852 . . . . 74.129999999999995 110.036 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -50.33 71.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.218 -0.926 . . . . 54.210000000000001 110.073 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.84 -35.58 26.21 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 74.049999999999997 110.22 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 79' ' ' TYR . . . -56.63 -48.18 78.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.206 -0.934 . . . . 65.310000000000002 110.189 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.717 HG22 ' O ' ' B' ' 10' ' ' LYS . 23.0 m -58.2 -32.81 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.128 -0.983 . . . . 74.120000000000005 110.182 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.23 -33.29 75.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.312 -0.868 . . . . 62.439999999999998 110.048 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -93.48 -13.93 27.3 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.915 . . . . 52.210000000000001 110.057 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.664 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.88 -21.81 15.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.879 . . . . 74.200000000000003 110.167 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.03 -52.43 5.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.266 -0.896 . . . . 44.229999999999997 110.1 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.33 -10.55 59.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.917 . . . . 63.119999999999997 110.193 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.9 -52.64 2.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.208 -0.932 . . . . 51.149999999999999 110.072 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -92.44 13.53 19.32 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.295 -0.878 . . . . 70.409999999999997 110.119 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.47 28.46 50.98 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.504 -1.438 . . . . 44.32 109.504 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.627 HD23 ' H ' ' B' ' 24' ' ' SER . 0.2 OUTLIER -68.23 -162.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -1.156 . . . . 62.0 110.277 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.627 ' H ' HD23 ' B' ' 23' ' ' LEU . 0.7 OUTLIER -82.47 162.25 22.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.425 -0.797 . . . . 31.440000000000001 110.359 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.856 HG23 ' HB ' ' B' ' 28' ' ' VAL . 6.8 p -107.4 83.31 1.46 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 55.5 110.22 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' B' ' 24' ' ' SER . 45.0 Cg_endo -71.8 -56.66 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.971 1.511 . . . . 71.230000000000004 110.533 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -138.2 36.24 1.94 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.514 -1.435 . . . . 62.210000000000001 109.514 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.856 ' HB ' HG23 ' B' ' 25' ' ' VAL . 57.8 t -64.35 -52.18 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.305 -1.115 . . . . 74.349999999999994 110.286 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.98 -1.48 4.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 74.109999999999999 110.279 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 46.93 37.3 4.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 72.140000000000001 110.119 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' B' ' 32' ' ' VAL . . . -75.26 -1.05 21.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 73.409999999999997 110.268 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 31' ' ' ALA . 4.9 t 64.36 9.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.315 -0.866 . . . . 73.040000000000006 110.298 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.633 HG22 ' H ' ' B' ' 34' ' ' GLY . 7.5 p -92.81 -179.83 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.426 -0.796 . . . . 71.409999999999997 110.061 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.633 ' H ' HG22 ' B' ' 33' ' ' VAL . . . -79.32 -98.44 0.27 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.496 -1.442 . . . . 52.130000000000003 109.496 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.248 -1.148 . . . . 74.140000000000001 110.246 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.602 -1.399 . . . . 62.340000000000003 109.602 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.58 128.75 42.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.196 . . . . 71.319999999999993 110.193 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' ND1' ' CD2' ' A' ' 5' ' ' HIS . 1.6 t-160 -109.7 -141.57 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.868 . . . . 74.510000000000005 110.176 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.19 71.01 0.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.267 -0.895 . . . . 74.540000000000006 110.167 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.519 ' CD2' ' ND1' ' A' ' 3' ' ' HIS . 94.0 m-70 -140.11 123.41 16.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.167 -0.958 . . . . 74.25 110.268 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.34 121.37 3.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.242 -0.911 . . . . 73.310000000000002 110.177 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -142.31 166.51 24.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.375 -0.828 . . . . 53.409999999999997 110.1 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -102.66 -79.85 0.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 74.420000000000002 110.125 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.508 ' OE1' ' N ' ' A' ' 56' ' ' SER . 4.0 mt-30 -163.76 129.07 2.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 74.150000000000006 110.267 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 81' ' ' GLN . 2.4 p -160.18 140.27 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 75.340000000000003 110.149 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 31.9 p -142.62 171.18 14.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.311 -0.868 . . . . 74.319999999999993 110.183 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.853 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -104.97 116.01 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 64.439999999999998 110.058 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.707 ' N ' HD12 ' A' ' 13' ' ' LEU . 4.7 mp -100.91 136.58 40.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.283 -0.886 . . . . 74.299999999999997 110.346 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 76' ' ' SER . 11.7 t -98.96 100.77 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 62.130000000000003 110.03 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.02 127.25 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 52.420000000000002 110.272 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.576 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 6.2 tt0 -108.04 112.04 24.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 71.129999999999995 110.147 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.036 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.91 168.8 18.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.291 -0.88 . . . . 54.140000000000001 109.879 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.16 149.2 0.23 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.911 . . . . 71.420000000000002 109.78 179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -47.22 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 74.310000000000002 111.018 -179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -91.9 -5.36 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.828 -1.149 . . . . 74.319999999999993 110.457 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.7 mmm180 -74.92 -51.21 14.37 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.154 -1.054 . . . . 73.140000000000001 108.154 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.036 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.94 -42.19 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 120.272 -0.571 . . . . 71.400000000000006 110.818 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.4 t -52.44 -40.33 62.1 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 118.427 -1.309 . . . . 60.25 108.399 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.495 ' O ' HG22 ' A' ' 27' ' ' THR . 0.8 OUTLIER -72.22 -59.04 2.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.482 -0.761 . . . . 63.530000000000001 111.048 179.074 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.779 HD13 HG11 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -79.36 -49.42 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.417 -0.802 . . . . 71.319999999999993 111.53 -178.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.797 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -51.95 -52.62 48.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.893 -1.13 . . . . 61.219999999999999 110.018 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.7 t -55.45 -33.63 63.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -0.974 . . . . 55.109999999999999 110.027 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.03 -43.69 98.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 74.040000000000006 110.089 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 29' ' ' LEU . 3.0 mm? -50.26 -25.87 4.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 73.129999999999995 109.658 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -68.35 -28.47 67.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.337 -0.852 . . . . 74.230000000000004 109.81 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 30' ' ' ASN . . . -73.83 -28.27 61.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.332 -0.855 . . . . 74.439999999999998 110.427 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.78 146.34 97.45 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.252 -0.905 . . . . 72.219999999999999 110.385 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.98 -53.84 0.13 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.099 1.578 . . . . 74.209999999999994 110.261 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -65.83 -58.47 9.05 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.353 -1.499 . . . . 63.240000000000002 109.353 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' HG21 ' A' ' 62' ' ' THR . 0.1 OUTLIER -77.79 142.49 38.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -1.109 . . . . 43.240000000000002 110.194 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.27 127.21 8.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.351 -0.843 . . . . 72.439999999999998 110.257 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 37' ' ' VAL . 33.3 m -62.63 120.12 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.289 -0.882 . . . . 62.420000000000002 110.267 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.407 ' HB2' HG13 ' A' ' 50' ' ' VAL . . . -94.78 -51.78 4.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 74.530000000000001 110.128 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.607 HG12 ' OD2' ' A' ' 41' ' ' ASP . 13.6 t -120.53 120.42 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.226 -0.921 . . . . 72.510000000000005 110.035 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -106.75 100.5 10.01 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.249 -0.907 . . . . 71.420000000000002 110.259 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.607 ' OD2' HG12 ' A' ' 39' ' ' VAL . 31.8 m-20 -133.24 148.09 51.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.363 -0.836 . . . . 75.439999999999998 110.155 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.424 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 53.69 0.41 Allowed Pre-proline 0 C--N 1.301 -1.542 0 O-C-N 121.301 -0.874 . . . . 61.109999999999999 111.291 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.95 -39.24 4.38 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 O-C-N 123.644 1.339 . . . . 63.299999999999997 109.84 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.1 12.08 1.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.861 . . . . 72.219999999999999 110.146 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.47 26.68 14.81 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 72.450000000000003 109.655 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' O ' HD23 ' A' ' 47' ' ' LEU . 14.8 pt20 -130.15 136.07 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -1.227 . . . . 75.129999999999995 110.353 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.797 HD12 ' CB ' ' A' ' 26' ' ' SER . 45.0 mt -120.16 159.75 24.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.318 -0.864 . . . . 65.549999999999997 110.22 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.767 HD11 HD22 ' B' ' 23' ' ' LEU . 13.6 mt -98.09 126.9 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -0.923 . . . . 63.240000000000002 110.202 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' O ' HG13 ' A' ' 49' ' ' VAL . 2.6 p -131.33 124.34 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 55.509999999999998 110.178 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.853 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.1 m -96.45 148.22 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 75.109999999999999 110.305 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.618 HG13 ' HG ' ' A' ' 59' ' ' LEU . 7.2 p -140.2 141.14 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 62.210000000000001 110.213 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.45 ' HA ' HD11 ' A' ' 59' ' ' LEU . 10.1 pt-20 -122.8 146.61 47.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 74.430000000000007 110.237 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.772 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -156.95 175.34 14.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 52.119999999999997 110.212 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -46.73 -46.55 20.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 63.43 110.174 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 57' ' ' GLU . 18.0 p30 -155.22 -171.81 3.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.174 -0.954 . . . . 64.319999999999993 110.225 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.508 ' N ' ' OE1' ' A' ' 9' ' ' GLN . 7.6 t -61.27 -40.02 92.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 51.200000000000003 110.17 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' O ' HG12 ' A' ' 60' ' ' ILE . 33.8 mt-10 -48.71 -47.53 41.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.225 -0.922 . . . . 74.340000000000003 110.197 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.636 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 6.7 m -74.67 -33.11 62.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 61.32 110.301 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.772 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.2 OUTLIER -65.07 -45.31 85.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.297 -0.877 . . . . 71.129999999999995 110.163 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.757 ' O ' HG22 ' A' ' 63' ' ' ILE . 48.0 pt -66.87 -28.81 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 74.310000000000002 109.589 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -52.4 -45.53 65.92 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.298 -0.876 . . . . 72.400000000000006 109.87 179.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.451 HG21 ' SG ' ' A' ' 35' ' ' CYS . 30.4 m -56.65 -41.22 76.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.35 -0.844 . . . . 70.299999999999997 110.516 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.4 tt -49.22 -36.32 9.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 74.340000000000003 110.378 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.0 pp20? -52.05 -32.62 35.34 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.05 -1.031 . . . . 73.239999999999995 109.83 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.972 ' O ' HG23 ' A' ' 69' ' ' VAL . 12.2 t -69.16 -55.43 10.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.321 -0.862 . . . . 74.049999999999997 110.536 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.537 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -65.87 -42.54 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 75.019999999999996 111.328 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -64.68 -40.81 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.989 -1.069 . . . . 73.530000000000001 110.313 -179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.496 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 49.4 t30 -75.62 -20.13 58.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.106 -0.996 . . . . 74.439999999999998 110.553 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.972 HG23 ' O ' ' A' ' 65' ' ' SER . 39.2 t -66.97 123.65 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.16 -0.963 . . . . 72.120000000000005 109.976 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -57.82 -49.26 77.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.217 -0.927 . . . . 64.340000000000003 110.58 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.529 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -47.21 -32.75 7.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.585 -1.406 . . . . 61.399999999999999 109.585 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' CG1' ' A' ' 69' ' ' VAL . 28.3 t -78.67 116.7 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.318 -1.107 . . . . 72.019999999999996 110.366 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.59 -20.97 15.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.871 . . . . 71.0 110.223 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -150.21 173.49 13.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 72.120000000000005 110.266 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.7 p -157.73 118.48 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 75.219999999999999 110.33 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -123.45 101.05 7.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.296 -0.877 . . . . 65.239999999999995 110.227 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.495 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.5 OUTLIER -111.6 104.95 13.37 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.108 -0.995 . . . . 70.040000000000006 110.306 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 36.0 t -138.34 92.64 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 71.349999999999994 110.256 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.511 ' CD2' ' HB2' ' A' ' 12' ' ' SER . 84.1 t80 -178.53 112.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.273 -0.892 . . . . 71.200000000000003 110.231 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' CE1' ' NE2' ' A' ' 82' ' ' GLN . 2.1 t-160 -94.55 136.58 34.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 75.409999999999997 110.21 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.681 ' HB3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -133.52 108.81 8.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 72.140000000000001 110.274 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.458 ' NE2' ' CE1' ' A' ' 80' ' ' HIS . 3.4 pt20 -161.4 138.71 8.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 72.420000000000002 110.21 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -99.95 118.71 36.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.885 . . . . 74.219999999999999 110.27 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 -155.14 0.45 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.503 -0.748 . . . . 70.230000000000004 110.166 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.8 49.81 2.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.144 -0.972 . . . . 64.099999999999994 110.163 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.04 154.01 11.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 65.510000000000005 109.528 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 88' ' ' GLU . 2.4 mm-40 -134.57 0.87 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -1.155 . . . . 54.329999999999998 110.281 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.831 ' O ' HG23 ' A' ' 89' ' ' THR . 60.7 mm-40 38.83 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.442 -0.786 . . . . 54.43 110.963 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.831 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 177.87 61.95 0.07 OUTLIER Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.907 . . . . 73.140000000000001 110.179 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo . . . . . 0 C--N 1.304 -1.764 0 O-C-N 123.985 1.519 . . . . 71.439999999999998 110.408 179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.32 0.581 . . . . 72.430000000000007 110.276 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -103.72 65.43 0.83 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.247 -0.908 . . . . 74.450000000000003 110.181 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.734 ' C ' HD12 ' B' ' 3' ' ' LEU . 3.3 pp -77.13 -28.88 54.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -0.908 . . . . 74.439999999999998 110.238 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.578 ' C ' HD12 ' B' ' 3' ' ' LEU . 0.9 OUTLIER 57.18 -85.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.229 -0.92 . . . . 64.420000000000002 110.19 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 3' ' ' LEU . 1.1 tmm_? -158.59 -37.24 0.06 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 74.420000000000002 110.289 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.3 OUTLIER -56.67 -22.14 32.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 64.230000000000004 110.093 -179.901 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' B' ' 3' ' ' LEU . 0.3 OUTLIER -78.08 -40.39 38.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.26 -0.9 . . . . 61.020000000000003 109.682 179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.539 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.8 OUTLIER -80.56 -41.49 24.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.455 -0.778 . . . . 61.409999999999997 109.694 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 14.7 ttp -66.74 -47.18 73.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.341 -0.849 . . . . 72.340000000000003 110.116 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.832 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -48.62 -32.28 7.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.964 . . . . 65.140000000000001 110.049 179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.466 ' HB1' ' HD2' ' B' ' 30' ' ' ARG . . . -60.2 -45.53 92.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 64.329999999999998 110.129 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.8 OUTLIER -82.85 -40.12 20.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 62.210000000000001 110.136 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.13 -47.71 77.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.315 -0.866 . . . . 52.020000000000003 110.23 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.832 HG22 ' O ' ' B' ' 10' ' ' LYS . 20.0 m -57.78 -31.24 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.227 -0.921 . . . . 73.219999999999999 110.124 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.15 -33.58 76.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 64.239999999999995 110.041 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.19 -13.94 23.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 61.530000000000001 110.068 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.713 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -97.97 -20.5 17.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 52.200000000000003 110.101 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -51.43 6.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 74.310000000000002 110.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.82 -10.47 59.61 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.892 . . . . 63.240000000000002 110.184 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -110.74 -52.74 2.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 52.340000000000003 110.192 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.86 13.46 14.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 63.439999999999998 110.221 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.37 28.26 49.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 53.229999999999997 109.598 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.767 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -69.89 -162.97 0.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 74.200000000000003 110.346 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.489 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 5.7 t -82.85 162.16 21.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.343 -0.848 . . . . 74.109999999999999 110.251 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.763 HG23 ' CG2' ' B' ' 28' ' ' VAL . 7.6 p -107.46 83.27 1.47 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 75.310000000000002 110.138 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.556 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.2 Cg_endo -71.73 -90.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.029 1.541 . . . . 71.310000000000002 110.518 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -117.2 52.16 0.7 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.648 -1.381 . . . . 74.439999999999998 109.648 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.763 ' CG2' HG23 ' B' ' 25' ' ' VAL . 51.7 t -43.93 -26.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.282 -1.128 . . . . 71.409999999999997 110.177 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.464 ' O ' ' HB3' ' B' ' 30' ' ' ARG . . . -91.64 -53.2 4.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 71.230000000000004 110.29 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.633 ' O ' ' HB3' ' B' ' 31' ' ' ALA . 15.5 ttt85 56.7 159.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.225 -0.922 . . . . 75.299999999999997 110.089 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' B' ' 30' ' ' ARG . . . 64.81 17.44 10.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.287 -0.883 . . . . 61.420000000000002 110.334 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 33' ' ' VAL . 61.4 t -71.51 -28.6 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 71.540000000000006 110.176 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' B' ' 32' ' ' VAL . 10.9 t 60.16 126.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 52.200000000000003 110.227 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -112.79 -147.24 10.07 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.566 -1.414 . . . . 62.310000000000002 109.566 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.289 -1.124 . . . . 72.140000000000001 110.205 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.302 0 N-CA-C 109.578 -1.409 . . . . 35.450000000000003 109.578 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -126.0 -45.34 1.72 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -1.148 . . . . 61.420000000000002 110.324 179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 2' ' ' SER . 21.4 t-80 60.06 143.38 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.251 -0.906 . . . . 71.129999999999995 110.237 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 5.8 tpp -177.33 73.87 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 73.209999999999994 110.196 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.487 ' HB3' ' HG3' ' A' ' 83' ' ' GLU . 82.8 m-70 -116.44 118.68 33.34 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 75.409999999999997 110.225 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 5' ' ' HIS . 14.0 m -166.83 121.4 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 74.099999999999994 110.192 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -152.22 163.34 39.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.229 -0.919 . . . . 62.520000000000003 110.339 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -109.2 -69.47 0.86 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.435 -0.791 . . . . 65.129999999999995 109.946 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -153.07 121.34 6.24 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 74.109999999999999 109.728 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 51' ' ' VAL . 2.6 p -168.99 142.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 72.120000000000005 110.181 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.885 ' SG ' HD11 ' A' ' 13' ' ' LEU . 5.0 p -135.86 171.5 14.37 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.379 -0.826 . . . . 64.310000000000002 110.069 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.942 ' C ' HD13 ' A' ' 13' ' ' LEU . 26.0 p -104.1 113.52 27.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 71.219999999999999 109.284 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.942 HD13 ' C ' ' A' ' 12' ' ' SER . 0.1 OUTLIER -106.07 136.58 45.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.587 -0.845 . . . . 72.310000000000002 110.37 -178.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.612 HG22 HG12 ' A' ' 48' ' ' ILE . 21.5 t -98.93 101.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.46 -0.775 . . . . 71.329999999999998 109.953 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 72.8 t -77.84 129.03 37.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 74.5 110.25 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.661 ' HG2' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -106.69 112.36 25.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 74.209999999999994 110.154 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.82 169.21 18.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.354 -0.841 . . . . 55.210000000000001 109.821 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -41.41 146.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.304 -0.872 . . . . 62.409999999999997 109.843 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.14 -47.29 45.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -0.864 . . . . 70.530000000000001 111.178 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.05 -5.47 52.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.796 -1.19 . . . . 72.329999999999998 110.571 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 8.6 mmm180 -75.1 -50.5 16.17 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.033 -1.042 . . . . 71.530000000000001 108.249 177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.57 -41.21 63.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 115.964 -0.562 . . . . 71.310000000000002 110.905 -179.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.3 OUTLIER -52.5 -40.32 62.26 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.343 -1.343 . . . . 52.140000000000001 108.393 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.531 ' HB2' ' NH2' ' A' ' 21' ' ' ARG . 39.1 m-20 -72.15 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.673 -0.642 . . . . 73.420000000000002 111.164 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.973 HD13 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.6 -49.02 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.459 -0.776 . . . . 64.200000000000003 111.412 -178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.774 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.8 t -52.06 -52.74 49.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.736 -1.227 . . . . 75.349999999999994 109.855 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.1 t -54.92 -33.24 61.98 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.168 -0.957 . . . . 73.219999999999999 109.832 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.4 -44.12 97.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.483 -0.76 . . . . 75.540000000000006 109.904 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.828 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.19 -28.52 11.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -0.872 . . . . 73.430000000000007 109.998 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' HB2' ' CG2' ' A' ' 37' ' ' VAL . 19.3 t30 -78.61 -21.25 48.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 25.23 110.206 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.26 -28.13 61.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 54.399999999999999 110.385 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.583 ' CG ' ' HD2' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -77.83 152.93 80.46 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.168 -0.958 . . . . 72.420000000000002 110.176 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 32' ' ' PHE . 46.0 Cg_endo -73.06 -49.95 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 75.430000000000007 110.399 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -64.21 -60.14 7.54 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.453 -1.459 . . . . 54.229999999999997 109.453 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.7 t -77.71 143.63 37.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.268 -1.136 . . . . 73.519999999999996 110.296 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 8.0 mt-10 -155.19 128.56 8.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.226 -0.921 . . . . 75.510000000000005 110.279 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 30' ' ' ASN . 64.9 t -70.11 120.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.247 -0.908 . . . . 63.32 110.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -51.09 5.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 52.439999999999998 110.24 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 ' OD1' ' A' ' 41' ' ' ASP . 16.1 t -121.15 120.38 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.197 -0.939 . . . . 73.120000000000005 110.025 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.461 ' O ' ' OG ' ' A' ' 40' ' ' SER . 8.8 p -106.73 103.46 12.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 74.239999999999995 110.218 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.676 ' OD1' HG12 ' A' ' 39' ' ' VAL . 4.8 m-20 -133.43 148.17 51.76 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.417 -0.802 . . . . 43.229999999999997 110.094 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.08 54.43 0.44 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.495 -0.753 . . . . 54.539999999999999 111.101 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.4 Cg_endo -70.67 -39.03 5.11 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.692 1.364 . . . . 62.450000000000003 109.791 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 m -149.85 14.98 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.461 -0.775 . . . . 40.140000000000001 110.151 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.87 28.92 10.36 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.567 -1.413 . . . . 42.5 109.567 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' HD23 ' A' ' 47' ' ' LEU . 3.7 pt20 -130.38 137.63 49.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.233 -1.157 . . . . 72.329999999999998 110.33 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.774 HD12 ' CB ' ' A' ' 26' ' ' SER . 68.4 mt -124.25 159.75 29.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 55.240000000000002 110.124 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.883 HD11 HD22 ' B' ' 23' ' ' LEU . 13.3 mt -100.03 123.55 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.107 -0.995 . . . . 74.430000000000007 110.162 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.828 HG21 ' HB3' ' A' ' 29' ' ' LEU . 4.4 p -134.55 124.96 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 74.420000000000002 110.269 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.738 HG12 ' HA ' ' A' ' 12' ' ' SER . 4.0 m -98.5 143.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 64.420000000000002 110.203 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.6 p -131.8 137.06 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.33 -0.856 . . . . 72.409999999999997 110.246 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' CB ' ' HB ' ' A' ' 10' ' ' VAL . 3.8 pt-20 -118.55 145.29 45.47 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 65.510000000000005 110.211 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.8 ' HB3' HD12 ' A' ' 59' ' ' LEU . . . -154.19 176.82 11.8 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.912 . . . . 53.299999999999997 110.25 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -48.82 -45.72 40.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.902 . . . . 63.5 110.294 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -155.38 -172.63 4.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.119 -0.988 . . . . 63.030000000000001 110.204 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.72 -41.0 94.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 74.340000000000003 110.155 179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.476 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.3 mt-10 -48.49 -46.87 38.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 73.209999999999994 110.181 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.796 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -74.65 -33.72 62.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.85 . . . . 54.530000000000001 110.252 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.8 HD12 ' HB3' ' A' ' 53' ' ' ALA . 0.1 OUTLIER -65.72 -44.35 86.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.188 -0.945 . . . . 61.119999999999997 110.197 179.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 63' ' ' ILE . 40.0 pt -66.43 -28.46 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 74.340000000000003 109.669 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -52.42 -45.56 65.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.426 -0.796 . . . . 72.0 109.747 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 33.6 m -56.68 -41.58 77.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.311 -0.868 . . . . 74.140000000000001 110.474 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 60' ' ' ILE . 1.9 tt -49.68 -36.68 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.222 -0.924 . . . . 60.32 110.163 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 23.1 mt-10 -52.35 -33.13 41.52 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.099 -1.0 . . . . 72.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 69' ' ' VAL . 69.5 m -68.9 -55.69 10.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.201 -0.937 . . . . 53.420000000000002 110.365 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.8 m -65.4 -42.25 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.375 -0.828 . . . . 73.430000000000007 111.017 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.587 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -66.09 -40.8 91.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 74.010000000000005 110.538 -179.758 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.583 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.6 t-20 -76.13 -20.45 57.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 73.510000000000005 110.66 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.973 HG11 HD13 ' A' ' 25' ' ' ILE . 38.1 t -69.49 121.32 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.906 -1.121 . . . . 63.149999999999999 109.988 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -57.31 -46.21 83.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.932 . . . . 51.439999999999998 110.526 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' ALA . . . -46.32 -32.89 5.44 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.699 -1.36 . . . . 55.32 109.699 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG23 ' CG1' ' A' ' 69' ' ' VAL . 47.5 t -75.5 110.66 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 74.319999999999993 110.415 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' HG ' ' N ' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -93.79 -19.47 21.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.267 -0.896 . . . . 71.409999999999997 109.972 179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.661 ' HB3' ' HG2' ' A' ' 16' ' ' GLN . . . -152.01 173.54 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.472 -0.767 . . . . 60.020000000000003 110.047 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 75' ' ' VAL . 7.2 p -158.81 116.34 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.187 -0.946 . . . . 54.420000000000002 110.393 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 70.5 m -119.45 90.94 3.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.255 -0.903 . . . . 75.109999999999999 110.025 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.865 ' HB2' HD12 ' A' ' 13' ' ' LEU . 2.0 pp -107.02 105.05 14.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.234 -0.916 . . . . 61.25 110.256 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 42.0 t -145.97 94.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.213 -0.929 . . . . 62.219999999999999 110.424 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.56 ' CD2' ' OG ' ' A' ' 12' ' ' SER . 86.1 t80 -177.85 107.41 0.05 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.351 -0.843 . . . . 74.439999999999998 110.188 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.5 132.56 36.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.112 -0.993 . . . . 72.5 110.327 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.528 ' HG2' ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -139.43 111.32 7.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 72.349999999999994 110.234 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -154.9 138.7 16.2 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -0.916 . . . . 72.230000000000004 110.321 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 5' ' ' HIS . 4.9 tm-20 -83.93 148.79 26.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 74.340000000000003 110.216 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -170.42 -101.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -0.87 . . . . 73.209999999999994 110.184 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -108.76 58.31 0.61 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.886 -1.134 . . . . 63.0 110.15 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 64.48 135.24 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.456 -1.458 . . . . 33.450000000000003 109.456 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.38 42.04 1.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.257 -1.143 . . . . 53.509999999999998 110.271 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' O ' HG23 ' A' ' 89' ' ' THR . 7.9 pt-20 -111.21 135.01 52.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 72.109999999999999 110.184 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -157.05 58.42 1.56 Allowed Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.231 -0.918 . . . . 64.109999999999999 110.204 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 C--N 1.305 -1.743 0 O-C-N 124.004 1.528 . . . . 54.100000000000001 110.366 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.437 ' HB2' ' HB2' ' B' ' 4' ' ' SER . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.236 0.541 . . . . 72.530000000000001 110.343 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mtmt -66.53 -46.68 75.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.146 -0.971 . . . . 72.140000000000001 110.156 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.705 ' H ' HD12 ' B' ' 3' ' ' LEU . 0.5 OUTLIER -96.62 -63.46 1.14 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 63.399999999999999 109.78 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' B' ' 1' ' ' MET . 10.0 t 59.3 19.84 8.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.346 -0.846 . . . . 70.239999999999995 110.253 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 6' ' ' ARG . 1.6 tpt180 -153.53 -72.59 0.13 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.218 -0.926 . . . . 61.5 110.273 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 3.6 ttt85 -57.13 -29.78 63.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 75.209999999999994 110.214 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 7.8 t -75.12 -41.25 58.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 74.319999999999993 109.66 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.518 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.6 OUTLIER -80.58 -37.61 30.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.455 -0.778 . . . . 73.030000000000001 109.749 179.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.409 ' HE1' HG11 ' A' ' 50' ' ' VAL . 6.2 ttp -67.35 -55.62 13.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.222 -0.924 . . . . 63.549999999999997 110.194 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.688 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -54.46 -27.87 40.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -0.901 . . . . 72.439999999999998 110.138 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.61 -47.8 71.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 24.43 110.159 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.474 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.7 OUTLIER -82.78 -40.09 20.93 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.147 -0.971 . . . . 72.239999999999995 110.121 -179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -54.59 -48.45 72.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 31.5 110.214 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.688 HG22 ' O ' ' B' ' 10' ' ' LYS . 27.5 m -59.04 -33.69 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.104 -0.997 . . . . 71.510000000000005 110.164 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.405 ' N ' HG23 ' B' ' 14' ' ' VAL . . . -65.6 -31.98 73.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.303 -0.873 . . . . 63.539999999999999 110.095 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.05 -9.59 25.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.348 -0.845 . . . . 61.539999999999999 110.066 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.69 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.22 -23.55 13.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.199 -0.938 . . . . 63.399999999999999 110.178 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.4 ' HA ' ' CB ' ' B' ' 23' ' ' LEU . . . -87.95 -47.67 8.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 72.140000000000001 110.196 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.19 -10.49 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 71.329999999999998 110.215 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.32 -52.86 2.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 45.039999999999999 110.18 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -89.16 13.52 13.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -0.931 . . . . 41.399999999999999 110.237 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.49 25.79 50.5 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.632 -1.387 . . . . 70.340000000000003 109.632 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -64.39 -162.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 63.509999999999998 110.322 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 0.6 OUTLIER -81.91 162.14 22.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.41 -0.806 . . . . 62.420000000000002 110.23 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 25' ' ' VAL . 15.9 m -107.81 82.86 1.5 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.288 -0.883 . . . . 74.420000000000002 110.182 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' B' ' 24' ' ' SER . 44.9 Cg_endo -71.89 -90.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.124 1.592 . . . . 71.420000000000002 110.464 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.05 38.76 3.18 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.58 -1.408 . . . . 74.400000000000006 109.58 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 92.1 t -90.43 -71.15 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -1.151 . . . . 51.509999999999998 110.308 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' B' ' 30' ' ' ARG . . . -165.91 73.98 0.19 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 71.019999999999996 110.217 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' B' ' 29' ' ' ALA . 0.0 OUTLIER 178.48 -69.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.231 -0.918 . . . . 52.409999999999997 110.336 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.0 59.14 4.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.536 -0.728 . . . . 71.5 110.185 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -119.87 -41.58 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 72.319999999999993 110.254 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 p -141.69 127.63 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.24 -0.913 . . . . 72.25 110.209 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 48.82 -118.46 4.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.507 -1.437 . . . . 75.239999999999995 109.507 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.199 -1.177 . . . . 73.239999999999995 110.222 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.616 -1.394 . . . . 70.129999999999995 109.616 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 1.7 p -133.82 70.09 1.46 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.217 -1.166 . . . . 53.229999999999997 110.28 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 2' ' ' SER . 2.1 t60 178.25 72.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.279 -0.888 . . . . 74.239999999999995 110.198 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 3' ' ' HIS . 10.9 ttm -178.71 70.46 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 52.149999999999999 110.263 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.521 ' O ' HG23 ' A' ' 6' ' ' THR . 52.4 m-70 -115.3 116.26 28.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -0.915 . . . . 62.32 110.237 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 5' ' ' HIS . 0.0 OUTLIER -167.25 119.78 0.94 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 61.030000000000001 110.073 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.51 ' ND2' HG12 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -152.29 165.46 34.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 74.239999999999995 110.495 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.506 ' O ' ' NE2' ' A' ' 85' ' ' GLN . 92.9 m95 -104.98 -69.49 0.81 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.424 -0.798 . . . . 74.439999999999998 109.954 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.02 121.65 6.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.203 -0.935 . . . . 74.310000000000002 109.989 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.54 ' CG1' ' NE2' ' A' ' 81' ' ' GLN . 2.6 p -168.59 142.55 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.28 -0.888 . . . . 74.439999999999998 110.284 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 30.0 p -132.28 171.62 13.48 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 70.519999999999996 109.992 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.768 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -104.43 114.31 28.46 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.231 -0.918 . . . . 71.310000000000002 110.03 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.747 HD11 HG12 ' A' ' 51' ' ' VAL . 4.1 mp -100.84 134.87 43.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 63.43 110.386 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.675 HG11 ' HB1' ' B' ' 21' ' ' ALA . 59.5 t -98.91 101.06 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 73.150000000000006 110.022 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 95.4 t -78.0 126.51 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.224 -0.922 . . . . 75.530000000000001 110.211 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.599 ' CG ' ' HB3' ' A' ' 74' ' ' ALA . 3.5 tp-100 -107.63 111.45 23.68 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.892 . . . . 73.219999999999999 110.147 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.051 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.85 168.84 18.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 74.329999999999998 109.889 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.82 148.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.384 -0.823 . . . . 62.329999999999998 109.757 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -48.7 -47.15 41.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.125 -0.984 . . . . 75.040000000000006 111.041 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.08 -5.45 52.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.776 -1.203 . . . . 62.329999999999998 110.417 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.551 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.6 mmm180 -74.79 -51.13 14.92 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.093 -1.077 . . . . 74.319999999999993 108.093 177.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.051 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.74 -40.22 59.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 120.203 -0.599 . . . . 70.510000000000005 110.854 -179.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 27' ' ' THR . 0.5 OUTLIER -52.36 -40.49 62.07 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.523 -1.36 . . . . 75.120000000000005 108.414 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.509 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -72.05 -59.0 2.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 73.030000000000001 111.105 179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.787 HD13 HG11 ' A' ' 69' ' ' VAL . 1.2 pt -79.77 -48.99 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.418 -0.801 . . . . 62.240000000000002 111.502 -178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.81 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -52.28 -52.43 52.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.82 -1.175 . . . . 63.140000000000001 109.97 -179.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.0 t -54.97 -33.33 62.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.226 -0.922 . . . . 72.109999999999999 109.81 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 0.2 OUTLIER -61.52 -43.9 98.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.368 -0.833 . . . . 71.099999999999994 110.009 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.942 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.23 -36.37 41.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.364 -0.835 . . . . 72.219999999999999 110.113 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -69.67 -25.61 63.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 74.230000000000004 110.138 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.62 -28.19 61.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 43.340000000000003 110.269 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -76.35 151.66 83.41 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.201 -0.937 . . . . 64.319999999999993 110.274 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.28 -53.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.027 1.541 . . . . 54.210000000000001 110.346 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.18 -60.08 9.25 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 63.509999999999998 109.561 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.782 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.5 OUTLIER -77.62 145.94 36.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -1.164 . . . . 72.540000000000006 110.065 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 35' ' ' CYS . 0.6 OUTLIER -153.68 126.68 8.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.269 -0.894 . . . . 71.129999999999995 110.176 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 70.6 t -70.87 120.09 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.247 -0.908 . . . . 62.409999999999997 110.198 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.06 -51.06 5.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 74.120000000000005 110.232 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 ' HB ' HD12 ' A' ' 48' ' ' ILE . 19.2 t -120.52 120.32 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 52.210000000000001 110.076 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 41' ' ' ASP . 9.8 p -106.93 103.19 12.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.185 -0.947 . . . . 60.219999999999999 110.29 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 24.7 m-20 -133.5 148.02 51.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 73.340000000000003 110.24 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.418 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.93 53.75 0.41 Allowed Pre-proline 0 C--N 1.301 -1.512 0 O-C-N 121.386 -0.822 . . . . 71.209999999999994 111.229 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' A' ' 41' ' ' ASP . 45.0 Cg_endo -70.66 -39.16 5.03 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.675 1.355 . . . . 73.049999999999997 109.896 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.2 m -150.27 15.81 0.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.399 -0.813 . . . . 75.439999999999998 110.011 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.69 30.32 9.8 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.598 -1.401 . . . . 42.299999999999997 109.598 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 11.3 pt20 -130.36 137.05 49.7 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -1.136 . . . . 63.450000000000003 110.419 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.81 HD12 ' CB ' ' A' ' 26' ' ' SER . 73.7 mt -126.28 154.88 42.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.364 -0.835 . . . . 74.349999999999994 109.982 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.574 HD11 HD22 ' B' ' 23' ' ' LEU . 40.1 mt -95.22 124.96 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 74.019999999999996 110.07 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 29' ' ' LEU . 9.2 p -134.27 124.73 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 41.340000000000003 110.239 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.768 HG12 ' HA ' ' A' ' 12' ' ' SER . 21.6 m -95.18 144.6 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 70.439999999999998 110.156 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.747 HG12 HD11 ' A' ' 13' ' ' LEU . 12.0 p -131.95 141.98 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.233 -0.917 . . . . 73.030000000000001 110.241 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.504 ' HA ' HD11 ' A' ' 59' ' ' LEU . 4.6 pt-20 -121.64 142.16 50.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.306 -0.872 . . . . 65.329999999999998 110.118 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.559 ' HB1' ' CG2' ' A' ' 58' ' ' THR . . . -152.51 -177.79 6.44 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.319 -0.863 . . . . 70.129999999999995 110.196 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.83 -50.09 27.14 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 60.210000000000001 110.254 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -155.45 -169.55 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.294 -0.879 . . . . 72.219999999999999 110.299 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -60.91 -36.69 79.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 62.100000000000001 110.116 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 18.5 tt0 -56.73 -44.18 81.4 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.333 -0.854 . . . . 64.450000000000003 110.134 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.559 ' CG2' ' HB1' ' A' ' 53' ' ' ALA . 2.8 m -74.37 -33.15 62.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 73.030000000000001 110.069 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG13 ' A' ' 51' ' ' VAL . 1.1 tp -62.29 -44.36 96.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 74.209999999999994 110.104 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.721 ' O ' HG22 ' A' ' 63' ' ' ILE . 25.5 pt -66.49 -28.62 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 73.420000000000002 109.523 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.0 tt0 -52.6 -45.16 66.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 62.43 109.683 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.9 m -56.29 -40.62 74.59 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.487 -0.758 . . . . 65.310000000000002 110.443 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.721 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.2 tt -48.77 -36.53 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.131 -0.981 . . . . 62.539999999999999 110.269 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.586 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 2.5 pp20? -52.37 -32.35 38.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.141 -0.975 . . . . 74.200000000000003 109.911 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.94 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.5 p -69.26 -51.91 32.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 41.039999999999999 110.384 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG22 ' HA ' ' A' ' 63' ' ' ILE . 32.8 m -70.35 -39.41 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.31 -0.868 . . . . 74.150000000000006 111.136 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -69.27 -38.64 78.48 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.093 -1.005 . . . . 73.230000000000004 111.196 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 69' ' ' VAL . 3.1 p-10 -76.16 -20.1 57.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.621 -1.299 . . . . 45.520000000000003 110.639 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.94 HG23 ' O ' ' A' ' 65' ' ' SER . 48.0 t -68.41 126.92 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.082 -1.011 . . . . 72.219999999999999 110.008 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -59.42 -42.8 92.67 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.025 . . . . 61.25 110.371 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.534 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -52.88 -31.47 39.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.52 -1.432 . . . . 55.310000000000002 109.52 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.519 HG23 ' CG1' ' A' ' 69' ' ' VAL . 22.1 t -80.45 115.33 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.406 -1.055 . . . . 70.25 110.278 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.654 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.71 -21.27 15.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 72.540000000000006 110.076 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.599 ' HB3' ' CG ' ' A' ' 16' ' ' GLN . . . -148.1 173.59 12.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.239 -0.913 . . . . 74.319999999999993 110.158 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 75' ' ' VAL . 4.8 p -162.63 118.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 52.439999999999998 110.292 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.83 100.9 6.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 54.450000000000003 110.18 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.697 HD13 HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.63 104.97 12.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.326 -0.859 . . . . 53.109999999999999 110.34 -179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 46.8 t -142.87 94.9 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.391 -0.818 . . . . 74.230000000000004 110.131 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 78.7 t80 -177.23 111.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 73.209999999999994 110.436 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.478 ' CE1' ' OE2' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -102.49 126.31 49.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.16 -0.962 . . . . 74.430000000000007 109.857 179.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.54 ' NE2' ' CG1' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -130.4 112.1 12.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.22 -0.925 . . . . 73.310000000000002 110.323 -179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' NE2' ' HA2' ' A' ' 86' ' ' GLY . 11.4 pt20 -153.74 138.63 17.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 72.230000000000004 110.178 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.509 ' O ' ' N ' ' A' ' 85' ' ' GLN . 0.0 OUTLIER -94.75 119.09 32.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.242 -0.911 . . . . 75.120000000000005 110.244 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' A' ' 83' ' ' GLU . 1.8 mt-10 65.89 -66.96 0.15 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.197 -0.939 . . . . 72.019999999999996 110.039 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -42.03 147.49 0.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.531 -0.73 . . . . 74.239999999999995 110.32 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' GLU . . . -163.53 -134.76 1.7 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.45 -1.46 . . . . 71.340000000000003 109.45 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 25.0 mt-10 61.97 59.27 1.73 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -1.124 . . . . 61.539999999999999 110.197 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.478 ' OE2' ' CE1' ' A' ' 80' ' ' HIS . 7.1 pt-20 -117.53 140.77 49.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.345 -0.847 . . . . 63.450000000000003 110.295 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 p -87.49 137.66 32.23 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.261 -0.899 . . . . 74.450000000000003 110.198 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.684 0 O-C-N 123.919 1.484 . . . . 74.299999999999997 110.442 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 5.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.333 0.587 . . . . 71.239999999999995 110.228 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -93.41 -9.77 37.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.919 . . . . 75.400000000000006 110.273 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.616 HD23 ' O ' ' B' ' 3' ' ' LEU . 0.9 OUTLIER -79.8 -24.86 41.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 64.310000000000002 110.26 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.75 59.04 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 72.450000000000003 110.176 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' B' ' 3' ' ' LEU . 0.0 OUTLIER -174.12 -33.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.285 -0.884 . . . . 73.439999999999998 110.23 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -65.0 -18.22 65.11 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 74.510000000000005 110.199 179.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.36 -38.53 30.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.299 -0.875 . . . . 64.329999999999998 109.722 179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 0.9 OUTLIER -80.61 -42.81 21.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.31 -0.869 . . . . 72.239999999999995 109.748 179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.43 ' HE3' HG11 ' A' ' 50' ' ' VAL . 8.4 ttp -67.44 -45.38 76.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.888 . . . . 71.120000000000005 110.067 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.781 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -50.69 -27.0 6.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.874 . . . . 72.310000000000002 110.091 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -59.89 -49.65 76.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.143 -0.973 . . . . 74.25 109.96 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.407 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.4 OUTLIER -82.93 -32.78 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 62.340000000000003 110.148 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -59.55 -47.58 85.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.296 -0.878 . . . . 62.420000000000002 110.234 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.781 HG22 ' O ' ' B' ' 10' ' ' LYS . 17.4 m -58.38 -30.89 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.203 -0.936 . . . . 74.140000000000001 110.122 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' B' ' 12' ' ' ASN . . . -64.12 -33.33 75.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -0.867 . . . . 52.32 110.09 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.523 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -97.56 -14.05 21.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.149 -0.969 . . . . 62.149999999999999 110.184 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -98.17 -21.3 16.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.354 -0.841 . . . . 64.010000000000005 110.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' B' ' 24' ' ' SER . . . -85.79 -53.58 5.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.401 -0.812 . . . . 53.32 110.163 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.46 -10.51 59.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 64.109999999999999 110.105 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -110.43 -52.59 2.77 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 74.319999999999993 110.087 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.27 14.11 13.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.318 -0.864 . . . . 64.530000000000001 110.183 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.85 24.35 48.93 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.647 -1.381 . . . . 21.530000000000001 109.647 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.574 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -69.86 -162.84 0.05 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.219 -1.165 . . . . 63.25 110.211 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.452 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 15.5 m -78.18 162.07 26.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.3 -0.875 . . . . 72.049999999999997 110.243 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.492 HG23 ' O ' ' B' ' 25' ' ' VAL . 21.4 m -109.86 74.54 0.76 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 74.310000000000002 110.379 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.637 ' HG2' HG21 ' B' ' 14' ' ' VAL . 46.8 Cg_endo -73.16 -90.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.998 1.525 . . . . 72.120000000000005 110.376 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.422 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -108.68 48.65 0.92 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.421 -1.472 . . . . 52.009999999999998 109.421 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' B' ' 27' ' ' GLY . 79.4 t -41.49 -41.81 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -1.06 . . . . 62.450000000000003 110.34 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' B' ' 28' ' ' VAL . . . -176.67 -48.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 51.43 110.176 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.421 ' O ' ' HG3' ' B' ' 30' ' ' ARG . 0.0 OUTLIER -106.44 99.07 8.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 73.150000000000006 110.298 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -137.65 6.99 2.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 71.230000000000004 110.267 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' B' ' 34' ' ' GLY . 88.4 t -62.3 -42.06 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 61.329999999999998 110.108 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.617 HG23 ' O ' ' B' ' 33' ' ' VAL . 29.4 m -51.8 89.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.157 -0.964 . . . . 73.430000000000007 110.173 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' B' ' 32' ' ' VAL . . . -174.64 -70.36 0.05 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.607 -1.397 . . . . 75.239999999999995 109.607 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.295 -1.121 . . . . 63.109999999999999 110.201 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.551 -1.42 . . . . 44.520000000000003 109.551 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 3' ' ' HIS . 81.1 p -158.88 -80.2 0.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -1.177 . . . . 54.109999999999999 110.171 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.43 ' N ' ' OG ' ' A' ' 2' ' ' SER . 19.0 m-70 -158.74 162.53 37.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.249 -0.907 . . . . 74.340000000000003 110.143 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' ' 4' ' ' MET . 3.0 ptp -159.63 70.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.298 -0.876 . . . . 63.25 110.281 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.447 ' O ' ' CG ' ' A' ' 5' ' ' HIS . 23.0 p80 -142.21 119.6 11.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.162 -0.961 . . . . 63.399999999999999 110.252 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.35 119.55 2.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.318 -0.864 . . . . 74.120000000000005 110.165 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -142.83 148.94 37.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.337 -0.852 . . . . 74.25 110.249 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.536 ' N ' ' CD1' ' A' ' 8' ' ' TRP . 26.8 m95 -103.46 -69.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 72.340000000000003 110.093 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -153.56 122.67 6.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 74.430000000000007 110.138 -179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG13 ' HG3' ' A' ' 81' ' ' GLN . 2.7 p -158.63 142.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 72.329999999999998 110.224 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 50' ' ' VAL . 26.2 p -142.83 171.22 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 72.530000000000001 110.029 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.779 ' OG ' HG12 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -104.91 117.81 34.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.906 . . . . 71.120000000000005 110.165 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.629 HD11 HG12 ' A' ' 51' ' ' VAL . 1.9 mp -102.22 133.13 47.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 73.319999999999993 110.207 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.65 HG11 ' HB1' ' B' ' 21' ' ' ALA . 17.8 t -98.96 100.9 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.305 -0.872 . . . . 53.32 110.164 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.2 t -78.19 127.46 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.211 -0.931 . . . . 65.519999999999996 110.317 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.639 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 3.3 tt0 -108.72 111.81 23.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 74.129999999999995 110.283 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.082 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -141.09 168.71 19.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.209 -0.932 . . . . 50.32 109.933 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.542 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.1 OUTLIER -42.72 149.0 0.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.266 -0.896 . . . . 73.219999999999999 109.738 179.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.18 -47.24 35.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.12 -0.987 . . . . 62.32 110.953 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -92.11 -5.42 52.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.841 -1.162 . . . . 74.25 110.386 -179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.546 ' CZ ' ' HA3' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -74.69 -49.92 19.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.038 -1.039 . . . . 73.540000000000006 108.243 177.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.082 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.59 -41.11 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 120.246 -0.582 . . . . 74.349999999999994 110.753 -179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.538 ' O ' ' CG2' ' A' ' 27' ' ' THR . 5.2 t -52.42 -40.49 62.23 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.565 -1.334 . . . . 51.420000000000002 108.361 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.84 -58.77 3.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.523 -0.736 . . . . 72.409999999999997 111.14 179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.812 HG21 HG11 ' A' ' 69' ' ' VAL . 1.1 pt -79.62 -48.87 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.47 -0.769 . . . . 75.099999999999994 111.465 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.893 ' CB ' HD12 ' A' ' 47' ' ' LEU . 2.2 p -52.09 -52.87 48.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.713 -1.242 . . . . 52.229999999999997 109.783 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 23' ' ' SER . 2.5 t -55.89 -33.19 64.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.139 -0.976 . . . . 65.25 109.826 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -61.49 -44.36 97.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.82 . . . . 71.519999999999996 109.871 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 49' ' ' VAL . 2.8 mm? -51.22 -31.51 20.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.823 . . . . 75.150000000000006 109.917 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.562 ' CG ' HG22 ' A' ' 37' ' ' VAL . 49.8 t-20 -70.67 -26.84 63.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.331 -0.856 . . . . 52.32 110.031 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.269 -0.895 . . . . 72.409999999999997 110.252 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.07 150.86 97.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.29 -0.882 . . . . 72.420000000000002 110.151 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' O ' ' OE2' ' A' ' 36' ' ' GLU . 46.1 Cg_endo -73.08 -48.69 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 124.136 1.598 . . . . 62.229999999999997 110.542 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.29 -63.29 2.99 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.561 -1.416 . . . . 53.219999999999999 109.561 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.526 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -68.75 147.85 51.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -1.138 . . . . 65.540000000000006 110.214 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' OE2' ' O ' ' A' ' 33' ' ' PRO . 2.7 mt-10 -158.8 130.66 6.58 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.142 -0.974 . . . . 72.0 110.159 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 37' ' ' VAL . 18.1 m -72.78 121.13 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 74.439999999999998 110.301 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.892 ' HB1' ' HE2' ' B' ' 9' ' ' MET . . . -94.09 -47.57 6.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.151 -0.968 . . . . 60.140000000000001 110.105 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.605 HG12 ' OD1' ' A' ' 41' ' ' ASP . 5.3 t -120.41 120.44 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 71.200000000000003 110.085 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.433 ' HA ' HD22 ' A' ' 47' ' ' LEU . 0.7 OUTLIER -106.9 100.85 10.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.307 -0.871 . . . . 34.450000000000003 110.259 -179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' OD1' HG12 ' A' ' 39' ' ' VAL . 3.2 m-20 -133.29 148.16 51.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.821 . . . . 73.120000000000005 110.08 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.86 54.09 0.41 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.358 -0.839 . . . . 71.030000000000001 111.259 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 46.4 Cg_endo -70.8 -39.08 4.8 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.547 1.288 . . . . 64.409999999999997 109.757 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.0 t -151.41 16.39 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.533 -0.729 . . . . 44.409999999999997 110.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.534 ' O ' HG21 ' A' ' 22' ' ' ILE . . . 91.56 30.18 11.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.661 -1.375 . . . . 52.140000000000001 109.661 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' HD23 ' A' ' 47' ' ' LEU . 8.0 pt20 -130.37 136.75 49.41 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.273 -1.133 . . . . 64.219999999999999 110.462 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.893 HD12 ' CB ' ' A' ' 26' ' ' SER . 66.7 mt -126.26 154.77 42.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 74.430000000000007 109.986 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.514 HD11 HD22 ' B' ' 23' ' ' LEU . 16.9 mt -94.72 123.48 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.193 -0.942 . . . . 73.239999999999995 110.199 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 29' ' ' LEU . 3.0 p -128.57 124.24 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.194 -0.941 . . . . 63.32 110.085 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG12 ' OG ' ' A' ' 12' ' ' SER . 4.8 m -95.25 146.78 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 55.119999999999997 110.285 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 13' ' ' LEU . 9.3 p -141.24 147.31 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 71.140000000000001 110.119 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -127.58 143.65 51.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 62.310000000000002 110.214 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.862 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -152.16 177.58 10.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.899 . . . . 64.439999999999998 110.167 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 10.1 tp10 -45.73 -49.65 14.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.098 -1.001 . . . . 73.010000000000005 110.069 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -155.38 -168.75 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.275 -0.891 . . . . 72.200000000000003 110.192 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 60' ' ' ILE . 1.7 p -60.84 -39.25 88.36 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.384 -0.823 . . . . 74.310000000000002 110.158 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' O ' ' CG1' ' A' ' 60' ' ' ILE . 3.1 tt0 -52.69 -46.68 67.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.356 -0.84 . . . . 63.340000000000003 110.205 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.862 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -72.16 -33.66 67.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.150000000000006 110.182 179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.71 -44.5 93.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.284 -0.885 . . . . 65.209999999999994 110.187 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.783 ' O ' HG22 ' A' ' 63' ' ' ILE . 16.1 pt -66.53 -28.68 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.217 -0.927 . . . . 72.109999999999999 109.578 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.532 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -52.6 -45.31 66.5 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.308 -0.87 . . . . 55.350000000000001 109.809 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.1 m -56.74 -40.93 76.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.216 -0.928 . . . . 75.430000000000007 110.396 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.783 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.0 tt -49.16 -35.98 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.208 -0.932 . . . . 73.319999999999993 110.367 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.597 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 13.9 pt-20 -51.97 -32.85 35.27 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.064 -1.023 . . . . 72.030000000000001 109.922 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.978 ' O ' HG23 ' A' ' 69' ' ' VAL . 31.8 t -69.17 -55.41 10.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 75.120000000000005 110.545 179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.547 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.2 m -66.24 -42.49 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.323 -0.861 . . . . 70.099999999999994 111.177 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.597 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -64.88 -40.48 95.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.039 -1.038 . . . . 73.319999999999993 110.606 -179.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.533 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 6.2 t30 -75.95 -20.56 57.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.076 -1.015 . . . . 75.209999999999994 110.63 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 65' ' ' SER . 42.4 t -67.25 123.95 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.999 -1.063 . . . . 73.549999999999997 109.844 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -56.35 -49.97 72.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.267 -0.895 . . . . 75.329999999999998 110.693 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.546 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -48.47 -31.73 9.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.606 -1.398 . . . . 73.510000000000005 109.606 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.614 HG23 ' CG1' ' A' ' 69' ' ' VAL . 48.9 t -75.92 115.97 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -1.142 . . . . 72.129999999999995 110.377 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.61 -21.42 15.28 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.196 -0.94 . . . . 61.340000000000003 110.183 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 16' ' ' GLN . . . -152.07 173.53 14.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.236 -0.915 . . . . 74.439999999999998 110.236 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 75' ' ' VAL . 6.2 p -157.55 118.58 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -0.872 . . . . 53.420000000000002 110.251 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 0.3 OUTLIER -124.92 101.01 6.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.127 -0.983 . . . . 75.040000000000006 110.236 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD22 HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -113.74 104.92 12.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 61.119999999999997 110.275 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.823 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 22.1 t -143.18 94.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.907 . . . . 73.510000000000005 110.16 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CD1' ' HA ' ' B' ' 13' ' ' ALA . 87.7 t80 -176.53 107.69 0.07 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.913 . . . . 74.230000000000004 110.204 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -96.8 127.9 43.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.93 . . . . 64.230000000000004 110.139 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.588 ' HG3' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -137.61 109.69 7.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.318 -0.864 . . . . 73.209999999999994 110.28 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.518 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 7.1 pt20 -159.99 138.62 10.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.248 -0.908 . . . . 40.039999999999999 110.24 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 2.9 tp10 -90.12 119.69 30.66 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.243 -0.91 . . . . 54.229999999999997 110.281 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.518 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 1.4 pt-20 177.38 -30.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -0.944 . . . . 64.109999999999999 110.188 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -163.74 50.01 0.14 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.27 -0.894 . . . . 72.400000000000006 110.1 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 155.19 -135.34 4.59 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.509 -1.436 . . . . 54.43 109.509 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.407 ' OE2' ' N ' ' A' ' 82' ' ' GLN . 0.8 OUTLIER 49.38 23.2 0.81 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -1.126 . . . . 60.420000000000002 110.14 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 89' ' ' THR . 6.3 pt-20 -63.17 152.72 36.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 74.209999999999994 110.188 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -155.11 159.98 31.3 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.321 -0.862 . . . . 73.120000000000005 110.18 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 C--N 1.304 -1.795 0 O-C-N 123.948 1.499 . . . . 70.099999999999994 110.349 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.316 0.579 . . . . 34.409999999999997 110.203 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.941 ' O ' HD22 ' B' ' 3' ' ' LEU . 12.9 pttp -172.87 143.48 1.22 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.951 . . . . 75.319999999999993 110.182 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.941 HD22 ' O ' ' B' ' 2' ' ' LYS . 0.3 OUTLIER -147.34 141.45 26.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.272 -0.892 . . . . 52.039999999999999 110.266 -179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 3' ' ' LEU . 8.1 t -177.98 -45.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.381 -0.825 . . . . 62.009999999999998 110.078 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' B' ' 9' ' ' MET . 0.2 OUTLIER -137.31 -35.73 0.67 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 63.329999999999998 110.025 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' B' ' 10' ' ' LYS . 0.0 OUTLIER -34.77 -61.87 0.38 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.689 -0.632 . . . . 75.409999999999997 110.991 -179.148 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.426 ' C ' ' O ' ' B' ' 6' ' ' ARG . 0.9 OUTLIER -43.0 -43.66 4.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 64.200000000000003 110.379 -179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' B' ' 11' ' ' ALA . 0.0 OUTLIER -81.22 -45.86 15.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 72.439999999999998 110.448 -179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.892 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 13.6 ttp -71.53 -55.74 7.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.016 -1.052 . . . . 71.239999999999995 109.79 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.844 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -49.3 -25.58 2.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 65.430000000000007 109.759 179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' B' ' 8' ' ' PHE . . . -59.82 -50.86 72.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 64.319999999999993 109.827 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.458 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 0.6 OUTLIER -83.11 -33.09 26.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 73.25 109.926 179.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.571 ' HA ' ' CD1' ' A' ' 79' ' ' TYR . . . -60.38 -47.71 84.91 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.362 -0.836 . . . . 74.319999999999993 110.235 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.844 HG22 ' O ' ' B' ' 10' ' ' LYS . 19.4 m -57.22 -31.7 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 73.239999999999995 110.25 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.643 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -63.93 -33.85 76.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -0.861 . . . . 71.150000000000006 109.682 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 78' ' ' VAL . . . -100.96 -10.81 20.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -0.83 . . . . 62.43 109.879 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.67 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -103.68 -25.85 12.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 60.450000000000003 110.087 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' B' ' 14' ' ' VAL . . . -82.47 -48.12 11.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.283 -0.886 . . . . 65.25 110.142 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.41 -10.6 60.02 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.201 -0.937 . . . . 53.399999999999999 110.155 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -111.99 -52.57 2.78 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 72.010000000000005 110.218 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -88.92 13.42 12.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 74.340000000000003 110.154 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 55.29 27.45 46.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.556 -1.418 . . . . 72.310000000000002 109.556 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.514 HD22 HD11 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -67.0 -162.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.187 -1.184 . . . . 74.420000000000002 110.356 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.483 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 2.3 m -79.0 162.23 26.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 72.0 110.292 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.747 HG23 ' HB ' ' B' ' 28' ' ' VAL . 2.7 p -107.63 82.81 1.41 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.324 -0.86 . . . . 72.219999999999999 110.192 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.786 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.1 Cg_endo -72.28 -54.64 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 63.340000000000003 110.443 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -137.23 33.65 2.28 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.574 -1.41 . . . . 71.129999999999995 109.574 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.747 ' HB ' HG23 ' B' ' 25' ' ' VAL . 29.2 t -94.49 -79.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 65.239999999999995 110.203 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.55 ' N ' HG12 ' B' ' 28' ' ' VAL . . . -101.23 -9.87 20.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 74.430000000000007 110.249 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' B' ' 29' ' ' ALA . 1.0 OUTLIER 64.96 110.31 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 75.120000000000005 110.243 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.31 -29.97 68.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.284 -0.885 . . . . 74.510000000000005 110.339 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.517 ' C ' HG13 ' B' ' 33' ' ' VAL . 27.0 m -50.08 -21.43 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.9 . . . . 72.540000000000006 110.281 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.517 HG13 ' C ' ' B' ' 32' ' ' VAL . 32.8 m -151.15 157.57 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.93 . . . . 62.0 110.128 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.81 78.22 0.1 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.496 -1.442 . . . . 63.310000000000002 109.496 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.276 -1.132 . . . . 61.020000000000003 110.162 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.428 0 N-CA-C 109.483 -1.447 . . . . 55.530000000000001 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 3' ' ' HIS . 0.2 OUTLIER -89.37 73.44 7.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -1.174 . . . . 73.340000000000003 110.147 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 2' ' ' SER . 1.7 m80 58.99 118.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.27 -0.894 . . . . 62.509999999999998 110.247 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.41 76.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 73.420000000000002 110.232 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -124.56 117.86 25.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 62.119999999999997 110.279 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.555 ' O ' HG23 ' A' ' 6' ' ' THR . 6.8 t -166.87 126.39 1.47 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -0.902 . . . . 70.109999999999999 110.154 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -143.74 168.49 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.272 -0.892 . . . . 54.32 110.338 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -112.82 -69.66 0.85 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 63.439999999999998 110.095 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -153.48 124.44 7.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 62.310000000000002 110.194 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 81' ' ' GLN . 3.3 p -158.4 142.4 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.816 . . . . 73.329999999999998 110.399 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 30.9 p -137.83 171.26 14.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 73.129999999999995 110.103 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.639 ' HA ' HG12 ' A' ' 50' ' ' VAL . 11.1 t -104.86 117.94 35.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.894 . . . . 51.100000000000001 110.229 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 77' ' ' LEU . 2.9 mp -100.7 133.83 44.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.962 . . . . 72.219999999999999 110.24 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 76' ' ' SER . 14.3 t -99.03 98.69 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 74.340000000000003 110.15 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 46' ' ' GLN . 61.3 t -78.39 123.3 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 61.200000000000003 110.085 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.605 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 2.6 tt0 -105.46 110.78 23.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 62.130000000000003 110.188 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.094 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -140.93 168.84 18.82 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.183 -0.948 . . . . 74.299999999999997 109.927 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -43.39 149.09 0.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.178 -0.951 . . . . 65.319999999999993 109.73 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -48.5 -47.29 38.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 72.430000000000007 110.946 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -92.25 -5.28 52.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.827 -1.171 . . . . 64.439999999999998 110.418 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.544 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.5 mmm180 -74.83 -50.43 17.14 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.164 -1.05 . . . . 63.530000000000001 108.164 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.094 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -55.71 -38.97 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 120.252 -0.579 . . . . 64.219999999999999 110.686 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 27' ' ' THR . 1.1 p -52.39 -39.97 61.5 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.751 -1.218 . . . . 64.019999999999996 108.529 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 27' ' ' THR . 0.3 OUTLIER -71.12 -58.75 3.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.472 -0.768 . . . . 72.450000000000003 110.909 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.715 HG21 HG11 ' A' ' 69' ' ' VAL . 5.9 pt -79.83 -49.78 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.375 -0.828 . . . . 73.109999999999999 111.816 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.914 ' CB ' HD12 ' A' ' 47' ' ' LEU . 1.9 p -51.01 -50.94 57.55 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.029 -1.044 . . . . 70.310000000000002 109.663 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 24' ' ' ASP . 2.7 t -57.31 -33.01 67.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.343 -0.848 . . . . 74.109999999999999 110.057 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -61.49 -44.42 97.11 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.363 -0.835 . . . . 70.540000000000006 109.855 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.933 ' HB3' HG21 ' A' ' 49' ' ' VAL . 3.0 mm? -51.37 -32.08 24.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.349 -0.845 . . . . 72.129999999999995 109.959 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 36' ' ' GLU . 34.6 t-20 -75.75 -22.47 56.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.875 . . . . 64.25 110.154 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.49 -28.08 61.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 73.310000000000002 110.185 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.32 151.47 85.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 75.120000000000005 110.221 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.09 -43.33 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.03 1.542 . . . . 62.130000000000003 110.41 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.82 -59.93 4.16 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.573 -1.411 . . . . 65.340000000000003 109.573 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.785 ' SG ' HD12 ' A' ' 29' ' ' LEU . 1.6 t -76.14 144.34 40.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.31 -1.112 . . . . 74.150000000000006 110.197 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 30' ' ' ASN . 2.7 mt-10 -154.72 128.34 8.6 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.858 . . . . 74.409999999999997 110.106 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.7 t -68.86 120.16 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.219 -0.926 . . . . 73.230000000000004 110.155 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.13 -49.36 6.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.364 -0.835 . . . . 72.319999999999993 110.096 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 48' ' ' ILE . 6.9 t -120.51 120.55 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 74.340000000000003 110.117 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 24.7 p -106.71 99.7 9.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.211 -0.931 . . . . 72.409999999999997 110.257 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.527 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 84.7 m-20 -133.55 148.17 51.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.431 -0.793 . . . . 72.409999999999997 110.26 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -112.06 53.81 0.42 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.344 -0.847 . . . . 55.020000000000003 111.163 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 41' ' ' ASP . 44.9 Cg_endo -70.72 -39.15 4.91 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.718 1.378 . . . . 73.420000000000002 109.858 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 t -146.34 12.55 1.2 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 55.549999999999997 110.072 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 93.52 27.35 13.21 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.594 -1.402 . . . . 65.099999999999994 109.594 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' VAL . 3.4 pt20 -130.36 134.6 47.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -1.112 . . . . 42.439999999999998 110.441 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.914 HD12 ' CB ' ' A' ' 26' ' ' SER . 49.1 mt -119.26 154.63 33.14 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 72.109999999999999 110.065 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.684 HD11 HD22 ' B' ' 23' ' ' LEU . 12.9 mt -95.23 123.49 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.158 -0.964 . . . . 51.509999999999998 110.213 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.933 HG21 ' HB3' ' A' ' 29' ' ' LEU . 14.9 p -131.32 126.52 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.25 -0.906 . . . . 64.450000000000003 110.19 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.639 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.4 m -101.25 141.28 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 64.530000000000001 110.214 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' A' ' 59' ' ' LEU . 9.2 p -133.6 146.46 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 64.150000000000006 110.198 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 7.2 pm0 -125.09 146.04 49.64 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 72.540000000000006 110.169 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.535 ' CB ' ' HB ' ' A' ' 58' ' ' THR . . . -157.68 -178.74 7.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.266 -0.896 . . . . 70.150000000000006 110.16 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -47.14 -49.84 21.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.286 -0.884 . . . . 72.140000000000001 110.248 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.55 -168.42 2.81 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.292 -0.88 . . . . 74.209999999999994 110.202 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 60' ' ' ILE . 2.4 t -63.47 -38.35 90.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 70.310000000000002 110.178 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.482 ' O ' HG12 ' A' ' 60' ' ' ILE . 6.1 tt0 -48.55 -47.71 39.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.847 . . . . 74.340000000000003 110.195 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.535 ' HB ' ' CB ' ' A' ' 53' ' ' ALA . 0.5 OUTLIER -74.68 -33.68 62.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 64.549999999999997 110.147 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HG ' HG13 ' A' ' 51' ' ' VAL . 0.8 OUTLIER -63.71 -44.4 93.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.246 -0.909 . . . . 53.109999999999999 110.198 179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.751 ' O ' HG22 ' A' ' 63' ' ' ILE . 31.2 pt -66.3 -28.56 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.303 -0.873 . . . . 74.310000000000002 109.664 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' N ' HG13 ' A' ' 60' ' ' ILE . 6.8 tp60 -52.4 -45.2 65.78 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 74.450000000000003 109.76 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 65' ' ' SER . 22.2 m -56.62 -40.85 76.07 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.473 -0.767 . . . . 63.32 110.37 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.751 HG22 ' O ' ' A' ' 60' ' ' ILE . 3.1 tt -48.94 -36.12 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.835 . . . . 73.129999999999995 110.273 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.592 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 10.4 pt-20 -51.65 -32.75 30.64 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 44.049999999999997 109.76 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.856 ' O ' HG23 ' A' ' 69' ' ' VAL . 1.1 m -68.73 -55.31 11.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 74.010000000000005 110.12 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.4 m -66.92 -42.53 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 65.5 111.052 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' CG ' ' HA ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -67.97 -39.14 83.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.106 -0.996 . . . . 75.540000000000006 110.792 -179.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.407 ' H ' ' HG3' ' A' ' 67' ' ' ARG . 19.2 t-20 -76.37 -21.17 56.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.919 -1.113 . . . . 54.509999999999998 110.299 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 65' ' ' SER . 24.5 t -71.68 125.22 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.126 -0.984 . . . . 75.219999999999999 109.845 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.84 -44.58 96.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.212 -0.93 . . . . 71.340000000000003 110.494 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.17 -33.04 5.29 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.507 -1.437 . . . . 70.129999999999995 109.507 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.461 ' CG2' HD12 ' A' ' 25' ' ' ILE . 40.5 t -79.49 116.76 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -1.128 . . . . 72.409999999999997 110.579 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -98.86 -19.44 17.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.296 -0.877 . . . . 73.030000000000001 110.042 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.63 173.59 13.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.194 -0.941 . . . . 63.210000000000001 110.083 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 HG22 HD23 ' A' ' 77' ' ' LEU . 2.4 p -159.3 118.6 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 75.109999999999999 110.473 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 14' ' ' VAL . 0.3 OUTLIER -126.79 101.05 6.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 71.329999999999998 110.178 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 13' ' ' LEU . 0.3 OUTLIER -113.89 105.07 12.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.178 -0.952 . . . . 65.319999999999993 110.33 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 77' ' ' LEU . 39.2 t -147.85 93.3 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 63.5 110.349 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' CE2' ' HB3' ' A' ' 81' ' ' GLN . 84.2 t80 -177.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 74.140000000000001 110.318 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -99.43 126.42 45.33 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.304 -0.873 . . . . 74.209999999999994 110.027 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.571 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . 1.7 pp0? -139.68 112.0 7.67 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 55.340000000000003 110.317 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.496 ' NE2' ' OE2' ' A' ' 84' ' ' GLU . 2.6 pt20 -155.34 138.66 15.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 74.109999999999999 110.302 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 84' ' ' GLU . 4.4 mm-40 -103.59 135.65 44.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 72.219999999999999 110.207 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' OE2' ' NE2' ' A' ' 82' ' ' GLN . 7.5 pt-20 177.62 -32.02 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -0.873 . . . . 74.319999999999993 110.12 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.432 ' HG3' ' O ' ' A' ' 84' ' ' GLU . 7.4 mt-30 -156.9 147.03 21.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.32 -0.863 . . . . 74.230000000000004 110.231 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 88' ' ' GLU . . . -132.68 174.62 20.37 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.596 -1.401 . . . . 41.240000000000002 109.596 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 67.05 -59.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.332 -1.099 . . . . 72.340000000000003 110.229 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' O ' ' O ' ' A' ' 87' ' ' GLU . 6.6 pt-20 34.28 99.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.703 0.764 . . . . 64.040000000000006 111.487 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 47.78 96.39 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.164 -0.96 . . . . 71.239999999999995 110.176 179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 C--N 1.305 -1.715 0 O-C-N 124.026 1.54 . . . . 73.150000000000006 110.41 -179.897 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.243 0.544 . . . . 70.5 110.152 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt 52.78 -138.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 72.129999999999995 110.21 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.39 -149.91 0.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 71.329999999999998 110.18 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.26 -16.07 9.71 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 74.319999999999993 110.298 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -147.84 -55.98 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 65.209999999999994 110.243 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.2 OUTLIER -50.21 -21.57 1.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.262 -0.899 . . . . 73.340000000000003 110.174 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . . . . . . . . . 35.6 t -81.05 -35.82 31.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 75.109999999999999 109.624 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' B' ' 8' ' ' PHE . 1.6 t80 -80.48 -41.49 24.26 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.498 -0.751 . . . . 45.310000000000002 109.911 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.2 ttp -66.86 -50.86 61.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.105 -0.997 . . . . 72.340000000000003 110.118 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.773 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.0 OUTLIER -51.68 -29.12 16.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 75.219999999999999 110.086 179.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.411 ' O ' ' CG2' ' B' ' 14' ' ' VAL . . . -63.31 -45.04 93.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.334 -0.854 . . . . 42.100000000000001 110.129 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.458 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 1.2 m120 -82.96 -42.64 17.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.367 -0.833 . . . . 61.140000000000001 110.055 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.548 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.94 -47.7 71.01 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.301 -0.874 . . . . 72.409999999999997 110.311 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' B' ' 10' ' ' LYS . 26.5 m -57.82 -31.16 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.949 . . . . 72.519999999999996 110.074 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' CG1' ' B' ' 28' ' ' VAL . . . -64.12 -33.37 75.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 73.329999999999998 110.046 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.73 -13.89 22.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.27 -0.894 . . . . 74.040000000000006 110.027 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.63 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -100.59 -19.94 15.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 74.400000000000006 110.115 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.45 -52.29 5.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.274 -0.891 . . . . 74.209999999999994 110.18 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.49 -10.58 59.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 64.329999999999998 110.198 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -108.94 -54.64 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.151 -0.968 . . . . 63.210000000000001 110.146 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -90.97 17.2 8.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 70.040000000000006 110.227 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 53.42 29.52 38.9 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.512 -1.435 . . . . 74.129999999999995 109.512 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -68.47 -162.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.275 -1.132 . . . . 72.230000000000004 110.518 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 26' ' ' PRO . 23.5 t -82.93 158.74 22.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.456 -0.778 . . . . 53.420000000000002 110.412 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 25' ' ' VAL . 15.3 m -107.56 85.18 2.17 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.334 -0.854 . . . . 74.120000000000005 109.909 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.644 ' HG2' HG21 ' B' ' 14' ' ' VAL . 43.5 Cg_endo -70.07 -89.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.19 1.626 . . . . 75.129999999999995 110.972 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' B' ' 28' ' ' VAL . . . -92.4 -15.48 53.12 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.175 -1.17 . . . . 73.420000000000002 110.175 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.491 HG23 ' N ' ' B' ' 29' ' ' ALA . 16.8 m -43.56 -42.01 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.115 -1.226 . . . . 72.230000000000004 110.299 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.491 ' N ' HG23 ' B' ' 28' ' ' VAL . . . -179.66 -40.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 53.100000000000001 110.267 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.427 ' NH1' ' CG ' ' B' ' 30' ' ' ARG . 1.8 mtt-85 63.75 88.59 0.1 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 72.209999999999994 110.253 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' B' ' 30' ' ' ARG . . . -42.93 -55.52 3.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 45.130000000000003 110.288 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.925 HG13 HG23 ' B' ' 33' ' ' VAL . 9.3 p -46.5 -30.1 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 71.319999999999993 110.184 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.925 HG23 HG13 ' B' ' 32' ' ' VAL . 81.7 t -133.88 83.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.374 -0.829 . . . . 71.120000000000005 110.229 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.64 63.63 4.33 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.487 -1.445 . . . . 72.420000000000002 109.487 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.314 -1.11 . . . . 64.420000000000002 110.226 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.529 -1.428 . . . . 63.32 109.529 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 0.3 OUTLIER -92.37 -15.09 27.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.215 -1.168 . . . . 44.520000000000003 110.242 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.41 ' CB ' ' O ' ' A' ' 2' ' ' SER . 1.6 t60 63.03 122.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 74.209999999999994 110.172 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 4.4 ttt -160.56 71.24 0.43 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 75.109999999999999 110.14 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 83' ' ' GLU . 22.9 p80 -142.28 122.36 13.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 54.509999999999998 110.313 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.63 122.21 3.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 73.230000000000004 110.178 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -143.06 167.0 23.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 74.030000000000001 110.25 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.518 ' HB3' ' NE2' ' A' ' 9' ' ' GLN . 94.1 m95 -110.5 -73.56 0.68 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.887 . . . . 72.310000000000002 110.195 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.518 ' NE2' ' HB3' ' A' ' 8' ' ' TRP . 0.1 OUTLIER -153.41 126.07 8.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 71.230000000000004 110.238 179.849 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' A' ' 81' ' ' GLN . 1.9 p -168.74 137.65 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.472 -0.767 . . . . 50.43 109.984 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.568 ' SG ' HD21 ' A' ' 59' ' ' LEU . 21.2 p -138.56 171.24 14.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 65.420000000000002 110.171 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.752 ' HA ' HG12 ' A' ' 50' ' ' VAL . 10.8 m -105.18 117.42 33.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 74.340000000000003 110.153 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.86 137.64 39.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.278 -0.889 . . . . 72.129999999999995 110.245 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.39 100.03 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.888 . . . . 71.120000000000005 110.151 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.23 128.63 38.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 61.520000000000003 110.269 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.67 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -110.38 112.29 24.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.878 . . . . 75.109999999999999 110.2 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.043 ' HB3' HG23 ' A' ' 22' ' ' ILE . . . -142.1 168.79 18.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 35.119999999999997 109.989 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HB2' ' CG ' ' A' ' 21' ' ' ARG . 6.9 tptp -43.74 148.35 0.37 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 71.420000000000002 109.656 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.405 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 1.9 m -48.31 -47.24 36.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 63.140000000000001 111.017 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -91.91 -5.45 53.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.864 -1.147 . . . . 63.32 110.407 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 18' ' ' LYS . 1.4 mmm180 -74.6 -50.62 17.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.273 -1.01 . . . . 72.209999999999994 108.273 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.043 HG23 ' HB3' ' A' ' 17' ' ' ALA . 0.6 OUTLIER -55.78 -41.17 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.943 -0.571 . . . . 73.319999999999993 111.056 -179.647 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.531 ' O ' ' CG2' ' A' ' 27' ' ' THR . 3.1 m -52.5 -40.37 62.31 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.581 -1.324 . . . . 61.130000000000003 108.483 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.499 ' O ' HG22 ' A' ' 27' ' ' THR . 11.4 m-20 -72.15 -58.58 3.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.567 -0.708 . . . . 75.319999999999993 111.02 179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.917 HD13 HG11 ' A' ' 69' ' ' VAL . 0.9 OUTLIER -79.59 -48.94 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.371 -0.831 . . . . 72.120000000000005 111.446 -178.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.838 ' OG ' HD12 ' A' ' 47' ' ' LEU . 1.4 p -52.21 -53.4 43.94 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.83 -1.169 . . . . 72.409999999999997 110.106 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 23' ' ' SER . 3.2 t -53.88 -26.54 25.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.81 . . . . 71.329999999999998 109.738 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' A' ' 25' ' ' ILE . 2.8 tp60 -61.25 -43.86 98.2 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.54 -0.725 . . . . 51.530000000000001 109.072 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 29' ' ' LEU . 2.3 mm? -59.51 -25.76 64.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.51 -0.744 . . . . 74.409999999999997 109.379 179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.965 ' ND2' HG21 ' A' ' 37' ' ' VAL . 1.1 m120 -67.65 -34.72 77.51 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.877 0.846 . . . . 73.519999999999996 109.204 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.22 -28.69 57.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.635 -0.666 . . . . 43.210000000000001 110.928 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -67.1 142.79 97.37 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 60.140000000000001 110.898 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.09 -58.51 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.08 1.568 . . . . 73.409999999999997 109.99 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.09 -60.35 9.04 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.759 -1.736 . . . . 74.519999999999996 108.759 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -77.93 142.44 38.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.359 -1.083 . . . . 71.099999999999994 109.769 179.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.469 ' O ' HG22 ' A' ' 50' ' ' VAL . 3.6 mt-10 -153.47 127.83 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.133 -0.979 . . . . 72.140000000000001 110.095 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.965 HG21 ' ND2' ' A' ' 30' ' ' ASN . 12.5 m -62.1 125.15 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.233 -0.917 . . . . 73.439999999999998 110.465 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.72 -47.59 6.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 73.219999999999999 109.846 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.687 HG12 ' OD1' ' A' ' 41' ' ' ASP . 11.3 t -125.36 120.57 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.294 -0.879 . . . . 75.129999999999995 109.951 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.49 102.16 11.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 72.040000000000006 110.225 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.687 ' OD1' HG12 ' A' ' 39' ' ' VAL . 5.9 m-20 -133.45 148.1 51.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.456 -0.778 . . . . 73.409999999999997 110.259 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.411 ' N ' ' CD ' ' A' ' 43' ' ' PRO . . . -111.92 54.27 0.42 Allowed Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.456 -0.777 . . . . 52.229999999999997 111.167 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 41' ' ' ASP . 45.6 Cg_endo -70.58 -38.9 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.555 1.292 . . . . 72.319999999999993 109.892 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.3 m -150.64 15.74 0.78 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.421 -0.799 . . . . 64.319999999999993 110.039 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' ALA . . . 92.81 29.84 10.22 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.641 -1.384 . . . . 53.310000000000002 109.641 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.772 ' O ' HD23 ' A' ' 47' ' ' LEU . 19.7 pt20 -130.24 134.27 47.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.15 -1.206 . . . . 53.200000000000003 110.446 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.838 HD12 ' OG ' ' A' ' 26' ' ' SER . 15.0 mt -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.319 -0.863 . . . . 70.019999999999996 110.041 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.963 HD11 HD22 ' B' ' 23' ' ' LEU . 26.0 mt -94.63 125.98 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 70.349999999999994 110.124 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 37' ' ' VAL . 2.0 p -128.45 131.53 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 74.219999999999999 110.252 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 12' ' ' SER . 27.4 m -102.14 147.39 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 75.510000000000005 109.99 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.46 ' HB ' ' SG ' ' A' ' 35' ' ' CYS . 7.8 p -142.03 137.26 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 72.340000000000003 110.353 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 10' ' ' VAL . 15.4 pt-20 -119.73 143.66 47.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.367 -0.833 . . . . 75.140000000000001 109.866 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.651 ' HB1' ' HB ' ' A' ' 58' ' ' THR . . . -149.33 -177.39 5.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.182 -0.949 . . . . 72.510000000000005 110.367 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' O ' ' NE2' ' A' ' 9' ' ' GLN . 64.2 tt0 -55.83 -44.21 77.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 63.439999999999998 110.006 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.39 -172.65 4.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.278 -0.889 . . . . 73.310000000000002 110.215 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 60' ' ' ILE . 44.3 t -62.61 -31.81 72.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 51.509999999999998 110.116 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 60' ' ' ILE . 3.5 tt0 -54.48 -46.94 73.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.241 -0.912 . . . . 54.450000000000003 110.271 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.651 ' HB ' ' HB1' ' A' ' 53' ' ' ALA . 18.6 m -76.14 -33.7 59.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.231 -0.918 . . . . 63.200000000000003 110.193 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.568 HD21 ' SG ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -61.14 -46.35 90.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 71.310000000000002 110.239 179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.732 ' O ' HG22 ' A' ' 63' ' ' ILE . 41.7 pt -66.87 -28.73 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 61.43 109.408 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -52.45 -45.2 65.95 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.436 -0.79 . . . . 75.329999999999998 109.729 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -41.53 76.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.41 -0.806 . . . . 73.099999999999994 110.444 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 60' ' ' ILE . 2.1 tt -49.41 -36.68 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 73.319999999999993 110.097 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.571 ' HA ' ' CG ' ' A' ' 67' ' ' ARG . 40.3 mm-40 -52.47 -33.06 42.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.149 -0.969 . . . . 73.540000000000006 109.75 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.963 ' O ' HG23 ' A' ' 69' ' ' VAL . 19.6 m -68.84 -55.77 10.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.473 -0.767 . . . . 75.319999999999993 110.228 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 67' ' ' ARG . 33.1 m -65.67 -41.46 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.379 -0.825 . . . . 74.109999999999999 110.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.584 ' CD ' ' N ' ' A' ' 68' ' ' ASN . 0.0 OUTLIER -66.64 -40.35 88.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -0.982 . . . . 74.120000000000005 110.553 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.584 ' N ' ' CD ' ' A' ' 67' ' ' ARG . 4.1 t30 -75.98 -20.55 57.78 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.008 -1.057 . . . . 71.319999999999993 110.427 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.963 HG23 ' O ' ' A' ' 65' ' ' SER . 41.4 t -69.01 122.8 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 52.509999999999998 109.909 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -60.24 -47.17 87.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.434 -0.791 . . . . 65.329999999999998 110.753 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 21' ' ' ARG . . . -46.05 -32.4 4.8 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.576 -1.41 . . . . 60.020000000000003 109.576 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CG1' ' A' ' 69' ' ' VAL . 60.7 t -76.11 116.84 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -1.069 . . . . 74.209999999999994 110.383 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.805 HD23 ' HA ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -99.58 -19.23 16.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 43.439999999999998 110.156 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB3' ' CB ' ' A' ' 16' ' ' GLN . . . -148.54 173.49 13.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 72.540000000000006 110.144 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.1 p -158.63 118.6 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 64.040000000000006 110.342 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.04 93.24 3.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.15 -0.969 . . . . 75.040000000000006 110.177 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.805 ' HB3' HD23 ' A' ' 13' ' ' LEU . 1.0 OUTLIER -105.09 98.66 8.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.279 -0.888 . . . . 64.329999999999998 110.176 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.549 ' O ' ' HB1' ' B' ' 16' ' ' ALA . 43.4 t -148.61 94.27 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.268 -0.895 . . . . 73.420000000000002 110.339 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.546 ' CE1' ' HA ' ' B' ' 13' ' ' ALA . 93.3 t80 -179.33 107.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 72.120000000000005 110.314 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 126.36 44.62 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.922 . . . . 72.540000000000006 110.054 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.514 ' CG ' ' O ' ' A' ' 81' ' ' GLN . 1.3 pp0? -135.01 106.9 7.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.224 -0.922 . . . . 65.409999999999997 110.323 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.452 ' HB2' ' OE2' ' A' ' 84' ' ' GLU . 3.4 pt20 -161.47 138.45 8.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.334 -0.854 . . . . 62.409999999999997 110.286 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.486 ' HG2' ' ND1' ' A' ' 5' ' ' HIS . 0.1 OUTLIER -104.19 122.42 45.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 73.430000000000007 110.12 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HG3' ' HG2' ' A' ' 85' ' ' GLN . 8.5 pt-20 177.67 -44.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.332 -0.855 . . . . 74.209999999999994 110.21 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' HG2' ' HG3' ' A' ' 84' ' ' GLU . 19.9 pt20 -129.3 175.45 8.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.202 -0.936 . . . . 74.319999999999993 110.239 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -54.64 139.31 39.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.512 -1.435 . . . . 64.019999999999996 109.512 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -132.28 -37.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.247 -1.149 . . . . 75.530000000000001 110.256 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -107.01 157.05 18.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 75.239999999999995 110.178 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.7 p -138.12 83.49 22.44 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.337 -0.852 . . . . 62.43 110.23 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.674 0 O-C-N 123.944 1.497 . . . . 74.030000000000001 110.37 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.436 ' O ' ' CB ' ' B' ' 2' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.286 0.565 . . . . 72.129999999999995 110.13 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' B' ' 1' ' ' MET . 0.0 OUTLIER 65.23 42.26 4.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.184 -0.947 . . . . 73.299999999999997 110.242 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.531 ' HG ' ' CB ' ' B' ' 7' ' ' SER . 0.3 OUTLIER -119.17 177.97 4.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.912 . . . . 73.230000000000004 110.2 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.82 -71.1 0.73 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 41.229999999999997 110.238 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.83 -42.16 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 75.329999999999998 110.181 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' B' ' 6' ' ' ARG . 0.0 OUTLIER -49.63 -21.74 1.11 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.855 . . . . 73.439999999999998 110.243 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' SER . . . . . 0.531 ' CB ' ' HG ' ' B' ' 3' ' ' LEU . 0.7 OUTLIER -79.31 -42.37 25.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.926 . . . . 53.109999999999999 109.833 179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PHE . . . . . 0.45 ' C ' ' CD1' ' B' ' 8' ' ' PHE . 1.6 t80 -73.65 -39.15 64.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.365 -0.834 . . . . 75.140000000000001 109.923 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 7.4 ttp -67.15 -50.69 60.32 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 63.240000000000002 110.162 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.812 ' O ' HG22 ' B' ' 14' ' ' VAL . 0.1 OUTLIER -56.82 -33.32 66.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 63.310000000000002 110.099 179.856 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.91 -45.81 91.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 41.25 110.037 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ASN . . . . . 0.476 ' O ' ' HB3' ' B' ' 15' ' ' ALA . 0.1 OUTLIER -82.81 -41.0 19.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.311 -0.868 . . . . 65.129999999999995 110.228 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . 0.546 ' HA ' ' CE1' ' A' ' 79' ' ' TYR . . . -53.96 -47.64 71.13 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.288 -0.883 . . . . 70.450000000000003 110.235 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . 0.812 HG22 ' O ' ' B' ' 10' ' ' LYS . 21.5 m -59.63 -29.49 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.344 -0.848 . . . . 52.219999999999999 110.103 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.923 ' HA ' HG22 ' B' ' 28' ' ' VAL . . . -64.44 -32.98 74.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.211 -0.931 . . . . 71.409999999999997 110.099 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ALA . . . . . 0.558 ' O ' ' HB3' ' B' ' 20' ' ' ALA . . . -96.76 -13.95 22.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.183 -0.948 . . . . 75.430000000000007 110.125 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.595 ' O ' ' HB3' ' B' ' 21' ' ' ALA . . . -99.71 -23.66 14.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.36 -0.837 . . . . 60.0 110.152 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . 0.401 ' HA ' ' N ' ' B' ' 23' ' ' LEU . . . -86.18 -53.22 5.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 53.299999999999997 110.115 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.21 -10.44 59.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.171 -0.956 . . . . 64.540000000000006 110.173 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.558 ' HB3' ' O ' ' B' ' 16' ' ' ALA . . . -107.7 -52.92 2.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.872 . . . . 54.409999999999997 110.152 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' B' ' 17' ' ' ALA . . . -94.24 15.86 16.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.211 -0.931 . . . . 61.5 110.2 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . 56.72 27.24 55.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.494 -1.442 . . . . 64.239999999999995 109.494 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.963 HD22 HD11 ' A' ' 48' ' ' ILE . 0.4 OUTLIER -68.78 -162.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -1.198 . . . . 54.409999999999997 110.277 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' B' ' 26' ' ' PRO . 25.0 m -73.98 162.15 29.34 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.781 . . . . 74.340000000000003 110.259 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 25' ' ' VAL . 26.9 m -111.3 73.33 0.98 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.194 -0.941 . . . . 63.450000000000003 110.259 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' B' ' 14' ' ' VAL . 45.8 Cg_endo -73.0 -89.76 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.952 1.501 . . . . 61.450000000000003 110.474 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.75 29.08 8.93 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.502 -1.439 . . . . 63.520000000000003 109.502 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.923 HG22 ' HA ' ' B' ' 15' ' ' ALA . 69.0 t -90.97 -21.75 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -1.127 . . . . 75.439999999999998 110.285 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.06 18.78 15.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 71.099999999999994 110.289 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' B' ' 30' ' ' ARG . 0.3 OUTLIER -124.28 -13.21 7.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 74.519999999999996 110.485 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.519 ' C ' HG12 ' B' ' 32' ' ' VAL . . . -91.88 63.97 4.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 72.420000000000002 110.012 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.741 HG22 HG23 ' B' ' 33' ' ' VAL . 1.5 p 170.66 -27.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.535 -0.728 . . . . 72.329999999999998 109.54 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . 0.741 HG23 HG22 ' B' ' 32' ' ' VAL . 29.8 t -143.03 171.35 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.39 -0.819 . . . . 73.299999999999997 110.063 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . 0.572 ' N ' HG12 ' B' ' 33' ' ' VAL . . . 160.84 -30.91 0.35 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.519 -1.433 . . . . 71.430000000000007 109.519 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.163 -1.198 . . . . 74.409999999999997 110.228 -179.983 . . . . . . . . 0 0 . 1 stop_ save_